Crystal structure of human JAK3 kinase domain complex and binding pockets thereof

ABSTRACT

The present invention relates to human Janus Kinase 3 (JAK3) and JAK3-like binding pockets. The present invention provides a computer comprising a data storage medium encoded with the structure coordinates of such binding pockets. This invention also relates to methods of using the structure coordinates to solve the structure of homologous proteins or protein complexes. In addition, this invention relates to methods of using the structure coordinates to screen for and design compounds, including inhibitory compounds, that bind to JAK3 protein or JAK3 protein homologues, or complexes thereof. The invention also relates to crystallizable compositions and crystals comprising JAK3 kinase domain and JAK3 kinase domain complexes with AMP-PNP.

This application is a divisional of U.S. application Ser. No. 12/471,896, filed May 26, 2009, now U.S. Pat. No. 8,192,972; which is a divisional of U.S. application Ser. No. 11/114,979, filed Apr. 26, 2005, now U.S. Pat. No. 7,558,717; which claims priority from Provisional Application No. 60/669,771, filed Apr. 8, 2005 and Provisional Application No. 60/566,393, filed Apr. 28, 2004. Each of these prior applications is incorporated herein by reference.

TECHNICAL FIELD OF INVENTION

The present invention relates to human Janus Kinase 3 (JAK3) and JAK3-like binding pockets. The present invention provides a computer comprising a data storage medium encoded with the structure coordinates of such binding pockets. This invention also relates to methods of using the structure coordinates to solve the structure of homologous proteins or protein complexes. In addition, this invention relates to methods of using the structure coordinates to screen for and design compounds, including inhibitory compounds, that bind to JAK3 protein or JAK3 protein homologues, or complexes thereof. The invention also relates to crystallizable compositions and crystals comprising JAK3 kinase domain and JAK3 kinase domain complexes with AMP-PNP.

BACKGROUND OF THE INVENTION

Janus kinases (JAKs) are non-receptor tyrosine kinases that play an essential role in cytokine signaling (Darnell et al., Science 264: 1415-1421 (1994); Ihle, Adv. Immunol. 60: 1-35 (1995)). The JAK family consists of four evolutionary-conserved mammalian JAK proteins JAK1, JAK2, JAK3 and TYK2, which are each approximately 120 kDa in molecular mass, and homologues in other vertebrates such as chicken, and zebrafish and drosophila. These kinases appear to be responsible for the transmission of signal by most cytokines and neurokines (Rane and Reddy, Oncogene 19: 5662-5679 (2000)). Accumulated evidence suggests that binding of cytokines to their receptors induces receptor oligomerization, which results in an increased affinity of the cytoplasmic domain of the receptor for the JAK kinases. As a consequence of this increased affinity, the JAK kinases are recruited to the receptors resulting in their phosphorylation and subsequent activation. The activated JAKs then phosphorylate the cytoplasmic tails of the receptors on target tyrosines residues, which in turn serve as the docking sites for the Src-homology-2 (SH2) domains of signal transducer and activation of transcription (STAT) proteins. The recruited STATs are phosphorylated by JAKs on specific tryosine residues, which causes their release from the receptor and finally dimerization through a reciprocal phosphotyrosine-SH2 domain interaction (Chen et al., Cell 93:827-839 (1998); Becker et al., Nature 394: 145-151 (1998)). The dimerized STAT proteins then translocate to the nucleus where they act as transcription factors.

A unique feature of the domain-structure of JAKs that distinguishes them from other tyrosine kinases, a C-terminal catalytic domain and an immediately preceded pseudokinase domain (Ihle, supra). The pseudokinase domain lacks canonical residues that are essential for catalytic function. Several lines of evidence suggest that this domain regulates catalytic activity and autophosphorylation (Saharinen et al., Mol. Biol. Cell 14: 1448-1459 (2003); Saharinen et al., Mol. Cell. Biol. 20: 3387-3395 (2000); Saharinen et al., J. Biol. Chem. 277: 47954-47963 (2002); Chen et al., Mol. Cell. Biol. 20: 947-956 (2000)).

In addition to the two kinase domains, JAKs contain an N-terminal band four-point-one, erzin, radixin, moesin (FERM) homology domain and an SH2-like domain (Girault et al., Trends Biochem. Sci. 24: 54-57 (1999)). The FERM domain is a 300-amino acid protein-protein interaction module that mediates receptor interactions and is important for the preservation of proper catalytic function (Terawaki et al., Acta Crystallog. D59: 177-179 (2003); Smith et al., J. Biol. Chem. 278: 4949-4956 (2003); Hamada et al., EMBO J. 19: 4449-4462 (2000); Hamada et al., EMBO J. 22: 502-514 (2003); Pearson et al., Cell 101: 259-270 (2000); Zhou et al., Mol. Cell. 8: 959-969 (2001)).

The activity of JAKs is also regulated by the two tyrosines in the activation loop of the catalytic domain (Gauzzi et al., J. Biol. Chem. 271: 20494-20500 (1996); Feng et al., Mol. Cell. Biol. 17: 2497-2501 (1997); Zhou et al., Proc. Natl. Acad. Sci. USA 94: 13850-13855 (1997)). In JAK3, phosphorylation of Tyr980 and Tyr981 results in positive and negative regulation of its enzymatic activity, respective (Zhou, supra).

JAK3 is predominantly expressed in lymphoid and myeloid cell lines and in hematopoietic tissues such as the thymus, bone marrow, spleen, and fetal liver (Rane and Reddy, Oncogene 21:3334-3358 (2002)). In contrast, other JAKs are ubiquitously expressed. JAK3 specifically associates with the common γ chain (γc) of the cytokine receptors for interleukin-2 (IL-2), IL-4, IL-7, IL-9, IL-15 and IL-21 (Kisseleva et al., Gene 285:1-24 (2002); O'Shea et al., Cell 109 Suppl; S121-131 (2002)). In humans, mutations in JAK3 or γc result in sever combined immunodeficiency (SCID), which is characterized by the absence of circulating mature T cells and natural killer cells, but not B cells (TB⁺SCID) (Notarangelo et al., Hum. Mutat. 18: 255-263 (2001); Roberts et al., Blood 103:2009-2018 (2004); Epub in November 2003). JAK3−/− mice also exhibit severe immunodeficiency (Thomis et al., Science 270: 794-797 (1995)).

Therapeutic targeting of JAK3 kinase has received particular attention, because the effects owing to the complete absence of JAK3 are limited to the immune system. Several JAK3 inhibitors, such as JANEX-1, AG-490, WHI-P154 and PNU156804 have been reported (Sudbeck et al., Clin. Cancer Res. 5: 1569-1582 (1999); Cetkovic-Cvrlje et al. Arzeneimittolforschung 53: 648-654 (2003); Cetkovic-Cvrlje et al., Clin. Immunol. 106: 213-225 (2003); Saemann et al., Transplantation 75: 1864-1874 (2003); Stepkowski et al., Blood 99: 680-689 (2002)). More recently, Pfizer imported an orally active JAK3 selective inhibitor, CP-690,550 as an immunosuppressive agent in mouse and monkey transplant models (Changelian et al., Science 302: 875-878 (2003)). Collectively these data suggest that JAK3 is an attractive pharmacologic target for the treatment of immune-mediated transplant rejection Kirken, Transplant Proc. 33: 3268-3270 (2001)).

Despite its importance in SCID and as a clinical target for immunosuppression, very little is known about the three-dimensional structure of JAK3. Drug design for human therapy has been hampered because the structure of JAK3 was not previously known. Without structural information of JAK3, the detailed knowledge of the mechanism is limited and progress of designing drugs as specific inhibitors is impeded. Structural information on the unique features of the active site of human JAK3 would facilitate drug discovery.

SUMMARY OF THE INVENTION

The present invention solves the problems identified above by providing for the first time the crystal structure of JAK3-AMP-PNP complex. This crystal structure of human JAK3 kinase domain in complex with AMP-PNP bound to its ATP-binding site provides important structural information for the development of novel JAK3 selective inhibitors.

The present invention also provides molecules comprising JAK3 binding pockets, or JAK3-like binding pockets that have similar three-dimensional shapes. In one embodiment, the molecules are JAK3 kinase domain complexes. In another embodiment, the molecules are JAK3 kinase domain homologues, or complexes thereof. In another embodiment, the molecules are in crystalline form.

The invention provides crystallizable compositions and crystals comprising JAK3 kinase domain, complexes thereof, or homologues thereof.

The invention provides a computer comprising a machine-readable storage medium, comprising a data storage material encoded with machine-readable data, wherein the data defines the JAK3 or JAK3-like binding pocket or domain according to the structure coordinates of Table 2. Such storage medium when read and utilized by a computer programmed with appropriate software can display, on a computer screen or similar viewing device, a three-dimensional graphical representation of such binding pockets. In one embodiment, the structure coordinates of said binding pocket or domain are produced by homology modeling of at least portion of the coordinates of Table 2.

The invention also provides method for designing, selecting, evaluating and identifying and/or optimizing compounds which bind to the molecules or molecular complexes or their binding pockets. Such compounds are potential inhibitors of JAK3, JAK3-like proteins or its homologues.

The invention also provides a method for determining at least a portion of the three-dimensional structure of molecules or molecular complexes which contain at least some structurally similar features to JAK3, particular JAK3 homologues. This is achieved by using at least some of the structure coordinates obtained from the JAK3 kinase domain.

The present invention provides a crystal comprising a human Janus Kinase 3 kinase domain.

The present invention provides a crystal comprising a Janus Kinase 3 kinase domain homologue.

The present invention provides a crystal comprising a human Janus Kinase 3 kinase domain complex.

The present invention provides a crystal comprising a Janus Kinase 3 kinase domain homologue complex.

The present invention also provides a crystal comprising a human Janus Kinase 3 kinase domain complex, wherein said human Janus Kinase 3 kinase domain complex comprises human Janus Kinase 3 kinase domain and a chemical entity selected from the group consisting of adenosine, ATP, an ATP analogue, AMP-PNP, a nucleotide triphosphate, a nucleotide diphosphate, phosphate and active site inhibitor.

The present invention also provides a crystal comprising a human Janus Kinase 3 kinase domain complex, wherein said human Janus Kinase 3 kinase domain complex comprises human Janus Kinase 3 kinase domain and AMP-PNP.

The present invention also provides a crystal comprising a human Janus Kinase 3 kinase domain; a crystal comprising a human Janus Kinase 3 kinase domain complex; a crystal comprising a human Janus Kinase 3 kinase domain complex, wherein said human Janus Kinase 3 kinase domain complex comprises human Janus Kinase 3 kinase domain and a chemical entity selected from the group consisting of adenosine, ATP, an ATP analogue, AMP-PNP, a nucleotide triphosphate, a nucleotide diphosphate, phosphate and active site inhibitor; and a human Janus Kinase 3 kinase domain complex, wherein said human Janus Kinase 3 kinase domain complex comprises human Janus Kinase 3 kinase domain and AMP-PNP; wherein said human Janus Kinase 3 kinase domain is selected from the group consisting of amino acid residues 810-1100 of SEQ ID NO:1, amino acid residues 810-1104 of SEQ ID NO:1, amino acid residues 810-1115 of SEQ ID NO:1, amino acid residues 810-1124 of SEQ ID NO:1, and amino acid residues 813-1100 of SEQ ID NO:1.

The present invention also provides crystal comprising a human Janus Kinase 3 kinase domain; a human Janus Kinase 3 kinase domain complex; a human Janus Kinase 3 kinase domain complex, wherein said human Janus Kinase 3 kinase domain complex comprises human Janus Kinase 3 kinase domain and a chemical entity selected from the group consisting of adenosine, ATP, an ATP analogue, AMP-PNP, a nucleotide triphosphate, a nucleotide diphosphate, phosphate and active site inhibitor; and a crystal comprising a human Janus Kinase 3 kinase domain complex, wherein said human Janus Kinase 3 kinase domain complex comprises human Janus Kinase 3 kinase domain and AMP-PNP; wherein said human Janus Kinase 3 kinase domain is amino acid residues 810-1115 of SEQ ID NO:1.

The present invention provides a crystallizable composition comprising a human Janus Kinase 3 kinase domain.

The present invention provides a crystallizable composition comprising a Janus Kinase 3 kinase domain homologue.

The present invention provides a crystallizable composition comprising a human Janus Kinase 3 kinase domain complex.

The present invention provides a crystallizable composition comprising a Janus Kinase 3 kinase domain homologue complex.

The present invention also provides a crystallizable composition comprising a human Janus Kinase 3 kinase domain complex, wherein said human Janus Kinase 3 kinase domain complex comprises human Janus Kinase 3 kinase domain and a chemical entity selected from the group consisting of adenosine, ATP, an ATP analogue, AMP-PNP, a nucleotide triphosphate, a nucleotide diphosphate, phosphate and active site inhibitor.

The present invention also provides a crystallizable composition comprising a human Janus Kinase 3 kinase domain complex, wherein said human Janus Kinase 3 kinase domain complex comprises human Janus Kinase 3 kinase domain and AMP-PNP.

The present invention also provides a crystallizable composition comprising a human Janus Kinase 3 kinase domain; a crystallizable composition comprising a human Janus Kinase 3 kinase domain complex; a crystallizable composition comprising a human Janus Kinase 3 kinase domain complex, wherein said human Janus Kinase 3 kinase domain complex comprises human Janus Kinase 3 kinase domain and a chemical entity selected from the group consisting of adenosine, ATP, an ATP analogue, AMP-PNP, a nucleotide triphosphate, a nucleotide diphosphate, phosphate and active site inhibitor; and a crystallizable composition comprising a human Janus Kinase 3 kinase domain complex, wherein said human Janus Kinase 3 kinase domain complex comprises human Janus Kinase 3 kinase domain and AMP-PNP, wherein said human Janus Kinase 3 kinase domain is selected from the group consisting of amino acid residues 810-1100 of SEQ ID NO:1, amino acid residues 813-1104 of SEQ ID NO:1, amino acid residues 810-1115 of SEQ ID NO:1, amino acid residues 810-1124 of SEQ ID NO:1, and amino acid residues 813-1100 of SEQ ID NO:1.

The present invention also provides a crystallizable composition comprising a human Janus Kinase 3 kinase domain; a crystallizable composition comprising a human Janus Kinase 3 kinase domain complex; a crystallizable composition comprising a human Janus Kinase 3 kinase domain complex, wherein said human Janus Kinase 3 kinase domain complex comprises human Janus Kinase 3 kinase domain and a chemical entity selected from the group consisting of adenosine, ATP, an ATP analogue, AMP-PNP, a nucleotide triphosphate, a nucleotide diphosphate, phosphate and active site inhibitor; and a crystallizable composition comprising a human Janus Kinase 3 kinase domain complex, wherein said human Janus Kinase 3 kinase domain complex comprises human Janus Kinase 3 kinase domain and AMP-PNP, wherein said human Janus Kinase 3 kinase domain is amino acid residues 810-1115 of SEQ ID NO:1.

The present invention provides a computer comprising:

-   -   (a) a machine-readable data storage medium, comprising a data         storage material encoded with machine-readable data, wherein         said data defines a binding pocket or domain selected from the         group consisting of:         -   (i) a set of amino acid residues that are identical to human             Janus Kinase 3 amino acid residues Gln827, Leu828, Gly829,             Lys830, Gly831, Asn 832, Phe833, Gly834, Ser835, Val836,             Glu837, Leu838, Val852, Ala853, Val854, Lys855, Gln856,             Leu857, Val884, Lys885, Tyr886, Leu900, Val901, Met902,             Glu903, Tyr904, Leu905, Pro906, Ser907, Gly908, Cys909,             Leu910, Arg911, Asp912, His947, Asp949, Leu950, Ala951,             Ala952, Arg953, Asn954, Ile955, Leu956, Val957, Ala966,             Asp967, Leu970, Lys978, Glu985, Gln988, Ser989, Pro990 and             Trp 993 according to Table 2, wherein the root mean square             deviation of the backbone atoms between said set of amino             acid residues and said human Janus Kinase 3 amino acid             residues is not greater than about 2.5 Å; and         -   (ii) a set of amino acid residues that are identical to             human Janus Kinase 3 amino acid residues according to Table             2, wherein the root mean square deviation between said set             of amino acid residues and said human Janus Kinase 3 amino             acid residues is not more than about 3.0 Å;     -   (b) a working memory for storing instructions for processing         said machine-readable data;     -   (c) a central processing unit coupled to said working memory and         to said machine-readable data storage medium for processing said         machine-readable data and a means for generating         three-dimensional structural information of said binding pocket         or domain; and     -   (d) output hardware coupled to said central processing unit for         outputting three-dimensional structural information of said         binding pocket or domain, or information produced using said         three-dimensional structural information of said binding pocket         or domain.

The present invention also provides a computer comprising:

-   -   (a) a machine-readable data storage medium, comprising a data         storage material encoded with machine-readable data, wherein         said data defines a binding pocket or domain selected from the         group consisting of:         -   (i) a set of amino acid residues that are identical to human             Janus Kinase 3 amino acid residues Gln827, Leu828, Gly829,             Lys830, Gly831, Asn 832, Phe833, Gly834, Ser835, Val836,             Glu837, Leu838, Val852, Ala853, Val854, Lys855, Gln856,             Leu857, Val884, Lys885, Tyr886, Leu900, Val901, Met902,             Glu903, Tyr904, Leu905, Pro906, Ser907, Gly908, Cys909,             Leu910, Arg911, Asp912, His947, Asp949, Leu950, Ala951,             Ala952, Arg953, Asn954, Ile955, Leu956, Val957, Ala966,             Asp967, Leu970, Lys978, Glu985, Gln988, Ser989, Pro990 and             Trp 993 according to Table 2, wherein the root mean square             deviation of the backbone atoms between said set of amino             acid residues and said human Janus Kinase 3 amino acid             residues is not greater than about 2.5 Å; and         -   (ii) a set of amino acid residues that are identical to             human Janus Kinase 3 amino acid residues according to Table             2, wherein the root mean square deviation between said set             of amino acid residues and said human Janus Kinase 3 amino             acid residues is not more than about 3.0 Å;     -   (b) a working memory for storing instructions for processing         said machine-readable data;     -   (c) a central processing unit coupled to said working memory and         to said machine-readable data storage medium for processing said         machine-readable data and a means for generating         three-dimensional structural information of said binding pocket         or domain; and     -   (d) output hardware coupled to said central processing unit for         outputting three-dimensional structural information of said         binding pocket or domain, or information produced using said         three-dimensional structural information of said binding pocket         or domain,     -   wherein the binding pocket is produced by homology modeling of         the structure coordinates of said Janus Kinase 3 amino acid         residues according to Table 2.

The present invention also provides a computer comprising:

-   -   (a) a machine-readable data storage medium, comprising a data         storage material encoded with machine-readable data, wherein         said data defines a binding pocket or domain selected from the         group consisting of:         -   (i) a set of amino acid residues that are identical to human             Janus Kinase 3 amino acid residues Gln827, Leu828, Gly829,             Lys830, Gly831, Asn 832, Phe833, Gly834, Ser835, Val836,             Glu837, Leu838, Val852, Ala853, Val854, Lys855, Gln856,             Leu857, Val884, Lys885, Tyr886, Leu900, Val901, Met902,             Glu903, Tyr904, Leu905, Pro906, Ser907, Gly908, Cys909,             Leu910, Arg911, Asp912, His947, Asp949, Leu950, Ala951,             Ala952, Arg953, Asn954, Ile955, Leu956, Val957, Ala966,             Asp967, Leu970, Lys978, Glu985, Gln988, Ser989, Pro990 and             Trp 993 according to Table 2, wherein the root mean square             deviation of the backbone atoms between said set of amino             acid residues and said human Janus Kinase 3 amino acid             residues is not greater than about 2.5 Å; and         -   (ii) a set of amino acid residues that are identical to             human Janus Kinase 3 amino acid residues according to Table             2, wherein the root mean square deviation between said set             of amino acid residues and said human Janus Kinase 3 amino             acid residues is not more than about 3.0 Å;     -   (b) a working memory for storing instructions for processing         said machine-readable data;     -   (c) a central processing unit coupled to said working memory and         to said machine-readable data storage medium for processing said         machine-readable data and a means for generating         three-dimensional structural information of said binding pocket         or domain; and     -   (d) output hardware coupled to said central processing unit for         outputting three-dimensional structural information of said         binding pocket or domain, or information produced using said         three-dimensional structural information of said binding pocket         or domain,

wherein said means for generating three-dimensional structural information is provided by means for generating a three-dimensional graphical representation of said binding pocket or domain.

The present invention also provides a computer comprising:

-   -   (a) a machine-readable data storage medium, comprising a data         storage material encoded with machine-readable data, wherein         said data defines a binding pocket or domain selected from the         group consisting of:         -   (i) a set of amino acid residues that are identical to human             Janus Kinase 3 amino acid residues Gln827, Leu828, Gly829,             Lys830, Gly831, Asn 832, Phe833, Gly834, Ser835, Val836,             Glu837, Leu838, Val852, Ala853, Val854, Lys855, Gln856,             Leu857, Val884, Lys885, Tyr886, Leu900, Val901, Met902,             Glu903, Tyr904, Leu905, Pro906, Ser907, Gly908, Cys909,             Leu910, Arg911, Asp912, His947, Asp949, Leu950, Ala951,             Ala952, Arg953, Asn954, Ile955, Leu956, Val957, Ala966,             Asp967, Leu970, Lys978, Glu985, Gln988, Ser989, Pro990 and             Trp 993 according to Table 2, wherein the root mean square             deviation of the backbone atoms between said set of amino             acid residues and said human Janus Kinase 3 amino acid             residues is not greater than about 2.5 Å; and         -   (ii) a set of amino acid residues that are identical to             human Janus Kinase 3 amino acid residues according to Table             2, wherein the root mean square deviation between said set             of amino acid residues and said human Janus Kinase 3 amino             acid residues is not more than about 3.0 Å;     -   (b) a working memory for storing instructions for processing         said machine-readable data;     -   (c) a central processing unit coupled to said working memory and         to said machine-readable data storage medium for processing said         machine-readable data and a means for generating         three-dimensional structural information of said binding pocket         or domain; and     -   (d) output hardware coupled to said central processing unit for         outputting three-dimensional structural information of said         binding pocket or domain, or information produced using said         three-dimensional structural information of said binding pocket         or domain,

wherein said output hardware is a display terminal, a printer, CD or DVD recorder, ZIP™ or JAZ™ drive, a disk drive, or other machine-readable data storage device.

The present invention provides a method of using a computer for selecting an orientation of a chemical entity that interacts favorably with a binding pocket or domain selected from the group consisting of;

-   -   -   (i) a set of amino acid residues that are identical to human             Janus Kinase 3 amino acid residues Gln827, Leu828, Gly829,             Lys830, Gly831, Asn 832, Phe833, Gly834, Ser835, Val836,             Glu837, Leu838, Val852, Ala853, Val854, Lys855, Gln856,             Leu857, Val884, Lys885, Tyr886, Leu900, Val901, Met902,             Glu903, Tyr904, Leu905, Pro906, Ser907, Gly908, Cys909,             Leu910, Arg911, Asp912, His947, Asp949, Leu950, Ala951,             Ala952, Arg953, Asn954, Ile955, Leu956, Val957, Ala966,             Asp967, Leu970, Lys978, Glu985, Gln988, Ser989, Pro990 and             Trp 993 according to Table 2, wherein the root mean square             deviation of the backbone atoms between said set of amino             acid residues and said human Janus Kinase 3 amino acid             residues is not greater than about 2.5 Å; and         -   (ii) a set of amino acid residues that are identical to             human Janus Kinase 3 amino acid residues according to Table             2, wherein the root mean square deviation between said set             of amino acid residues and said human Janus Kinase 3 amino             acid residues is not more than about 3.0 Å;

said method comprising the steps of:

-   -   (a) providing the structure coordinates of said binding pocket         or domain thereof on a computer comprising the means for         generating three-dimensional structural information from said         structure coordinates;     -   (b) employing computational means to dock a first chemical         entity in the binding pocket or domain;     -   (c) quantifying the association between said chemical entity and         all or part of the binding pocket or domain for different         orientation of the chemical entity; and     -   (d) selecting the orientation of the chemical entity with the         most favorable interaction based on said quantified association.

The present invention also provides a method of using a computer for selecting an orientation of a chemical entity that interacts favorably with a binding pocket or domain selected from the group consisting of:

-   -   -   (i) a set of amino acid residues that are identical to human             Janus Kinase 3 amino acid residues Gln827, Leu828, Gly829,             Lys830, Gly831, Asn 832, Phe833, Gly834, Ser835, Val836,             Glu837, Leu838, Val852, Ala853, Val854, Lys855, Gln856,             Leu857, Val884, Lys885, Tyr886, Leu900, Val901, Met902,             Glu903, Tyr904, Leu905, Pro906, Ser907, Gly908, Cys909,             Leu910, Arg911, Asp912, His947, Asp949, Leu950, Ala951,             Ala952, Arg953, Asn954, Ile955, Leu956, Val957, Ala966,             Asp967, Leu970, Lys978, Glu985, Gln988, Ser989, Pro990 and             Trp 993 according to Table 2, wherein the root mean square             deviation of the backbone atoms between said set of amino             acid residues and said human Janus Kinase 3 amino acid             residues is not greater than about 2.5 Å; and         -   (ii) a set of amino acid residues that are identical to             human Janus Kinase 3 amino acid residues according to Table             2, wherein the root mean square deviation between said set             of amino acid residues and said human Janus Kinase 3 amino             acid residues is not more than about 3.0 Å;

    -   said method comprising the steps of:

    -   (a) providing the structure coordinates of said binding pocket         or domain thereof on a computer comprising the means for         generating three-dimensional structural information from said         structure coordinates;

    -   (b) employing computational means to dock a first chemical         entity in the binding pocket or domain;

    -   (c) quantifying the association between said chemical entity and         all or part of the binding pocket or domain for different         orientations of the chemical entity; and

    -   (d) selecting the orientation of the chemical entity with the         most favorable interaction based on said quantified association,

    -   further comprising generating a three-dimensional graphical         representation of the binding pocket or domain prior to step         (b).

The present invention also provides a method of using a computer for selecting an orientation of a chemical entity that interacts favorably with a binding pocket or domain selected from the group consisting of:

-   -   -   (i) a set of amino acid residues that are identical to human             Janus Kinase 3 amino acid residues Gln827, Leu828, Gly829,             Lys830, Gly831, Asn 832, Phe833, Gly834, Ser835, Val836,             Glu837, Leu838, Val852, Ala853, Val854, Lys855, Gln856,             Leu857, Val884, Lys885, Tyr886, Leu900, Val901, Met902,             Glu903, Tyr904, Leu905, Pro906, Ser907, Gly908, Cys909,             Leu910, Arg911, Asp912, His947, Asp949, Leu950, Ala951,             Ala952, Arg953, Asn954, Ile955, Leu956, Val957, Ala966,             Asp967, Leu970, Lys978, Glu985, Gln988, Ser989, Pro990 and             Trp 993 according to Table 2, wherein the root mean square             deviation of the backbone atoms between said set of amino             acid residues and said human Janus Kinase 3 amino acid             residues is not greater than about 2.5 Å; and         -   (ii) a set of amino acid residues that are identical to             human Janus Kinase 3 amino acid residues according to Table             2, wherein the root mean square deviation between said set             of amino acid residues and said human Janus Kinase 3 amino             acid residues is not more than about 3.0 Å;

    -   said method comprising the steps of:

    -   (a) providing the structure coordinates of said binding pocket         or domain thereof on a computer comprising the means for         generating three-dimensional structural information from said         structure coordinates;

    -   (b) employing computational means to dock a first chemical         entity in the binding pocket or domain;

    -   (c) quantifying the association between said chemical entity and         all or part of the binding pocket or domain for different         orientations of the chemical entity; and

    -   (d) selecting the orientation of the chemical entity with the         most favorable interaction based on said quantified association,

    -   wherein energy minimization, molecular dynamics simulations, or         rigid-body minimizations are performed simultaneously with or         following step (b).

The present invention also provides a method of using a computer for selecting an orientation of a chemical entity that interacts favorably with a binding pocket or domain selected from the group consisting of:

-   -   -   (i) a set of amino acid residues that are identical to human             Janus Kinase 3 amino acid residues Gln827, Leu828, Gly829,             Lys830, Gly831, Asn 832, Phe833, Gly834, Ser835, Val836,             Glu837, Leu838, Val852, Ala853, Val854, Lys855, Gln856,             Leu857, Val884, Lys885, Tyr886, Leu900, Val901, Met902,             Glu903, Tyr904, Leu905, Pro906, Ser907, Gly908, Cys909,             Leu910, Arg911, Asp912, His947, Asp949, Leu950, Ala951,             Ala952, Arg953, Asn954, Ile955, Leu956, Val957, Ala966,             Asp967, Leu970, Lys978, Glu985, Gln988, Ser989, Pro990 and             Trp 993 according to Table 2, wherein the root mean square             deviation of the backbone atoms between said set of amino             acid residues and said human Janus Kinase 3 amino acid             residues is not greater than about 2.5 Å; and         -   (ii) a set of amino acid residues that are identical to             human Janus Kinase 3 amino acid residues according to Table             2, wherein the root mean square deviation between said set             of amino acid residues and said human Janus Kinase 3 amino             acid residues is not more than about 3.0 Å;

    -   said method comprising the steps of:

    -   (a) providing the structure coordinates of said binding pocket         or domain thereof on a computer comprising the means for         generating three-dimensional structural information from said         structure coordinates;

    -   (b) employing computational means to dock a first chemical         entity in the binding pocket or domain;

    -   (c) quantifying the association between said chemical entity and         all or part of the binding pocket or domain for different         orientations of the chemical entity; and

    -   (d) selecting the orientation of the chemical entity with the         most favorable interaction based on said quantified association,

    -   further comprising the steps of:

    -   (e) repeating steps (b) through (d) with a second chemical         entity; and

    -   (f) selecting at least one of said first or second chemical         entity that interacts more favorably with said binding pocket or         domain based on said quantified association of said first or         second chemical entity.

The present invention provides a method of using a computer for selecting an orientation of a chemical entity with a favorable shape complementarity in a binding pocket consisting of a set of amino acid residues that are identical to human Kinase 3 amino acid residues Gln827, Leu828, Gly829, Lys830, Gly831, Asn 832, Phe833, Gly834, Ser835, Val836, Glu837, Leu838, Val852, Ala853, Val854, Lys855, Gln856, Leu857, Val884, Lys885, Tyr886, Leu900, Val901, Met902, Glu903, Tyr904, Leu905, Pro906, Ser907, Gly908, Cys909, Leu910, Arg911, Asp912, His947, Asp949, Leu950, Ala951, Ala952, Arg953, Asn954, Ile955, Leu956, Val957, Ala966, Asp967, Leu970, Lys978, Glu985, Gln988, Ser989, Pro990 and Trp 993 according to Table 2, wherein the root mean square deviation of the backbone atoms between said set of amino acid residues and said human Janus Kinase 3 amino acid residues is not greater than about 2.5 Å;

said method comprising the steps of:

-   -   (a) providing the structure coordinates of said binding pocket         and all or part of the ligand bound therein on a computer         comprising the means for generating three-dimensional structural         information from said structure coordinates;     -   (b) employing computational means to dock a first chemical         entity in the binding pocket;     -   (c) quantitating the contact score of said chemical entity in         different orientations; and     -   (d) selecting an orientation with the highest contact score.

The present invention also provides a method of using a computer for selecting an orientation of a chemical entity with a favorable shape complementarity in a binding pocket consisting of a set of amino acid residues that are identical to human Janus Kinase 3 amino acid residues Gln827, Leu828, Gly829, Lys830, Gly831, Asn832, Phe833, Gly834, Ser835, Val836, Glu837, Leu838, Val852, Ala853, Val854, Lys855, Gln856, Leu857, Val884, Lys885, Tyr886, Leu900, Val901, Met902, Glu903, Tyr904, Leu905, Pro906, Ser907, Gly908, Cys909, Leu910, Arg911, Asp912, His947, Asp949, Leu950, Ala951, Ala952, Arg953, Asn954, Ile955, Leu956, Val957, Ala966, Asp967, Leu970, Lys978, Glu985, Gln988, Ser989, Pro990 and Trp 993 according to Table 2, wherein the root mean square deviation of the backbone atoms between said set of amino acid residues and said human Janus Kinase 3 amino acid residues is not greater than about 2.5 Å;

said method comprising the steps of:

-   -   (a) providing the structure coordinates of said binding pocket         and all or part of the ligand bound therein on a computer         comprising the means for generating three-dimensional structural         information from said structure coordinates;     -   (b) employing computational means to dock a first chemical         entity in the binding pocket;     -   (c) quantitating the contact score of said chemical entity in         different orientations; and     -   (d) selecting an orientation with the highest contact score,     -   further comprising generating a three-dimensional graphical         representation of the binding pocket and all or part of the         ligand bound therein prior to step (b).

The present invention also provides a method of using a computer for selecting an orientation of a chemical entity with a favorable shape complementarity in a binding pocket consisting of a set of amino acid residues that are identical to human Janus Kinase 3 amino acid residues Gln827, Leu828, Gly829, Lys830, Gly831, Asn 832, Phe833, Gly834, Ser835, Val836, Glu837, Leu838, Val852, Ala853, Val854, Lys855, Gln856, Leu857, Val884, Lys885, Tyr886, Leu900, Val901, Met902, Glu903, Tyr904, Leu905, Pro906, Ser907, Gly908, Cys909, Leu910, Arg911, Asp912, His947, Asp949, Leu950, Ala951, Ala952, Arg953, Asn954, Ile955, Leu956, Val957, Ala966, Asp967, Leu970, Lys978, Glu985, Gln988, Ser989, Pro990 and Trp 993 according to Table 2, wherein the root mean square deviation of the backbone atoms between said set of amino acid residues and said human Janus Kinase 3 amino acid residues is not greater than about 2.5 Å;

said method comprising the steps of:

-   -   (a) providing the structure coordinates of said binding pocket         and all or part of the ligand bound therein on a computer         comprising the means for generating three-dimensional structural         information from said structure coordinates;     -   (b) employing computational means to dock a first chemical         entity in the binding pocket;     -   (c) quantitating the contact score of said chemical entity in         different orientations; and     -   (d) selecting an orientation with the highest contact score,

further comprising the steps of:

-   -   (e) repeating steps (b) through (d) with a second chemical         entity; and     -   (f) selecting at least one of said first or second chemical         entity that has a higher contact score based on said quantitated         contact score of said first or second chemical entity.

The present invention provides a method for identifying a candidate inhibitor of a molecule or molecular complex comprising a binding pocket or domain selected from the group consisting of:

-   -   (i) a set of amino acid residues that are identical to human         Janus Kinase 3 amino acid residues Gln827, Leu828, Gly829,         Lys830, Gly831, Asn 832, Phe833, Gly834, Ser835, Val836, Glu837,         Leu838, Val852, Ala853, Val854, Lys855, Gln856, Leu857, Val884,         Lys885, Tyr886, Leu900, Val901, Met902, Glu903, Tyr904, Leu905,         Pro906, Ser907, Gly908, Cys909, Leu910, Arg911, Asp912, His947,         Asp949, Leu950, Ala951, Ala952, Arg953, Asn954, Ile955, Leu956,         Val957, Ala966, Asp967, Leu970, Lys978, Glu985, Gln988, Ser989,         Pro990 and Trp 993 according to Table 2, wherein the root mean         square deviation of the backbone atoms between said set of amino         acid residues and said human Janus Kinase 3 amino acid residues         is not greater than about 2.5 Å; and     -   (ii) a set of amino acid residues that are identical to human         Janus Kinase 3 amino acid residues according to Table 2, wherein         the root mean square deviation between said set of amino acid         residues and said human Janus Kinase 3 amino acid residues is         not more than about 3.0 Å;

comprising the steps of:

-   -   (a) using a three-dimensional structure of the binding pocket or         domain to design, select or optimize a plurality of chemical         entities;     -   (b) contacting each chemical entity with the molecule or the         molecular complex;     -   (c) monitoring the inhibition to the catalytic activity of the         molecule or molecular complex by each chemical entity; and     -   (d) selecting a chemical entity based on the inhibitory effect         of the chemical entity on the catalytic activity of the molecule         or molecular complex.

The present invention provides a method of designing a compound or complex that interacts with a binding pocket or domain selected from the group consisting of:

-   -   (i) a set of amino acid residues that are identical to human         Janus kinase 3 amino acid residues Gln827, Leu828, Gly829,         Lys830, Gly831, Asn 832, Phe833, Gly834, Ser835, Val836, Glu837,         Leu838, Val852, Ala853, Val854, Lys855, Gln856, Leu857, Val884,         Lys885, Tyr886, Leu900, Val901, Met902, Glu903, Tyr904, Leu905,         Pro906, Ser907, Gly908, Cys909, Leu910, Arg911, Asp912, His947,         Asp949, Leu950, Ala951, Ala952, Arg953, Asn954, Ile955, Leu956,         Val957, Ala966, Asp967, Leu970, Lys978, Glu985, Gln988, Ser989,         Pro990 and Trp 993 according to Table 2, wherein the root mean         square deviation of the backbone atoms between said set of amino         acid residues and said human Janus Kinase 3 amino acid residues         is not greater than about 2.5 Å; and     -   (ii) a set of amino acid residues that are identical to human         Janus Kinase 3 amino acid residues according to Table 2, wherein         the root mean square deviation between said set of amino acid         residues and said human Janus Kinase 3 amino acid residues is         not more than about 3.0 Å;     -   comprising the steps of:     -   (a) providing the structure coordinates of said binding pocket         or domain on a computer comprising the means for generating         three-dimensional structural information from said structure         coordinates;     -   (b) using the computer to dock a first chemical entity in part         of the binding pocket or domain;     -   (c) docking at least a second chemical entity in another part of         the binding pocket or domain;     -   (d) quantifying the association between the first or second         chemical entity and part of the binding pocket or domain;     -   (e) repeating steps (b) to (d) with another first and second         chemical entity, selecting a first and a second chemical entity         based on said quantified association of all of said first and         second chemical entity;     -   (f) optionally, visually inspecting the relationship of the         first and second chemical entity to each other in relation to         the binding pocket or domain on a computer screen using the         three-dimensional graphical representation of the binding pocket         or domain and said first and second chemical entity; and     -   (g) assembling the first and second chemical entity into a         compound or complex that interacts with said binding pocket or         domain by model building.

The present invention provides a method of utilizing molecular replacement to obtain structural information about a molecule or molecular complex of unknown structure, wherein the molecule is sufficiently homologous to human Janus Kinase 3 kinase domain, comprising the steps of:

-   -   (a) crystallizing said molecule or molecular complex;     -   (b) generating an X-ray diffraction pattern from said         crystallized molecule or molecular complex; and     -   (c) applying at least a portion of the structure coordinates set         forth in Table 2 or homology model thereof to the X-ray         diffraction pattern to generate a three-dimensional electron         density map of at least a portion of the molecule or molecular         complex whose structure is unknown; and     -   (d) generating a structural model of the molecule or molecular         complex from the three-dimensional electron density map.

The present invention also provides a method of utilizing molecular replacement to obtain structural information about a molecule or a molecular complex of unknown structure, wherein the molecule is sufficiently homologous to human Janus Kinase 3 kinase domain, comprising the steps of:

-   -   (a) crystallizing said molecule or molecular complex;     -   (b) generating an X-ray diffraction pattern from said         crystallized molecule or molecular complex; and     -   (c) applying at least a portion of the structure coordinates set         forth in Table 2 or homology model thereof to the X-ray         diffraction pattern to generate a three-dimensional electron         density map of at least a portion of the molecule or molecular         complex whose structure is unknown; and     -   (d) generating a structural model of the molecule or molecular         complex from the three-dimensional electron density map,

wherein the molecule is selected from the group consisting of a Janus Kinase 3 protein and a protein comprising a Janus Kinase 3 kinase domain homologue.

The present invention also provides a method of utilizing molecular replacement to obtain structural information about a molecule or a molecular complex of unknown structure, wherein the molecule is sufficiently homologous to human Janus Kinase 3 kinase domain, comprising the steps of:

-   -   (a) crystallizing said molecule or molecular complex;     -   (b) generating an X-ray diffraction pattern from said         crystallized molecule or molecular complex; and     -   (c) applying at least a portion of the structure coordinates set         forth in Table 2 or homology model thereof to the X-ray         diffraction pattern to generate a three-dimensional electron         density map of at least a portion of the molecule or molecular         complex whose structure is unknown; and     -   (d) generating a structural model of the molecule or molecular         complex from the three-dimensional electron density map,

wherein the molecular complex is selected from the group consisting of a Janus Kinase 3 protein complex, a Janus Kinase 3 kinase domain complex, and a Janus Kinase 3 kinase domain homologue complex.

The present invention also provides a method for identifying a candidate inhibitor that interacts with a binding site of a human Janus Kinase 3 kinase protein or a homologue thereof, comprising the steps of:

-   -   (a) obtaining a crystal comprising said human Janus Kinase 3         kinase protein or said homologue thereof, wherein the crystal is         characterized with space group P2₁ and has unit cell parameters         of a=59.98 Å, b=90.19 Å, c=69.00 Å; β=111.5°;     -   (b) obtaining the structure coordinates of amino acids of the         crystal of step (a), wherein the structure coordinates are set         forth in Table 1;     -   (c) generating a three-dimensional model of said human Janus         Kinase 3 kinase protein or said homologue thereof using the         structure coordinates of the amino acids obtained in step (b), a         root mean square deviation from backbone atoms of said amino         acids of not more than ±2.0 Å;     -   (d) determining a binding site of said human Janus Kinase 3         kinase protein or said homologue thereof from said         three-dimensional model; and     -   (e) performing computer fitting analysis to identify the         candidate inhibitor which interacts with said binding site.

The present invention also provides a method for identifying a candidate inhibitor that interacts with a binding site of a human Janus Kinase 3 kinase protein or a homologue thereof, comprising the steps of:

-   -   (a) obtaining a crystal comprising said human Janus Kinase 3         kinase protein or said homologue thereof, wherein the crystal is         characterized with space group P2₁ and has unit cell parameters         of a=59.98 Å, b=90.19 Å, c=69.00 Å; β=111.5°;     -   (b) obtaining the structure coordinates of amino acids of the         crystal of step (a), wherein the structure coordinates are set         forth in Table 1;     -   (c) generating a three-dimensional model of said human Janus         Kinase 3 kinase protein or said homologue thereof using the         structure coordinates of the amino acids obtained in step (b), a         root mean square deviation from backbone atoms of said amino         acids of not more than ±2.0 Å;     -   (d) determining a binding site of said human Janus Kinase 3         kinase protein or said homologue thereof from said         three-dimensional model; and     -   (e) performing computer fitting analysis to identify the         candidate inhibitor which interacts with said binding site,

further comprising the step of:

-   -   (f) contacting the identified candidate inhibitor with said         human Janus Kinase 3 kinase protein or said homologue thereof in         order to determine the effect of the inhibitor on human Janus         Kinase 3 kinase protein activity.

The present invention also provides a method for identifying a candidate inhibitor that interacts with a binding site of a human Janus Kinase 3 kinase protein or a homologue thereof, comprising the steps of:

-   -   (a) obtaining a crystal comprising said human Janus Kinase 3         kinase protein or said homologue thereof, wherein the crystal is         characterized with space group P2₁ and has unit cell parameters         of a=59.98 Å, b=90.19 Å, c=69.00 Å; β=111.5°;     -   (b) obtaining the structure coordinates of amino acids of the         crystal of step (a), wherein the structure coordinates are set         forth in Table 1;     -   (c) generating a three-dimensional model of said human Janus         Kinase 3 kinase protein or said homologue thereof using the         structure coordinates of the amino acids obtained in step (b), a         root mean square deviation from backbone atoms of said amino         acids of not more than ±2.0 Å,     -   (d) determining a binding site of said human Janus Kinase 3         kinase protein or said homologue thereof from said         three-dimensional model; and     -   (e) performing computer fitting analysis to identify the         candidate inhibitor which interacts with said binding site,     -   wherein the binding site said human Janus Kinase 3 kinase         protein or said homologue thereof determined in step (d)         comprises the structure coordinates according to Table 1 of         amino acid residues that are identical to human Janus Kinase 3         amino acid residues Gln827, Leu828, Gly829, Lys830, Gly831, Asn         832, Phe833, Gly834, Ser835, Val836, Glu837, Leu838, Val852,         Ala853, Val854, Lys855, Gln856, Leu857, Val884, Lys885, Tyr886,         Leu900, Val901, Met902, Glu903, Tyr904, Leu905, Pro906, Ser907,         Gly908, Cys909, Leu910, Arg911, Asp912, His947, Asp949, Leu950,         Ala951, Ala952, Arg953, Asn954, Ile955, Leu956, Val957, Ala966,         Asp967, Leu970, Glu985, Glu988, Scr989, Pro990 and Trp 993,         wherein the root mean square deviation from the backbone atoms         of said amino acids is not more than ±2.0 Å.

The present invention also provides a method for identifying a candidate inhibitor that interacts with a binding site of a human Janus Kinase 3 kinase protein or a homologue thereof, comprising the steps of:

-   -   (a) obtaining a crystal comprising said human Janus Kinase 3         kinase protein or said homologue thereof, wherein the crystal is         characterized with space group P2₁ and has unit cell parameters         of a=59.98 Å, b=90.19 Å, c=69.00 Å; β=111.5°;     -   (b) obtaining the structure coordinates of amino acids of the         crystal of step (a);     -   (c) generating a three-dimensional model of said human Janus         Kinase 3 kinase protein or said homologue thereof using the         structure coordinates of the amino acids obtained in step (b), a         root mean square deviation from backbone atoms of said amino         acids of not more than ±2.0 Å;     -   (d) determining a binding site of said human Janus Kinase 3         kinase protein or said homologue thereof from said         three-dimensional model; and     -   (e) performing computer fitting analysis to identify the         candidate inhibitor which interacts with said binding site.

The present invention also provides a method for identifying a candidate inhibitor that interacts with a binding site of a human Janus Kinase 3 kinase protein or a homologue thereof, comprising the steps of:

-   -   (a) obtaining a crystal comprising said human Janus Kinase 3         kinase protein or said homologue thereof, wherein the crystal is         characterized with space group P2₁ and has unit cell parameters         of a=59.98 Å, b=90.19 Å, c=69.00 Å; β=111.5°;     -   (b) obtaining the structure coordinates of amino acids of the         crystal of step (a);     -   (c) generating a three-dimensional model of said human Janus         Kinase 3 kinase protein or said homologue thereof using the         structure coordinates of the amino acids generated in step (b),         a root mean square deviation from backbone atoms of said amino         acids of not more than ±2.0 Å;     -   (d) determining a binding site of said human Janus Kinase 3         kinase protein or said homologue thereof from said         three-dimensional model; and     -   (e) performing computer fitting analysis to identify the         candidate inhibitor which interacts with said binding site,

further comprising the step of:

-   -   (f) contacting the identified candidate inhibitor with said         human Janus Kinase 3 kinase protein or said homologue thereof in         order to determine the effect of the inhibitor on human Janus         Kinase 3 kinase protein activity.

The present invention also provides a method for identifying a candidate inhibitor that interacts with a binding site of a human Janus Kinase 3 kinase protein or a homologue thereof, comprising the steps of:

-   -   (a) obtaining a crystal comprising said human Janus Kinase 3         kinase protein or said homologue thereof, wherein the crystal is         characterized with space group P2₁ and has unit cell parameters         of a=59.98 Å, b=90.19 Å, c=69.00 Å; β=111.5%     -   (b) obtaining the structure coordinates of amino acids of the         crystal of step (a);     -   (c) generating a three-dimensional model of said human Janus         Kinase 3 kinase protein or said homologue thereof using the         structure coordinates of the amino acids generated in step (b),         a root mean square deviation from backbone atoms of said amino         acids of not more than ±2.0 Å;     -   (d) determining a binding site of said human Janus Kinase 3         kinase protein or said homologue thereof from said         three-dimensional model; and     -   (e) performing computer fitting analysis to identify the         candidate inhibitor which interacts with said binding site,

wherein the binding site of said human Janus Kinase 3 kinase protein or said homologue thereof determined in step (d) comprises the structure coordinates according to Table 1 of a set of amino acid residues that are identical to human Janus Kinase 3 amino acid residues Gln827, Leu828, Gly829, Lys830, Gly831, Asn 832, Phe833, Gly834, Ser835, Val836, Glu837, Leu838, Val852, Ala853, Val854, Lys855, Gln856, Leu857, Val884, Lys885, Tyr886, Leu900, Val901, Met902, Glu903, Tyr904, Leu905, Pro906, Ser907, Gly908, Cys909, Leu910, Arg911, Asp912, His947, Asp949, Leu950, Ala951, Ala952, Arg953, Asn954, Ile955, Leu956, Val957, Ala966, Asp967, Leu970, Glu985, Glu988, Ser989, Pro990 and Trp993, wherein the root mean square deviation from the backbone atoms of said amino acids is not more than ±2.0 Å.

The present invention also provides the method for identifying a candidate inhibitor that interacts with a binding site of a human Janus Kinase 3 kinase protein or a homologue thereof, comprising the step of determining a binding site of said human Janus Kinase 3 kinase protein or the homologue thereof from a three-dimensional model to design or identify the candidate inhibitor which interacts with said binding site.

The present invention also provides a method for identifying a candidate inhibitor that interacts with a binding site of a human Janus Kinase 3 kinase protein or a homologue thereof, comprising the step of determining a binding site of said human Janus Kinase 3 kinase protein or the homologue thereof from a three-dimensional model to design or identify the candidate inhibitor which interacts with said binding site,

wherein the binding site of said human Janus Kinase 3 kinase protein or said homologue thereof determined comprises the structure coordinates according to Table 1 of a set of amino acid residues that are identical to human Janus Kinase 3 amino acid residues Gln827, Leu828, Gly829, Lys830, Gly831, Asn 832, Phe833, Gly834, Ser835, Val836, Glu837, Leu838, Val852, Ala853, Val854, Lys855, Gln856, Leu857, Val884, Lys885, Tyr886, Leu900, Val901, Met902, Glu903, Tyr904, Leu905, Pro906, Ser907, Gly908, Cys909, Leu910, Arg911, Asp912, His947, Asp949, Leu950, Ala951, Ala952, Arg953, Asn954, Ile955, Leu956, Val957, Ala966, Asp967, Leu970, Glu985, Glu988, Ser989, Pro990 and Trp 993, wherein the root mean square deviation from the backbone atoms of said amino acids is not more than ±2.0 Å.

The present invention also provides a method for identifying a candidate inhibitor of a molecule or molecular complex comprising a binding pocket or domain selected from the group consisting of:

-   -   (i) a set of amino acid residues which are identical to human         Janus Kinase 3 kinase a set of amino acid resides that are         identical to human Janus Kinase 3 amino acid residues Gln827,         Leu828, Gly829, Lys830, Gly831, Asn 832, Phe833, Gly834, Ser835,         Val836, Glu837, Leu838, Val852, Ala853, Val854, Lys855, Gln856,         Leu857, Val884, Lys885, Tyr886, Leu900, Val901, Met902, Glu903,         Tyr904, Leu905, Pro906, Ser907, Gly908, Cys909, Leu910, Arg911,         Asp912, His947, Asp949, Leu950, Ala951, Ala952, Arg953, Asn954,         Ile955, Leu956, Val957, Ala966, Asp967, Leu970, Lys978, Glu985,         Gln988, Ser989, Pro990 and Trp 993 according to Table 1, wherein         the root mean square deviation of the backbone atoms between         said set of amino acid residues and said human Janus Kinase 3         amino acid residues is not greater than about 2.0 Å; and     -   (ii) a set of amino acid residues that are identical to human         Janus Kinase 3 kinase amino acid residues according to Table 1,         wherein the root mean square deviation between said set of amino         acid residues and said human Janus Kinase 3 kinase amino acid         residues is not more than about 3.0 Å; comprising the steps of:     -   (a) using a three-dimensional structure of the binding pocket or         domain to design, select or optimize a plurality of chemical         entities; and     -   (b) selecting said candidate inhibitor based on the inhibitory         effect of said chemical entities a human Janus Kinase 3 kinase         protein or a human Janus Kinase 3 kinase protein homologue on         the catalytic activity of the molecule or molecular complex.

The present invention also provides a method of using a crystal comprising a human Janus Kinase 3 kinase domain and a crystal comprising a Janus Kinase 3 kinase domain homologue in an inhibitor screening assay comprising:

-   -   (a) selecting a potential inhibitor by performing rational drug         design with a three-dimensional structure determined for the         crystal, wherein said selecting is performed in conjunction with         computer modeling;     -   (b) contacting the potential inhibitor with a kinase; and     -   (c) detecting the ability of the potential inhibitor for         inhibiting the kinase.

BRIEF DESCRIPTION OF THE FIGURES

FIG. 1 depicts a ribbon diagram of the overall fold of the JAK3-AMP-PNP complex. The N-terminal and the C-terminal domains are colored light gray and dark gray, respectively. The N-terminal domain, the C-terminal domain, the glycine-rich loop or P-loop which contains the G-X-G-X-X-G motif (SEQ ID NO: 7) in the N-terminal lobe, the hinge region between the N- and C-terminal domains, and the activation loop or A-loop in the C-terminal domain are labeled. The AMP-PNP is shown in a stick representation, and the magnesium ion is represented by a sphere. The two tyrosines which have been shown to be phosphorylated (Y980 and Y981) are on the A-loop and are shown in sticks representation and labeled.

FIG. 2 depicts the overall structure of the Jak3-AMP-PNP complex. The structure is shown with β-sheets as arrows and the α-helices are cylinders. The N-terminal lobe is shown with the glycine rich loop. The C-terminal lobe is shown with the activation loop. The α-FG helix is labeled. The non-hydrolyzable ATP analogue, AMP-PNP, is shown as ball-and-stick format, in the active site. The sites of phosphorylation located in the activation loop, Tyr980 and Tyr981, are shown. All structural figures were prepared with Pymol (DeLano W. L. (2002), DeLano Scientific, San Carlos, Calif., USA).

FIG. 3 shows a detailed representation of the active site of JAK3 with AMP-PNP depicting some of the hydrogen bonds formed between the AMP-PNP and amino acid sidechains of JAK3 as dashed-lines. The bond between the catalytic amino acid residue K855 and D967 is also shown as a dashed-line.

FIG. 4 shows αF and αG of Jak3 were superimposed on c-Src. The I1 and I3 regions jut out from this area. This is perhaps an area for either intra or inter protein-protein interactions. The proximity of the α-FG region to the activation loop suggests that it may play a role in the activation of Jak3.

FIG. 5 shows the α-FG region is unique to Janus kinases. The sequence between αF and αG is conserved in the janus kinases and unique among the other tyrosine kinases. The aligned sequences of Jak3 (amino acid residues 967-1052 of SEQ ID NO: 1) with a variety of other tyrosine kinases, including Ack (SEQ ID NO: 2); MuSK (SEQ ID NO: 3); Insr (SEQ ID NO: 4); FGFR1 (SEQ ID NO: 5); c-Src (SEQ ID NO: 6). The sequences were aligned using the “Align and Superpose” option in Quanta, and then manually aligned based on the resultant structural superposition. The bold black residue corresponds to the residue in the P+1 loop that is typical an arginine or lysine in all tyrosine kinases except the four mammalian Jaks and the closely related 2 Ack kinases, Ack1 and Tnk1.

FIG. 6 shows interactions between inactivated Jak3 and AMP-PNP in the ATP-binding site. Interactions between Jak3 and AMP-PNP in the ATP-binding site. The protein backbone is depicted as a thin coil. Fo-Fc experimental electron density for the inhibitor is shown in a wire lines, contoured at 2.0σ at 2.5 Å resolution.

FIG. 7 shows the location of SCID mutation L910S. Leucine 910 is located at the beginning of the αD helix and is surrounded by a number of other hydrophobic residues from adjoining parts of the C-lobe. Burying a polar sidechain, serine 910, in this hydrophobic pocket would probably lead to disruption of this region of the protein. The results could be the disruption of ATP, substrate binding, or both, resulting in a nonfunctioning kinase. The sidechains of L910 and the surrounding residues are shown.

FIG. 8 shows a diagram of a system used to carry out the instructions encoded by the storage medium of FIGS. 9 and 10.

FIG. 9 shows a cross section of a magnetic storage medium.

FIG. 10 shows a cross section of a optically-readable data storage medium.

DESCRIPTION OF THE INVENTION

In order that the invention described herein may be more fully understood, the following detailed description is set forth.

Throughout the specification, the word “comprise”, or variations such as “comprises” or “comprising” will be understood to imply the inclusion of a stated integer or groups of integers but not exclusion of any other integer or groups of integers.

The following abbreviations are used throughout the application:

A = Ala = Alanine T = Thr = Threonine V = Val = Valine C = Cys = Cysteine L = Leu = Leucine Y = Tyr = Tyrosine I = Ile = Isoleucine N = Asn = Asparagine P = Pro = Proline Q = Gln = Glutamine F = Phe = Phenylalanine D = Asp = Aspartic Acid W = Trp = Tryptophan E = Glu = Glutamic Acid M = Met = Methionine K = Lys = Lysine G = Gly = Glycine R = Arg = Arginine S = Ser = Serine H = His = Histidine Other abbreviations that are used throughout the application include: ANP (for AMP-PNP).

As used herein, the following definitions shall apply unless otherwise indicated.

The term “about” when used in the context of root mean square deviation (RMSD) values takes into consideration the standard error of the RMSD value, which is ±0.1 Å.

The term “associating with” refers to a condition of proximity between a chemical entity or compound, or portions thereof, and a binding pocket or binding site on a protein. The association may be non-covalent—wherein the juxtaposition is energetically favored by hydrogen bonding, hydrophobic, van der Waals or electrostatic interactions—or it may be covalent.

The term “ATP analogue” refers to a compound derived from adenosine-5′-triphosphate (ATP). The compound can be adenosine, AMP, ADP, or a non-hydrolyzable analogue, such as, but not limited to AMP-PNP. The analogue may be in complex with magnesium or manganese ions.

The term “binding pocket” refers to a region of a molecule or molecular complex, that, as a result of its shape, favorably associates with another chemical entity. The term “pocket” includes, but is not limited to, a cleft, channel or site. JAK3, JAK3-like molecules or homologues thereof may be binding pockets which include, but are not limited to, peptide or substrate binding sites, and ATP-binding sites. The shape of a binding pocket may be largely pre-formed before binding of a chemical entity, may be formed simultaneously with binding of a chemical entity, or may be formed by the binding of another chemical entity to a different binding pocket of the molecule, which in turn induces a change in shape of the binding pocket.

The term “catalytic active site” or “active site” refers to the portion of the protein kinase to which nucleotide substrates bind. For example, the catalytic active site of JAK3 is at the interface between the N-terminal and C-terminal domains.

The term “chemical entity” refers to chemical compounds, complexes of at least two chemical compounds, and fragments of such compounds or complexes. The chemical entity can be, for example, a ligand, substrate, nucleotide triphosphate, nucleotide diphosphate, phosphate, nucleotide, agonist, antagonist, inhibitor, antibody, peptide, protein or drug. In one embodiment, the chemical entity is an inhibitor or substrate for the active site.

The term “conservative substitutions” refers to residues that are physically or functionally similar to the corresponding reference residues. That is, a conservative substitution and its reference residue have similar size, shape, electric charge, chemical properties including the ability to form covalent or hydrogen bonds, or the like. Preferred conservative substitutions are those fulfilling the criteria defined for an accepted point mutation in Dayhoff et al., Atlas of Protein Sequence and Structure, 5: 345-352 (1978 & Supp.), which is incorporated herein by reference. Examples of conservative substitutions are substitutions including but not limited to the following groups: (a) valine, glycine; (b) glycine, alanine; (c) valine, isoleucine, leucine; (d) aspartic acid, glutamic acid; (e) asparagine, glutamine; (f) serine, threonine; (g) lysine, arginine, methionine; and (h) phenylalanine, tyrosine.

The term “contact score” refers to a measure of shape complementarity between the chemical entity and binding pocket, which is correlated with an RMSD value obtained from a least square superimposition between all or part of the atoms of the chemical entity and all or part of the atoms of the ligand bound (for example, AMP-PNP) in the binding pocket according to Table 2. The docking process may be facilitated by the contact score or RMSD values. For example, if the chemical entity moves to an orientation with high RMSD, the system will resist the motion. A set of orientations of a chemical entity can be ranked by contact score. A lower RMSD value will give a higher contact score. See Meng et al. J. Comp. Chem. 4: 505-524 (1992).

The term “corresponds to” to “corresponding amino acid” when used in the context of amino acid residues that correspond to JAK3 amino acid residues refers to particular amino acid residues or analogues thereof in a JAK3 kinase domain homologue that corresponds to amino acid residues in the human JAK3 kinase domain. The corresponding amino acid may be an identical, mutated, chemically modified, conserved, conservatively substituted, functionally equivalent or homologous amino acid residue when compared to the JAK3 amino acid residue to which it corresponds.

Methods for identifying a corresponding amino acid are known in the art and are based upon are sequence, structural alignment, its functional position, or a combination thereof as compared to the JAK3 kinase. For example, corresponding amino acids may be identified by superimposing the backbone atoms of the amino acids in JAK3 and the protein using well known software applications, such as QUANTA (Accelrys, San Diego, Calif. ©2001, 2002). The corresponding amino acids may also be identified using sequence alignment programs such as the “bestfit” program or CLUSTAL W Alignment Tool (Higgins et al., Methods Enzymol. 266: 383-402 (1996)).

The term “crystallization solution” refers to a solution that promotes crystallization comprising at least one agent, including a buffer, one or more salts, a precipitating agent, one or more detergents, sugars or organic compounds, lanthanide ions, a poly-ionic compound and/or a stabilizer.

The term “docking” refers to orienting, rotating, translating a chemical entity in the binding pocket, domain, molecule or molecular complex or portion thereof based on distance geometry or energy. Docking may be performed by distance geometry methods that find sets of atoms of a chemical entity that match sets of sphere centers of the binding pocket, domain, molecule or molecular complex or portion thereof. See Meng et al., J. Comp. Chem. 4: 505-524 (1992). Sphere centers are generated by providing an extra radius of given length from the atoms (excluding hydrogen atoms) in the binding pocket, domain, molecule or molecular complex or portion thereof. Real-time interaction energy calculations, energy minimizations or rigid-body minimizations (Gschwend et al., J. Mol. Recognition 9:175-186 (1996)) can be performed while orienting the chemical entity to facilitate docking. For example, interactive docking experiments can be designed to follow the path of least resistance. If the user in an interactive docking experiment makes a move to increase the energy, the system will resist that move. However, if that user makes a move to decrease energy, the system will favor that move by increased responsiveness. (Cohen et al., J. Med. Chem. 33:889-894 (1990)). Docking can also be performed by combining a Monte Carlo search technique with rapid energy evaluation using molecular affinity potentials. See Goodsell and Olsen, Proteins: Structures, Function and Genetics 8:195-202 (1990). Software programs that carry out docking functions include but are not limited to MATCHMOL (Cory et al., J. Mol. Graphics 2: 39 (1984); MOLFIT (Redington, Comput. Chem. 16 216 (1992)) and DOCK (Meng et al., supra).

The term “full-length JAK3” refers to the complete human JAK3 protein (amino acid residues 1 to 1124; SEQ ID NO:1).

The term “generating a three-dimensional structure” or “generating a three-dimensional representation” refers to converting the lists of structure coordinates into structural models or graphical representation in three-dimensional space. This can be achieved through commercially or publicly available software. A model of a three-dimensional structure of a molecule or molecular complex can thus be constructed on a computer screen by a computer that is given the structure coordinates and that comprises the correct software. The three-dimensional structure may be displayed or used to perform computer modeling or fitting operations. In addition, the structure coordinates themselves, without the displayed model, may be used to perform computer-based modeling and fitting operations.

The term “homologue of JAK3 kinase domain” or “JAK3 kinase domain homologue” refers to a domain that retains JAK3 kinase activity and that has mutations, conservative substitutions, or both, as compared to the human JAK3 kinase domain. In one embodiment, the homologue is at least 95%, 96%, 97%, 98% or 99% identical in sequence to amino acid residues 810-1124 of SEQ ID NO:1, and has conservative substitutions as compared to the JAK3 kinase domain. In another embodiment, the homologue is at least 95%, 96%, 97%, 98% or 99% identical in sequence to amino acid residues 813-1100 of SEQ ID NO:1, and has conservative substitutions as compared to the JAK3 kinase domain. Examples of homologues include but are not limited to the following: the kinase domains of JAK3 from another species or the foregoing, with mutations, conservative substitutions, or both. Such animal species include, but are not limited to, mouse, rat, a primate such as monkey or other primates.

The term “homology model” refers to a structural model derived from know three-dimensional structure(s). Generation of the homology model, termed “homology modeling”, can include sequence alignment, residue replacement, residue conformation adjustment through energy minimization, or a combination thereof.

The term “interaction energy” refers to the energy determined for the interaction of a chemical entity and a binding pocket, domain, molecule or molecular complex or portion thereof. Interactions include but are not limited to one or more of covalent interactions, non-covalent interactions such as hydrogen bond, electrostatic, hydrophobic, aromatic, van der Waals interactions, and non-complementary electrostatic, interactions such as repulsive charge-charge, dipole-dipole and charge-dipole interactions. As interactions energies are measured in negative values, the lower the value the more favorable the interaction.

The term “JAK” refers to the kinases from the JAK kinase family. Examples of this family of kinases include but are not limited to JAK3, JAK2, JAK1 and TYK2.

The term “JAK3 ATP-binding pocket” refers to a binding pocket of a molecule or molecular complex defined by the structure coordinates of a certain set of amino acid residues present in the JAK3 structure, as described below. In general, the ligand for the ATP-binding pocket is a nucleotide such as ATP. This binding pocket is in the catalytic active site of the catalytic domain. In the protein kinase family, the ATP-binding pocket is generally located at the interface of the N-terminal and C-terminal domains, and is bordered by the glycine rich loop and the hinge (see, Xie et al., Structure 6: 983-991 (1998), incorporated herein by reference).

The term “JAK3 catalytic domain”, “JAK3 kinase catalytic domain”, “JAK3 protein kinase catalytic domain”, “JAK3 catalytic kinase domain” or “JAK3 kinase domain” refers to human JAK3 amino acid residues 810-1115 of SEQ ID NO:1, or the foregoing with additions and deletions of up to 9 amino acid residues at the C-terminal and/or 20 amino acids at the N-terminal of these amino acid residues. The kinase domain includes the catalytic active site.

The term “JAK3 inhibitor-binding pocket” refers to that portion of the JAK3 enzyme active site to which the inhibitor binds. The inhibitor-binding pocket is defined by the structure coordinates of a certain set of amino acid residues present in the JAK3-inhibitor structure.

The term “JAK3-like” refers to all or a portion of a molecule or molecular complex that has a commonality of shape to all or a portion of the JAK3 protein. For example, in the JAK3-like ATP-binding pocket, the commonality of shape is defined by a root mean square deviation of the structure coordinates of the backbone atoms between the amino acids in the JAK3-like ATP-binding pocket and the JAK3 amino acids of the JAK3 ATP-binding pocket, the corresponding amino acid residues in the JAK3-like binding pocket may or may not be identical. Depending on the set of JAK3 amino acid residues that define the JAK3 ATP-binding pocket, one skilled in the art would be able to locate the corresponding amino acid residues, that define a JAK3-like binding pocket in a protein based on sequence or structural homology.

The term “JAK3 protein complex” or “JAK3 homologue complex” refers to a molecular complex formed by associating the JAK3 protein or JAK3 homologue with a chemical entity, for example, a ligand, a substrate, nucleotide triphosphate, nucleotide diphosphate, phosphate, an agonist or antagonist, inhibitor, antibody, drug or compound.

The term “motif” refers to a group of amino acid residues in the JAK3 kinase or homologue that defines a structural compartment or carries out a function in the protein, for example, catalysis, structural stabilization or phosphorylation. The motif may be conserved in sequence, structure and function. The motif can be contiguous in primary sequence or three-dimensional space. Examples of a motif include, but are not limited to, a binding pocket, activation loop, the glycine-rich loop, and the DFG loop (See, Xie et al., Structure 6: 983-991 (1998).

The term “part of a binding pocket” refers to less than all of the amino acid residues that define the binding pocket. The structure coordinates of amino acid residues that constitute part of a binding pocket may be specific for defining the chemical environment of the binding pocket, or useful in designing fragments of an inhibitor that may interact with those residues. For example, the portion of amino acid residues may be key residues that play a role in ligand binding, or may be residues that are spatially related and define a three-dimensional compartment of the binding pocket. The amino acid residues may be contiguous or non-contiguous in primary sequence. In one embodiment, part of the binding pocket has at least two amino acid residues, preferably at least three, six, eight, ten, fourteen or fifteen amino acid residues.

The term “part of a JAK3 kinase domain” or “part of a JAK3 kinase domain homologue” refers to less than all of the amino acid residues of a JAK3 kinase domain or kinase domain homologue. In one embodiment part of the JAK3 kinase domain or kinase domain homologue defines the binding pockets, sub-domains, and motifs. The structure coordinates of amino acid residues that constitute part of a JAK3 kinase domain or JAK3 kinase domain homologue may be specific for defining the chemical environment of the protein, or useful in designing fragments of an inhibitor that interact with those residues. The portion of amino acid residues may also be residues that are spatially related and define a three-dimensional compartment of the binding pocket or motif. The amino acid residues may be contiguous or non-contiguous in primary sequence. For example, the portion of amino acid residues may be key residues that play a role in ligand or substrate binding, peptide binding, antibody binding, catalysis, structural stabilization or degradation.

The term “quantified association” refers to calculations of distance geometry and energy. Energy can include but is not limited to interaction energy, free energy and deformation energy. See Cohen, supra.

The term “root mean square deviation” or “RMSD” means the square root of the arithmetic mean of the squares of the deviations from the mean. It is a way to express the deviation or variation from a trend or object. For purposes of the invention, the “root means square deviation” defines the variation in the backbone atoms of JAK3, a binding pocket, a motif, a domain, or portion thereof, as defined by the structure coordinates of JAK3 described herein. It would be apparent to the skilled worker that the calculation of RMSD involves a standard error of a ±0.1 Å.

The term “soaked” refers to a process in which the crystal is transferred to a solution containing the compound of interest.

The term “structure coordinates” refers to Cartesian coordinates derived from mathematical equations related to the patterns obtained on diffraction of a monochromatic beam of X-rays by the atoms (scattering centers) of a protein or protein complex in crystal form. The diffraction data are used to calculate an electron density map of the repeating unit of the crystal. The electron density maps are then used to establish the positions of the individual atoms of the molecule or molecular complex.

The term “sub-domain” refers to a portion of the domain.

The term “substantially all of a JAK3 binding pocket” or “substantially all of a JAK3 kinase domain” refers to all or almost all of the amino acids in the JAK3 binding pocket or kinase domain. For example, substantially all of a JAK3 binding pocket can be 100%, 95%, 90%, 80%, or 70% of the residues defining the JAK3 binding pocket.

The term “substrate binding pocket” refers to the binding pocket for a substrate of JAK3 or homologue thereof. A substrate is generally defined as the molecule upon which an enzyme performs catalysis. Natural substrates, synthetic substrates or peptides, or mimics of a natural substrate of JAK3 or homologue thereof may associate with the substrate binding pocket.

The term “sufficiently homologous to JAK3” kinase domain refers to a protein that has a sequence identity of at least 25% compared to JAK3 kinase domain. In other embodiments, the sequence identity is at least 40%. In other embodiments, the sequence identity is at least 50%, 60%, 70%, 80%, 90%, 95% 96%, 97%, 98% or 99%.

The term “three-dimensional structural information” refers to information obtained from the structure coordinates. Structural information generated can include the three-dimensional structure or graphical representation of the structure. Structural information can also be generated when subtracting distances between atoms in the structure coordinates, calculating chemical energies for a JAK3 molecule or molecular complex or homologues thereof, calculating or minimizing energies for an association of a JAK3 molecule or molecular complex or homologues thereof to a chemical entity.

Crystallizable Compositions and Crystals of JAK3 Kinase Domain and Complexes Thereof

According to one embodiment, the invention provides a crystal or crystallizable composition comprising a JAK3 kinase domain, a JAK3 kinase domain homologue, a JAK3 kinase domain complex, or a JAK3 kinase domain homologue complex. In one embodiment, the chemical entry is an ATP analogue, nucleotide triphosphate, nucleotide diphosphate, phosphate, adenosine or AMP-PNP. In a certain embodiment, the chemical entity is AMP-PNP.

The JAK3 kinase domain in the crystal or crystallizable composition may be amino acid residues 810-1124 of SEQ ID NO:1, amino acid residues 810-1115 of SEQ ID NO:1, amino acid residues 810-1104 of SEQ ID NO:1, amino acid residues 810-1100 of SEQ ID NO:1 or amino acid residues 813-1100 of SEQ ID NO:1, the JAK3 kinase domain homologue may be the foregoing with conservative substitutions.

SEQ ID NO: 1         10         20         30         40          MAPPSEETPL IPQRSCSLLS TEAGALHVLL PARGPGFFQR          50         60         70         80 LSFSFGDHLA EDLCVQAAKA SGILPVYHSL FALATEDLSC         90        100        110        120 WFPPSHIFSV EDASTQVLLY RIRFYFPNWF GLEKCHRFGL        130        140        150        160 RKDLASAILD LPVLEHLFAQ HRSDLVSGRL PVGLSLKEQG        170        180        190        200 ECLSLAVLDL ARMAREQAQR PGELLKTVSY KACLPPSLRD        210        220        230        240         LIQGLSFVTR RRIRRTVRRA LRRVAACQAD RHSLMAKYTM         250        260        270        280 DLERLDPAGA AETFHVGLPG ALGGHDGLGL LRVAGDGGIA        290        300        310        320 WTQGEQEVLQ PFCDFPEIVD ISIKQAPRVG PAGEHRLVTV        330        340        350        360 TRTDNQILEA EFPGLPEALS FVALVDGYFR LTTDSQHFFC        370        380        390        400 KEVAPPRLLE EVAEQCHGPI TLDFAINKLK TGGSRPGSYV        410        420        430        440 LRRSPQDFDS FLLTVCVQNP LGPDYKGCLI RRSPTGTFLL         450        460        470        480 VGLSRPHSSL RELLATCWDG GLHVDGVAVT LTSCCIPRPK        490        500        510        520 EKSNLIVVQR GHSPPTSSLV QPQSQYQLSQ MTFHKIPADS        530        540        550        560 LEWHENLGHG SFTKIYRGCR HEVVDGEARK TEVLLKVMDA        570        580        590        600 KHKNCMESFL EAASLMSQVS YRHLVLLHGV CMAGDSTMVQ        610        620        630        640         EPVHLGAIDM YLRKRGHLVP ASWKLQVVKQ LAYALNYLED         650        660        670        680         KGLPHGNVSA RKVLLAREGA DGSPPFIKLS DPGVSPAVLS         690        700        710        720         LEMLTDRIPW VAPECLREAQ TLSLEADKWG FGATVWEVFS         730        740        750        760         GVTMPISALD PAKKLQFYED RQQLPAPKWT ELALLIQQCM         770        780        780        800 AYEPVQRPSF RAVIRDLNSL ISSDYELLSD PTPGALAPRD        810        820        830        840         GLWNGAQLYA CQDPTIFEER HLKYISQLGK GNFGSVELCR         850        960        870        880         YDPLGDNTGA LVAVKQLQHS GPDQQRDFQR EIQILKALHS         890        900        910        920                DFIVKYRGVS YGPGRQSLRL VMEYLPSGCL RDFLQRHRAR          930        940        950        960                LDASRLLLYS SQICKGMEYL GSRRCVHRDL AARNILVESE          970        980        990       1000               AHVKIADFGL AKLLPLDKDY YVVREPGQSP IFWYAPESLS        1010       1020       1030       1040 DINFSRQSDV WSFGVVLYEL FTYCDKSCSP SAEFLRMMGC       1050       1060       1070       1080              ERDVPALCRL LELLEEGQRL PAPPACPAEV HELMKLCWAP         1090       1100       1110       1120 SPQDRPSFSA LGPQLDMLWS GSRGCETHAF TAHPEGKHHS LSFS

In one embodiment, the a crystallizable composition comprises a crystallization solution of equal volumes of JAK3 protein (7.5-30 mg/ml), a salt, a buffer between pH 5.0 and 7.0, 0-10 mM DTT and a polyethylene glycol. The salt includes, but is not limited to KCl, NaCl and (NH₄)₂SO₄. The polyethylene glycol includes, but is limited to, PEGMME 550, PEGMME2000, PEG4000, PEG6000. If the crystals are derived from seeding techniques, the concentration of the polyethylene glycol may be less than 20%. In another embodiment, the crystallizable composition comprises a crystallization solution of equal volumes of JAK3 protein (10-15 mg/mL in 50 mM Hepes at pH 8.0, 500 mM NaCl, 20% (v/v) glycerol, 5 mM DTT, and 0.05% (w/v) β-octylglucopyranoside and a solution of 20-26% PEG 3350, 200-260 mM KCl, 20 mM spermine, 10 mM DTT and 100 mM bis-Tris pH 6.0. In one embodiment, the volume of protein used is 0.5 μL. In another embodiment, the volume of protein used in 1.0 μL. In another embodiment, the volume of protein used in 2.0 μL.

Crystals can be grown using sitting drop or hanging drop vapour diffusion techniques, such as, but not limited to techniques described in Example 3. Crystals can be grown in the Corning® 384 Well plate (available from Fisher Scientific), Greiner crystallization low profile plates (available from Hampton Research (Aliso Veijo, Calif.)), both the 96-well CrystalQuick™ standard profile round and flat bottom plates (available from Hampton Research (Aliso Viejo, Calif.)), and the 24 well VDX plates (available from Hampton Research (Aliso Viejo, Calif.)). The volume of the reservoir for the 384-well plate can be 50 μL. The volume of the reservoir for the 96-well low profile plate can be 100 μL, and for the CrystalQuick™ plates it can be varied between 70-100 μL. Crystals can also be grown in 72-well terasaki plates using the microbatch method. They also can be grown in 96-well Corning® (available from Hampton Research (Aliso Viejo, Calif.)) with a reservoir of 50 μL.

According to one embodiment, the invention provides for a crystal with unit cell dimensions of a=59.98 Å b=90.19 Å, c=69.00 Å, α=γ=90, β=111.5° and space group P2₁ with 2 molecules in the asymmetric unit. Preferably, the crystal comprises the JAK3-AMP-PNP complex.

According to another embodiment, the invention provides for a crystal with unit cell dimensions of a=72.36 Å b=90.04 Å, c=105.60 Å, α=β=γ=90° and a space P2₁2₁2₁ with 2 molecules in the symmetric unit. Preferably, the crystal comprises the JAK3-AMP-PNP complex.

It will be readily apparent to those skilled in the art that the unit cells of the crystal compositions may deviate up to ±1-4 Å in cell length (and 7-8° in β angle in the P2₁ space group) from the above cell dimensions depending on the deviation in the unit calculations or conformational change in the protein.

The JAK3 kinase domain or homologue thereof may be produced by any well-known method, including synthetic methods, such as solid phase, liquid phase and combination solid phase/liquid phase syntheses; recombinant DNA methods, including cDNA cloning, optionally combined with site directed mutagenesis; and/or purification of the natural products. In one embodiment, the protein is overexpressed in baculovirus system.

Methods of Obtaining Crystals of JAK3 Kinase Domain, Complexes Thereof or Homologues Thereof

The invention also relates to a method of obtaining a crystal of JAK3 kinase domain of JAK3 homologue thereof, comprising the steps of:

-   -   a) producing and purifying a JAK3 kinase domain or homologue         thereof;     -   b) combining a crystallizable solution with said JAK3 kinase         domain or homologue thereof to produce a crystallizable         composition; and     -   c) subjecting said crystallizable composition to conditions         which promote crystallization and obtaining said crystals.

The invention also relates to a method of obtaining a crystal of a JAK3 kinase domain complex or JAK3 kinase domain homologue complex, further comprising the step of:

-   -   d) soaking said crystal in a buffer solution comprising a         chemical entity.

The invention also relates to a method of obtaining a crystal of JAK3 kinase domain complex or JAK3 kinase domain homologue complex, comprising the steps of:

-   -   a) producing and purifying a JAK3 kinase domain or homologue         thereof;     -   b) b) combining a crystallizable solution with said JAK3 kinase         domain or homologue thereof in the presence of a chemical entity         to produce a crystallizable composition; and     -   c) subjecting said crystallizable composition to conditions         which promote crystallization and obtaining said crystals.

In one embodiment, the chemical entity is selected from the group consisting of an ATP analogue, nucleotide triphosphate, nucleotide diphosphate, phosphate, adenosine, AMP-PNP, substrate inhibitor, or active site inhibitor. In another embodiment, the crystallization solution is as described previously. In another embodiment, the composition is treated with micro-crystals of JAK3 kinase domain or JAK3 kinase domain homologues, or complexes thereof.

In certain embodiments, the method of making crystals of JAK3 kinase domain. JAK3 kinase domain homologues, or complexes thereof, includes the use of a device for promoting crystallizations. Devices for promoting crystallization can include but are not limited to the hanging-drop, sitting drop, dialysis or microtube batch devices. (U.S. Pat. Nos. 4,886,646, 5,096,676, 5,130,105, 5,221,410 and 5,400, 741; Pav et al., Proteins: Structure, Function, and Genetics 20: 98-102 (1994), incorporated herein by reference). The hanging-drop, sitting-drop, and some adaptations of the microbatch methods (D'Arcy et al., J. Cryst. Growth 168: 175-180 (1996) and Chayen, J. Appl. Cryst. 30: 198-202 (1997)) produce crystals by vapor diffusion. The hanging drop and sitting drop containing the crystallizable composition is equilibrated in a reservoir containing a higher or lower concentration of the precipitant. As the drop approaches equilibrium with the reservoir, the saturation of protein in the solution leads to the formation of crystals.

Microseeding or seeding may be used to increase the size and quality of crystals. In this instance, micro-crystals are crushed to yield a stock seed solution. The stock seed solution is diluted in series. Using a needle, glass rod, micro-pipet, micro-loop or strand of hair, a small sample from each diluted solution is added to a set of equilibrated drops containing a protein concentration equal to or less than a concentration needed to create crystals without the presence of seeds. The aim is to end up with a single seed crystal that will act to nucleate crystal growth in the drop.

In would be readily apparent to one of skill the art to vary the crystallization conditions disclosed above to identify other crystallization conditions that would produce crystals of a JAK3 kinase domain homologue, a JAK3 kinase domain homologue complex, a JAK3 kinase domain or another JAK3 kinase domain complex. Such variations include, but are not limited to, adjusting pH, protein concentration and/or crystallization temperature, changing the identity or concentration of salt and/or precipitant used, using a different method of crystallization, or introducing additives such as detergents (e.g., TWEEN 20 (monolaurate), LDAO, Brij 30 (4 lauryl ether)), sugars (e.g., glucose, maltose), organic compounds (e.g., dioxane, dimethylformamide), lanthanide ions or polyionic compounds that aid in crystallization. High throughput crystallization assays may also be used to assist in finding or optimizing the crystallization condition.

Binding Pockets of JAK3 Kinase Domain or Homologue Thereof

As disclosed herein, applicants have provided the three-dimensional X-ray structure of JAK3-AMP-PNP complex. The atomic coordinates for the structures of JAK3-AMP-PNP complex are presented in Table 2.

To use the structure coordinates generated for the JAK3 complex or one of its binding pockets or homologues thereof, it may be necessary to convert the structure coordinates, or portions thereof, into a three-dimensional shape (i.e., a three-dimensional representation of these complexes or binding pockets). This is achieved through the use of a computer and commercially available software that is capable of generating the three-dimensional representations or structures of molecules or molecular complexes, or portions thereof, from a set of structural coordinates. These three-dimensional representations may be displayed on a computer screen.

Binding pockets, also referred to as binding sites in the present invention, are of significant utility in fields such as drug discovery. The association of natural ligands or substrates with the binding pockets of their corresponding receptors or enzymes is the basis of many biological mechanisms of action. Similarly, many drugs exert their biological effects through association with the binding pockets of receptors and enzymes. Such associations may occur with all or part of the binding pocket. An understanding of such associations will help lead to the design of drugs having more favorable associations with their target receptor or enzyme, and thus, improved biological effects. Therefore, this information is valuable in designing potential inhibitors of the binding pockets of biologically important targets. The binding pockets of this invention will be important for drug design.

The conformations of JAK3 and other proteins at a particular amino acid site, along the polypeptide backbone, can be compared using well-known procedures for performing sequence alignments of the amino acids. Such sequence alignments allow for the equivalent sites on these proteins to be compared. Such methods for performing sequence alignment include, but are not limited to, the “bestfit” program and CLUSTAL W Alignment Tool, Higgins et al., supra.

In one embodiment, the ATP-binding pocket comprises amino acid residues Leu828, Gly829, Lys830, Gly831, Asn 832, Phe833, Gly834, Ser835, Val836, Ala853, Lys855, Val884, Met902, Glu903, Tyr904, Leu905, Pro906, Cys909, Arg911, Asp949, Arg953, Asn954, Leu956, Asp967, and Gln988 according to the structure of the JAK3-AMP-PNP complex in Table 2. These amino acid residues are within 5 Å (“5 Å sphere of amino acids”) of AMP-PNP bound in the ATP-binding pocket as identified using the program QUANTA (Accelrys, San Diego, Calif. ©2001, 2002).

In another embodiment, the ATP-binding pocket comprises amino acid residues Gln827, Leu828, Gly829, Lys830, Gly831, Asn 832, Phe833, Gly834, Ser835, Val836, Glu837, Leu838, Val852, Ala853, Val854, Lys855, Gln856, Leu857, Val884, Lys885, Tyr886, Leu900, Val901, Met902, Glu903, Tyr904, Leu905, Pro906, Ser907, Gly908, Cys909, Leu910, Arg911, Asp912, His947, Asp949, Leu950, Ala951, Ala952, Arg953, Asn954, Ile955, Leu956, Val957, Ala966, Asp967, Leu970, Lys978, Glu985, Gln988, Ser989, Pro990 and Trp 993 according to the structure of the JAK3-AMP-PNP complex in Table 2. These amino acid residues are within 8 Å (“8 Å sphere of amino acids”) of AMP-PNP bound in the ATP-binding pockets as identified using the program QUANTA (Accelrys, San Diego, Calif. ©2001, 2002).

It will be readily apparent to those of skill in the art that the numbering of amino acid residues in homologues of human JAK3 may be different than that set forth for human JAK3. Corresponding amino acids in JAK3 homologues are easily identified by visual inspection of the amino acid sequences or by using commercially available homology software programs. Homologues of JAK3 include, for example, JAK3 from other species, such as non-humans primates, mouse, rat, etc.

Those of skill in the art understand that set of structure coordinates for an enzyme or an enzyme-complex, or a portion thereof, is a relative set of points that define a shape in three dimensions. Thus, it is possible that an entirely different set of coordinates could define a similar or identical shape. Moreover, slight variations in the individual coordinates will have little effect on overall shape. In terms of binding pockets, these variations would not be expected to significantly alter the nature of ligands that could associate with those pockets.

The variations in coordinates discussed above may be generated because of mathematical manipulations of the JAK3-AMP-PNP structure coordinates. For example, the structure coordinates set forth in Table 2 may undergo crystallographic permutations of the structure coordinates, fractionalization of the structure coordinates, integer additions or subtractions to sets of the structure coordinates, inversion of the structure coordinates or any combinations of the above.

Alternatively, modifications in the crystal structure due to mutations, additions, substitutions, and/or deletions of amino acids, or other changes in any of the components that make up the crystal may also account for variations in structure coordinates. If such variations are within a certain root mean square deviation as compared to the original coordinates, the resulting three-dimensional shape is considered encompassed by this invention. Thus, for example, a ligand that bound to the ATP-binding pocket of JAK3 would also be expected to bind to another binding pocket whose structure coordinates defined a shape that fell within the RMSD value.

Various computational analyses may be necessary to determine whether a molecule or binding pocket, or portion thereof, is sufficiently similar to the binding pockets above-described. Such analyses may be carried out in well known software applications, such as ProFit (A.C.R. Martin, ProFit version 1.8, http://www.bioinf.org.uk/software), Swiss-Pdb Viewer (Guex and Peitsch, Electrophoresis 18: 2714-2723 (1997)), the Molecular Similarity application of QUANTA (Accelrys, San Diego, Calif. ©2001, 2002) and as described in the accompanying User's Guide, which are incorporated herein by reference.

The above programs permit comparisons between different structures, different conformations of the same structure, and different parts of the same structure. The procedure used in QUANTA (Accelrys, San Diego, Calif. ©2001, 2002) and Swiss-Pdb Viewer (Guex and Peitsch, Electrophoresis 18: 2714-2723 (1997) to compare structures is divided into four steps: 1) load the structures to be compared; 2) define the atom equivalences in these structures; 3) perform a fitting operation on the structures; and 4) analyze the results.

The procedure used in ProFit to compare structures includes the following steps: 1) load the structures to be compared; 2) specify selected residues of interest; 3) define the atom equivalences in the selected residues; 4) perform a fitting operation on the selected residues; and 5) analyze the results.

Each structure in the comparison is identified by a name. One structure is identified as the target (i.e., the fixed structure); all remaining structures are working structures (i.e., moving structures). Since atom equivalency within QUANTA (Accelrys, San Diego, Calif. ©2001, 2002) is defined by user input, for the purposes of this invention, we will define equivalent atoms as protein backbone atoms N, O, C and Cα for all corresponding amino acid residues between two structures being compared.

The corresponding amino acids may be identified by sequence alignment programs such as the “bestfit” program available from the Genetics Computer Group which uses the local homology algorithm described by Smith and Waterman in Advances in Applied Mathematics 2: 482 (1981), which is incorporated herein by reference. A suitable amino acid sequence alignment will require that the proteins being aligned share minimum percentage of identical amino acids. Generally, a first protein being aligned with a second protein should share in excess of about 35% identical amino acids (Hanks et al., Science 241: 42 (1988); Hanks and Quinn, Methods in Enzymology 200: 38 (1991)). The identification of equivalent residues can also be assisted by secondary structure alignment, for example, aligning the α-helices, β-sheets in the structure. The program Swiss-Pdb viewer (Guex and Peitsch, Electrophoresis 18: 2714-2723 (1997) utilizes a best fit algorithm that is based on secondary sequence alignment.

When a rigid fitting method is used, the working structure is translated and rotated to obtain an optimum fit with the target structure. The fitting operation uses an algorithm that computes the optimum translation and rotation to be applied to the moving structure, such that the root mean square difference of the fit over the specified pairs of equivalent atom is an absolute minimum. This number, given in angstroms, is reported by the above programs. The Swiss-Pdb Viewer program (Guex and Peitsch, Electrophoresis 18: 2714-2723 (1997) sets an RMSD cutoff for eliminating pairs of equivalent atoms that have high RMSD values. An RMSD cutoff value can be used to exclude pairs of equivalent atoms with extreme individual RMSD values. In the program ProFit, the RMSD cutoff value can be specified by the user.

For the purpose of this invention, any molecule, molecular complex, binding pocket, motif, domain thereof or portion thereof that is within a root mean square deviation for backbone atoms (N, Cα, C, O) when superimposed on the relevant backbone atoms described by structure coordinates listed in Table 2 are encompassed by this invention.

One embodiment of this invention provides a crystalline molecule comprising a protein defined by structure coordinates of a set of amino acid residues that are identical to JAK3 amino acid residues according to Table 2, wherein the RMSD between backbone atoms of said set of amino acid residues and said JAK3 amino acid residues is not more than about 3.0 Å. In other embodiments, the RMSD between backbone atoms of said set of amino acid residues and said JAK3 amino acid residues is not greater than about 2.0 Å, not greater than about 1.5 Å, not greater than about 1.1 Å, not greater than about 1.0 Å, not greater than about 0.9 Å, not greater than about 0.8 Å, not greater than about 0.7 Å, not greater than about 0.6 Å, or not greater than about 0.5 Å. Calculations of RMSD values were done with Swiss Pdb Viewer (Guex Peitsch, Electrophoresis 18: 2714-2723 (1997)).

In one embodiment, the present invention provides a crystalline molecule comprising all or part of a binding pocket defined by a set of amino acid residues comprising amino acid residues which are identical to human JAK3 amino acid residues Gln827, Leu828, Gly829, Lys830, Gly831, Asn 832, Phe833, Gly834, Ser835, Val836, Glu837, Leu838, Val852, Ala853, Val854, Lys855, Gln856, Leu857, Val884, Lys885, Tyr886, Leu900, Val901, Met902, Glu903, Tyr904, Leu905, Pro906, Ser907, Gly908, Cys909, Leu910, Arg911, Asp912, His947, Asp949, Leu950, Ala951, Ala952, Arg953, Asn954, Ile955, Leu956, Val957, Ala966, Asp967, Leu970, Lys978, Glu985, Gln988, Ser989, Pro990 and Trp 993 according to Table 2, wherein the RMSD of the backbone atoms between said JAK3 amino acid residues and said amino acid residues which are identical is not greater than about 2.5 Å. In other embodiments, the RMSD is not greater than about 2.4 Å, 2.2 Å, 2.0 Å, 1.8 Å, 1.6 Å, 1.4 Å, 1.2 Å, 1.0 Å, 0.8 Å, 0.5 Å, 0.3 Å, or 0.2 Å. In other embodiments, the binding pocket is defined by a set of amino acid residues comprising at least four, six, eight, ten, twelve, fifteen, twenty, twenty-five, thirty, thirty-five, forty, forty-five or fifty amino acid residues which are identical to said JAK3 amino acid residues.

Computer Systems

According to another embodiment, this invention provides a machine-readable data storage medium, comprising a data storage material encoded with machine-readable data, wherein said data defines the above-mentioned molecules or molecular complexes. In one embodiment, the data defines the above-mentioned binding pockets by comprising the structure coordinates of said amino acid residues according to Table 2. To use the structure coordinates generated for JAK3 homologues thereof, or one of its binding pockets, it is at times necessary to convert them into a three-dimensional shape or to extract three-dimensional structural information from them. This is achieved through the use of commercially or publicly available software that is capable of generating a three-dimensional structure or a three-dimensional representation of molecules or portions thereof from a set of structure coordinates. In one embodiment, three-dimensional structure or representation may be displayed graphically.

Therefore, according to another embodiment, this invention provides a machine-readable data storage medium comprising a data storage material encoded with machine readable data. In one embodiment, a machine programmed with instructions for using said data is capable of generating a three-dimensional structure or three-dimensional representation of any of the molecules, or molecular complexes or binding pockets thereof, that are described herein.

This invention also provides a computer comprising:

-   -   (a) a machine-readable data storage medium, comprising a data         storage material encoded with machine-readable data, wherein         said data defines any one of the above molecules or molecular         complexes;     -   (b) a working memory for storing instructions for processing         said machine-readable data;     -   (c) a central processing unit (CPU) coupled to said working         memory and to said machine-readable data storage medium for         processing said machine readable data and means for generating         three-dimensional structural information of said molecule or         molecular complex; and     -   (d) output hardware coupled to said central processing unit for         outputting three-dimensional structural information of said         molecule or molecular complex, or information produced by using         said three-dimensional structural information of said molecule         or molecular complex.

In one embodiment, the data defines the binding pocket of the molecule or molecular complex.

Three-dimensional data generation may be provided by an instruction or set of instructions such as a computer program or commands for generating a three-dimensional structure or graphical representation from structure coordinates, or by subtracting distances between atoms, calculating chemical energies for a JAK3 molecule or molecular complex or homologues thereof, or calculating or minimizing energies for an association of a JAK3 molecule or molecular complex or homologues thereof to a chemical entity. The graphical representation can be generated or displayed by commercially available software programs. Examples of software programs include but are not limited to QUANTA (Accelrys, San Diego, Calif. ©2001, 2002), O (Jones et al., Acta Crystallogr. A47: 110-119 (1991)) and RIBBONS (Carson, J. Appl. Crystallogr. 24: 958-961 (1991)), which are incorporated herein by reference. Certain software programs may imbue this representation with physico-chemical attributes which are know from the chemical composition of the molecule, such as residue charge, hydrophobicity, torsional and rotational degrees of freedom for the residue or segment, etc. Examples of software programs for calculating chemical energies are described in the Rational Drug Design section.

Information of said binding pocket or information produced by using said binding pocket can be outputted through display terminals, touchscreens, facsimile machines, modems, CD-ROMS, printers, a CD or DVD recorder, ZIP™ or JAZ™ drives or disk drives. The information can be in graphical or alphanumeric form.

In one embodiment, the computer is executing an instruction such as a computer program for generating three-dimensional structure or docking. In another embodiment, the computer further comprises a commercially available software program to display the information as a graphical representation. Examples of software programs include but as not limited to, QUANTA (Accelrys, San Diego, Calif. ©2001, 2002), O (Jones et al., Acta Crystallogr. A47: 110-119 (1991)) and RIBBONS (Carson, J. Appl. Crystallogr. 24: 958-961 (1991)), all of which are incorporated herein by reference.

FIG. 8 demonstrates one version of these embodiments. System (10) includes a computer (11) comprising a central processing unit (“CPU”) (20), a working memory (22) which may be, e.g., RAM (random-access memory) or “core” memory, mass storage memory (24) (such as one or more disk drives, CD-ROM drives or DVD-ROM drives), one or more cathode-ray tube (“CRT”) display terminals (26), one or more keyboards (28), one or more input lines (30), and one or more output lines (40), all of which are, interconnected by a conventional bi-directional system bus (50).

Input hardware (35), coupled to computer (11) by input lines (30), may be implemented in a variety of ways. Machine-readable data of this invention may be inputted via the use of a modem or modems (32) connected by a telephone line or dedicated data line (34). Alternatively or additionally, the input hardware (35) may comprise CD-ROM or DVD-ROM drives or disk drives (24). In conjunction with display terminal (26), keyboard (28) may also be used as an input device.

Output hardware (46), coupled to computer (11) by output lines (40), may similarly be implemented by conventional devices. By way of example, output hardware (46) may include CRT display terminal (26) for displaying a graphical representation of a binding pocket of this invention using a program such as QUANTA (Accelrys, San Diego, Calif. ©2001, 2002) as described herein. Output hardware may also include a printer (42), so that hard copy output may be produced, or a disk drive (24), to store system output for later use. Output hardware may also include a display terminal, touchscreens, facsimile machines, modems, a CD or DVD recorder, ZIP™ or JAZ™ drives, disk drives, or other machine-readable data storage device.

In operation, CPU (20) coordinates the use of the various input and output devices (35), (46), coordinates data accesses from mass storage (24) and accesses to and from working memory (22), and determines the sequence of data processing steps. A number of programs may be used to process the machine-readable data of this invention. Such programs are discussed in reference to the computational methods of drug discovery as described herein. Specific references to components of the hardware system (10) are included as appropriate throughout the following description of the data storage medium.

FIG. 9 shows a cross section of a magnetic data storage medium (100) which can be encoded with a machine-readable data that can be carried out by a system such as system (10) of FIG. 8. Medium (100) can be a conventional floppy diskette or hard disk, having a suitable substrate (101), which may be conventional, and a suitable coating (102), which may be conventional, on one or both sides, containing magnetic domains (not visible) whose polarity or orientation can be altered magnetically. Medium (100) may also have an opening (not shown) for receiving the spindle of a disk drive or other data storage device (24).

The magnetic domains of coating (102) of medium (100) are polarized or oriented so as to encode in manner which may be conventional, machine readable data such as that described herein, for execution by a system such as system (10) of FIG. 8.

FIG. 10 shows a cross-section of an optically-readably data storage medium (110) which also can be encoded with such a machine-readable data, or set of instructions, which can be carried out by a system such as system (10) or FIG. 8. Medium (110) can be a conventional compact disk read only memory (CD-ROM) or a rewritable medium such as a magneto-optical disk which is optically readable and magneto-optically writable. Medium (100) preferably has a suitable substrate (111), which may be conventional, and a suitable coating (112), which may be conventional, usually of one side of substrate (111).

In the case of CD-ROM, as is well known, coating (112) is reflective and is impressed with a plurality of pits (113) to encode the machine-readable data. The arrangement of pits is read by reflecting laser light off the surface of coating (112). A protective coating (114), which preferably is substantially transparent, is provided on top of coating (112).

In the case of a magneto-optical disk, as is well known, coating (112) has no pits (113), but has a plurality of magnetic domains whose polarity or orientation can be changed magnetically when heated above a certain temperature, as by a laser (not shown). The orientation of the domains can be read by measuring the polarization of laser light reflected from coating (112). The arrangement of the domains encodes the data as described above.

In one embodiment, the structure coordinates of said molecules or molecular complexes are provided by homology modeling of at least a portion of the structure coordinates of Table 2. Homology modeling can be used to generate structural models of JAK3 homologues or other homologues proteins based on the known structure of JAK3. This can be achieved by performing one or more of the following steps: performing sequence alignment between the amino acid sequence of a molecule (possibly an unknown molecule) against the amino acid sequence of JAK3; identifying conserved and variable regions by sequence or structure; generating structure coordinates for structurally conserved residues of the unknown structure from those of JAK3; generating conformation for the structurally variable residues in the unknown structure; replacing the non-conserved residues of JAK3 with residues in the unknown structure; building side chain conformations; and refining and/or evaluating the unknown structure.

Software programs that are useful in homology modeling include XALIGN (Wishart et al., Comput. Appl. Biosci. 10: 687-688 (1994)) and CLUSTAL W Alignment Tool, Higgins et al., supra. See also, U.S. Pat. No. 5,884,230. These references are incorporated herein by reference.

To perform the sequence alignment, programs such as the “bestfit” program available from the Genetics Computer Group (Waterman in Advances in Applied Mathematics 2: 482 (1981), which is incorporated herein by reference) and CLUSTAL W Alignment Tool (Higgins et al., supra, which is incorporated by reference) can be used. To model the amino acid side chains of homologous molecules, the amino acid residues in JAK3 can be replaced, using a computer graphics program such as “O” (Jones et al., Acta Cryst. Sect. A 47: 110-119 (1997)), by those of the homologous protein, where they differ. The same orientation or a different orientation of the amino acid can be used. Insertions and deletions of amino acid residues may be necessary where gaps occur in the sequence alignment. However, certain portions of the active site of JAK3 and its homologues are highly conserved with essentially no insertions and deletions.

Homology modeling can be performed using, for example, the computer programs SWISS-MODEL available through Glaxo Wellcome Experimental Research in Geneva, Switzerland; WHATIF available on EMBL servers; Schnare et al., J. Mol. Biol. 256: 701-719 (1996); Blundell et al., Nature 326: 347-352 (1987); Fetrow and Bryant, Bio/Technology 11:479-484 (1993); Greer, Methods in Enzymology 202:239-252 (1991); and Johnson et al., Crit. Rev. Biochem. Mol Biol. 29: 1-68 (1994). An example of homology modeling can be found, for example, in Szklarz, Life Sci. 61: 2507-2520 (1997). These references are incorporated herein by reference.

Thus, in accordance with the present invention, data capable of generating the three-dimensional structure or three-dimensional representation of the above molecules or molecular complexes, or binding pockets thereof, can be stored in a machine-readable storage medium, which is capable of displaying structural information or a graphical three-dimensional representation of the structure. In one embodiment, the means of generating a three-dimensional is provided by the means for generating a three-dimensional structural representation of the binding pocket or protein of a molecule or molecular complex.

Rational Drug Design

The JAK3 structure coordinates or the three-dimensional graphical representation generated from these coordinates may be used in conjunction with a computer for a variety of purposes, including drug discovery.

For example, the structure encoded by the data may be computationally evaluated for its ability to associate with chemical entities. Chemical entities that associate with JAK3 may inhibit or activate JAK3 or its homologues, and are potential drug candidates. Alternatively, the structure encoded by the data may be displayed in a graphical three-dimensional representation on a computer screen. This allows visual inspection of the structure, as well as visual inspection of the structure's association with chemical entities.

In one embodiment, the invention provides for a method of using a computer for selecting an orientation of a chemical entity that interacts favorably with a binding pocket or domain comprising the steps of:

-   -   (a) providing the structure coordinates of said binding pocket         or domain on a computer comprising the means for generating         three-dimensional structural information from said structure         coordinates;     -   (b) employing computational means to dock a first chemical         entity in the binding pocket or domain;     -   (c) quantifying the association between said chemical entity and         all or part of the binding pocket or domain for different         orientations of the chemical entity; and     -   (d) selecting the orientation of the chemical entity with the         most favorable interaction based on said quantified association.

In one embodiment, the docking is facilitated by said quantified association.

In one embodiment, the above method further comprises the following steps before step (a):

-   -   (e) producing a crystal of a molecule or molecular complex         comprising JAK3 kinase domain or homologue thereof;     -   (f) determining the three-dimensional structure coordinates of         the molecule or molecular complex by X-ray diffraction of the         crystal; and     -   (g) identifying all or part of a binding pocket that corresponds         to said binding pocket.

Three-dimensional structural information in step (a) may be generated by instructions such as a computer program or commands that can generate a three-dimensional representation; subtract distances between atoms; calculate chemical energies for a JAK3 molecule, molecular complex or homologues thereof; or calculate or minimize the chemical energies of an association of JAK3 molecule, molecular complex or homologues thereof to a chemical entity. These types of computer programs are known in the art. The graphical representation can be generated or displayed by commercially available software programs. Examples of software programs include but are not limited to QUANTA (Accelrys, San Diego, Calif. ©2001, 2002), O (Jones et al., Acta Crystallogr. A47: 110-119 (1991)) and RIBBONS (Carson, J. Appl. Crystallogr. 24: 958-961 (1991)), which are incorporated herein by reference. Certain software programs may imbue this representation with physico-chemical attributes which are known from the chemical composition of the molecule, such as residue charge, hydrophobicity, torsional and rotational degrees of freedom for the residue or segment, etc. Examples of software programs for calculating chemical energies are described below.

The above method may further comprise the following step after step (d): outputting said quantified association to a suitable output hardware, such as a CRT display terminal, a CD or DVD recorder, ZIP™ or JAZ™ drive, a disk drive, or other machine-readable data storage device, as described previously. The method may further comprise generating a three-dimensional structure, graphical representation thereof, or both, of the molecule or molecular complex prior to step (b).

One embodiment of this invention provides for the above method, wherein energy minimization, molecular dynamics simulations, or rigid body minimizations are performed simultaneously with or following step (b).

The above method may further comprise the steps of:

-   -   (e) repeating steps (b) through (d) with a second chemical         entity; and     -   (f) selecting at least one of said first or second chemical         entity that interacts more favorably with said binding pocket or         domain based on said quantified association of said first or         second chemical entity.

In another embodiment, the invention provides for the method of using a computer for selecting an orientation of a chemical entity with a favorable shape complementarity in a binding pocket comprising the steps of:

-   -   (a) providing the structure coordinates of said binding pocket         and all or part of the ligand bound therein on a computer         comprising the means for generating three-dimensional structural         information from said structure coordinates;     -   (b) employing computational means to dock a first chemical         entity in the binding pocket;     -   (c) quantitating the contact score of said chemical entity in         different orientations; and     -   (d) selecting an orientation with the highest contact score.

In one embodiment, the docking is facilitated by the contact score.

The method above may further comprise the step of generating a three-dimensional graphical representation of the binding pocket and all or part of the ligand bound therein prior to step (b).

The method above may further comprise the steps of:

-   -   (e) repeating steps (b) through (d) with a second chemical         entity; and     -   (f) selecting at least one of said first or second chemical         entity that has a higher contact score based on said quantitated         contact score of said first or second chemical entity.

In another embodiment, the invention provides a method for screening a plurality of chemical entities to associate at a deformation energy of binding of less than −7 kcal/mol with said binding pocket;

-   -   (a) employing computational means, which utilize said structure         coordinates to dock one of said plurality of chemical entities         in said binding pocket;     -   (b) quantifying the deformation energy of binding between the         chemical entity and the binding pocket;     -   (c) repeating steps (a) and (b) for each remaining chemical         entity; and     -   (d) outputting a set of chemical entities that associate with         the binding pocket at a deformation energy of binding of less         than −7 kcal/mol to a suitable output hardware.

In another embodiment, the method comprises the steps of:

-   -   (a) constructing a computer model of the binding pocket of said         molecule or molecular complex;     -   (b) selecting a chemical entity to be evaluated by a method         selected from the group consisting of assembling said chemical         entity; selecting a chemical entity from a small molecule         database; de novo ligand design of said chemical entity; and         modifying a known agonist or inhibitor, or a portion thereof, of         a JAK3 kinase domain, or homologue thereof;     -   (c) employing computational means to dock said chemical entity         to be evaluated in said binding pocket in order to provide an         energy-minimized configuration of said chemical entity in the         binding pocket; and     -   (d) evaluating the results of said docking to quantify the         association between said chemical entity and the binding pocket.

Alternatively, the structure coordinates of the JAK3 binding pocket may be utilized in a method for identifying a candidate inhibitor of a molecule or molecular complex comprising a binding pocket of JAK3. This method comprises the steps of:

-   -   (a) using a three-dimensional structure of the binding pocket or         domain to design, select or optimize a plurality of chemical         entities;     -   (b) contacting each chemical entity with the molecule said         molecular complex;     -   (c) monitoring the inhibition to the catalytic activity of the         molecule or molecular complex by the chemical entity; and     -   (d) selecting a chemical entity based on the effect of the         chemical entity on the activity of the molecule or molecular         complex.

In one embodiment, the three-dimensional structure is displayed as a graphical representation.

In another embodiment, the method comprises the steps of:

-   -   (a) constructing a computer model of a binding pocket of the         molecule or molecular complex;     -   (b) selecting a chemical entity to be evaluated by a method         selected from the group consisting of assembling said chemical         entity; selecting a chemical entity from a small molecule         database; de novo ligand design of said chemical entity; and         modifying a known agonist or inhibitor, or a portion thereof, of         a JAK3 kinase domain or homologue thereof;     -   (c) employing computation means to dock said chemical entity to         be evaluated and said binding pocket in order to provide an         energy-minimized configuration of said chemical entity in the         binding pocket; and     -   (d) evaluating the results of said docking to quantify the         association between said chemical entity and the binding pocket;     -   (e) synthesizing said chemical entity; and     -   (f) contacting said chemical entity with said molecule or         molecular complex to determine the ability of said chemical         entity to activate or inhibit said molecule.

In one embodiment, the invention provides a method of designing a compound or complex that associates with all or part of the binding pocket comprising the steps of:

-   -   (a) providing the structure coordinates of said binding pocket         or domain on a computer comprising the means for generating         three-dimensional structural information from said structure         coordinates;     -   (b) using the computer to dock a first chemical entity in part         of the binding pocket or domain;     -   (c) docking a second chemical entity in another part of the         binding pocket or domain;     -   (d) quantifying the association between the first and second         chemical entity and part of the binding pocket or domain;     -   (e) repeating steps (b) to (d) with another first and second         chemical entity, selecting a first and a second chemical entity         based on said quantified association of all of said first and         second chemical entity;     -   (f) optionally, visually inspecting the relationship of the         first and second chemical entity to each other in relation to         the binding pocket or domain on a computer screen using the         three-dimensional graphical representation of the binding pocket         or domain and said first and second chemical entity; and     -   (g) assembling the first and second chemical entity into a         compound or complex that interacts with said binding pocket by         modeling building.

For the first time, the present invention permits the use of molecular design techniques to identify, select and design chemical entities, including inhibitory compounds, capable of binding to JAK3 or JAK3-like binding pockets, motifs and domains.

Applicant's elucidation of binding pockets on JAK3 provides the necessary information for designing new chemical entities and compounds that may interact with JAK3 substrate, active site, in whole or in part.

Throughout this section, discussions about the ability of a chemical entity to bind to, interact with or inhibit JAK3 binding pockets refer to features of the entity alone.

The design of compounds that bind to or inhibit JAK3 binding pockets according to this invention generally involves consideration of two factors. First, the chemical entity must be capable of physically and structurally associating with parts or all of the JAK3 binding pockets. Non-covalent molecular interactions important in this association include hydrogen bonding, van der Waals interactions, hydrophobic interactions and electrostatic interactions.

Second, the chemical entity must be able to assume a conformation that allows it to associate with the JAK3 binding pockets directly. Although certain positions of the chemical entity will not directly participate in these associations, those portions of the chemical entity may still influence the overall conformation of the molecule. This, in turn, may have a significant impact on potency. Such conformational requirements include the overall three-dimensional structure and orientation of the chemical entity in relation to all or a portion of the binding pocket, or the spacing between functional groups of a chemical entity comprising several chemical entities that directly interact with the JAK3 or JAK3-like binding pockets.

The potential inhibitory or binding effect of a chemical entity on JAK3 binding pockets may be analyzed prior to its actual synthesis and testing by the use of computer modeling techniques. If the theoretical structure of the given entity suggests insufficient interaction and association between it and the JAK3 binding pockets, testing of the entity is obviated. However, if computer modeling indicates a strong interaction, the molecule may then be synthesized and tested for its ability to bind to a JAK3 binding pocket. This may be achieved by testing the ability of the molecule to inhibit JAK3 using the assay described in Example 9.

A potential inhibitor of a JAK3 binding pocket may be computationally evaluated by means of a series of steps in which chemical entities or fragments are screened and selected for their ability to associate with the JAK3 binding pockets.

One skilled in the art may use one of several methods to screen chemical entities or fragments or moieties thereof for their ability to associate with the binding pockets described herein. This process may begin by visual inspection of, for example, any of the binding pockets on the computer screen based on the JAK3 structure coordinates Table 2 or other coordinates which define a similar shape generated from the machine-readable storage medium. Selected chemical entities, or fragments or moieties thereof may then be positioned in a variety of orientations, or docked, within that binding pocket as defined supra. Docking may be accomplished using software such as QUANTA (Accelrys, San Diego, Calif. ©2001, 2002) and Sybyl (Tripos Associates, St. Louis, Mo.), followed by, or performed simultaneously with, energy minimization, rigid-body minimization (Gshwend, supra) and molecular dynamics with standard molecular mechanics force fields, such as CHARMM and AMBER.

Specialized computer programs may also assist in the process of selecting fragments or chemical entities. These include:

-   -   1. GRID (Goodford, P. J., “A Computational Procedure for         Determining Energetically Favorable Binding Sites on         Biologically Important Macromolecules”, J. Med. Chem. 28:         849-857 (1985)). GRID is available from Oxford University,         Oxford, UK.     -   2. MCSS (Miranker et al., “Functionality Maps of Binding Sites:         A Multiple Copy Simultaneous Search Method,” Proteins Struct.         Funct. Genet. 11: 29-34 (1991)). MCSS is available from         Molecular Simulations, San Diego, Calif.     -   3. AUTODOCK (Goodsell, et al., “Automated Docking of Substrates         to Proteins by Simulated Annealing”, Proteins Struct. Funct. and         Genet. 8: 195-202 (1990)). AUTODOCK is available from Scripps         Research Institute, La Jolla, Calif.     -   4. DOCK (Kuntz et al., “A Geometric Approach to         Macromolecule-Ligand Interactions”, J. Mol. Biol. 161: 269-288         (1982)). DOCK is available from University of California, San         Francisco, Calif.

Once suitable chemical entities or fragments have been selected, they can be assembled into single compound or complex. Assembly may be preceded by visual inspection of the relationship of the fragments to each other on the three-dimensional image displayed on a computer screen in relation to the structure coordinates of JAK3. This would be followed by manual model building using software such as QUANTA (Accelrys, San Diego, Calif. ©2001, 2002) or Sybyl (Tripos Associates, St. Louis, Mo.).

Useful programs to aid one of skill in the art in connecting the individual chemical entities or fragments include:

-   -   1. CAVEAT (Bartlett et al., “CAVEAT: A Program to Facilitate the         Structure-Derived Design of Biologically Active Molecules”, in         Molecular Recognition in Chemical and Biological Problems, S. M.         Roberts, Ed., Royal Society of Chemistry, Special Publication         No. 78: 182-196 (1989); Lauri, G. and Bartlett, P. A., “CAVEAT:         A Program to Facilitate the Design of Organic Molecules”, J.         Comp. Aid. Molec. Design 8: 51-66 (1994)), CAVEAT is available         from the University of California, Berkeley, Calif.     -   2. 3D Database systems such as ISIS (MDL Information Systems,         San Leandro, Calif.). This area is reviewed in Martin, Y. C.,         “3D Database Searching in Drug Design”, J. Med. Chem. 35:         2145-2154 (1992).     -   3. HOOK (Eisen et al., “HOOK: A program for Finding Novel         Molecular Architectures that Satisfy the Chemical and Steric         Requirements of a Macromolecule Binding Site”, Proteins Struct.         Funct. Genet. 19: 199-221 (1994)). HOOK is available from         Molecular Simulations, San Diego, Calif.

Instead of proceeding to build an inhibitor of a JAK3 binding pocket in a step-wise fashion one fragment or chemical entity at a time as described above, inhibitory or other JAK3 binding compounds may be designed as a whole or “de novo” using either an empty binding pocket or optionally including some portion(s) of a known inhibitor(s). There are many de novo ligand design methods including:

-   -   1. LUDI (Böhm, J.-J., “The Computer Program LUDI: A New Method         for the De Novo Design of Enzyme Inhibitors”, J. Comp. Aid.         Molec. Design 6: 61-78 (1992)). LUDI is available from Molecular         Simulations Incorporated, San Diego, Calif.     -   2. LEGEND (Nishibata et al., Tetrahedron 47: 8985-8990 (1991)).         LEGEND is available from Molecular Simulations Incorporated, San         Diego, Calif.     -   3. LeapFrog (available from Tripos Associates, St. Louis, Mo.).     -   4. SPROUT (Gillet et al., “SPROUT: A program for Structure         Generation)”, J. Comp. Aid. Molec. Design 7: 127-153 (1993)).         SPROUT is available from the University of Leeds, UK.

Other molecular modeling techniques may also be employed in accordance with this invention (see, e.g., Cohen et al., “Molecular Modeling Software and Methods for Medicinal Chemistry, J. Med. Chem. 33: 883-894 (1990); see also, Navia, M. A. and Murcko, M. A., “The Use of Structural Information in Drug Design”, Current Opinions in Structural Biology 2: 202-210 (1992); Balbes et al., “A Perspective of Modern Methods in Computer-Aided Drug Design”, in Reviews in Computational Chemistry, K. B. Lipkowitz and D. B. Boyd, Eds., VCH Publishers, New York, 5: 337-379 (1994); see also, Guida, W. C., “Software For Structure-Based Drug Design”, Curr. Opin. Struct. Biology 4: 777-781 (1994)).

Once a chemical entity has boon designed or selected by the above methods, the efficiency with which that entity may bind to any of the above binding, pockets may be tested and optimized by computational evaluation. For example, an effective binding pocket inhibitor must preferably demonstrate a relatively small difference in energy between its bound and free states (i.e., a small deformation energy of binding). Thus, the most efficient binding pocket inhibitors should preferably be designed with a deformation energy of binding of not greater than about 10 kcal/mole, more preferably, not greater than 7 kcal/mole. Binding pocket inhibitors may interact with the binding pocket in more than one conformation that is similar in overall binding energy. In those cases, the deformation energy of binding is taken to be the difference between the energy of the free entity and the average energy of the conformation observed when the inhibitor binds to the protein.

A chemical entity designed or selected as binding to any one of the above binding pocket may be further computationally optimized so that in its bound state it would preferably lack repulsive electrostatic interaction with the target enzyme and with the surrounding water molecules. Such non-complementary electrostatic interactions include repulsive charge-charge, dipole-dipole and charge-dipole interactions.

Specific computer software is available in the art to evaluate compound deformation energy and electrostatic interactions. Examples of programs designed for such uses include: Gaussian 94, revision C (M. J. Frisch, Gaussian, Inc., Pittsburgh, Pa. ©1995); AMBER version 4.1 (P. A. Kollman, University of California at San Francisco, ©1995); QUANT/CHARMM (Accelrys, San Diego, Calif. ©2001, 2002); Insight II/Discover (Molecular Simulations, Inc., San Diego, Calif. ©1998); DelPhi (Molecular Simulations, Inc., San Diego, Calif. ©1998); and AMSOL (Quantum Chemistry Program Exchange, Indiana University). These programs may be implemented, for instance, using a Silicon Graphics workstation such as an Indigo2 with “IMPACT” graphics. Other hardware systems and software packages will be known to those skilled in the art.

Another approach enabled by this invention is the computational screening of small molecule databases for chemical entities or compounds that can bind in whole, or in part, to any of the above binding pocket. In this screening, the quality of fit of such entities to the binding pocket may be judged either by shape complementarity or by estimated interaction energy (Meng et al., J. Comp. Chem. 13: 505-524 (1992)).

Another particularly useful drug design technique enabled by this invention is iterative drug design. Iterative drug design is a method for optimizing associations between a protein and a chemical entity by determining and evaluating the three-dimensional structures of successive sets protein/chemical entity complexes.

In iterative drug design, crystals of a series of protein or protein complexes are obtained and then the three-dimensional structures of each crystal is solved. Such an approach provides insight into the associated between the proteins and compounds of each complex. This is accomplished by selecting compounds with inhibitory activity, obtaining crystals of this new protein/compound complex, solving the three-dimensional structure of the complex, and comparing the associations between the new protein/compound complex and previously solved protein/compound complexes. By observing how changes in compound affected the protein-compound associations, these associations may be optimized.

In some cases, iterative drug design is carried out by forming successive protein-compound complexes and then crystallizing each new complex. High throughput crystallization assays may be used to find a new crystallization condition or to optimize the original protein crystallization condition for the new complex. Alternatively, a pre-formed protein crystal may be soaked in the presence of an inhibitor, thereby forming a protein/compound complex and obviating the need to crystallize each individual protein/compound complex.

In one embodiment, this invention provides a method for identifying a candidate inhibitor that interacts with a binding site of a Janus Kinase 3 kinase protein or a homologue thereof, comprising the steps of:

-   -   (a) obtaining a crystal comprising said human Janus Kinase 3         kinase protein or said homologue thereof, wherein the crystal is         characterized with space group P2₁ and has unit cell parameters         of a=59.98 Å, b=90.19 Å, c=69.00 Å; β=111.5°;     -   (b) obtaining the structure coordinates of amino acids of the         crystal step (a), wherein the structure coordinates are set         forth in Table 1;     -   (c) generating a three-dimensional model of said human Janus         Kinase 3 kinase protein or said homologue thereof using the         structure coordinates of the amino acids obtained in step (b), a         root mean square deviation from backbone atoms of said amino         acids of not more than ±2.0 Å;     -   (d) determining a binding site of said human Janus Kinase 3         kinase protein or said homologue thereof from said         three-dimensional model; and     -   (e) performing computer fitting analysis to identify the         candidate inhibitor which interacts with said binding site.

In one embodiment, this method further comprising the step of:

-   -   (f) contacting the identified candidate inhibitor with said         human Janus Kinase 3 kinase protein or said homologue thereof in         order to determine the effect of the inhibitor on human Janus         Kinase 3 kinase protein activity.

In another embodiment, the binding site of said human Janus Kinase 3 kinase protein or said homologue thereof determined in step (d) comprises the structure coordinates according to Table 1 of amino acid residues Gln827, Leu828, Gly829, Lys830, Gly831, Asn 832, Phe833, Gly834, Ser835, Val836, Glu837, Leu838, Val852, Ala853, Val854, Lys855, Gln856, Leu857, Val884, Lys885, Tyr886, Leu900, Val901, Met902, Glu903, Tyr904, Leu905, Pro906, Ser907, Gly908, Cys909, Leu910, Arg911, Asp912, His947, Asp949, Leu950, Ala951, Ala952, Arg953, Asn954, Ile955, Leu956, Val957, Ala966, Asp967, Leu970, Lys978, Glu985, Gln988, Ser989, Pro990 and Trp 993, wherein the root mean square deviation from the backbone atoms of said amino acids is not more than ±2.0 Å.

In one embodiment, this invention provides for a method of for identifying a candidate inhibitor that interacts with a binding site of a human Janus Kinase 3 kinase protein or a homologue thereof, comprising the steps of:

-   -   (a) obtaining a crystal comprising said human Janus Kinase 3         kinase protein or said homologue thereof, wherein the crystal is         characterized with space group P2₁ and has unit cell parameters         of a=59.98 Å, b=90.19 Å, c=69.00 Å; β=111.5°;     -   (b) obtaining the structure coordinates of amino acids of the         crystal of step (a);     -   (c) generating a three-dimensional model of said human Janus         Kinase 3 kinase protein or said homologue thereof using the         structure coordinates of the amino acids generated in step (b),         a root mean square deviation from backbone atoms of said amino         acids of not more than ±2.0 Å;     -   (d) determining a binding site of said human Janus Kinase 3         kinase protein or said homologue thereof from said         three-dimensional model; and     -   (e) performing computer fitting analysis to identify the         candidate inhibitor which interacts with said binding site.

In one embodiment, this method further comprising the step of:

-   -   (f) contacting the identified candidate inhibitor with said         human Janus Kinase 3 kinase protein or said homologue thereof in         order to determine the effect of the inhibitor on human Janus         Kinase 3 kinase protein activity.

In another embodiment, the binding site of said human Janus Kinase 3 kinase protein or said homologue thereof determined in step (d) comprises the structure coordinates according to Table 1 of amino acid residues Gln827, Leu828, Gly829, Lys830, Gly831, Asn 832, Phe833, Gly834, Ser835, Val836, Glu837, Leu838, Val852, Ala853, Val854, Lys855, Gln856, Leu857, Val884, Lys885, Tyr886, Leu900, Val901, Met902, Glu903, Tyr904, Leu905, Pro906, Ser907, Gly908, Cys909, Leu910, Arg911, Asp912, His947, Asp949, Leu950, Ala951, Ala952, Arg953, Asn954, Ile955, Leu956, Val957, Ala966, Asp967, Leu970, Lys978, Glu985, Gln988, Ser989, Pro990 and Trp 993, wherein the root mean square deviation from the backbone atoms of said amino acids is not more than ±2.0 Å.

In another embodiment, this invention provides a method for identifying a candidate inhibitor that interacts with a binding site of a human Janus Kinase 3 kinase protein or a homologue thereof, comprising the step of determining a binding site said human Janus Kinase 3 kinase protein or the homologue thereof from a three-dimensional model to design or identify the candidate inhibitor which interacts with said binding site.

In another embodiment, the binding site of said human Janus Kinase 3 kinase protein or said homologue thereof determined in step (d) comprises the structure coordinates according to Table 1 of amino acid residues Gln827, Leu828, Gly829, Lys830, Gly831, Asn 832, Phe833, Gly834, Ser835, Val836, Glu837, Leu838, Val852, Ala853, Val854, Lys855, Gln856, Leu857, Val884, Lys885, Tyr886, Leu900, Val901, Met902, Glu903, Tyr904, Leu905, Pro906, Ser907, Gly908, Cys909, Leu910, Arg911, Asp912, His947, Asp949, Leu950, Ala951, Ala952, Arg953, Asn954, Ile955, Leu956, Val957, Ala966, Asp967, Leu970, Lys978, Glu985, Gln988, Ser989, Pro990 and Trp 993, wherein the root mean square deviation from the backbone atoms of said amino acids is not more than ±2.0 Å.

In one embodiment, this invention provides a method for identifying a candidate inhibitor of a molecule or molecular complex comprising a binding pocket or domain selected from the group consisting of:

-   -   (i) a set of amino acid residues which are identical to human         Janus Kinase 3 kinase a set of amino acid residues that are         identical to human Janus Kinase 3 amino acid residues Gln827,         Leu828, Gly829, Lys830, Gly831, Asn 832, Phe833, Gly834, Ser835,         Val836, Glu837, Leu838, Val852, Ala853, Val854, Lys855, Gln856,         Leu857, Val884, Lys885, Tyr886, Leu900, Val901, Met902, Glu903,         Tyr904, Leu905, Pro906, Ser907, Gly908, Cys909, Leu910, Arg911,         Asp912, His947, Asp949, Leu950, Ala951, Ala952, Arg953, Asn954,         Ile955, Leu956, Val957, Ala966, Asp967, Leu970, Lys978, Glu985,         Gln988, Ser989, Pro990 and Trp 993, according to Table 1,         wherein the root mean square deviation from the backbone atoms         of said amino acid residues and said human Janus Kinase 3 kinase         amino residues is not greater than about 2.0 Å; and     -   (ii) a set of amino acid residues that are identical to Janus         Kinase 3 kinase amino acid residues according to Table 1,         wherein the root mean square deviation between said set of amino         acid residues and said human Janus Kinase 3 kinase amino acid         residues is not more than about 3.0 Å;     -   comprising the steps of:     -   (a) using a three-dimensional structure of the binding pocket or         domain to design, select or optimize a plurality of chemical         entities; and     -   (b) selecting said candidate inhibitor based on the inhibitory         effect of said chemical entities on a human Janus Kinase 3         kinase protein or a human Janus Kinase 3 kinase protein         homologue on the catalytic activity of the molecule or molecular         complex.

In another embodiment, this invention provides a method of using a crystal of this invention in an inhibitor screening assay comprising:

-   -   (a) selecting a potential inhibitor by performing rational drug         design with a three-dimensional structure determined for the         crystal, wherein said selecting is performed in conjunction with         computer modeling;     -   (b) contacting the potential inhibitor with a kinase; and     -   (c) detecting the ability of the potential inhibitor for         inhibiting the kinase.

Any of the above methods may be used to design peptide or small molecule mimics of the a ligand which may have inhibitory effects on full-length JAK3 protein or fragments thereof, or on full-length JAK3 protein which is mutated in or fragments of the mutated protein thereof.

Structure Determination of Other Molecules

The structure coordinates set forth in Table 2 can also be used in obtaining structural information about other crystallized molecules or molecular complexes. This may be achieved by any of a number of well-known techniques, including molecular replacement.

According to one embodiment, the machine-readable data storage medium comprises a data storage material encoded with a first set of machine readable data which comprises the Fourier transform of at least a portion of the structure coordinates set forth in Table 2 or homology model thereof, and which, when using a machine programmed with instructions for using said data, can be combined with a second set of machine readable data comprising the X-ray diffraction pattern of a molecule or molecular complex to determine at least a portion of the structure coordinates corresponding to the second set of machine readable data.

In another embodiment, the invention provides a computer for determining at least a portion of the structure coordinates corresponding to X-ray diffraction data obtained from a molecule or molecular complex having an unknown structure, wherein said computer comprises:

-   -   (a) a machine-readable data storage medium comprising a data         storage material encoded with machine-readable data, wherein         said data comprises at least a portion of the structure         coordinates of JAK3 according to Table 2 or homology model         thereof;     -   (b) a machine-readable data storage medium comprising a data         storage material encoded with machine-readable data, wherein         said data comprises X-ray diffraction data obtained from said         molecule or molecular complex having an unknown structure; and     -   (c) instructions for performing a Fourier transform of the         machine-readable data of (a) and for processing said         machine-readable data of (b) into structure coordinates.

For example, the Fourier transform of at least a portion of the structure coordinates set forth in Table 2 or homology model thereof may be used to determine at least a portion of the structure coordinates of the molecule or molecular complex.

Therefore, in another embodiment this invention provides a method of utilizing molecular replacement to obtain structural information about a molecule or molecular complex of unknown structure wherein the molecule or molecular complex is sufficiently homologous to JAK3 kinase domain, comprising the steps of:

-   -   (a) crystallizing said molecule or molecular complex of unknown         structure;     -   (b) generating X-ray diffractions data from said crystallized         molecule or molecular complex;     -   (c) applying at least a portion of the JAK3 structure         coordinates set forth in one of Table 2 or a homology model         thereof to the X-ray diffraction data to generate a         three-dimensional electron density map of at least a portion of         the molecule or molecular complex whose structure is unknown;         and     -   (d) generating a structural model of the model or molecular         complex from the three-dimensional electron density map.

In one embodiment, the methods is performed using a computer. In another embodiment, the molecule is selected from the group consisting of JAK3 kinase domain and a JAK3 kinase domain homologue. In another embodiment, the molecular complex is a JAK3 kinase domain complex or a JAK3 kinase domain homologue complex.

By using molecular replacement, all or part of the structure coordinates of JAK3 as provided by this invention (and set forth in Table 2) can be used to determine the structure of a crystallized molecule or molecular complex whose structure is unknown more quickly and efficiently than attempting to determine such information ab initio.

Molecular replacement provides an accurate estimation of the phases for an unknown structure. Phases are a factor in equations used to solve crystal structures that can not be determined directly. Obtaining accurate values for the phases, by methods other than molecular replacement, is a time-consuming process that involves iterative cycles of approximations and refinements and greatly hinders the solution of crystal structures. However, when the crystal structure of a protein containing at least a homologous portion has been solved, the phases from the known structure may provide a satisfactory estimate of the phases for the unknown structure.

Thus, this method involves generating a preliminary model of a molecule or molecular complex whose structure coordinates are unknown, by orienting and positioning the relevant portion of JAK3 kinase domain according to Table 2 within the unit cell of the crystal of the unknown molecule or molecular complex so as best to account for the observed X-ray diffraction pattern of the crystal of the molecule or molecular complex whose structure is unknown. Phases can then be calculated from this model and combined with the observed X-ray diffraction pattern amplitudes to generate an electron density map of the structure whose coordinates are unknown. This, in turn, can be subjected to any well-known model building and structure refinement techniques to provide a final, accurate structure of the unknown crystallized molecule or molecular complex (E. Lattman, “Use of the Rotation and Translation Functions”, in Meth. Enzymol. 115: 55-77 (1985); M. G. Rossmann, ed., “The Molecular Replacement Method”, Int. Sci. Rev. Ser. No. 13, Gordon & Breach, New York (1972)).

The structure of any portion of any crystallized molecule or molecular complex that is sufficiently homologous to any portion of the structure of human JAK3 kinase domain can be resolved by this method.

In one embodiment, the method of molecular replacement is utilized to obtain structural information about a JAK3 homologue. The structure coordinates of JAK3 as provided by this invention are particularly useful in solving the structure of JAK3 complexes that are bound by ligands, substrates and inhibitors.

Furthermore, the structure coordinates of JAK3 kinase domain as provided by this invention are useful in solving the structure of JAK3 kinase domains that have amino acid substitutions, additions and/or deletions (referred to collectively as “JAK3 mutants”, as compared to naturally occurring JAK3). These JAK3 mutants may optionally be crystallized in co-complex with a chemical entity. The crystal structures of a series of such complexes may then be solved by molecular replacement and compared with that of wild-type JAK3. Potential sites for modification within the various binding pockets of the enzyme may thus be identified. This information provides an additional tool for determining the most efficient binding interactions, for example, increased hydrophobic interactions, between JAK3 and a chemical entity or compound.

The structure coordinates are also particularly useful in solving the structure of crystals of the kinase domain of JAK3 or homologues co-complexes with a variety of chemical entities. This approach enables the determination of the optimal sites for interaction between chemical entities, including candidate JAK3 inhibitors. For example, high resolution X-ray diffraction data collected from crystals exposed to different types of solvent allows the determination of where each type of solvent molecule resides. Small molecules that bind tightly to those sites can then be designed and synthesized and tested for their JAK3 inhibition activity.

All of the complexes referred to above may be studied using well-known X-ray diffraction techniques and may be refined using 1.5-3.4 Å resolution X-ray data to an R value of about 0.30 or less using computer software, such as X-PLOR (Yale University, ©1992, distributed by Molecular Simulations, Inc.; see, e.g., Blundell & Johnson, supra; Meth. Enzymol. vol. 114 & 115, H. W. Wyckoff et al., eds. Academic Press (1985)) or CNS (Brunger et al., Acta Cryst. D54: 905-921, (1998)).

In order that this invention be more fully understood, the following examples are set forth. These examples are for the purpose of illustration only and are not to be construed as limiting the scope of the invention in any way.

Example 1 Cloning and Expression of JAK3

The full-length JAK3 cDNA (GenBank accession number AAD22741) was obtained by RT-PCR from human bone marrow mRNA (Clontech). A kinase domain JAK3 (A810-E1115) was cloned by PCR from the previously isolated full-length JAK3 cDNA. The PCR product of the kinase domain was cloned into the baculoviral transfer vector pBEV10 for insect cell expression. The recombinant virus was plaque purified and amplified to obtain a high-titer clonal viral stock. For production, High-5 insect cells were grown to 2×10⁶ cells/ml in Excell-405 medium (JRH Bioscience, Kans., US) and infected with virus at a multiplicity of infection of 2.5 and incubated for 72-96 hours at 27° C.

Using the same procedure above, the following kinase domains of human JAK3 were also cloned and expressed: amino acid residues 810-1124, amino acid residues 810-1104, and amino acid residues 810-1100.

Example 2 Purification of JAK3

Frozen cell paste was thawed in 5 volumes of Buffer A (50 mM Hepes at pH 8.0, 500 mM NaCl, 20% (v/v) glycerol, 0.2% (v/v) Tween 20, 0.05% (v/v) mM β-mercaptoethanol, 5 mM imidazole, 1 mM PMSF, 5 μg/ml leupeptin, 3 mM benzamidine, and 25 μl/L Benzonase (Novagen, Madison, Wis.) and mechanically lysed in a microfluidizer (Microfluidics, Newton, Mass.). The lysate was centrifuged at 54,000×g for 1 hour, and the supernatant incubated with Talon metal affinity resin (Clonetech, Palo Alto, Calif.) overnight at 4° C. After extensive washing with 20 column volumes of Buffer A, the kinase domain was eluted with Buffer A containing 100 mM imidazole with the pH readjusted to 8.0.

The elution pool was concentrated by ultrafiltration (30 KDa MWCO) in an Amicon stirred cell concentrator (Millipore, Billerica, Mass.) and loaded onto a HR 16/60 Superdex-200 size-exclusion column (Amersham Biosciences, Uppsala, Sweden) equilibrated in Buffer B (50 mM Hepes at pH 8.0, 500 mM NaCl, 20% (v/v) glycerol, 5 mM DTT, and 0.05% (w/v) β-octylglucopyranoside). The JAK3 kinase domain was pooled based on SDS-PAGE analysis and MgCl₂ was added to give a final concentration of 20 mM MgCl₂.

The JAK3 kinase domain was loaded onto a γ-phenyl ATP-Sepharose column (Haystead et al., Eur. J. Biochem. 214: 459-467 (1993)) pre-equilibrated with Buffer C (50 mM Hepes at pH 8.0, 20% (v/v) glycerol, 0.5 M NaCl, 20 mM MgCl₂, 0.05% β-octylglucopyranoside, and 5 mM DTT). After washing with two column volumes of Buffer C, JAK3 kinase domain was eluted from the column with 10 mM ADP in Buffer C and the fractions containing JAK3 kinase domain were pooled based on SDS-PAGE analysis.

The hexahistidine tag was cleaved by incubating the protein with 4 units/ml thrombin (Calbiochem, La Jolla, Calif.) at room temperature for two hours. The completion of the cleavage was confirmed by SDS-PAGE and thrombin was removed by treating the protein with benzamidine Sepharose™ 6B (Amersham Biosciences, Uppsala, Sweden) for 30 minutes at room temperature.

The buffer was exchanged to Buffer B using a HR 16/60 Superdex-200 size exclusion column (Amersham Biosciences, Uppsala, Sweden). The kinase domain containing fractions were pooled and concentrated to 15 mg/ml using a 10 KDa MWCO Vivaspin concentrator (Vivascience, Hanover, Germany) in the presence of 2 mM AMP-PNP (ANP) and 4 mM MgCl₂. Samples were subjected to ultracentrifugation at 90,000×g for 10 minutes prior to freezing for storage at −80° C.

Example 3 Crystallization of JAK3-Adenosine Complex

The concentrated protein stored at −80° C. from Example 2 above was thawed on ice and centrifuged in a microcentrifuge for 5 minutes prior to crystallization. The protein (10-15 mg/mL in 50 mM Hepes at pH 8.0, 500 mM NaCl, 20% (v/v) glycerol, 5 mM DTT, and 0.05% (w/v) β-octylglucopyranoside) was crystallized by the vapor diffusion method in sitting drop or hanging drop plates using 20-26% PEG 3350 as the precipitant, 200-260 mM KCl, 20 mM spermine, 10 mM DTT and 100 mM bis-tris pH 6.0. Equal volumes of protein and reservoir solution (0.5 μL) were used to form drops. Bigger drops would also grow from 1.0 μL of protein and 1.0 μL of reservoir solution. Crystals usually grew overnight as extremely thin (150×50×<10 μm) highly malleable plates.

Crystals were grown in the Corning® 384 Well plate (available from Fisher Scientific), Greiner crystallization low profile plates (available from Hampton Research (Aliso Viejo, Calif.)), both the 96-well CrystalQuick™ standard profile round and flat bottom plates (available from Hampton Research (Aliso Viejo, Calif.)), and the 24 well VDX plates (available from Hampton Research Aliso Viejo, Calif.)). The volume of the reservoir for the 384-well plate was 50 μL. The volume of the reservoir for the 96-well low profile plate was 100 μL, and for the CrystalQuick™ plates, it was varied between 70-100 μL.

Crystals were obtained for JAK3 protein constructs comprising amino acid residues 810-1100, amino acid residues 810-1104, amino acid residues 810-1115 and amino acid residues 810-1124.

Example 4 X-Ray Data Collection and Structure Determination

Data was collected from crystals of the protein constructs comprising amino acid residues 810-1115 and 810-1124. The details described below, which generated the final data sets used to solve the structure of human JAK3 kinase domain, are for the protein construct comprising amino acid residues 810-1115.

Cryosolvent (reservoir solution containing 25% glycerol) was slowly mixed with the protein drop until no further mixing was observed. The crystals were mounted in nylon loops and flash frozen directly in the nitrogen stream and then stored in liquid nitrogen until the time of data collection. Flash freezing in the nitrogen stream caused less damage to the crystals than freezing directly into liquid nitrogen. The crystals diffracted to greater than 2.1 Å resolution, but the spot shape was distorted at higher than 2.5 Å resolution, and the data suffered from severe anisotropy. Therefore, although the crystals diffracted to greater than 2.1 Å, data were only useable to 2.5 Å.

The data were collected at the beamline 5.0.2 at the Advanced Light Source (ALS) Berkeley, Calif. using 1.0 Å X-rays and an ADSC CCD detector. The data from the crystal were integrated and scaled using d*TREK (Pflugrath, Acta Crystallogr. D55: 1718-1725 (1999)). Structure factors were calculated using TRUNCATE (Bailey, Acta Crystallogr. D50: 760-763). Table 1 summarizes data collection.

The crystal belonged to spacegroup P2₁ with unit cell dimensions a=59.98 Å, b=90.19 Å, c=69.00 Å, α=90°, β=111.5°, γ=90° with 2 molecules in the asymmetric unit. A second crystal form that belonged to spacegroup P2₁2₁2₁ with unit cell dimensions a=72.36 Å, b=90.04 Å, c=105.60 Å, α=β=γ=90° also formed. The discussions below will be limited to the crystals belonging to the P2₁ spacegroup.

The orientation and position of JAK3 within the asymmetric unit was achieved by molecular replacement using BEAST (Read, Acta Crystallogr. D547: 1373-1382 (2001)). BEAST uses maximum likelihood targets for the rotation and translation functions, and allows the use of multiple models, allowing the creation of a statically-weighted set of averaged structure factors. The use of BEAST was essential in solving the structure. Protein kinases are very flexible molecules in their inactive state (Huse and Kuriyan, Cell 109: pp. 275-282 (20002)). While conventional molecular replacement methods failed, BEAST, which uses maximum likelihood targets for the rotation and translation functions, allowed the use of multiple models, and created from these models a statistically-weighted set of averaged structure factors.

Multiple superimposed kinase domains with the activation loop removed were used as the search model (Protein Data Bank (PDB) accession codes 1M17, 1LUF, 1FVR, 1IEP, 1JPA, 1AGW, 1IR3, 1QPC, and 1GJO). The superposition of the structures was done using the program DeepView (Guex and Peitsch, Electrophoresis 18: 2714-2723). The initial set of structures chosen represented molecules with high sequence homology to JAK3, and were in a variety of conformations. The BEAST rotation function yielded two distinct peaks, which were related by the observed non-crystallographic symmetric. Of the kinase domains used, epidermal grown factor receptor (1M17), had the highest sequence homology to JAK3, therefore, EGFR was used as the initial model for rigid body refinement in CNX (Accelrys, San Diego, Calif.).

Initial calculated electron density maps revealed that the C-terminal domain was positioned correctly, but the N-terminal domain was not. In order to find the proper orientation of the N-terminal domain, several hybrid molecules were created. The C-terminal domain of another tyrosine kinase was superimposed onto the C-terminal domain of EGFR. The new molecule used for rigid body refinement consisted of the C-terminal domain of EGFR and the newly positioned N-terminal domain of the other kinase. Of the hybrid kinases created, the molecule with the N-terminal domain of src kinase (PDB accession code 2SRC) and the C-terminal domain of EGFR yielded an easily interpretable electron density map in both domains.

The position of the ANP ligand could be clearly seen in the initial electron density maps. The structure was refined using CNX (Accelrys, San Diego, Calif.). Initial rigid-body refinement of the hybrid Src-EGFR kinase domain was followed by mutation of the necessary side chains in order to reflect the human JAK3 sequence, and proper placement of those side chains into the initial electron density maps. Subsequent refinement consisted of rounds of energy minimization, simulated annealing, and B factor refinement using NCS restraints, which were alternated with manual rebuilding of the structure in QUANTA (Accelrys, San Diego, Calif. ©2001, 2002).

Table 1 summarizes refinement statistics. Poor electron density was observed for the extreme N-terminus of the molecule (residues 810-812) and no electron density was observed for the extreme C-terminus (residues 1102-1115). A glycerol molecule was modeled into unaccounted electron density near the surface of the molecule. The final refined structure model includes human JAK3 kinase amino acid residues 813-1100 of SEQ ID NO:1.

The asymmetric unit contains two molecules of human JAK3 (labeled as mol A and B in FIG. 1). The overall RMSD for 288 Cα atoms between the two structures is 0.20 Å, and the overall RMSSD for 1152 backbone atoms is 0.23 Å. Throughout the refinement non-crystallographic restraints were used. The largest area of difference between the two molecules is the activation loop. If Molecule B is the fixed molecule and Molecule A is the moving molecule, then the relationship between A and B is the following:

ROTATION MATRIX: −0.54749 −0.00940 0.83676 0.00861 −0.99995 −0.00560 0.83677 0.00414 0.54754 TRANSLATION VECTOR IN AS 4.32576 73.98868 6.79225

The overall R-factor and R_(free) of the final model were 24.5% and 31.1%, respectively. The test set was composed of 7.9% of the total reflections.

Table 2 lists the atomic structure coordinates in Protein Data Bank (PDB)-like format and header for human JAK3 in complex with AMP-PNP (JAK3-AMP-PNP complex), as derived by X-ray diffraction from a crystal of the complex. The structure model includes human JAK3 kinase amino acid residues 813-1100 of SEQ ID NO:1).

The following abbreviations are used in Table 2:

“Atom type” refers to the element whose coordinates are measured. The first letter in the column defines the element.

“Resid” refers to the amino acid residue in the molecular model.

“X, Y, Z” define the atomic position of the element measured.

“B” is a thermal factor that measures movement of the atom around its atomic center.

“Occ” is an occupancy factor that refers to the fraction of the molecules in which each atom occupies the position specified by the coordinates. A value of “1” indicates that each atom has the same conformation, i.e., the same position, in the molecules.

“Mol” refers to a molecule in the asymmetric unit. Mol A and Mol B are JAK3 protein molecules. Mol Y and Mol Z are AMP-PNP. Mol Y and Mol Z binds to Mol A and Mol B of JAK3 protein, respectively. Mol W is water.

Residue “AMP” represents AMP-PNP.

Example 8 Overview of Crystal Structure of JAK3-AMP-PNP Complex

FIG. 1 shows the overall fold of the JAK3 kinase domain. The overall structure of the unactivated JAK3 kinase domain is similar to the typical kinase-fold found in both serine-threonine and tyrosine kinases. The protein structure is composed of two domains connected by a flexible linker or hinge (residues 898-905). The smaller N-terminal domain is mostly β-sheet structure (β1-β5), with the exception of a predominant helix, called the αC helix. The C-terminal domain is composed of two β-strands (β and β8) and seven conserved helices (αD, αE, αEF, and αF-αI), which are found in all protein kinases. However, the JAK3 C-terminal domain also contains structural insertions including an extra helix between αF and αG, referred to herein as αFG.

The JAK3 C-terminal domain region between αF and αG contains a total of three structural insertions when compared to other tyrosine kinases. The first insertion (I1) is between amino acid residues 1024 and 1029. Here the chain juts out away from the C-terminal domain as compared to that of other tyrosine kinases. The structure briefly returns to register with other tyrosine kinases at P1030. The second structural insertion is the short αFG helix (1030-1038). In the αFG helix the side chain of amino acid residue F1034 is in the approximate position of the phenyl ring of a conserved tyrosine found in other tyrosine kinases. The final insertion (I3), amino acid residues 1039-1046, like I1, extends away from The C-terminal domain.

Comparisons of Structures of JAK3-Inhibitor Complexes to Structures of Other Kinases

Comparison of the JAK3 with other protein kinases reveals that the overall orientation of the N- and C-terminal domains is related to that of the Src-2 structure (Xu et al., Mol. Cell 3: pp. 629-638 (1999)). The root mean square deviation between Src-2 and JAK3 using 260 equivalent Cα positions is 3.4 Å. Both structures are in an inactive conformation. Like Src-2 and the unactivated CDK2/ATP structure (Schulze-Gahmen et al., J. Med. Chem. 39: pp. 4540-4546 (1996)), the position of the C-helix results in a nonproductive alignment of the AMP-PNP phosphate groups. The major difference in the overall architecture of the JAK3 structure and the structures of the inactive forms of Src-2 and CDK2/ATP is the αFG helix region and the conformation of the activation loop. In addition, CDK2 is a Serine/Threonine kinase, not a Tyrosine kinase as are Src-2 and JAK3, and as such it has a large insertion region between the G and H helices.

While the N-terminus of the activation loop of JAK3 is similar to that of Src-2 structure, the C-terminus of the activation loop is kinked similar to the activation loops of the FGF-1 receptor/ACP and CDK2/ATP complex structures. This kink effectively blocks the peptide substrate site. In the FGF-1 receptor, although the C-terminus of the activation loop is kinked, the overall structure is in a more open conformation and the activation loop does not reach the glycine-rich loop. However, in the unactivated CDK2/ATP structure, the activation loops does interact with the glycine-rich loop (Schulze-Gahmen et al., J. Med. Chem. 39: pp. 4540-4546 (1996)). In JAK3, N832 of the glycine-rich loop makes two hydrogen bonds to the activation loop. The main chain carbonyl group is hydrogen bonded to the Nζ group of K978 and the Nδ of the side chain is hydrogen bonded to the main chain carbonyl group of E988. The interaction network also includes the γ-phosphate of the ATP analogue.

The active site, which contains the non-hydrolyzable ATP analogue, AMP-PNP, is formed by a groove at the interface between the N and C-terminal lobes. The hinge region, the glycine rich loop (residues 829-834), and the activation loop (residues 967-990) enclose the ligand. The NH2 of the purine ring is hydrogen bonded to the backbone oxygen of Glu 903 (FIG. 6). The phosphates of the AMP-PNP participate in an extensive hydrogen bonding network that includes both the activation and glycine-rich loops (FIG. 6).

The orientation of the N and C-terminal lobes of Jak3 KD1 structure is most similar to that of the unactivated Src kinase (Xu, W., Doshi, A., Lei, M., Eck, M. J. and Harrison, S. C. (1999) Mol Cell 3, 629-638), Cdk-2 (Schulze Gahmen, U. Brandsen, J., Jones, H. D., Morgan, D. O. Meijer, L., Vesely, J., and Kim, S. H. (1995) Proteins 22, 378-391), and the recently solved structures of Mek1 and Mek2 (Ohren, J. F., Chen, H., Pavlovsky, A., Whitehead, C., Zhang, E., Kuffa, P., Yan, C., McConnell, P., Spessard, C., Banotai, C., Mueller, W. T., Delaney, A., Omer, C., Sebolt-Leopold, J. Dudley, D. T., Leung, I. K. Flamme, C., Warmus J., Kaufman, M., Barrett, S., Tecle, H., and Hasemann, C. A. (2004) Nat Struct Mol Biol 11, 1192-1197). The root mean square deviation (r.m.s.d.) between Jak3 and the Src-2, Cdk-2, Mek-1, and Mek-2 structures is 1.15 Å (using 215 equivalent Cα positions), 1.36 Å (using 186 equivalent Cα positions), 1.56 Å (using 190 equivalent Cα positions), and 1.63 Å (using 191 equivalent Cα positions) respectively. As in the previously mentioned structures, the αC-helix which contains the conserved glutamic acid, Glu 871, is swung out, away from the active site preventing the formation of the salt bridge between Glu 871 and the conserved catalytic lysine, Lys 855, which in activated kinases coordinates the α and β phosphates of the ATP. Instead Lys 855 is hydrogen bonded to the α-phosphate of the AMP-PNP, and the aspartic acid, Asp 967, at the beginning of the activation loop. The conformation of the AMP-PNP, the coordination of the Mg²⁺ ion, and the interaction with the catalytic lysine, Lys 855, are all very similar to that seen in the inactive Cdk-2/ATP (Schulze Gahmen, U., De Bondt, H. L., and Kim, S. H. (1996) J Med Chem 39, 4540-4546) and Src-2 structures (Xu, W. Doshi, A., Lei, M., Eck, M. J., and Harrison, S. C. (1999) Mol Cell 3, 629-638).

The beginning of the activation loop, containing the conserved DFG sequence (residues 967-968), is almost identical in conformation to that in the Src-2 and unactivated Cdk-2 structures. However, the Jak3 KD1 activation loop notably diverges from the previously mentioned structures, Src-2 and Cdk-2, as it kinks toward the glycine-rich loop. Superposition of Jak3 on insulin receptor kinase with a bound peptide substrate (PDB #IIR3) clearly showed the kink in the activation loop (residues 978-989) blocks the protein substrate binding site, similar to that seen in unactivated Cdk-2 (PDB #1HCK) (Schulze-Gahmen, U., De Bondt, H. L., and Kim, S. H. (1996) J Med Chem 39, 4540-4546) and fibroblast growth factor receptor kinase (PDB #1FGK (Mohammadi, M., Schlessinger, J., and Hubbard, S. R. (1996) Cell 86, 577-587). This region of the activation loop includes the potential autophosphorylation tyrosines, Tyr 980 and Tyr 981.

Regulation of the Catalytic Domain of JAK3

Regulation of the catalytic domain of Janus kinases takes place through interactions with domains N-terminal to the kinase domain. Both the pseudokinase domain and the FERM domain play pivotal roles in controlling activity of the catalytic domain. Furthermore, it has been shown that both of these domains can interact with the kinase domain. Previous studies in JAK3 have focused on naturally occurring mutations in the FERM domain and pseudokinase domain that have been found in SCID patients. Unique region around αFG is a possible site for interaction with the other JAK3 domains.

Some known SCID mutations affect the kinase domain. There are two known SCID mutations that prematurely terminate the kinase domain. These premature stops remove the αFG-α1 helices. These prematurely terminated kinases probably result in an unstable kinase domain, which may be rapidly degraded in cells. This would explain the undetectable levels of protein expressed in cells containing these mutations. The only naturally occurring point mutation in the catalytic domain resulting in SCID known is the mutation of a leucine at position 910 (L910) to serine. L910 occurs at the beginning of the αD helix. The side chain of L910 contributes to the hydrophobic core of the C-terminal domain. This residue is only five residues away from L905, which is involved in positioning the purine ring of the ATP substrate, and one residue away from R911, R918, have been implicated in binding the peptide substrate at the P-1, P-2 and P-3 positions. The replacement of a highly conserved hydrophobic residue, leucine, with a polar residue, serine, may result in the disruption or distortion of the αD helix, which may affect the binding of either the ATP substrate and/or the peptide substrate.

The invention between αF and αG appears to be a unique feature of the JAK family when compared to the same region in other receptor and non-receptor tyrosine kinases. This insertion structurally encompasses a rather large region on the surface of the kinase domain as compared to other kinases, such as c-scr. The αFG insertion region creates a large potential binding surface for recognition by another domain of the JAK kinases, specifically, the N-terminal FERM domain or the pseudokinase domain or perhaps another protein. In fact, it has been suggested that messages in other domains affect the function of the kinase domain. This region may be docking site for either another domain within the JAK kinase or for an exogenous protein substrate.

Example 9 Activity Assay

To each well of a 96-well polycarbonate plate is added 1.5 μL of a candidate JAK3 inhibitor along with 50 μL of kinase buffer (100 mM Hepes at pH 7.4, 1 mM DTT, 10 mM MgCl₂, 25 mM NaCl and 0.01% BSA) containing 2 uM poly(Glu)₄Tyr and 10 μM ATP. This is then mixed and 50 μL of kinase buffer containing 2 nM JAK3 enzyme is added to start the reaction. After 20 minutes at room temperature (25° C.), the reaction is stopped with 50 μL of 20% trichloroacetic acid (TCA) that also contains 0.4 mM ATP. The entire contents of each well is then transferred to a 96-well glass fiber filter plate using a TomTek Cell Harvester. After washing, 60 μL of scintillation fluid is added and ³³P incorporated is detected on a Perkin Elmer® TopCount instrument.

JAK2 activity can be assayed as above, except that final poly(Glu)₄Tyr concentration is 15 μM and final ATP concentration is 12 μM.

While we have described a number of embodiments of this invention, it is apparent that our basic constructions may be altered to provide other embodiments which utilize the products, processes and methods of this invention.

TABLE 1 Data Collection and Refinement Statistics Data set AMP-PNP Data collection X-ray source ALS 5.0.2 Space group P2₁ Unit cell parameters (Å) a = 59.98 Å, b = 90.19 Å, c = 69.00 Å, β = 111.5° Resolution (Å) 45.54-2.50 (2.59-2.50) Unique reflections 23427 Redundancy 3.23 (3.12) Completeness (%)* 98.6 (94.2) R_(merge)* 0.124 (0.393) <I/σ>* 5.4 (2.2) Refinement Reflections used 22832 Test reflections 1806 R-factor 24.5% (28.5%) Free R-factor (% data) 31.1% (36.1%) RMS deviation Bond lengths (Å) 0.009 Bond angles (°) 1.4 Dihedral angles (°) 22.4 Protein atoms 4612 Solvent atoms 176 *Values for the highest resolution shell are shown in parentheses, R_(merge) = Σ_(hkl )Σ_(i)|I(hkl)_(i )− I(hkl)

|/Σ_(hkl) Σ_(i )

I(hkl)_(i )

 over i observations of reflection hkl. R-factor = Σ||F_(obs)| − |F_(calc)||/Σ|F_(obs)| where F_(obs )and F_(calc )are the observed and calculated structure factors, respectively. Free R-factor is calculated from a randomly chosen subset of reflections not used for refinement.

TABLE 2 REMARK REMARK 3 REFINEMENT. REMARK 3  PROGRAM : CNX 2002 REMARK 3  AUTHORS : Brunger, Adams, Clore, Delano, REMARK 3   Gros, Grosse-Kunstleve, Jiang, REMARK 3   Kuszewski, Nilges, Pannu, Read, REMARK 3   Rice, Simonson, Warren REMARK 3  And REMARK 3 Accelrys Inc., REMARK 3    (Badger, Berard, Kumar, Szalma, REMARK 3  Yip, Dzakula). REMARK 3 REMARK 3  DATA USED IN REFINEMENT. REMARK 3  RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3  RESOLUTION RANGE LOW (ANGSTROMS) :  19.83 REMARK 3  DATA CUTOFF (SIGMA(F)) : 1.0 REMARK 3  DATA CUTOFF HIGH (ABS(F)) :  1153422.38 REMARK 3  DATA CUTOFF LOW (ABS(F)) :   0.000000 REMARK 3  COMPLETENESS (WORKING + TEST) (%) : 96.2 REMARK 3  NUMBER OF REFLECTIONS : 22832 REMARK 3 REMARK 3  FIT TO DATA USED IN REFINEMENT. REMARK 3  CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3  FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3  R VALUE (WORKING SET) : 0.245 REMARK 3  FREE R VALUE : 0.311 REMARK 3  FREE R VALUE TEST SET SIZE (%) :  7.9 REMARK 3  FREE R VALUE TEST SET COUNT :  1806 REMARK 3  ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3  FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3  TOTAL NUMBER OF BINS USED :   6 REMARK 3  BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3  BIN RESOLUTION RANGE LOW (A) : 2.66 REMARK 3  BIN COMPLETENESS (WORKING + TEST) (%) : 94.7 REMARK 3  REFLECTIONS IN BIN (WORKING SET) :  3423 REMARK 3  BIN R VALUE (WORKING SET) : 0.285 REMARK 3  BIN FREE R VALUE : 0.361 REMARK 3  BIN FREE R VALUE TEST SET SIZE (%) :  7.7 REMARK 3  BIN FREE R VALUE TEST SET COUNT :   286 REMARK 3  ESTIMATED ERROR OF BIN FREE R VALUE : 0.021 REMARK 3 REMARK 3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3  PROTEIN ATOMS : 4612 REMARK 3  NUCLEIC ACID ATOMS :   0 REMARK 3  HETEROGEN ATOMS :  64 REMARK 3  SOLVENT ATOMS :  176 REMARK 3 REMARK 3  B VALUES. REMARK 3  FROM WILSON PLOT (A**2) : 24.1 REMARK 3  MEAN B VALUE (OVERALL, A**2) : 33.3 REMARK 3  OVERALL ANISOTROPIC B VALUE. REMARK 3   B11 (A**2) : 5.72 REMARK 3   B22 (A**2) : 0.10 REMARK 3   B33 (A**2) : −5.81 REMARK 3   B12 (A**2) : 0.00 REMARK 3   B13 (A**2) : −4.61 REMARK 3   B23 (A**2) : 0.00 REMARK 3 REMARK 3  BULK SOLVENT MODELING. REMARK 3  METHOD USED : FLAT MODEL REMARK 3  KSOL : 0.398536 REMARK 3  BSOL : 68.0347 (A**2) REMARK 3 REMARK 3  ESTIMATED COORDINATE ERROR. REMARK 3  ESD FROM LUZZATI PLOT (A) : 0.34 REMARK 3  ESD FROM SIGMAA (A) : 0.35 REMARK 3  LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3  CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3  ESD FROM C-V LUZZATI PLOT (A) : 0.45 REMARK 3  ESD FROM C-V SIGMAA (A) : 0.42 REMARK 3 REMARK 3  RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3  BOND LENGTHS (A) : 0.009 REMARK 3  BOND ANGLES (DEGREES) : 1.4 REMARK 3  DIHEDRAL ANGLES (DEGREES) : 22.4 REMARK 3  IMPROPER ANGLES (DEGREES) : 0.82 REMARK 3 REMARK 3  ISOTROPIC THERMAL MODEL: RESTRAINED REMARK 3 REMARK 3  ISOTROPIC THERMAL FACTOR RESTRAINTS.  RMS  SIGMA REMARK 3  MAIN-CHAIN BOND (A**2) :  1.38 ;  1.50 REMARK 3  MAIN-CHAIN ANGLE (A**2) :  2.29 ;  2.00 REMARK 3  SIDE-CHAIN BOND (A**2) :  2.01 ;  2.00 REMARK 3  SIDE-CHAIN ANGLE (A**2) :  2.92 ;  2.50 REMARK 3 REMARK 3  NCS MODEL: CONSTR REMARK 3 REMARK 3  NCS RESTRAINTS.  RMS SIGMA/WEIGHT REMARK 3  GROUP  1  POSITIONAL (A) : NULL ; NULL REMARK 3  GROUP  1  B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3  PARAMETER FILE  1 : ACCELRYS_CNX: libraries/toppar/protein_rep.param REMARK 3  PARAMETER FILE  2 : ACCELRYS_CNX: libraries/toppar/water_rep.param REMARK 3  PARAMETER FILE  3 : parm/missing.dat REMARK 3  PARAMETER FILE  4 : parm/parmxray.xpl REMARK 3  PARAMETER FILE  5 : ACCELRYS_CNX: libraries/toppar/ion.param REMARK 3  TOPOLOGY FILE  1   : ACCELRYS_CNX: libraries/toppar/protein.top REMARK 3  TOPOLOGY FILE  2   : parm/mass1.dat REMARK 3  TOPOLOGY FILE  3   : ACCELRYS_CNX: libraries/toppar/water.top REMARK 3  TOPOLOGY FILE  4   : inhib.gol.rtf REMARK 3  TOPOLOGY FILE  5   : ACCELRYS_CNX: libraries/toppar/ion.top REMARK 3 REMARK 3  OTHER REFINEMENT REMARKS: NULL SEQRES 1 A 288 ASP PRO THR ILE PHE GLU GLU ARG HIS LEU LYS TYR ILE SEQRES 2 A 288 SER GLN LEU GLY LYS GLY ASN PHE GLY SER VAL GLU LEU SEQRES 3 A 288 CYS ARG TYR ASP PRO LEU GLY ASP ASN THR GLY ALA LEU SEQRES 4 A 288 VAL ALA VAL LYS GLN LEU GLN HIS SER GLY PRO ASP GLN SEQRES 5 A 288 GLN ARG ASP PHE GLN ARG GLU ILE GLN ILE LEU LYS ALA SEQRES 6 A 288 LEU HIS SER ASP PHE ILE VAL LYS TYR ARG GLY VAL SER SEQRES 7 A 288 TYR GLY PRO GLY ARG GLN SER LEU ARG LEU VAL MET GLU SEQRES 8 A 288 TYR LEU PRO SER GLY CYS LEU ARG ASP PHE LEU GLN ARG SEQRES 9 A 288 HIS ARG ALA ARG LEU ASP ALA SER ARG LEU LEU LEU TYR SEQRES 10 A 288 SER SER GLN ILE CYS LYS GLY MET GLU TYR LEU GLY SER SEQRES 11 A 288 ARG ARG CYS VAL HIS ARG ASP LEU ALA ALA ARG ASN ILE SEQRES 12 A 288 LEU VAL GLU SER GLU ALA HIS VAL LYS ILE ALA ASP PHE SEQRES 13 A 288 GLY LEU ALA LYS LEU LEU PRO LEU ASP LYS ASP TYR TYR SEQRES 14 A 288 VAL VAL ARG GLU PRO GLY GLN SER PRO ILE PHE TRP TYR SEQRES 15 A 288 ALA PRO GLU SER LEU SER ASP ASN ILE PHE SER ARG GLN SEQRES 16 A 288 SER ASP VAL TRP SER PHE GLY VAL VAL LEU TYR GLU LEU SEQRES 17 A 288 PHE THR TYR CYS ASP LYS SER CYS SER PRO SER ALA GLU SEQRES 18 A 288 PHE LEU ARG MET MET GLY CYS GLU ARG ASP VAL PRO ALA SEQRES 19 A 288 LEU CYS ARG LEU LEU GLU LEU LEU GLU GLU GLY GLN ARG SEQRES 20 A 288 LEU PRO ALA PRO PRO ALA CYS PRO ALA GLU VAL HIS GLU SEQRES 21 A 288 LEU MET LYS LEU CYS TRP ALA PRO SER PRO GLN ASP ARG SEQRES 22 A 288 PRO SER PHE SER ALA LEU GLY PRO GLN LEU ASP MET LEU SEQRES 23 A 288 TRP SER SEQRES 1 B 288 ASP PRO THR ILE PHE GLU GLU ARG HIS LEU LYS TYR ILE SEQRES 2 B 288 SER GLN LEU GLY LYS GLY ASN PHE GLY SER VAL GLU LEU SEQRES 3 B 288 CYS ARG TYR ASP PRO LEU GLY ASP ASN THR GLY ALA LEU SEQRES 4 B 288 VAL ALA VAL LYS GLN LEU GLN HIS SER GLY PRO ASP GLN SEQRES 5 B 288 GLN ARG ASP PHE GLN ARG GLU ILE GLN ILE LEU LYS ALA SEQRES 6 B 288 LEU HIS SER ASP PHE ILE VAL LYS TYR ARG GLY VAL SER SEQRES 7 B 288 TYR GLY PRO GLY ARG GLN SER LEU ARG LEU VAL MET GLU SEQRES 8 B 288 TYR LEU PRO SER GLY CYS LEU ARG ASP PHE LEU GLN ARG SEQRES 9 B 288 HIS ARG ALA ARG LEU ASP ALA SER ARG LEU LEU LEU TYR SEQRES 10 B 288 SER SER GLN ILE CYS LYS GLY MET GLU TYR LEU GLY SER SEQRES 11 B 288 ARG ARG CYS VAL HIS ARG ASP LEU ALA ALA ARG ASN ILE SEQRES 12 B 288 LEU VAL GLU SER GLU ALA HIS VAL LYS ILE ALA ASP PHE SEQRES 13 B 288 GLY LEU ALA LYS LEU LEU PRO LEU ASP LYS ASP TYR TYR SEQRES 14 B 288 VAL VAL ARG GLU PRO GLY GLN SER PRO ILE PHE TRP TYR SEQRES 15 B 288 ALA PRO GLU SER LEU SER ASP ASN ILE PHE SER ARG GLN SEQRES 16 B 288 SER ASP VAL TRP SER PHE GLY VAL VAL LEU TYR GLU LEU SEQRES 17 B 288 PHE THR TYR CYS ASP LYS SER CYS SER PRO SER ALA GLU SEQRES 18 B 288 PHE LEU ARG MET MET GLY CYS GLU ARG ASP VAL PRO ALA SEQRES 19 B 288 LEU CYS ARG LEU LEU GLU LEU LEU GLU GLU GLY GLN ARG SEQRES 20 B 288 LEU PRO ALA PRO PRO ALA CYS PRO ALA GLU VAL HIS GLU SEQRES 21 B 288 LEU MET LYS LEU CYS TRP ALA PRO SER PRO GLN ASP ARG SEQRES 22 B 288 PRO SER PHE SER ALA LEU GLY PRO GLN LEU ASP MET LEU SEQRES 23 B 288 TRP SER CRYST1 59.979   90.191   68.998  90.00 111.49   90.00 P 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016672 0.000000 0.006563 0.00000 SCALE2 0.000000 0.011088 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015576 0.00000 ATOM 1 CB ASP A 813 0.580 50.367 −0.785 1.00 41.79 A C ATOM 2 CG ASP A 813 1.998 49.832 −0.801 1.00 43.65 A C ATOM 3 OD1 ASP A 813 2.838 50.329 −0.016 1.00 46.37 A O ATOM 4 OD2 ASP A 813 2.273 48.916 −1.599 1.00 42.84 A O ATOM 5 C ASP A 813 1.327 52.295 −2.160 1.00 40.95 A C ATOM 6 O ASP A 813 1.392 51.562 −3.146 1.00 42.84 A O ATOM 7 N ASP A 813 −0.881 52.355 −1.021 1.00 40.53 A N ATOM 8 CA ASP A 813 0.529 51.886 −0.931 1.00 41.34 A C ATOM 9 N PRO A 814 1.959 53.476 −2.104 1.00 39.43 A N ATOM 10 CD PRO A 814 1.808 54.433 −0.997 1.00 38.58 A C ATOM 11 CA PRO A 814 2.775 54.055 −3.176 1.00 37.23 A C ATOM 12 CB PRO A 814 3.106 55.453 −2.654 1.00 37.73 A C ATOM 13 CG PRO A 814 1.992 55.748 −1.708 1.00 39.50 A C ATOM 14 C PRO A 814 4.044 53.287 −3.480 1.00 35.24 A C ATOM 15 O PRO A 814 4.660 52.693 −2.598 1.00 34.89 A O ATOM 16 N THR A 815 4.424 53.332 −4.748 1.00 34.06 A N ATOM 17 CA THR A 815 5.634 52.702 −5.241 1.00 31.98 A C ATOM 18 CB THR A 815 5.350 51.911 −6.492 1.00 30.59 A C ATOM 19 OG1 THR A 815 4.429 50.863 −6.172 1.00 30.79 A O ATOM 20 CG2 THR A 815 6.637 51.342 −7.065 1.00 26.89 A C ATOM 21 C THR A 815 6.534 53.867 −5.604 1.00 32.10 A C ATOM 22 O THR A 815 7.705 53.702 −5.925 1.00 30.98 A O ATOM 23 N ILE A 816 5.945 55.054 −5.552 1.00 32.69 A N ATOM 24 CA ILE A 816 6.628 56.297 −5.858 1.00 33.81 A C ATOM 25 CB ILE A 816 6.003 56.976 −7.097 1.00 35.98 A C ATOM 26 CG2 ILE A 816 6.212 58.473 −7.038 1.00 36.08 A C ATOM 27 CG1 ILE A 816 6.586 56.359 −8.378 1.00 38.71 A C ATOM 28 CD1 ILE A 816 6.128 54.918 −8.667 1.00 37.14 A C ATOM 29 C ILE A 816 6.482 57.205 −4.645 1.00 32.03 A C ATOM 30 O ILE A 816 5.380 57.406 −4.146 1.00 33.36 A O ATOM 31 N PHE A 817 7.603 57.736 −4.174 1.00 29.99 A N ATOM 32 CA PHE A 817 7.628 58.601 −3.011 1.00 28.59 A C ATOM 33 CB PHE A 817 8.362 57.897 −1.863 1.00 28.20 A C ATOM 34 CG PHE A 817 7.528 56.863 −1.149 1.00 25.21 A C ATOM 35 CD1 PHE A 817 6.790 57.203 −0.033 1.00 25.13 A C ATOM 36 CD2 PHE A 817 7.481 55.556 −1.593 1.00 23.71 A C ATOM 37 CE1 PHE A 817 6.022 56.258 0.630 1.00 22.04 A C ATOM 38 CE2 PHE A 817 6.712 54.609 −0.928 1.00 21.29 A C ATOM 39 CZ PHE A 817 5.987 54.965 0.181 1.00 19.64 A C ATOM 40 C PHE A 817 8.303 59.927 −3.324 1.00 28.82 A C ATOM 41 O PHE A 817 9.451 59.981 −3.778 1.00 27.53 A O ATOM 42 N GLU A 818 7.575 61.001 −3.064 1.00 29.51 A N ATOM 43 CA GLU A 818 8.067 62.344 −3.311 1.00 31.25 A C ATOM 44 CB GLU A 818 6.872 63.273 −3.540 1.00 31.85 A C ATOM 45 CG GLU A 818 7.228 64.650 −4.033 1.00 35.45 A C ATOM 46 CD GLU A 818 6.011 65.460 −4.446 1.00 36.12 A C ATOM 47 OE1 GLU A 818 6.193 66.667 −4.710 1.00 36.77 A O ATOM 48 OE2 GLU A 818 4.889 64.894 −4.510 1.00 34.70 A O ATOM 49 C GLU A 818 8.884 62.774 −2.097 1.00 30.93 A C ATOM 50 O GLU A 818 8.411 62.680 −0.958 1.00 30.09 A O ATOM 51 N GLU A 819 10.120 63.213 −2.342 1.00 30.52 A N ATOM 52 CA GLU A 819 11.017 63.635 −1.265 1.00 31.39 A C ATOM 53 CB GLU A 819 12.291 64.276 −1.836 1.00 29.12 A C ATOM 54 CG GLU A 819 13.384 63.303 −2.288 1.00 28.07 A C ATOM 55 CD GLU A 819 13.967 62.480 −1.138 1.00 26.19 A C ATOM 56 OE1 GLU A 819 13.771 62.869 0.031 1.00 27.05 A O ATOM 57 OE2 GLU A 819 14.632 61.455 −1.402 1.00 23.85 A O ATOM 58 C GLU A 819 10.349 64.607 −0.297 1.00 33.23 A C ATOM 59 O GLU A 819 10.489 64.477 0.923 1.00 34.49 A O ATOM 60 N ARG A 820 9.616 65.571 −0.843 1.00 34.22 A N ATOM 61 CA ARG A 820 8.917 66.574 −0.042 1.00 35.27 A C ATOM 62 CB ARG A 820 8.063 67.444 −0.973 1.00 36.97 A C ATOM 63 CG ARG A 820 7.375 68.619 −0.321 1.00 41.68 A C ATOM 64 CD ARG A 820 5.891 68.350 −0.106 1.00 46.06 A C ATOM 65 NE ARG A 820 5.539 68.200 1.306 1.00 49.53 A N ATOM 66 CZ ARG A 820 5.588 69.176 2.213 1.00 51.16 A C ATOM 67 NH1 ARG A 820 5.978 70.398 1.867 1.00 50.30 A N ATOM 68 NH2 ARG A 820 5.242 68.926 3.471 1.00 51.02 A N ATOM 69 C ARG A 820 8.046 65.991 1.087 1.00 34.18 A C ATOM 70 O ARG A 820 7.749 66.681 2.060 1.00 35.87 A O ATOM 71 N HIS A 821 7.638 64.730 0.964 1.00 32.13 A N ATOM 72 CA HIS A 821 6.809 64.097 1.980 1.00 29.99 A C ATOM 73 CB HIS A 821 5.700 63.251 1.327 1.00 31.61 A C ATOM 74 CG HIS A 821 4.699 64.054 0.547 1.00 35.95 A C ATOM 75 CD2 HIS A 821 4.203 63.889 −0.703 1.00 35.71 A C ATOM 76 ND1 HIS A 821 4.121 65.205 1.038 1.00 35.92 A N ATOM 77 CE1 HIS A 821 3.319 65.719 0.122 1.00 35.31 A C ATOM 78 NE2 HIS A 821 3.351 64.940 −0.943 1.00 34.98 A N ATOM 79 C HIS A 821 7.630 63.228 2.937 1.00 30.47 A C ATOM 80 O HIS A 821 7.084 62.609 3.845 1.00 31.60 A O ATOM 81 N LEU A 822 8.938 63.155 2.746 1.00 29.14 A N ATOM 82 CA LEU A 822 9.734 62.357 3.669 1.00 30.38 A C ATOM 83 CB LEU A 822 10.779 61.516 2.911 1.00 28.09 A C ATOM 84 CG LEU A 822 10.229 60.403 1.992 1.00 27.43 A C ATOM 85 CD1 LEU A 822 11.359 59.787 1.205 1.00 25.73 A C ATOM 86 CD2 LEU A 822 9.504 59.322 2.811 1.00 24.78 A C ATOM 87 C LEU A 822 10.402 63.296 4.678 1.00 30.74 A C ATOM 88 O LEU A 822 11.342 64.017 4.353 1.00 31.28 A O ATOM 89 N LYS A 823 9.893 63.305 5.903 1.00 31.44 A N ATOM 90 CA LYS A 823 10.455 64.169 6.934 1.00 31.93 A C ATOM 91 CB LYS A 823 9.367 64.596 7.917 1.00 32.76 A C ATOM 92 CG LYS A 823 8.439 65.660 7.385 1.00 35.51 A C ATOM 93 CD LYS A 823 7.557 65.135 6.284 1.00 37.19 A C ATOM 94 CE LYS A 823 6.627 66.226 5.808 1.00 36.96 A C ATOM 95 NZ LYS A 823 7.411 67.355 5.255 1.00 39.29 A N ATOM 96 C LYS A 823 11.601 63.513 7.700 1.00 30.88 A C ATOM 97 O LYS A 823 11.407 62.522 8.405 1.00 29.92 A O ATOM 98 N TYR A 824 12.793 64.080 7.549 1.00 30.36 A N ATOM 99 CA TYR A 824 13.986 63.584 8.225 1.00 31.67 A C ATOM 100 CB TYR A 824 15.169 64.521 7.956 1.00 31.69 A C ATOM 101 CG TYR A 824 16.378 64.226 8.821 1.00 33.19 A C ATOM 102 CD1 TYR A 824 17.277 63.221 8.476 1.00 34.10 A C ATOM 103 CE1 TYR A 824 18.358 62.910 9.281 1.00 34.40 A C ATOM 104 CD2 TYR A 824 16.598 64.921 10.006 1.00 34.17 A C ATOM 105 CE2 TYR A 824 17.681 64.613 10.822 1.00 36.17 A C ATOM 106 CZ TYR A 824 18.555 63.603 10.452 1.00 36.25 A C ATOM 107 OH TYR A 824 19.612 63.258 11.263 1.00 37.45 A O ATOM 108 C TYR A 824 13.788 63.481 9.738 1.00 32.15 A C ATOM 109 O TYR A 824 13.279 64.406 10.369 1.00 29.97 A O ATOM 110 N ILE A 825 14.190 62.356 10.321 1.00 33.67 A N ATOM 111 CA ILE A 825 14.065 62.188 11.762 1.00 34.78 A C ATOM 112 CB ILE A 825 13.177 60.959 12.123 1.00 34.51 A C ATOM 113 CG2 ILE A 825 13.321 60.619 13.600 1.00 32.74 A C ATOM 114 CG1 ILE A 825 11.703 61.262 11.801 1.00 33.78 A C ATOM 115 CD1 ILE A 825 10.735 60.128 12.156 1.00 31.83 A C ATOM 116 C ILE A 825 15.458 62.040 12.380 1.00 36.16 A C ATOM 117 O ILE A 825 15.781 62.696 13.377 1.00 36.26 A O ATOM 118 N SER A 826 16.284 61.194 11.770 1.00 36.00 A N ATOM 119 CA SER A 826 17.645 60.963 12.247 1.00 37.27 A C ATOM 120 CB SER A 826 17.637 60.362 13.653 1.00 37.84 A C ATOM 121 OG SER A 826 17.216 59.011 13.615 1.00 41.26 A O ATOM 122 C SER A 826 18.383 60.017 11.312 1.00 36.08 A C ATOM 123 O SER A 826 17.785 59.401 10.433 1.00 36.11 A O ATOM 124 N GLN A 827 19.693 59.914 11.499 1.00 35.73 A N ATOM 125 CA GLN A 827 20.495 59.034 10.672 1.00 35.07 A C ATOM 126 CB GLN A 827 21.853 59.660 10.372 1.00 36.39 A C ATOM 127 CG GLN A 827 21.839 60.555 9.144 1.00 41.54 A C ATOM 128 CD GLN A 827 23.123 61.333 8.970 1.00 44.27 A C ATOM 129 OE1 GLN A 827 23.527 62.094 9.852 1.00 46.01 A O ATOM 130 NE2 GLN A 827 23.773 61.147 7.830 1.00 46.06 A N ATOM 131 C GLN A 827 20.685 57.706 11.362 1.00 34.12 A C ATOM 132 O GLN A 827 20.851 57.646 12.579 1.00 32.64 A O ATOM 133 N LEU A 828 20.644 56.639 10.568 1.00 32.89 A N ATOM 134 CA LEU A 828 20.818 55.294 11.084 1.00 30.70 A C ATOM 135 CB LEU A 828 19.852 54.338 10.380 1.00 29.69 A C ATOM 136 CG LEU A 828 18.371 54.593 10.675 1.00 30.57 A C ATOM 137 CD1 LEU A 828 17.500 53.653 9.851 1.00 28.22 A C ATOM 138 CD2 LEU A 828 18.107 54.400 12.174 1.00 27.72 A C ATOM 139 C LEU A 828 22.253 54.793 10.937 1.00 28.35 A C ATOM 140 O LEU A 828 22.695 53.966 11.716 1.00 27.97 A O ATOM 141 N GLY A 829 22.981 55.293 9.945 1.00 29.46 A N ATOM 142 CA GLY A 829 24.354 54.853 9.756 1.00 28.42 A C ATOM 143 C GLY A 829 24.780 54.760 8.302 1.00 27.74 A C ATOM 144 O GLY A 829 23.968 54.944 7.394 1.00 25.98 A O ATOM 145 N LYS A 830 26.064 54.472 8.092 1.00 27.82 A N ATOM 146 CA LYS A 830 26.658 54.339 6.765 1.00 28.70 A C ATOM 147 CB LYS A 830 27.716 55.418 6.542 1.00 31.68 A C ATOM 148 CG LYS A 830 28.729 55.005 5.483 1.00 38.00 A C ATOM 149 CD LYS A 830 30.008 55.815 5.517 1.00 42.10 A C ATOM 150 CE LYS A 830 31.047 55.190 4.587 1.00 44.14 A C ATOM 151 NZ LYS A 830 32.187 56.113 4.301 1.00 46.55 A N ATOM 152 C LYS A 830 27.327 52.968 6.636 1.00 27.26 A C ATOM 153 O LYS A 830 28.028 52.535 7.546 1.00 27.49 A O ATOM 154 N GLY A 831 27.131 52.300 5.501 1.00 25.76 A N ATOM 155 CA GLY A 831 27.716 50.985 5.302 1.00 24.03 A C ATOM 156 C GLY A 831 28.751 50.940 4.196 1.00 23.33 A C ATOM 157 O GLY A 831 29.557 51.861 4.063 1.00 23.56 A O ATOM 158 N ASN A 832 28.704 49.869 3.401 1.00 23.05 A N ATOM 159 CA ASN A 832 29.613 49.614 2.278 1.00 21.30 A C ATOM 160 CB ASN A 832 29.756 48.104 2.063 1.00 19.33 A C ATOM 161 CG ASN A 832 30.556 47.424 3.150 1.00 18.24 A C ATOM 162 OD1 ASN A 832 31.731 47.712 3.315 1.00 18.72 A O ATOM 163 ND2 ASN A 832 29.927 46.511 3.890 1.00 13.29 A N ATOM 164 C ASN A 832 29.182 50.222 0.946 1.00 22.90 A C ATOM 165 O ASN A 832 29.986 50.315 0.018 1.00 22.04 A O ATOM 166 N PHE A 833 27.913 50.604 0.829 1.00 24.50 A N ATOM 167 CA PHE A 833 27.439 51.157 −0.434 1.00 25.47 A C ATOM 168 CB PHE A 833 26.633 50.109 −1.197 1.00 24.25 A C ATOM 169 CG PHE A 833 27.366 48.819 −1.401 1.00 24.66 A C ATOM 170 CD1 PHE A 833 27.226 47.778 −0.497 1.00 24.28 A C ATOM 171 CD2 PHE A 833 28.215 48.650 −2.485 1.00 23.57 A C ATOM 172 CE1 PHE A 833 27.919 46.591 −0.672 1.00 23.07 A C ATOM 173 CE2 PHE A 833 28.910 47.464 −2.662 1.00 23.02 A C ATOM 174 CZ PHE A 833 28.761 46.437 −1.755 1.00 21.21 A C ATOM 175 C PHE A 833 26.618 52.426 −0.333 1.00 26.66 A C ATOM 176 O PHE A 833 26.543 53.175 −1.299 1.00 29.44 A O ATOM 177 N GLY A 834 26.002 52.667 0.822 1.00 26.24 A N ATOM 178 CA GLY A 834 25.199 53.859 0.986 1.00 26.25 A C ATOM 179 C GLY A 834 24.949 54.274 2.428 1.00 29.49 A C ATOM 180 O GLY A 834 25.604 53.809 3.370 1.00 30.21 A O ATOM 181 N SER A 835 23.990 55.171 2.610 1.00 29.04 A N ATOM 182 CA SER A 835 23.665 55.644 3.938 1.00 30.18 A C ATOM 183 CB SER A 835 24.092 57.104 4.099 1.00 29.43 A C ATOM 184 OG SER A 835 24.164 57.744 2.840 1.00 32.95 A O ATOM 185 C SER A 835 22.178 55.480 4.138 1.00 29.88 A C ATOM 186 O SER A 835 21.420 55.418 3.166 1.00 31.77 A O ATOM 187 N VAL A 836 21.770 55.404 5.400 1.00 28.84 A N ATOM 188 CA VAL A 836 20.373 55.201 5.752 1.00 27.14 A C ATOM 189 CB VAL A 836 20.167 53.788 6.323 1.00 26.52 A C ATOM 190 CG1 VAL A 836 18.684 53.558 6.635 1.00 26.80 A C ATOM 191 CG2 VAL A 836 20.697 52.747 5.336 1.00 26.73 A C ATOM 192 C VAL A 836 19.874 56.195 6.783 1.00 28.59 A C ATOM 193 O VAL A 836 20.559 56.489 7.771 1.00 27.84 A O ATOM 194 N GLU A 837 18.666 56.698 6.550 1.00 28.68 A N ATOM 195 CA GLU A 837 18.032 57.646 7.460 1.00 29.30 A C ATOM 196 CB GLU A 837 17.847 58.998 6.780 1.00 29.51 A C ATOM 197 CG GLU A 837 19.100 59.647 6.279 1.00 29.26 A C ATOM 198 CD GLU A 837 18.836 61.075 5.896 1.00 28.21 A C ATOM 199 OE1 GLU A 837 17.661 61.375 5.602 1.00 29.43 A O ATOM 200 OE2 GLU A 837 19.781 61.890 5.880 1.00 29.52 A O ATOM 201 C GLU A 837 16.656 57.143 7.902 1.00 30.42 A C ATOM 202 O GLU A 837 16.020 56.341 7.206 1.00 30.43 A O ATOM 203 N LEU A 838 16.201 57.618 9.061 1.00 30.98 A N ATOM 204 CA LEU A 838 14.886 57.253 9.584 1.00 30.21 A C ATOM 205 CB LEU A 838 14.921 57.034 11.100 1.00 30.08 A C ATOM 206 CG LEU A 838 13.571 56.846 11.822 1.00 30.36 A C ATOM 207 CD1 LEU A 838 12.825 55.640 11.294 1.00 29.07 A C ATOM 208 CD2 LEU A 838 13.812 56.679 13.297 1.00 29.13 A C ATOM 209 C LEU A 838 14.002 58.437 9.271 1.00 31.11 A C ATOM 210 O LEU A 838 14.210 59.528 9.804 1.00 33.21 A O ATOM 211 N CYS A 839 13.030 58.225 8.392 1.00 30.58 A N ATOM 212 CA CYS A 839 12.113 59.282 7.996 1.00 31.03 A C ATOM 213 CB CYS A 839 12.262 59.581 6.503 1.00 29.27 A C ATOM 214 SG CYS A 839 13.914 59.993 5.930 1.00 27.80 A S ATOM 215 C CYS A 839 10.654 58.916 8.261 1.00 32.73 A C ATOM 216 O CYS A 839 10.316 57.768 8.563 1.00 33.99 A O ATOM 217 N ARG A 840 9.780 59.900 8.134 1.00 32.93 A N ATOM 218 CA ARG A 840 8.372 59.642 8.312 1.00 34.97 A C ATOM 219 CB ARG A 840 7.820 60.439 9.499 1.00 37.08 A C ATOM 220 CG ARG A 840 6.325 60.238 9.734 1.00 39.75 A C ATOM 221 CD ARG A 840 5.744 61.214 10.764 1.00 42.91 A C ATOM 222 NE ARG A 840 6.009 60.817 12.145 1.00 45.02 A N ATOM 223 CZ ARG A 840 6.779 61.492 12.995 1.00 46.42 A C ATOM 224 NH1 ARG A 840 7.378 62.617 12.616 1.00 45.99 A N ATOM 225 NH2 ARG A 840 6.950 61.036 14.231 1.00 46.11 A N ATOM 226 C ARG A 840 7.685 60.072 7.029 1.00 34.39 A C ATOM 227 O ARG A 840 7.911 61.177 6.544 1.00 33.96 A O ATOM 228 N TYR A 841 6.885 59.184 6.452 1.00 36.23 A N ATOM 229 CA TYR A 841 6.145 59.516 5.241 1.00 38.35 A C ATOM 230 CB TYR A 841 5.696 58.246 4.511 1.00 38.71 A C ATOM 231 CG TYR A 841 4.982 58.516 3.206 1.00 38.68 A C ATOM 232 CD1 TYR A 841 5.490 59.430 2.294 1.00 37.37 A C ATOM 233 CE1 TYR A 841 4.859 59.673 1.101 1.00 36.58 A C ATOM 234 CD2 TYR A 841 3.811 57.848 2.878 1.00 39.63 A C ATOM 235 CE2 TYR A 841 3.172 58.085 1.680 1.00 39.84 A C ATOM 236 CZ TYR A 841 3.703 58.998 0.798 1.00 38.61 A C ATOM 237 OH TYR A 841 3.066 59.234 −0.397 1.00 41.90 A O ATOM 238 C TYR A 841 4.947 60.259 5.801 1.00 40.68 A C ATOM 239 O TYR A 841 4.146 59.679 6.531 1.00 40.74 A O ATOM 240 N ASP A 842 4.832 61.543 5.474 1.00 43.88 A N ATOM 241 CA ASP A 842 3.755 62.370 6.009 1.00 46.15 A C ATOM 242 CB ASP A 842 4.326 63.219 7.152 1.00 46.02 A C ATOM 243 CG ASP A 842 3.358 63.397 8.303 1.00 46.16 A C ATOM 244 OD1 ASP A 842 2.749 62.395 8.730 1.00 46.36 A O ATOM 245 OD2 ASP A 842 3.225 64.538 8.797 1.00 44.93 A O ATOM 246 C ASP A 842 3.135 63.277 4.950 1.00 48.03 A C ATOM 247 O ASP A 842 3.262 64.500 5.029 1.00 47.67 A O ATOM 248 N PRO A 843 2.453 62.688 3.948 1.00 50.40 A N ATOM 249 CD PRO A 843 2.212 61.242 3.809 1.00 50.93 A C ATOM 250 CA PRO A 843 1.801 63.427 2.858 1.00 51.87 A C ATOM 251 CB PRO A 843 0.980 62.348 2.154 1.00 51.29 A C ATOM 252 CG PRO A 843 1.792 61.125 2.359 1.00 50.63 A C ATOM 253 C PRO A 843 0.923 64.556 3.389 1.00 53.34 A C ATOM 254 O PRO A 843 0.848 65.633 2.798 1.00 54.36 A O ATOM 255 N LEU A 844 0.263 64.295 4.511 1.00 54.96 A N ATOM 256 CA LEU A 844 −0.612 65.273 5.144 1.00 56.98 A C ATOM 257 CB LEU A 844 −1.832 64.569 5.745 1.00 57.16 A C ATOM 258 CG LEU A 844 −2.540 63.518 4.878 1.00 57.83 A C ATOM 259 CD1 LEU A 844 −2.826 64.080 3.490 1.00 57.39 A C ATOM 260 CD2 LEU A 844 −1.667 62.287 4.770 1.00 58.93 A C ATOM 261 C LEU A 844 0.158 66.004 6.245 1.00 58.02 A C ATOM 262 O LEU A 844 1.173 65.510 6.736 1.00 58.53 A O ATOM 263 N GLY A 845 −0.320 67.178 6.636 1.00 59.34 A N ATOM 264 CA GLY A 845 0.366 67.926 7.676 1.00 60.48 A C ATOM 265 C GLY A 845 0.607 67.135 8.956 1.00 61.50 A C ATOM 266 O GLY A 845 1.748 66.986 9.400 1.00 61.55 A O ATOM 267 N ASP A 846 −0.471 66.631 9.551 1.00 61.30 A N ATOM 268 CA ASP A 846 −0.383 65.862 10.785 1.00 61.54 A C ATOM 269 CB ASP A 846 −1.731 65.199 11.100 1.00 63.49 A C ATOM 270 CG ASP A 846 −2.244 64.334 9.960 1.00 64.35 A C ATOM 271 OD1 ASP A 846 −3.385 63.835 10.056 1.00 66.21 A O ATOM 272 OD2 ASP A 846 −1.510 64.148 8.968 1.00 65.16 A O ATOM 273 C ASP A 846 0.700 64.806 10.684 1.00 61.10 A C ATOM 274 O ASP A 846 0.805 64.108 9.677 1.00 61.50 A O ATOM 275 N ASN A 847 1.501 64.690 11.735 1.00 59.87 A N ATOM 276 CA ASN A 847 2.589 63.723 11.763 1.00 57.70 A C ATOM 277 CB ASN A 847 3.512 64.038 12.924 1.00 58.23 A C ATOM 278 CG ASN A 847 4.087 65.416 12.826 1.00 58.62 A C ATOM 279 OD1 ASN A 847 4.999 65.663 12.039 1.00 59.48 A O ATOM 280 ND2 ASN A 847 3.543 66.337 13.607 1.00 59.51 A N ATOM 281 C ASN A 847 2.083 62.304 11.895 1.00 55.91 A C ATOM 282 O ASN A 847 2.803 61.426 12.374 1.00 56.51 A O ATOM 283 N THR A 848 0.845 62.085 11.465 1.00 53.41 A N ATOM 284 CA THR A 848 0.222 60.771 11.541 1.00 51.20 A C ATOM 285 CB THR A 848 −1.273 60.836 11.136 1.00 50.55 A C ATOM 286 OG1 THR A 848 −1.390 61.250 9.768 1.00 49.25 A O ATOM 287 CG2 THR A 848 −2.023 61.818 12.023 1.00 49.29 A C ATOM 288 C THR A 848 0.920 59.735 10.663 1.00 50.05 A C ATOM 289 O THR A 848 0.606 58.547 10.732 1.00 51.27 A O ATOM 290 N GLY A 849 1.866 60.184 9.845 1.00 47.22 A N ATOM 291 CA GLY A 849 2.582 59.274 8.965 1.00 44.27 A C ATOM 292 C GLY A 849 3.322 58.124 9.632 1.00 41.86 A C ATOM 293 O GLY A 849 3.518 58.109 10.848 1.00 42.65 A O ATOM 294 N ALA A 850 3.750 57.159 8.822 1.00 40.05 A N ATOM 295 CA ALA A 850 4.467 55.984 9.315 1.00 37.02 A C ATOM 296 CB ALA A 850 3.994 54.730 8.571 1.00 36.14 A C ATOM 297 C ALA A 850 5.979 56.103 9.188 1.00 36.11 A C ATOM 298 O ALA A 850 6.501 56.891 8.397 1.00 35.06 A O ATOM 299 N LEU A 851 6.682 55.309 9.982 1.00 34.16 A N ATOM 300 CA LEU A 851 8.130 55.307 9.930 1.00 33.37 A C ATOM 301 CB LEU A 851 8.704 54.832 11.264 1.00 35.31 A C ATOM 302 CG LEU A 851 9.165 55.901 12.257 1.00 36.20 A C ATOM 303 CD1 LEU A 851 8.253 57.120 12.182 1.00 36.82 A C ATOM 304 CD2 LEU A 851 9.181 55.297 13.664 1.00 34.32 A C ATOM 305 C LEU A 851 8.611 54.394 8.806 1.00 31.96 A C ATOM 306 O LEU A 851 8.015 53.354 8.540 1.00 31.31 A O ATOM 307 N VAL A 852 9.682 54.802 8.134 1.00 31.01 A N ATOM 308 CA VAL A 852 10.258 54.012 7.055 1.00 27.90 A C ATOM 309 CB VAL A 852 9.715 54.441 5.672 1.00 26.77 A C ATOM 310 CG1 VAL A 852 8.205 54.243 5.603 1.00 28.29 A C ATOM 311 CG2 VAL A 852 10.065 55.876 5.416 1.00 24.56 A C ATOM 312 C VAL A 852 11.773 54.200 7.047 1.00 29.02 A C ATOM 313 O VAL A 852 12.286 55.216 7.528 1.00 28.76 A O ATOM 314 N ALA A 853 12.486 53.212 6.513 1.00 28.28 A N ATOM 315 CA ALA A 853 13.937 53.293 6.404 1.00 27.51 A C ATOM 316 CB ALA A 853 14.564 51.949 6.642 1.00 27.05 A C ATOM 317 C ALA A 853 14.218 53.749 4.985 1.00 28.18 A C ATOM 318 O ALA A 853 13.746 53.132 4.016 1.00 28.55 A O ATOM 319 N VAL A 854 14.983 54.828 4.857 1.00 26.18 A N ATOM 320 CA VAL A 854 15.297 55.366 3.546 1.00 25.26 A C ATOM 321 CB VAL A 854 14.806 56.815 3.404 1.00 24.58 A C ATOM 322 CG1 VAL A 854 15.175 57.355 2.020 1.00 25.67 A C ATOM 323 CG2 VAL A 854 13.306 56.868 3.640 1.00 20.74 A C ATOM 324 C VAL A 854 16.779 55.343 3.275 1.00 25.34 A C ATOM 325 O VAL A 854 17.523 56.142 3.827 1.00 27.35 A O ATOM 326 N LYS A 855 17.211 54.430 2.418 1.00 24.66 A N ATOM 327 CA LYS A 855 18.622 54.339 2.091 1.00 25.16 A C ATOM 328 CB LYS A 855 19.087 52.877 2.050 1.00 22.54 A C ATOM 329 CG LYS A 855 20.264 52.682 1.088 1.00 20.44 A C ATOM 330 CD LYS A 855 20.761 51.253 0.972 1.00 18.74 A C ATOM 331 CE LYS A 855 21.444 50.753 2.237 1.00 18.04 A C ATOM 332 NZ LYS A 855 22.347 49.633 1.878 1.00 16.00 A N ATOM 333 C LYS A 855 18.944 54.987 0.746 1.00 26.42 A C ATOM 334 O LYS A 855 18.185 54.861 −0.214 1.00 23.35 A O ATOM 335 N GLN A 856 20.071 55.693 0.702 1.00 27.46 A N ATOM 336 CA GLN A 856 20.557 56.315 −0.522 1.00 29.59 A C ATOM 337 CB GLN A 856 20.792 57.818 −0.325 1.00 29.19 A C ATOM 338 CG GLN A 856 21.044 58.568 −1.637 1.00 32.25 A C ATOM 339 CD GLN A 856 21.048 60.101 −1.489 1.00 33.60 A C ATOM 340 OE1 GLN A 856 21.849 60.654 −0.742 1.00 38.48 A O ATOM 341 NE2 GLN A 856 20.157 60.782 −2.213 1.00 28.07 A N ATOM 342 C GLN A 856 21.882 55.624 −0.875 1.00 30.88 A C ATOM 343 O GLN A 856 22.804 55.563 −0.054 1.00 31.97 A O ATOM 344 N LEU A 857 21.967 55.088 −2.085 1.00 32.50 A N ATOM 345 CA LEU A 857 23.178 54.412 −2.542 1.00 35.93 A C ATOM 346 CB LEU A 857 22.837 53.379 −3.620 1.00 33.15 A C ATOM 347 CG LEU A 857 21.875 52.268 −3.202 1.00 31.85 A C ATOM 348 CD1 LEU A 857 21.562 51.361 −4.379 1.00 31.75 A C ATOM 349 CD2 LEU A 857 22.494 51.484 −2.072 1.00 31.93 A C ATOM 350 C LEU A 857 24.202 55.386 −3.114 1.00 38.69 A C ATOM 351 O LEU A 857 23.845 56.347 −3.796 1.00 37.21 A O ATOM 352 N GLN A 858 25.473 55.146 −2.814 1.00 43.02 A N ATOM 353 CA GLN A 858 26.540 55.979 −3.347 1.00 48.51 A C ATOM 354 CB GLN A 858 27.899 55.516 −2.808 1.00 49.56 A C ATOM 355 CG GLN A 858 29.091 56.039 −3.601 1.00 52.69 A C ATOM 356 CD GLN A 858 30.384 55.277 −3.320 1.00 55.55 A C ATOM 357 OE1 GLN A 858 30.403 54.044 −3.301 1.00 56.97 A O ATOM 358 NE2 GLN A 858 31.474 56.013 −3.113 1.00 56.46 A N ATOM 359 C GLN A 858 26.465 55.749 −4.854 1.00 51.62 A C ATOM 360 O GLN A 858 26.836 54.687 −5.354 1.00 52.30 A O ATOM 361 N HIS A 859 25.968 56.737 −5.579 1.00 56.16 A N ATOM 362 CA HIS A 859 25.827 56.591 −7.019 1.00 59.85 A C ATOM 363 CB HIS A 859 24.361 56.781 −7.414 1.00 60.11 A C ATOM 364 CG HIS A 859 24.025 56.251 −8.772 1.00 61.57 A C ATOM 365 CD2 HIS A 859 23.561 56.872 −9.882 1.00 62.54 A C ATOM 366 ND1 HIS A 859 24.157 54.921 −9.103 1.00 62.61 A N ATOM 367 CE1 HIS A 859 23.789 54.743 −10.360 1.00 63.08 A C ATOM 368 NE2 HIS A 859 23.423 55.911 −10.855 1.00 63.34 A N ATOM 369 C HIS A 859 26.699 57.605 −7.744 1.00 61.51 A C ATOM 370 O HIS A 859 26.380 58.794 −7.795 1.00 62.00 A O ATOM 371 N SER A 860 27.811 57.129 −8.291 1.00 63.34 A N ATOM 372 CA SER A 860 28.726 57.996 −9.018 1.00 64.52 A C ATOM 373 CB SER A 860 30.132 57.916 −8.416 1.00 65.20 A C ATOM 374 OG SER A 860 30.108 58.201 −7.025 1.00 65.35 A O ATOM 375 C SER A 860 28.746 57.574 −10.480 1.00 65.06 A C ATOM 376 O SER A 860 29.523 56.708 −10.886 1.00 64.96 A O ATOM 377 N GLY A 861 27.862 58.198 −11.252 1.00 65.21 A N ATOM 378 CA GLY A 861 27.738 57.924 −12.670 1.00 65.25 A C ATOM 379 C GLY A 861 26.374 58.427 −13.094 1.00 65.25 A C ATOM 380 O GLY A 861 25.606 58.885 −12.245 1.00 65.70 A O ATOM 381 N PRO A 862 26.032 58.368 −14.389 1.00 64.70 A N ATOM 382 CD PRO A 862 26.713 57.725 −15.526 1.00 65.03 A C ATOM 383 CA PRO A 862 24.707 58.854 −14.783 1.00 63.21 A C ATOM 384 CB PRO A 862 24.678 58.591 −16.287 1.00 63.52 A C ATOM 385 CG PRO A 862 25.548 57.375 −16.425 1.00 64.47 A C ATOM 386 C PRO A 862 23.598 58.107 −14.046 1.00 61.61 A C ATOM 387 O PRO A 862 23.425 56.904 −14.232 1.00 61.26 A O ATOM 388 N ASP A 863 22.865 58.823 −13.197 1.00 59.69 A N ATOM 389 CA ASP A 863 21.763 58.228 −12.444 1.00 56.82 A C ATOM 390 CB ASP A 863 20.950 59.303 −11.721 1.00 58.54 A C ATOM 391 CG ASP A 863 20.091 60.133 −12.680 1.00 59.27 A C ATOM 392 OD1 ASP A 863 20.662 60.803 −13.574 1.00 60.57 A O ATOM 393 OD2 ASP A 863 18.849 60.115 −12.541 1.00 58.02 A O ATOM 394 C ASP A 863 20.859 57.574 −13.461 1.00 54.16 A C ATOM 395 O ASP A 863 20.821 58.004 −14.612 1.00 54.94 A O ATOM 396 N GLN A 864 20.126 56.548 −13.044 1.00 49.49 A N ATOM 397 CA GLN A 864 19.212 55.875 −13.953 1.00 44.06 A C ATOM 398 CB GLN A 864 19.861 54.620 −14.509 1.00 46.96 A C ATOM 399 CG GLN A 864 21.098 54.950 −15.309 1.00 49.97 A C ATOM 400 CD GLN A 864 20.834 56.024 −16.348 1.00 51.95 A C ATOM 401 OE1 GLN A 864 21.748 56.732 −16.769 1.00 54.75 A O ATOM 402 NE2 GLN A 864 19.580 56.149 −16.769 1.00 53.04 A N ATOM 403 C GLN A 864 17.883 55.553 −13.297 1.00 39.54 A C ATOM 404 O GLN A 864 17.674 54.464 −12.767 1.00 37.98 A O ATOM 405 N GLN A 865 16.995 56.540 −13.343 1.00 34.60 A N ATOM 406 CA GLN A 865 15.671 56.455 −12.766 1.00 30.90 A C ATOM 407 CB GLN A 865 14.875 57.702 −13.173 1.00 29.99 A C ATOM 408 CG GLN A 865 13.395 57.657 −12.845 1.00 27.24 A C ATOM 409 CD GLN A 865 12.635 56.758 −13.792 1.00 25.91 A C ATOM 410 OE1 GLN A 865 12.783 56.867 −15.013 1.00 26.96 A O ATOM 411 NE2 GLN A 865 11.815 55.866 −13.241 1.00 26.05 A N ATOM 412 C GLN A 865 14.937 55.178 −13.164 1.00 30.14 A C ATOM 413 O GLN A 865 14.330 54.514 −12.317 1.00 29.46 A O ATOM 414 N ARG A 866 14.992 54.835 −14.446 1.00 28.26 A N ATOM 415 CA ARG A 866 14.339 53.630 −14.939 1.00 27.87 A C ATOM 416 CB ARG A 866 14.556 53.480 −16.442 1.00 30.08 A C ATOM 417 CG ARG A 866 13.762 54.460 −17.277 1.00 31.40 A C ATOM 418 CD ARG A 866 14.135 54.349 −18.744 1.00 30.86 A C ATOM 419 NE ARG A 866 13.327 55.237 −19.577 1.00 31.25 A N ATOM 420 CZ ARG A 866 13.453 56.561 −19.620 1.00 31.81 A C ATOM 421 NH1 ARG A 866 12.661 57.268 −20.410 1.00 30.66 A N ATOM 422 NH2 ARG A 866 14.370 57.181 −18.883 1.00 30.91 A N ATOM 423 C ARG A 866 14.843 52.386 −14.225 1.00 27.32 A C ATOM 424 O ARG A 866 14.039 51.559 −13.790 1.00 24.87 A O ATOM 425 N ASP A 867 16.165 52.247 −14.111 1.00 29.27 A N ATOM 426 CA ASP A 867 16.762 51.096 −13.420 1.00 30.55 A C ATOM 427 CB ASP A 867 18.287 51.202 −13.357 1.00 31.56 A C ATOM 428 CG ASP A 867 18.961 50.950 −14.701 1.00 34.40 A C ATOM 429 OD1 ASP A 867 18.384 50.263 −15.578 1.00 35.17 A O ATOM 430 OD2 ASP A 867 20.094 51.439 −14.869 1.00 36.88 A O ATOM 431 C ASP A 867 16.228 50.944 −12.001 1.00 31.08 A C ATOM 432 O ASP A 867 15.568 49.948 −11.694 1.00 31.13 A O ATOM 433 N PHE A 868 16.508 51.919 −11.134 1.00 31.00 A N ATOM 434 CA PHE A 868 16.018 51.844 −9.755 1.00 31.24 A C ATOM 435 CB PHE A 868 16.192 53.180 −9.024 1.00 30.81 A C ATOM 436 CG PHE A 868 17.597 53.467 −8.598 1.00 28.20 A C ATOM 437 CD1 PHE A 868 18.591 53.669 −9.536 1.00 27.55 A C ATOM 438 CD2 PHE A 868 17.921 53.533 −7.254 1.00 28.80 A C ATOM 439 CE1 PHE A 868 19.884 53.931 −9.143 1.00 28.47 A C ATOM 440 CE2 PHE A 868 19.207 53.793 −6.848 1.00 27.69 A C ATOM 441 CZ PHE A 868 20.194 53.993 −7.792 1.00 29.38 A C ATOM 442 C PHE A 868 14.536 51.487 −9.758 1.00 31.43 A C ATOM 443 O PHE A 868 14.076 50.687 −8.950 1.00 32.47 A O ATOM 444 N GLN A 869 13.800 52.095 −10.676 1.00 31.87 A N ATOM 445 CA GLN A 869 12.364 51.871 −10.814 1.00 33.84 A C ATOM 446 CB GLN A 869 11.827 52.814 −11.901 1.00 34.67 A C ATOM 447 CG GLN A 869 10.323 52.847 −12.055 1.00 39.76 A C ATOM 448 CD GLN A 869 9.621 53.521 −10.902 1.00 42.28 A C ATOM 449 OE1 GLN A 869 8.422 53.775 −10.960 1.00 43.86 A O ATOM 450 NE2 GLN A 869 10.366 53.815 −9.842 1.00 45.51 A N ATOM 451 C GLN A 869 12.053 50.405 −11.169 1.00 32.83 A C ATOM 452 O GLN A 869 11.157 49.777 −10.593 1.00 30.45 A O ATOM 453 N ARG A 870 12.807 49.868 −12.121 1.00 31.56 A N ATOM 454 CA ARG A 870 12.619 48.490 −12.567 1.00 29.61 A C ATOM 455 CB ARG A 870 13.578 48.192 −13.720 1.00 29.76 A C ATOM 456 CG ARG A 870 13.476 46.795 −14.306 1.00 30.49 A C ATOM 457 CD ARG A 870 14.608 46.577 −15.294 1.00 27.79 A C ATOM 458 NE ARG A 870 15.918 46.749 −14.671 1.00 26.84 A N ATOM 459 CZ ARG A 870 16.841 47.605 −15.098 1.00 27.83 A C ATOM 460 NH1 ARG A 870 16.588 48.373 −16.152 1.00 24.51 A N ATOM 461 NH2 ARG A 870 18.023 47.679 −14.485 1.00 25.65 A N ATOM 462 C ARG A 870 12.849 47.495 −11.438 1.00 29.71 A C ATOM 463 O ARG A 870 12.092 46.535 −11.266 1.00 30.22 A O ATOM 464 N GLU A 871 13.893 47.736 −10.658 1.00 30.06 A N ATOM 465 CA GLU A 871 14.244 46.851 −9.564 1.00 29.79 A C ATOM 466 CB GLU A 871 15.625 47.219 −9.054 1.00 29.83 A C ATOM 467 CG GLU A 871 16.677 47.061 −10.127 1.00 30.10 A C ATOM 468 CD GLU A 871 16.663 45.668 −10.734 1.00 32.26 A C ATOM 469 OE1 GLU A 871 16.906 45.543 −11.956 1.00 33.53 A O ATOM 470 OE2 GLU A 871 16.417 44.699 −9.985 1.00 32.71 A O ATOM 471 C GLU A 871 13.230 46.858 −8.435 1.00 32.02 A C ATOM 472 O GLU A 871 12.617 45.829 −8.127 1.00 31.99 A O ATOM 473 N ILE A 872 13.035 48.016 −7.822 1.00 33.05 A N ATOM 474 CA ILE A 872 12.081 48.115 −6.727 1.00 33.73 A C ATOM 475 CB ILE A 872 11.839 49.581 −6.320 1.00 34.18 A C ATOM 476 CG2 ILE A 872 10.647 49.683 −5.409 1.00 34.71 A C ATOM 477 CG1 ILE A 872 13.055 50.096 −5.563 1.00 35.67 A C ATOM 478 CD1 ILE A 872 13.377 49.261 −4.352 1.00 33.28 A C ATOM 479 C ILE A 872 10.753 47.453 −7.061 1.00 32.84 A C ATOM 480 O ILE A 872 10.156 46.805 −6.200 1.00 33.81 A O ATOM 481 N GLN A 873 10.286 47.594 −8.301 1.00 31.38 A N ATOM 482 CA GLN A 873 9.014 46.972 −8.669 1.00 31.13 A C ATOM 483 CB GLN A 873 8.554 47.407 −10.060 1.00 31.19 A C ATOM 484 CG GLN A 873 8.194 48.867 −10.119 1.00 33.73 A C ATOM 485 CD GLN A 873 7.213 49.198 −11.218 1.00 36.91 A C ATOM 486 OE1 GLN A 873 6.858 50.366 −11.396 1.00 41.17 A O ATOM 487 NE2 GLN A 873 6.761 48.181 −11.960 1.00 35.88 A N ATOM 488 C GLN A 873 9.128 45.462 −8.614 1.00 30.57 A C ATOM 489 O GLN A 873 8.187 44.773 −8.209 1.00 30.27 A O ATOM 490 N ILE A 874 10.291 44.961 −9.022 1.00 28.38 A N ATOM 491 CA ILE A 874 10.571 43.538 −9.000 1.00 26.50 A C ATOM 492 CB ILE A 874 11.906 43.224 −9.738 1.00 25.96 A C ATOM 493 CG2 ILE A 874 12.444 41.878 −9.304 1.00 25.39 A C ATOM 494 CG1 ILE A 874 11.693 43.227 −11.252 1.00 23.07 A C ATOM 495 CD1 ILE A 874 12.985 43.153 −12.033 1.00 24.11 A C ATOM 496 C ILE A 874 10.693 43.093 −7.542 1.00 27.93 A C ATOM 497 O ILE A 874 10.192 42.031 −7.157 1.00 27.66 A O ATOM 498 N LEU A 875 11.361 43.922 −6.737 1.00 27.30 A N ATOM 499 CA LEU A 875 11.576 43.629 −5.323 1.00 26.34 A C ATOM 500 CB LEU A 875 12.698 44.514 −4.769 1.00 25.39 A C ATOM 501 CG LEU A 875 14.108 44.249 −5.324 1.00 23.64 A C ATOM 502 CD1 LEU A 875 15.052 45.341 −4.844 1.00 23.64 A C ATOM 503 CD2 LEU A 875 14.610 42.897 −4.876 1.00 22.26 A C ATOM 504 C LEU A 875 10.308 43.802 −4.491 1.00 26.93 A C ATOM 505 O LEU A 875 10.068 43.056 −3.541 1.00 27.40 A O ATOM 506 N LYS A 876 9.486 44.774 −4.862 1.00 26.36 A N ATOM 507 CA LYS A 876 8.256 45.025 −4.134 1.00 27.17 A C ATOM 508 CB LYS A 876 7.669 46.380 −4.540 1.00 24.25 A C ATOM 509 CG LYS A 876 6.551 46.819 −3.634 1.00 24.74 A C ATOM 510 CD LYS A 876 5.952 48.150 −4.014 1.00 25.31 A C ATOM 511 CE LYS A 876 4.882 48.496 −3.008 1.00 24.35 A C ATOM 512 NZ LYS A 876 4.120 49.691 −3.413 1.00 28.04 A N ATOM 513 C LYS A 876 7.227 43.917 −4.369 1.00 29.28 A C ATOM 514 O LYS A 876 6.211 43.830 −3.666 1.00 32.41 A O ATOM 515 N ALA A 877 7.475 43.067 −5.358 1.00 28.69 A N ATOM 516 CA ALA A 877 6.533 41.990 −5.629 1.00 29.42 A C ATOM 517 CB ALA A 877 6.501 41.678 −7.130 1.00 27.23 A C ATOM 518 C ALA A 877 6.883 40.736 −4.814 1.00 29.56 A C ATOM 519 O ALA A 877 6.053 39.841 −4.653 1.00 28.54 A O ATOM 520 N LEU A 878 8.107 40.694 −4.288 1.00 29.51 A N ATOM 521 CA LEU A 878 8.585 39.573 −3.473 1.00 27.97 A C ATOM 522 CB LEU A 878 10.094 39.691 −3.250 1.00 26.08 A C ATOM 523 CG LEU A 878 10.959 39.783 −4.503 1.00 27.63 A C ATOM 524 CD1 LEU A 878 12.350 40.250 −4.135 1.00 27.67 A C ATOM 525 CD2 LEU A 878 10.991 38.444 −5.209 1.00 26.13 A C ATOM 526 C LEU A 878 7.896 39.556 −2.117 1.00 27.99 A C ATOM 527 O LEU A 878 7.899 40.560 −1.414 1.00 29.76 A O ATOM 528 N HIS A 879 7.308 38.425 −1.745 1.00 29.32 A N ATOM 529 CA HIS A 879 6.643 38.314 −0.451 1.00 31.36 A C ATOM 530 CB HIS A 879 5.130 38.240 −0.630 1.00 32.39 A C ATOM 531 CG HIS A 879 4.550 39.450 −1.285 1.00 39.51 A C ATOM 532 CD2 HIS A 879 3.661 39.582 −2.296 1.00 40.92 A C ATOM 533 ND1 HIS A 879 4.907 40.732 −0.918 1.00 42.50 A N ATOM 534 CE1 HIS A 879 4.266 41.599 −1.679 1.00 43.10 A C ATOM 535 NE2 HIS A 879 3.504 40.929 −2.525 1.00 44.26 A N ATOM 536 C HIS A 879 7.103 37.131 0.408 1.00 31.51 A C ATOM 537 O HIS A 879 6.948 35.968 0.022 1.00 31.05 A O ATOM 538 N SER A 880 7.666 37.454 1.575 1.00 30.02 A N ATOM 539 CA SER A 880 8.132 36.464 2.541 1.00 28.69 A C ATOM 540 CB SER A 880 9.564 36.052 2.251 1.00 27.94 A C ATOM 541 OG SER A 880 10.046 35.269 3.324 1.00 25.72 A O ATOM 542 C SER A 880 8.062 37.010 3.959 1.00 30.58 A C ATOM 543 O SER A 880 8.201 38.211 4.170 1.00 31.38 A O ATOM 544 N ASP A 881 7.848 36.132 4.933 1.00 31.77 A N ATOM 545 CA ASP A 881 7.762 36.568 6.322 1.00 32.73 A C ATOM 546 CB ASP A 881 7.001 35.543 7.169 1.00 36.42 A C ATOM 547 CG ASP A 881 5.539 35.439 6.786 1.00 41.67 A C ATOM 548 OD1 ASP A 881 4.841 36.479 6.830 1.00 43.68 A O ATOM 549 OD2 ASP A 881 5.090 34.318 6.446 1.00 43.38 A O ATOM 550 C ASP A 881 9.144 36.783 6.917 1.00 32.05 A C ATOM 551 O ASP A 881 9.284 37.257 8.046 1.00 31.81 A O ATOM 552 N PHE A 882 10.167 36.429 6.152 1.00 29.45 A N ATOM 553 CA PHE A 882 11.538 36.573 6.611 1.00 27.95 A C ATOM 554 CB PHE A 882 12.195 35.194 6.685 1.00 27.05 A C ATOM 555 CG PHE A 882 11.355 34.172 7.401 1.00 25.73 A C ATOM 556 CD1 PHE A 882 11.060 34.318 8.741 1.00 24.96 A C ATOM 557 CD2 PHE A 882 10.794 33.111 6.712 1.00 27.21 A C ATOM 558 CE1 PHE A 882 10.209 33.427 9.388 1.00 26.21 A C ATOM 559 CE2 PHE A 882 9.943 32.217 7.353 1.00 27.67 A C ATOM 560 CZ PHE A 882 9.650 32.378 8.691 1.00 24.82 A C ATOM 561 C PHE A 882 12.281 37.472 5.639 1.00 28.22 A C ATOM 562 O PHE A 882 13.422 37.210 5.282 1.00 27.42 A O ATOM 563 N ILE A 883 11.608 38.533 5.203 1.00 28.53 A N ATOM 564 CA ILE A 883 12.185 39.492 4.267 1.00 27.18 A C ATOM 565 CB ILE A 883 11.707 39.203 2.825 1.00 27.90 A C ATOM 566 CG2 ILE A 883 11.013 40.427 2.239 1.00 27.92 A C ATOM 567 CG1 ILE A 883 12.892 38.779 1.966 1.00 26.54 A C ATOM 568 CD1 ILE A 883 13.414 37.448 2.314 1.00 23.32 A C ATOM 569 C ILE A 883 11.749 40.898 4.661 1.00 26.07 A C ATOM 570 O ILE A 883 10.608 41.101 5.070 1.00 26.87 A O ATOM 571 N VAL A 884 12.652 41.865 4.551 1.00 25.78 A N ATOM 572 CA VAL A 884 12.327 43.245 4.900 1.00 25.41 A C ATOM 573 CB VAL A 884 13.579 44.019 5.310 1.00 25.86 A C ATOM 574 CG1 VAL A 884 13.209 45.438 5.667 1.00 25.61 A C ATOM 575 CG2 VAL A 884 14.244 43.327 6.479 1.00 27.98 A C ATOM 576 C VAL A 884 11.677 43.928 3.701 1.00 25.52 A C ATOM 577 O VAL A 884 12.314 44.168 2.680 1.00 24.56 A O ATOM 578 N LYS A 885 10.398 44.246 3.851 1.00 26.64 A N ATOM 579 CA LYS A 885 9.605 44.855 2.798 1.00 26.33 A C ATOM 580 CB LYS A 885 8.174 45.059 3.301 1.00 27.25 A C ATOM 581 CG LYS A 885 7.258 43.868 3.055 1.00 29.12 A C ATOM 582 CD LYS A 885 5.912 44.038 3.735 1.00 31.39 A C ATOM 583 CE LYS A 885 6.068 44.055 5.241 1.00 31.87 A C ATOM 584 NZ LYS A 885 4.750 43.980 5.915 1.00 34.16 A N ATOM 585 C LYS A 885 10.100 46.150 2.162 1.00 26.24 A C ATOM 586 O LYS A 885 10.219 47.179 2.825 1.00 25.99 A O ATOM 587 N TYR A 886 10.409 46.081 0.870 1.00 25.58 A N ATOM 588 CA TYR A 886 10.808 47.264 0.125 1.00 24.39 A C ATOM 589 CB TYR A 886 11.464 46.875 −1.209 1.00 22.20 A C ATOM 590 CG TYR A 886 12.945 46.541 −1.126 1.00 21.86 A C ATOM 591 CD1 TYR A 886 13.885 47.509 −0.768 1.00 20.74 A C ATOM 592 CE1 TYR A 886 15.236 47.200 −0.681 1.00 19.63 A C ATOM 593 CD2 TYR A 886 13.399 45.264 −1.397 1.00 20.05 A C ATOM 594 CE2 TYR A 886 14.742 44.949 −1.313 1.00 19.69 A C ATOM 595 CZ TYR A 886 15.655 45.917 −0.953 1.00 20.05 A C ATOM 596 OH TYR A 886 16.992 45.596 −0.860 1.00 17.58 A O ATOM 597 C TYR A 886 9.461 47.948 −0.130 1.00 24.24 A C ATOM 598 O TYR A 886 8.430 47.273 −0.267 1.00 24.22 A O ATOM 599 N ARG A 887 9.452 49.272 −0.189 1.00 22.95 A N ATOM 600 CA ARG A 887 8.201 49.982 −0.406 1.00 23.16 A C ATOM 601 CB ARG A 887 7.854 50.811 0.828 1.00 23.19 A C ATOM 602 CG ARG A 887 7.348 49.964 1.972 1.00 27.32 A C ATOM 603 CD ARG A 887 6.714 50.824 3.034 1.00 31.16 A C ATOM 604 NE ARG A 887 5.672 51.681 2.476 1.00 32.24 A N ATOM 605 CZ ARG A 887 4.932 52.523 3.192 1.00 33.92 A C ATOM 606 NH1 ARG A 887 5.124 52.618 4.502 1.00 33.39 A N ATOM 607 NH2 ARG A 887 3.998 53.263 2.597 1.00 33.24 A N ATOM 608 C ARG A 887 8.138 50.861 −1.644 1.00 23.65 A C ATOM 609 O ARG A 887 7.051 51.144 −2.140 1.00 24.45 A O ATOM 610 N GLY A 888 9.291 51.285 −2.150 1.00 24.72 A N ATOM 611 CA GLY A 888 9.299 52.139 −3.323 1.00 24.04 A C ATOM 612 C GLY A 888 10.585 52.927 −3.492 1.00 23.39 A C ATOM 613 O GLY A 888 11.577 52.673 −2.805 1.00 23.48 A O ATOM 614 N VAL A 889 10.562 53.877 −4.420 1.00 20.54 A N ATOM 615 CA VAL A 889 11.709 54.719 −4.722 1.00 20.10 A C ATOM 616 CB VAL A 889 12.123 54.570 −6.200 1.00 21.03 A C ATOM 617 CG1 VAL A 889 13.115 55.656 −6.584 1.00 21.45 A C ATOM 618 CG2 VAL A 889 12.719 53.200 −6.435 1.00 19.77 A C ATOM 619 C VAL A 889 11.317 56.167 −4.485 1.00 21.40 A C ATOM 620 O VAL A 889 10.159 56.527 −4.684 1.00 22.69 A O ATOM 621 N SER A 890 12.262 57.001 −4.057 1.00 20.80 A N ATOM 622 CA SER A 890 11.952 58.406 −3.830 1.00 22.34 A C ATOM 623 CB SER A 890 12.629 58.920 −2.556 1.00 21.30 A C ATOM 624 OG SER A 890 13.977 59.280 −2.804 1.00 24.15 A O ATOM 625 C SER A 890 12.410 59.250 −5.012 1.00 24.18 A C ATOM 626 O SER A 890 13.359 58.896 −5.717 1.00 24.15 A O ATOM 627 N TYR A 891 11.718 60.365 −5.229 1.00 25.30 A N ATOM 628 CA TYR A 891 12.060 61.284 −6.309 1.00 27.29 A C ATOM 629 CB TYR A 891 11.002 61.224 −7.411 1.00 27.04 A C ATOM 630 CG TYR A 891 11.081 59.936 −8.178 1.00 28.70 A C ATOM 631 CD1 TYR A 891 12.162 59.667 −9.000 1.00 29.90 A C ATOM 632 CE1 TYR A 891 12.291 58.455 −9.626 1.00 28.35 A C ATOM 633 CD2 TYR A 891 10.128 58.955 −8.014 1.00 26.81 A C ATOM 634 CE2 TYR A 891 10.248 57.743 −8.632 1.00 27.95 A C ATOM 635 CZ TYR A 891 11.333 57.491 −9.437 1.00 27.15 A C ATOM 636 OH TYR A 891 11.482 56.253 −10.028 1.00 25.99 A O ATOM 637 C TYR A 891 12.236 62.715 −5.803 1.00 27.89 A C ATOM 638 O TYR A 891 11.358 63.256 −5.136 1.00 28.25 A O ATOM 639 N GLY A 892 13.384 63.295 −6.149 1.00 29.35 A N ATOM 640 CA GLY A 892 13.791 64.640 −5.767 1.00 34.56 A C ATOM 641 C GLY A 892 12.859 65.827 −5.824 1.00 37.08 A C ATOM 642 O GLY A 892 11.709 65.745 −5.397 1.00 41.32 A O ATOM 643 N PRO A 893 13.343 66.975 −6.314 1.00 37.48 A N ATOM 644 CD PRO A 893 12.587 68.245 −6.303 1.00 37.32 A C ATOM 645 CA PRO A 893 14.706 67.183 −6.804 1.00 37.32 A C ATOM 646 CB PRO A 893 14.587 68.489 −7.576 1.00 36.43 A C ATOM 647 CG PRO A 893 13.638 69.267 −6.701 1.00 37.84 A C ATOM 648 C PRO A 893 15.710 67.298 −5.663 1.00 37.83 A C ATOM 649 O PRO A 893 15.576 66.660 −4.606 1.00 38.11 A O ATOM 650 N GLY A 894 16.714 68.134 −5.884 1.00 35.65 A N ATOM 651 CA GLY A 894 17.725 68.332 −4.865 1.00 33.37 A C ATOM 652 C GLY A 894 18.628 67.132 −4.686 1.00 30.83 A C ATOM 653 O GLY A 894 18.401 66.080 −5.272 1.00 29.44 A O ATOM 654 N ARG A 895 19.654 67.308 −3.861 1.00 31.54 A N ATOM 655 CA ARG A 895 20.645 66.280 −3.566 1.00 29.64 A C ATOM 656 CB ARG A 895 21.477 66.703 −2.359 1.00 30.82 A C ATOM 657 CG ARG A 895 21.949 68.136 −2.436 1.00 36.81 A C ATOM 658 CD ARG A 895 22.739 68.556 −1.201 1.00 37.21 A C ATOM 659 NE ARG A 895 23.919 67.725 −1.002 1.00 39.51 A N ATOM 660 CZ ARG A 895 23.966 66.658 −0.215 1.00 42.26 A C ATOM 661 NH1 ARG A 895 22.885 66.279 0.471 1.00 41.34 A N ATOM 662 NH2 ARG A 895 25.100 65.971 −0.125 1.00 41.86 A N ATOM 663 C ARG A 895 20.044 64.919 −3.283 1.00 27.07 A C ATOM 664 O ARG A 895 20.516 63.913 −3.784 1.00 26.22 A O ATOM 665 N GLN A 896 19.000 64.881 −2.474 1.00 25.66 A N ATOM 666 CA GLN A 896 18.418 63.605 −2.141 1.00 26.88 A C ATOM 667 CB GLN A 896 17.974 63.605 −0.674 1.00 27.75 A C ATOM 668 CG GLN A 896 19.095 63.703 0.367 1.00 23.25 A C ATOM 669 CD GLN A 896 18.560 63.532 1.786 1.00 25.71 A C ATOM 670 OE1 GLN A 896 17.686 64.279 2.219 1.00 25.96 A O ATOM 671 NE2 GLN A 896 19.077 62.538 2.511 1.00 24.24 A N ATOM 672 C GLN A 896 17.253 63.187 −3.041 1.00 28.96 A C ATOM 673 O GLN A 896 16.220 63.870 −3.113 1.00 32.60 A O ATOM 674 N SER A 897 17.436 62.056 −3.717 1.00 26.09 A N ATOM 675 CA SER A 897 16.436 61.488 −4.605 1.00 25.53 A C ATOM 676 CB SER A 897 16.200 62.418 −5.790 1.00 26.04 A C ATOM 677 OG SER A 897 15.213 61.887 −6.648 1.00 23.93 A O ATOM 678 C SER A 897 16.828 60.086 −5.101 1.00 25.24 A C ATOM 679 O SER A 897 17.987 59.674 −4.993 1.00 22.93 A O ATOM 680 N LEU A 898 15.856 59.365 −5.656 1.00 24.91 A N ATOM 681 CA LEU A 898 16.097 58.010 −6.125 1.00 24.03 A C ATOM 682 CB LEU A 898 17.112 57.998 −7.268 1.00 24.88 A C ATOM 683 CG LEU A 898 16.549 58.464 −8.609 1.00 23.32 A C ATOM 684 CD1 LEU A 898 17.616 58.439 −9.659 1.00 24.28 A C ATOM 685 CD2 LEU A 898 15.419 57.550 −9.015 1.00 26.25 A C ATOM 686 C LEU A 898 16.630 57.180 −4.962 1.00 24.34 A C ATOM 687 O LEU A 898 17.584 56.433 −5.117 1.00 24.06 A O ATOM 688 N ARG A 899 16.021 57.336 −3.791 1.00 24.15 A N ATOM 689 CA ARG A 899 16.433 56.589 −2.614 1.00 23.36 A C ATOM 690 CB ARG A 899 16.396 57.491 −1.376 1.00 22.23 A C ATOM 691 CG ARG A 899 17.290 58.737 −1.484 1.00 22.55 A C ATOM 692 CD ARG A 899 17.531 59.430 −0.121 1.00 23.29 A C ATOM 693 NE ARG A 899 16.342 60.077 0.435 1.00 22.79 A N ATOM 694 CZ ARG A 899 16.231 60.489 1.698 1.00 23.20 A C ATOM 695 NH1 ARG A 899 15.115 61.066 2.109 1.00 21.75 A N ATOM 696 NH2 ARG A 899 17.226 60.320 2.557 1.00 21.19 A N ATOM 697 C ARG A 899 15.522 55.370 −2.427 1.00 24.79 A C ATOM 698 O ARG A 899 14.410 55.313 −2.972 1.00 23.87 A O ATOM 699 N LEU A 900 16.005 54.395 −1.664 1.00 23.94 A N ATOM 700 CA LEU A 900 15.258 53.175 −1.425 1.00 23.43 A C ATOM 701 CB LEU A 900 16.234 51.992 −1.334 1.00 25.73 A C ATOM 702 CG LEU A 900 17.254 51.879 −2.479 1.00 22.68 A C ATOM 703 CD1 LEU A 900 18.236 50.767 −2.198 1.00 21.83 A C ATOM 704 CD2 LEU A 900 16.513 51.625 −3.782 1.00 23.99 A C ATOM 705 C LEU A 900 14.467 53.306 −0.134 1.00 23.36 A C ATOM 706 O LEU A 900 15.055 53.495 0.924 1.00 25.79 A O ATOM 707 N VAL A 901 13.140 53.215 −0.224 1.00 23.16 A N ATOM 708 CA VAL A 901 12.247 53.327 0.943 1.00 21.00 A C ATOM 709 CB VAL A 901 10.967 54.161 0.598 1.00 19.18 A C ATOM 710 CG1 VAL A 901 10.220 54.541 1.872 1.00 16.79 A C ATOM 711 CG2 VAL A 901 11.346 55.412 −0.179 1.00 16.04 A C ATOM 712 C VAL A 901 11.816 51.921 1.367 1.00 21.72 A C ATOM 713 O VAL A 901 11.301 51.163 0.550 1.00 20.89 A O ATOM 714 N MET A 902 12.018 51.573 2.635 1.00 22.44 A N ATOM 715 CA MET A 902 11.654 50.244 3.133 1.00 22.31 A C ATOM 716 CB MET A 902 12.914 49.415 3.418 1.00 23.41 A C ATOM 717 CG MET A 902 14.029 49.527 2.402 1.00 24.33 A C ATOM 718 SD MET A 902 15.610 48.975 3.107 1.00 28.16 A S ATOM 719 CE MET A 902 16.470 50.599 3.415 1.00 18.42 A C ATOM 720 C MET A 902 10.879 50.342 4.445 1.00 22.84 A C ATOM 721 O MET A 902 10.780 51.417 5.036 1.00 22.65 A O ATOM 722 N GLU A 903 10.341 49.212 4.901 1.00 23.07 A N ATOM 723 CA GLU A 903 9.637 49.174 6.175 1.00 24.06 A C ATOM 724 CB GLU A 903 8.908 47.835 6.369 1.00 21.47 A C ATOM 725 CG GLU A 903 9.829 46.644 6.571 1.00 25.28 A C ATOM 726 CD GLU A 903 9.094 45.325 6.793 1.00 25.14 A C ATOM 727 OE1 GLU A 903 8.169 45.267 7.634 1.00 23.48 A O ATOM 728 OE2 GLU A 903 9.458 44.333 6.129 1.00 27.12 A O ATOM 729 C GLU A 903 10.769 49.342 7.204 1.00 26.12 A C ATOM 730 O GLU A 903 11.907 48.919 6.962 1.00 25.33 A O ATOM 731 N TYR A 904 10.465 49.956 8.342 1.00 25.19 A N ATOM 732 CA TYR A 904 11.480 50.213 9.350 1.00 25.53 A C ATOM 733 CB TYR A 904 11.375 51.682 9.774 1.00 26.19 A C ATOM 734 CG TYR A 904 12.144 52.041 11.014 1.00 24.20 A C ATOM 735 CD1 TYR A 904 13.520 51.938 11.052 1.00 23.09 A C ATOM 736 CE1 TYR A 904 14.216 52.277 12.180 1.00 23.97 A C ATOM 737 CD2 TYR A 904 11.489 52.491 12.143 1.00 23.37 A C ATOM 738 CE2 TYR A 904 12.179 52.832 13.273 1.00 23.70 A C ATOM 739 CZ TYR A 904 13.541 52.728 13.287 1.00 22.96 A C ATOM 740 OH TYR A 904 14.225 53.123 14.408 1.00 26.04 A O ATOM 741 C TYR A 904 11.437 49.303 10.576 1.00 25.47 A C ATOM 742 O TYR A 904 10.451 49.286 11.309 1.00 25.58 A O ATOM 743 N LEU A 905 12.516 48.553 10.795 1.00 24.91 A N ATOM 744 CA LEU A 905 12.610 47.649 11.942 1.00 24.94 A C ATOM 745 CB LEU A 905 13.104 46.273 11.492 1.00 25.49 A C ATOM 746 CG LEU A 905 12.069 45.313 10.883 1.00 26.77 A C ATOM 747 CD1 LEU A 905 11.533 45.849 9.540 1.00 22.44 A C ATOM 748 CD2 LEU A 905 12.739 43.934 10.703 1.00 24.93 A C ATOM 749 C LEU A 905 13.567 48.243 12.977 1.00 24.77 A C ATOM 750 O LEU A 905 14.774 48.153 12.835 1.00 23.75 A O ATOM 751 N PRO A 906 13.021 48.844 14.043 1.00 25.08 A N ATOM 752 CD PRO A 906 11.573 48.801 14.296 1.00 25.48 A C ATOM 753 CA PRO A 906 13.717 49.499 15.157 1.00 26.75 A C ATOM 754 CB PRO A 906 12.564 50.077 15.981 1.00 24.51 A C ATOM 755 CG PRO A 906 11.499 49.097 15.781 1.00 25.37 A C ATOM 756 C PRO A 906 14.725 48.710 16.010 1.00 27.00 A C ATOM 757 O PRO A 906 15.696 49.291 16.514 1.00 27.95 A O ATOM 758 N SER A 907 14.511 47.408 16.171 1.00 26.18 A N ATOM 759 CA SER A 907 15.424 46.585 16.963 1.00 24.34 A C ATOM 760 CB SER A 907 14.858 45.187 17.145 1.00 22.15 A C ATOM 761 OG SER A 907 13.651 45.257 17.880 1.00 24.29 A O ATOM 762 C SER A 907 16.830 46.503 16.379 1.00 24.51 A C ATOM 763 O SER A 907 17.781 46.200 17.093 1.00 24.00 A O ATOM 764 N GLY A 908 16.963 46.765 15.085 1.00 23.26 A N ATOM 765 CA GLY A 908 18.277 46.751 14.485 1.00 22.85 A C ATOM 766 C GLY A 908 18.759 45.418 13.965 1.00 23.80 A C ATOM 767 O GLY A 908 18.047 44.407 14.014 1.00 23.46 A O ATOM 768 N CYS A 909 19.994 45.425 13.465 1.00 23.36 A N ATOM 769 CA CYS A 909 20.605 44.232 12.899 1.00 23.89 A C ATOM 770 CB CYS A 909 21.937 44.568 12.253 1.00 21.36 A C ATOM 771 SG CYS A 909 23.205 45.003 13.439 1.00 23.09 A S ATOM 772 C CYS A 909 20.822 43.143 13.931 1.00 24.75 A C ATOM 773 O CYS A 909 20.742 43.383 15.133 1.00 24.37 A O ATOM 774 N LEU A 910 21.113 41.943 13.438 1.00 24.76 A N ATOM 775 CA LEU A 910 21.331 40.788 14.285 1.00 25.40 A C ATOM 776 CB LEU A 910 21.058 39.497 13.501 1.00 23.11 A C ATOM 777 CG LEU A 910 21.209 38.168 14.251 1.00 19.95 A C ATOM 778 CD1 LEU A 910 20.317 38.176 15.486 1.00 19.52 A C ATOM 779 CD2 LEU A 910 20.833 37.002 13.331 1.00 17.68 A C ATOM 780 C LEU A 910 22.761 40.796 14.793 1.00 27.11 A C ATOM 781 O LEU A 910 23.032 40.324 15.892 1.00 27.00 A O ATOM 782 N ARG A 911 23.669 41.331 13.983 1.00 28.24 A N ATOM 783 CA ARG A 911 25.075 41.415 14.352 1.00 28.19 A C ATOM 784 CB ARG A 911 25.839 42.249 13.316 1.00 28.23 A C ATOM 785 CG ARG A 911 27.309 42.450 13.625 1.00 30.58 A C ATOM 786 CD ARG A 911 27.646 43.926 13.789 1.00 33.24 A C ATOM 787 NE ARG A 911 27.952 44.595 12.524 1.00 36.27 A N ATOM 788 CZ ARG A 911 27.695 45.878 12.268 1.00 37.56 A C ATOM 789 NH1 ARG A 911 27.115 46.636 13.194 1.00 34.55 A N ATOM 790 NH2 ARG A 911 28.029 46.408 11.090 1.00 36.66 A N ATOM 791 C ARG A 911 25.205 42.050 15.735 1.00 29.66 A C ATOM 792 O ARG A 911 25.791 41.461 16.633 1.00 28.96 A O ATOM 793 N ASP A 912 24.645 43.245 15.911 1.00 30.49 A N ATOM 794 CA ASP A 912 24.726 43.937 17.198 1.00 31.99 A C ATOM 795 CB ASP A 912 24.300 45.396 17.041 1.00 31.19 A C ATOM 796 CG ASP A 912 25.211 46.166 16.109 1.00 35.19 A C ATOM 797 OD1 ASP A 912 24.896 47.327 15.778 1.00 37.95 A O ATOM 798 OD2 ASP A 912 26.251 45.609 15.705 1.00 39.20 A O ATOM 799 C ASP A 912 23.885 43.274 18.283 1.00 32.12 A C ATOM 800 O ASP A 912 24.265 43.257 19.454 1.00 33.14 A O ATOM 801 N PHE A 913 22.744 42.729 17.877 1.00 31.11 A N ATOM 802 CA PHE A 913 21.818 42.053 18.780 1.00 29.01 A C ATOM 803 CB PHE A 913 20.610 41.561 17.984 1.00 27.73 A C ATOM 804 CG PHE A 913 19.543 40.927 18.820 1.00 25.27 A C ATOM 805 CD1 PHE A 913 18.543 41.699 19.380 1.00 25.20 A C ATOM 806 CD2 PHE A 913 19.529 39.559 19.028 1.00 25.36 A C ATOM 807 CE1 PHE A 913 17.544 41.121 20.132 1.00 26.53 A C ATOM 808 CE2 PHE A 913 18.533 38.966 19.783 1.00 27.33 A C ATOM 809 CZ PHE A 913 17.537 39.749 20.335 1.00 25.91 A C ATOM 810 C PHE A 913 22.476 40.857 19.472 1.00 29.07 A C ATOM 811 O PHE A 913 22.295 40.636 20.664 1.00 29.72 A O ATOM 812 N LEU A 914 23.219 40.074 18.707 1.00 28.66 A N ATOM 813 CA LEU A 914 23.883 38.910 19.242 1.00 28.77 A C ATOM 814 CB LEU A 914 24.586 38.145 18.119 1.00 28.26 A C ATOM 815 CG LEU A 914 23.745 37.401 17.074 1.00 29.50 A C ATOM 816 CD1 LEU A 914 24.598 37.156 15.834 1.00 28.14 A C ATOM 817 CD2 LEU A 914 23.220 36.097 17.634 1.00 25.43 A C ATOM 818 C LEU A 914 24.910 39.294 20.294 1.00 30.60 A C ATOM 819 O LEU A 914 25.041 38.616 21.305 1.00 30.77 A O ATOM 820 N GLN A 915 25.639 40.380 20.057 1.00 31.78 A N ATOM 821 CA GLN A 915 26.682 40.812 20.986 1.00 32.32 A C ATOM 822 CB GLN A 915 27.550 41.897 20.346 1.00 29.51 A C ATOM 823 CG GLN A 915 28.275 41.430 19.105 1.00 27.89 A C ATOM 824 CD GLN A 915 28.986 42.558 18.381 1.00 30.62 A C ATOM 825 OE1 GLN A 915 29.960 43.110 18.879 1.00 34.44 A O ATOM 826 NE2 GLN A 915 28.493 42.911 17.201 1.00 32.70 A N ATOM 827 C GLN A 915 26.147 41.309 22.314 1.00 32.56 A C ATOM 828 O GLN A 915 26.696 40.998 23.367 1.00 33.01 A O ATOM 829 N ARG A 916 25.072 42.080 22.259 1.00 35.64 A N ATOM 830 CA ARG A 916 24.470 42.618 23.466 1.00 38.93 A C ATOM 831 CB ARG A 916 23.378 43.623 23.111 1.00 40.92 A C ATOM 832 CG ARG A 916 22.567 44.085 24.316 1.00 46.49 A C ATOM 833 CD ARG A 916 23.376 45.002 25.246 1.00 51.88 A C ATOM 834 NE ARG A 916 23.508 46.365 24.717 1.00 55.94 A N ATOM 835 CZ ARG A 916 22.523 47.263 24.672 1.00 56.13 A C ATOM 836 NH1 ARG A 916 21.311 46.961 25.125 1.00 56.04 A N ATOM 837 NH2 ARG A 916 22.755 48.470 24.171 1.00 56.78 A N ATOM 838 C ARG A 916 23.880 41.530 24.350 1.00 39.54 A C ATOM 839 O ARG A 916 24.391 41.269 25.432 1.00 41.77 A O ATOM 840 N HIS A 917 22.814 40.890 23.881 1.00 40.60 A N ATOM 841 CA HIS A 917 22.128 39.861 24.657 1.00 40.90 A C ATOM 842 CB HIS A 917 20.702 39.682 24.144 1.00 41.88 A C ATOM 843 CG HIS A 917 20.000 40.970 23.863 1.00 43.18 A C ATOM 844 CD2 HIS A 917 19.191 41.736 24.632 1.00 43.95 A C ATOM 845 ND1 HIS A 917 20.124 41.635 22.660 1.00 43.84 A N ATOM 846 CE1 HIS A 917 19.421 42.750 22.702 1.00 45.33 A C ATOM 847 NE2 HIS A 917 18.844 42.838 23.889 1.00 45.00 A N ATOM 848 C HIS A 917 22.801 38.506 24.677 1.00 40.71 A C ATOM 849 O HIS A 917 22.189 37.520 25.080 1.00 40.37 A O ATOM 850 N ARG A 918 24.054 38.451 24.249 1.00 41.70 A N ATOM 851 CA ARG A 918 24.784 37.193 24.222 1.00 43.37 A C ATOM 852 CB ARG A 918 26.288 37.459 24.141 1.00 44.88 A C ATOM 853 CG ARG A 918 27.124 36.231 23.793 1.00 46.33 A C ATOM 854 CD ARG A 918 28.607 36.535 23.906 1.00 48.49 A C ATOM 855 NE ARG A 918 29.442 35.414 23.485 1.00 51.68 A N ATOM 856 CZ ARG A 918 29.319 34.174 23.942 1.00 53.95 A C ATOM 857 NH1 ARG A 918 28.386 33.879 24.840 1.00 55.47 A N ATOM 858 NH2 ARG A 918 30.137 33.228 23.502 1.00 55.10 A N ATOM 859 C ARG A 918 24.471 36.386 25.476 1.00 44.88 A C ATOM 860 O ARG A 918 24.252 35.176 25.416 1.00 45.56 A O ATOM 861 N ALA A 919 24.436 37.078 26.610 1.00 46.35 A N ATOM 862 CA ALA A 919 24.164 36.459 27.900 1.00 46.62 A C ATOM 863 CB ALA A 919 23.801 37.532 28.904 1.00 46.80 A C ATOM 864 C ALA A 919 23.082 35.375 27.886 1.00 46.74 A C ATOM 865 O ALA A 919 23.342 34.226 28.242 1.00 45.80 A O ATOM 866 N ARG A 920 21.871 35.737 27.477 1.00 46.25 A N ATOM 867 CA ARG A 920 20.774 34.780 27.457 1.00 46.08 A C ATOM 868 CB ARG A 920 19.622 35.308 28.316 1.00 47.54 A C ATOM 869 CG ARG A 920 19.363 36.807 28.203 1.00 47.40 A C ATOM 870 CD ARG A 920 18.610 37.168 26.940 1.00 49.45 A C ATOM 871 NE ARG A 920 18.194 38.569 26.925 1.00 49.65 A N ATOM 872 CZ ARG A 920 17.400 39.098 26.001 1.00 49.78 A C ATOM 873 NH1 ARG A 920 16.933 38.342 25.013 1.00 49.39 A N ATOM 874 NH2 ARG A 920 17.069 40.379 26.067 1.00 49.52 A N ATOM 875 C ARG A 920 20.261 34.405 26.074 1.00 46.13 A C ATOM 876 O ARG A 920 19.134 34.750 25.705 1.00 44.96 A O ATOM 877 N LEU A 921 21.085 33.678 25.322 1.00 45.06 A N ATOM 878 CA LEU A 921 20.727 33.241 23.973 1.00 44.84 A C ATOM 879 CB LEU A 921 21.149 34.290 22.942 1.00 44.96 A C ATOM 880 CG LEU A 921 20.422 35.635 22.925 1.00 45.84 A C ATOM 881 CD1 LEU A 921 21.093 36.550 21.892 1.00 45.14 A C ATOM 882 CD2 LEU A 921 18.940 35.427 22.594 1.00 45.08 A C ATOM 883 C LEU A 921 21.401 31.922 23.639 1.00 44.13 A C ATOM 884 O LEU A 921 22.491 31.906 23.071 1.00 44.16 A O ATOM 885 N ASP A 922 20.749 30.816 23.980 1.00 43.31 A N ATOM 886 CA ASP A 922 21.317 29.496 23.720 1.00 42.52 A C ATOM 887 CB ASP A 922 20.505 28.420 24.443 1.00 42.97 A C ATOM 888 CG ASP A 922 19.069 28.384 23.995 1.00 42.64 A C ATOM 889 OD1 ASP A 922 18.842 28.390 22.772 1.00 43.81 A O ATOM 890 OD2 ASP A 922 18.169 28.341 24.857 1.00 43.17 A O ATOM 891 C ASP A 922 21.418 29.150 22.235 1.00 40.48 A C ATOM 892 O ASP A 922 21.060 29.945 21.377 1.00 41.42 A O ATOM 893 N ALA A 923 21.896 27.947 21.942 1.00 38.52 A N ATOM 894 CA ALA A 923 22.068 27.495 20.565 1.00 36.73 A C ATOM 895 CB ALA A 923 22.890 26.215 20.546 1.00 36.05 A C ATOM 896 C ALA A 923 20.743 27.273 19.839 1.00 36.44 A C ATOM 897 O ALA A 923 20.691 27.246 18.610 1.00 35.30 A O ATOM 898 N SER A 924 19.675 27.103 20.604 1.00 35.48 A N ATOM 899 CA SER A 924 18.371 26.892 20.010 1.00 35.00 A C ATOM 900 CB SER A 924 17.343 26.562 21.095 1.00 34.87 A C ATOM 901 OG SER A 924 17.551 25.248 21.574 1.00 36.69 A O ATOM 902 C SER A 924 17.954 28.144 19.256 1.00 33.85 A C ATOM 903 O SER A 924 17.547 28.087 18.095 1.00 33.17 A O ATOM 904 N ARG A 925 18.067 29.276 19.931 1.00 32.59 A N ATOM 905 CA ARG A 925 17.707 30.548 19.348 1.00 32.54 A C ATOM 906 CB ARG A 925 17.974 31.663 20.364 1.00 33.17 A C ATOM 907 CG ARG A 925 17.325 32.978 20.013 1.00 36.60 A C ATOM 908 CD ARG A 925 16.015 33.157 20.747 1.00 39.24 A C ATOM 909 NE ARG A 925 15.178 31.964 20.685 1.00 42.43 A N ATOM 910 CZ ARG A 925 13.937 31.905 21.157 1.00 42.81 A C ATOM 911 NH1 ARG A 925 13.237 30.779 21.073 1.00 43.91 A N ATOM 912 NH2 ARG A 925 13.391 32.983 21.699 1.00 41.57 A N ATOM 913 C ARG A 925 18.522 30.776 18.066 1.00 31.35 A C ATOM 914 O ARG A 925 17.989 31.220 17.045 1.00 30.98 A O ATOM 915 N LEU A 926 19.812 30.461 18.123 1.00 29.39 A N ATOM 916 CA LEU A 926 20.684 30.645 16.968 1.00 26.98 A C ATOM 917 CB LEU A 926 22.137 30.278 17.321 1.00 25.24 A C ATOM 918 CG LEU A 926 22.729 30.922 18.586 1.00 26.47 A C ATOM 919 CD1 LEU A 926 24.164 30.453 18.762 1.00 22.76 A C ATOM 920 CD2 LEU A 926 22.660 32.470 18.498 1.00 23.66 A C ATOM 921 C LEU A 926 20.177 29.759 15.835 1.00 25.57 A C ATOM 922 O LEU A 926 20.222 30.144 14.674 1.00 25.52 A O ATOM 923 N LEU A 927 19.695 28.573 16.185 1.00 24.45 A N ATOM 924 CA LEU A 927 19.166 27.636 15.203 1.00 25.10 A C ATOM 925 CB LEU A 927 18.913 26.276 15.860 1.00 23.29 A C ATOM 926 CG LEU A 927 20.192 25.452 16.079 1.00 23.60 A C ATOM 927 CD1 LEU A 927 19.914 24.230 16.951 1.00 21.29 A C ATOM 928 CD2 LEU A 927 20.741 25.045 14.713 1.00 21.28 A C ATOM 929 C LEU A 927 17.881 28.176 14.579 1.00 25.54 A C ATOM 930 O LEU A 927 17.653 28.021 13.387 1.00 27.60 A O ATOM 931 N LEU A 928 17.043 28.813 15.382 1.00 26.21 A N ATOM 932 CA LEU A 928 15.817 29.377 14.860 1.00 28.46 A C ATOM 933 CB LEU A 928 14.986 29.994 15.990 1.00 29.01 A C ATOM 934 CG LEU A 928 13.640 30.609 15.580 1.00 30.63 A C ATOM 935 CD1 LEU A 928 12.726 29.543 14.983 1.00 28.56 A C ATOM 936 CD2 LEU A 928 12.984 31.247 16.798 1.00 30.31 A C ATOM 937 C LEU A 928 16.172 30.452 13.829 1.00 28.78 A C ATOM 938 O LEU A 928 15.627 30.467 12.727 1.00 31.05 A O ATOM 939 N TYR A 929 17.092 31.345 14.188 1.00 28.81 A N ATOM 940 CA TYR A 929 17.499 32.404 13.278 1.00 26.06 A C ATOM 941 CB TYR A 929 18.554 33.313 13.917 1.00 24.85 A C ATOM 942 CG TYR A 929 18.091 34.038 15.171 1.00 24.20 A C ATOM 943 CD1 TYR A 929 16.739 34.249 15.420 1.00 22.44 A C ATOM 944 CE1 TYR A 929 16.319 34.898 16.562 1.00 23.86 A C ATOM 945 CD2 TYR A 929 19.014 34.512 16.108 1.00 24.65 A C ATOM 946 CE2 TYR A 929 18.600 35.165 17.251 1.00 23.64 A C ATOM 947 CZ TYR A 929 17.255 35.352 17.476 1.00 23.72 A C ATOM 948 OH TYR A 929 16.836 35.970 18.627 1.00 26.16 A O ATOM 949 C TYR A 929 18.068 31.765 12.032 1.00 25.81 A C ATOM 950 O TYR A 929 17.813 32.217 10.924 1.00 26.45 A O ATOM 951 N SER A 930 18.843 30.707 12.208 1.00 25.98 A N ATOM 952 CA SER A 930 19.426 30.035 11.059 1.00 27.82 A C ATOM 953 CB SER A 930 20.325 28.885 11.513 1.00 28.75 A C ATOM 954 OG SER A 930 21.528 29.393 12.064 1.00 30.14 A O ATOM 955 C SER A 930 18.360 29.507 10.111 1.00 28.13 A C ATOM 956 O SER A 930 18.482 29.628 8.886 1.00 27.24 A O ATOM 957 N SER A 931 17.313 28.932 10.694 1.00 27.11 A N ATOM 958 CA SER A 931 16.211 28.360 9.934 1.00 25.57 A C ATOM 959 CB SER A 931 15.262 27.618 10.887 1.00 25.40 A C ATOM 960 OG SER A 931 14.196 26.996 10.183 1.00 26.62 A O ATOM 961 C SER A 931 15.446 29.432 9.148 1.00 23.59 A C ATOM 962 O SER A 931 15.193 29.284 7.957 1.00 21.65 A O ATOM 963 N GLN A 932 15.089 30.515 9.821 1.00 21.56 A N ATOM 964 CA GLN A 932 14.340 31.578 9.173 1.00 20.32 A C ATOM 965 CB GLN A 932 13.915 32.619 10.197 1.00 19.20 A C ATOM 966 CG GLN A 932 13.032 32.067 11.272 1.00 13.20 A C ATOM 967 CD GLN A 932 12.775 33.085 12.345 1.00 17.11 A C ATOM 968 OE1 GLN A 932 13.518 34.061 12.478 1.00 19.07 A O ATOM 969 NE2 GLN A 932 11.730 32.864 13.136 1.00 18.46 A N ATOM 970 C GLN A 932 15.146 32.228 8.066 1.00 19.98 A C ATOM 971 O GLN A 932 14.611 32.482 7.004 1.00 20.76 A O ATOM 972 N ILE A 933 16.430 32.487 8.304 1.00 19.95 A N ATOM 973 CA ILE A 933 17.294 33.088 7.287 1.00 19.59 A C ATOM 974 CB ILE A 933 18.744 33.298 7.834 1.00 16.81 A C ATOM 975 CG2 ILE A 933 19.716 33.611 6.700 1.00 13.19 A C ATOM 976 CG1 ILE A 933 18.747 34.420 8.876 1.00 14.44 A C ATOM 977 CD1 ILE A 933 19.937 34.392 9.822 1.00 10.84 A C ATOM 978 C ILE A 933 17.336 32.167 6.067 1.00 21.91 A C ATOM 979 O ILE A 933 17.282 32.635 4.931 1.00 24.84 A O ATOM 980 N CYS A 934 17.422 30.858 6.302 1.00 22.23 A N ATOM 981 CA CYS A 934 17.471 29.894 5.201 1.00 23.32 A C ATOM 982 CB CYS A 934 17.708 28.471 5.715 1.00 21.69 A C ATOM 983 SG CYS A 934 18.292 27.313 4.412 1.00 30.12 A S ATOM 984 C CYS A 934 16.174 29.912 4.401 1.00 23.55 A C ATOM 985 O CYS A 934 16.186 29.820 3.181 1.00 22.75 A O ATOM 986 N LYS A 935 15.053 30.005 5.101 1.00 25.04 A N ATOM 987 CA LYS A 935 13.758 30.047 4.447 1.00 26.11 A C ATOM 988 CB LYS A 935 12.641 30.114 5.487 1.00 28.76 A C ATOM 989 CG LYS A 935 12.201 28.770 5.994 1.00 30.78 A C ATOM 990 CD LYS A 935 11.682 27.924 4.849 1.00 37.03 A C ATOM 991 CE LYS A 935 10.571 28.633 4.079 1.00 38.59 A C ATOM 992 NZ LYS A 935 9.503 29.151 4.978 1.00 39.74 A N ATOM 993 C LYS A 935 13.684 31.280 3.558 1.00 25.61 A C ATOM 994 O LYS A 935 13.192 31.218 2.432 1.00 25.18 A O ATOM 995 N GLY A 936 14.184 32.401 4.063 1.00 23.46 A N ATOM 996 CA GLY A 936 14.139 33.625 3.288 1.00 25.18 A C ATOM 997 C GLY A 936 14.925 33.529 1.997 1.00 25.97 A C ATOM 998 O GLY A 936 14.438 33.854 0.910 1.00 25.47 A O ATOM 999 N MET A 937 16.160 33.068 2.122 1.00 25.86 A N ATOM 1000 CA MET A 937 17.025 32.935 0.968 1.00 25.43 A C ATOM 1001 CB MET A 937 18.398 32.465 1.415 1.00 21.83 A C ATOM 1002 CG MET A 937 19.145 33.521 2.195 1.00 22.95 A C ATOM 1003 SD MET A 937 19.251 35.048 1.253 1.00 19.04 A S ATOM 1004 CE MET A 937 20.391 34.539 0.040 1.00 19.63 A C ATOM 1005 C MET A 937 16.452 31.990 −0.070 1.00 25.93 A C ATOM 1006 O MET A 937 16.563 32.247 −1.269 1.00 25.39 A O ATOM 1007 N GLU A 938 15.844 30.898 0.396 1.00 25.81 A N ATOM 1008 CA GLU A 938 15.249 29.907 −0.492 1.00 28.06 A C ATOM 1009 CB GLU A 938 14.692 28.711 0.305 1.00 29.00 A C ATOM 1010 CG GLU A 938 13.949 27.709 −0.573 1.00 34.20 A C ATOM 1011 CD GLU A 938 12.966 26.819 0.187 1.00 37.81 A C ATOM 1012 OE1 GLU A 938 12.368 27.286 1.189 1.00 41.55 A O ATOM 1013 OE2 GLU A 938 12.781 25.653 −0.234 1.00 37.20 A O ATOM 1014 C GLU A 938 14.129 30.559 −1.309 1.00 28.74 A C ATOM 1015 O GLU A 938 14.013 30.344 −2.513 1.00 27.91 A O ATOM 1016 N TYR A 939 13.304 31.358 −0.647 1.00 28.43 A N ATOM 1017 CA TYR A 939 12.232 32.039 −1.341 1.00 27.01 A C ATOM 1018 CB TYR A 939 11.367 32.814 −0.346 1.00 27.10 A C ATOM 1019 CG TYR A 939 10.389 33.739 −1.025 1.00 26.91 A C ATOM 1020 CD1 TYR A 939 9.233 33.245 −1.631 1.00 25.87 A C ATOM 1021 CE1 TYR A 939 8.373 34.090 −2.330 1.00 25.22 A C ATOM 1022 CD2 TYR A 939 10.654 35.101 −1.130 1.00 26.73 A C ATOM 1023 CE2 TYR A 939 9.803 35.946 −1.825 1.00 26.34 A C ATOM 1024 CZ TYR A 939 8.671 35.436 −2.424 1.00 25.07 A C ATOM 1025 OH TYR A 939 7.873 36.269 −3.156 1.00 24.42 A O ATOM 1026 C TYR A 939 12.823 33.007 −2.377 1.00 27.57 A C ATOM 1027 O TYR A 939 12.354 33.085 −3.515 1.00 27.74 A O ATOM 1028 N LEU A 940 13.865 33.739 −1.986 1.00 27.06 A N ATOM 1029 CA LEU A 940 14.483 34.697 −2.892 1.00 25.89 A C ATOM 1030 CB LEU A 940 15.561 35.505 −2.160 1.00 25.81 A C ATOM 1031 CG LEU A 940 15.134 36.223 −0.866 1.00 27.33 A C ATOM 1032 CD1 LEU A 940 16.214 37.236 −0.463 1.00 25.01 A C ATOM 1033 CD2 LEU A 940 13.807 36.937 −1.051 1.00 25.43 A C ATOM 1034 C LEU A 940 15.057 34.002 −4.126 1.00 26.08 A C ATOM 1035 O LEU A 940 14.907 34.479 −5.252 1.00 26.56 A O ATOM 1036 N GLY A 941 15.707 32.865 −3.924 1.00 26.30 A N ATOM 1037 CA GLY A 941 16.246 32.138 −5.062 1.00 25.14 A C ATOM 1038 C GLY A 941 15.156 31.632 −6.004 1.00 23.69 A C ATOM 1039 O GLY A 941 15.274 31.741 −7.223 1.00 21.15 A O ATOM 1040 N SER A 942 14.079 31.089 −5.452 1.00 22.19 A N ATOM 1041 CA SER A 942 13.019 30.577 −6.306 1.00 24.17 A C ATOM 1042 CB SER A 942 11.900 29.952 −5.468 1.00 21.56 A C ATOM 1043 OG SER A 942 11.195 30.924 −4.706 1.00 21.92 A O ATOM 1044 C SER A 942 12.452 31.681 −7.199 1.00 26.30 A C ATOM 1045 O SER A 942 11.878 31.406 −8.257 1.00 27.98 A O ATOM 1046 N ARG A 943 12.623 32.928 −6.776 1.00 24.94 A N ATOM 1047 CA ARG A 943 12.117 34.059 −7.535 1.00 25.38 A C ATOM 1048 CB ARG A 943 11.431 35.055 −6.597 1.00 26.85 A C ATOM 1049 CG ARG A 943 10.155 34.526 −5.972 1.00 28.29 A C ATOM 1050 CD ARG A 943 9.079 34.335 −7.038 1.00 34.65 A C ATOM 1051 NE ARG A 943 7.827 33.831 −6.480 1.00 35.43 A N ATOM 1052 CZ ARG A 943 7.681 32.630 −5.926 1.00 37.49 A C ATOM 1053 NH1 ARG A 943 6.501 32.258 −5.435 1.00 36.56 A N ATOM 1054 NH2 ARG A 943 8.710 31.794 −5.871 1.00 36.84 A N ATOM 1055 C ARG A 943 13.247 34.734 −8.300 1.00 25.91 A C ATOM 1056 O ARG A 943 13.121 35.867 −8.767 1.00 25.66 A O ATOM 1057 N ARG A 944 14.356 34.015 −8.425 1.00 27.92 A N ATOM 1058 CA ARG A 944 15.539 34.497 −9.140 1.00 28.02 A C ATOM 1059 CB ARG A 944 15.225 34.609 −10.633 1.00 29.49 A C ATOM 1060 CG ARG A 944 14.771 33.282 −11.235 1.00 33.87 A C ATOM 1061 CD ARG A 944 14.640 33.361 −12.738 1.00 38.79 A C ATOM 1062 NE ARG A 944 13.924 32.213 −13.289 1.00 41.68 A N ATOM 1063 CZ ARG A 944 14.406 30.977 −13.353 1.00 42.92 A C ATOM 1064 NH1 ARG A 944 15.622 30.700 −12.903 1.00 44.38 A N ATOM 1065 NH2 ARG A 944 13.660 30.010 −13.865 1.00 43.95 A N ATOM 1066 C ARG A 944 16.134 35.806 −8.616 1.00 26.36 A C ATOM 1067 O ARG A 944 16.580 36.652 −9.380 1.00 27.18 A O ATOM 1068 N CYS A 945 16.158 35.957 −7.300 1.00 25.76 A N ATOM 1069 CA CYS A 945 16.715 37.152 −6.691 1.00 25.68 A C ATOM 1070 CB CYS A 945 15.708 37.756 −5.711 1.00 26.82 A C ATOM 1071 SG CYS A 945 16.350 39.138 −4.735 1.00 32.67 A S ATOM 1072 C CYS A 945 18.009 36.812 −5.951 1.00 23.68 A C ATOM 1073 O CYS A 945 18.003 36.003 −5.029 1.00 21.55 A O ATOM 1074 N VAL A 946 19.107 37.434 −6.369 1.00 22.39 A N ATOM 1075 CA VAL A 946 20.421 37.242 −5.748 1.00 22.12 A C ATOM 1076 CB VAL A 946 21.531 37.211 −6.820 1.00 20.56 A C ATOM 1077 CG1 VAL A 946 22.898 37.089 −6.167 1.00 19.82 A C ATOM 1078 CG2 VAL A 946 21.296 36.053 −7.757 1.00 18.31 A C ATOM 1079 C VAL A 946 20.699 38.396 −4.777 1.00 22.09 A C ATOM 1080 O VAL A 946 20.579 39.568 −5.152 1.00 25.08 A O ATOM 1081 N HIS A 947 21.070 38.058 −3.544 1.00 21.72 A N ATOM 1082 CA HIS A 947 21.360 39.037 −2.485 1.00 23.37 A C ATOM 1083 CB HIS A 947 21.438 38.345 −1.118 1.00 21.69 A C ATOM 1084 CG HIS A 947 21.439 39.299 0.036 1.00 20.53 A C ATOM 1085 CD2 HIS A 947 22.147 40.432 0.263 1.00 17.46 A C ATOM 1086 ND1 HIS A 947 20.554 39.183 1.088 1.00 16.91 A N ATOM 1087 CE1 HIS A 947 20.710 40.208 1.903 1.00 15.92 A C ATOM 1088 NE2 HIS A 947 21.669 40.982 1.427 1.00 17.07 A N ATOM 1089 C HIS A 947 22.657 39.792 −2.706 1.00 24.97 A C ATOM 1090 O HIS A 947 22.679 41.018 −2.693 1.00 27.85 A O ATOM 1091 N ARG A 948 23.741 39.051 −2.887 1.00 28.00 A N ATOM 1092 CA ARG A 948 25.065 39.629 −3.127 1.00 31.02 A C ATOM 1093 CB ARG A 948 25.015 40.688 −4.243 1.00 32.92 A C ATOM 1094 CG ARG A 948 26.344 41.444 −4.373 1.00 38.57 A C ATOM 1095 CD ARG A 948 26.349 42.551 −5.425 1.00 41.31 A C ATOM 1096 NE ARG A 948 27.434 43.507 −5.196 1.00 42.45 A N ATOM 1097 CZ ARG A 948 27.956 44.285 −6.138 1.00 47.28 A C ATOM 1098 NH1 ARG A 948 28.936 45.129 −5.838 1.00 48.64 A N ATOM 1099 NH2 ARG A 948 27.505 44.210 −7.384 1.00 48.13 A N ATOM 1100 C ARG A 948 25.797 40.218 −1.912 1.00 30.74 A C ATOM 1101 O ARG A 948 27.021 40.378 −1.951 1.00 32.58 A O ATOM 1102 N ASP A 949 25.080 40.531 −0.836 1.00 28.19 A N ATOM 1103 CA ASP A 949 25.741 41.085 0.347 1.00 25.95 A C ATOM 1104 CB ASP A 949 25.628 42.611 0.325 1.00 28.52 A C ATOM 1105 CG ASP A 949 26.488 43.282 1.373 1.00 29.95 A C ATOM 1106 OD1 ASP A 949 27.589 42.767 1.656 1.00 29.48 A O ATOM 1107 OD2 ASP A 949 26.069 44.339 1.899 1.00 29.30 A O ATOM 1108 C ASP A 949 25.110 40.515 1.613 1.00 24.72 A C ATOM 1109 O ASP A 949 24.730 41.245 2.522 1.00 21.62 A O ATOM 1110 N LEU A 950 25.006 39.194 1.672 1.00 23.77 A N ATOM 1111 CA LEU A 950 24.383 38.558 2.822 1.00 22.86 A C ATOM 1112 CB LEU A 950 23.932 37.141 2.451 1.00 19.95 A C ATOM 1113 CG LEU A 950 23.108 36.364 3.482 1.00 20.83 A C ATOM 1114 CD1 LEU A 950 21.733 37.032 3.667 1.00 15.52 A C ATOM 1115 CD2 LEU A 950 22.938 34.917 3.005 1.00 17.15 A C ATOM 1116 C LEU A 950 25.370 38.529 3.979 1.00 21.92 A C ATOM 1117 O LEU A 950 26.556 38.301 3.781 1.00 19.70 A O ATOM 1118 N ALA A 951 24.876 38.762 5.189 1.00 21.14 A N ATOM 1119 CA ALA A 951 25.740 38.768 6.358 1.00 19.64 A C ATOM 1120 CB ALA A 951 26.860 39.772 6.165 1.00 16.06 A C ATOM 1121 C ALA A 951 24.917 39.115 7.585 1.00 21.41 A C ATOM 1122 O ALA A 951 23.812 39.664 7.475 1.00 23.99 A O ATOM 1123 N ALA A 952 25.447 38.796 8.760 1.00 21.05 A N ATOM 1124 CA ALA A 952 24.729 39.063 10.002 1.00 19.39 A C ATOM 1125 CB ALA A 952 25.569 38.616 11.205 1.00 18.53 A C ATOM 1126 C ALA A 952 24.325 40.532 10.137 1.00 18.69 A C ATOM 1127 O ALA A 952 23.322 40.844 10.772 1.00 21.48 A O ATOM 1128 N ARG A 953 25.114 41.440 9.570 1.00 17.77 A N ATOM 1129 CA ARG A 953 24.757 42.854 9.618 1.00 19.31 A C ATOM 1130 CB ARG A 953 25.922 43.735 9.171 1.00 17.94 A C ATOM 1131 CG ARG A 953 26.277 43.580 7.723 1.00 16.54 A C ATOM 1132 CD ARG A 953 27.394 44.538 7.370 1.00 18.36 A C ATOM 1133 NE ARG A 953 28.034 44.230 6.088 1.00 20.26 A N ATOM 1134 CZ ARG A 953 28.894 43.232 5.895 1.00 18.10 A C ATOM 1135 NH1 ARG A 953 29.222 42.432 6.902 1.00 22.15 A N ATOM 1136 NH2 ARG A 953 29.437 43.039 4.703 1.00 14.98 A N ATOM 1137 C ARG A 953 23.551 43.142 8.704 1.00 20.52 A C ATOM 1138 O ARG A 953 22.786 44.069 8.955 1.00 19.49 A O ATOM 1139 N ASN A 954 23.384 42.376 7.629 1.00 20.55 A N ATOM 1140 CA ASN A 954 22.235 42.638 6.768 1.00 22.29 A C ATOM 1141 CB ASN A 954 22.614 42.519 5.274 1.00 18.54 A C ATOM 1142 CG ASN A 954 23.351 43.761 4.753 1.00 17.79 A C ATOM 1143 OD1 ASN A 954 23.022 44.875 5.122 1.00 19.98 A O ATOM 1144 ND2 ASN A 954 24.335 43.566 3.889 1.00 17.35 A N ATOM 1145 C ASN A 954 21.022 41.759 7.124 1.00 22.75 A C ATOM 1146 O ASN A 954 20.183 41.472 6.279 1.00 23.62 A O ATOM 1147 N ILE A 955 20.952 41.339 8.389 1.00 24.09 A N ATOM 1148 CA ILE A 955 19.837 40.533 8.902 1.00 23.45 A C ATOM 1149 CB ILE A 955 20.306 39.205 9.575 1.00 23.56 A C ATOM 1150 CG2 ILE A 955 19.135 38.562 10.335 1.00 22.40 A C ATOM 1151 CG1 ILE A 955 20.812 38.215 8.527 1.00 22.88 A C ATOM 1152 CD1 ILE A 955 19.716 37.621 7.691 1.00 21.73 A C ATOM 1153 C ILE A 955 19.211 41.390 9.988 1.00 24.33 A C ATOM 1154 O ILE A 955 19.818 41.580 11.038 1.00 25.58 A O ATOM 1155 N LEU A 956 18.014 41.917 9.737 1.00 25.10 A N ATOM 1156 CA LEU A 956 17.326 42.762 10.712 1.00 23.60 A C ATOM 1157 CB LEU A 956 16.487 43.821 9.990 1.00 20.79 A C ATOM 1158 CG LEU A 956 17.271 44.953 9.322 1.00 19.09 A C ATOM 1159 CD1 LEU A 956 16.344 45.759 8.426 1.00 15.72 A C ATOM 1160 CD2 LEU A 956 17.901 45.843 10.386 1.00 16.65 A C ATOM 1161 C LEU A 956 16.446 41.944 11.655 1.00 25.28 A C ATOM 1162 O LEU A 956 15.913 40.893 11.282 1.00 27.16 A O ATOM 1163 N VAL A 957 16.301 42.441 12.880 1.00 24.88 A N ATOM 1164 CA VAL A 957 15.505 41.773 13.902 1.00 24.09 A C ATOM 1165 CB VAL A 957 16.188 41.866 15.313 1.00 23.67 A C ATOM 1166 CG1 VAL A 957 15.218 41.439 16.419 1.00 18.34 A C ATOM 1167 CG2 VAL A 957 17.431 40.979 15.346 1.00 22.54 A C ATOM 1168 C VAL A 957 14.093 42.329 14.006 1.00 24.66 A C ATOM 1169 O VAL A 957 13.885 43.510 14.288 1.00 23.71 A O ATOM 1170 N GLU A 958 13.125 41.456 13.761 1.00 25.24 A N ATOM 1171 CA GLU A 958 11.729 41.821 13.842 1.00 27.40 A C ATOM 1172 CB GLU A 958 10.877 40.821 13.061 1.00 27.40 A C ATOM 1173 CG GLU A 958 9.407 40.926 13.373 1.00 29.36 A C ATOM 1174 CD GLU A 958 8.805 42.206 12.865 1.00 30.52 A C ATOM 1175 OE1 GLU A 958 7.699 42.558 13.321 1.00 33.77 A O ATOM 1176 OE2 GLU A 958 9.432 42.856 12.001 1.00 34.54 A O ATOM 1177 C GLU A 958 11.380 41.769 15.324 1.00 27.35 A C ATOM 1178 O GLU A 958 10.733 42.669 15.855 1.00 29.14 A O ATOM 1179 N SER A 959 11.822 40.704 15.982 1.00 28.13 A N ATOM 1180 CA SER A 959 11.598 40.519 17.409 1.00 29.62 A C ATOM 1181 CB SER A 959 10.139 40.162 17.700 1.00 27.47 A C ATOM 1182 OG SER A 959 9.899 38.786 17.467 1.00 27.72 A O ATOM 1183 C SER A 959 12.514 39.388 17.873 1.00 32.26 A C ATOM 1184 O SER A 959 13.239 38.808 17.071 1.00 31.08 A O ATOM 1185 N GLU A 960 12.474 39.083 19.168 1.00 34.51 A N ATOM 1186 CA GLU A 960 13.304 38.041 19.755 1.00 35.90 A C ATOM 1187 CB GLU A 960 12.896 37.807 21.208 1.00 39.24 A C ATOM 1188 CG GLU A 960 13.184 38.980 22.141 1.00 46.55 A C ATOM 1189 CD GLU A 960 12.187 40.140 22.010 1.00 48.81 A C ATOM 1190 OE1 GLU A 960 12.358 41.143 22.752 1.00 49.24 A O ATOM 1191 OE2 GLU A 960 11.244 40.048 21.183 1.00 46.66 A O ATOM 1192 C GLU A 960 13.252 36.721 19.002 1.00 35.00 A C ATOM 1193 O GLU A 960 14.272 36.044 18.834 1.00 34.68 A O ATOM 1194 N ALA A 961 12.060 36.361 18.547 1.00 32.61 A N ATOM 1195 CA ALA A 961 11.884 35.114 17.825 1.00 31.46 A C ATOM 1196 CB ALA A 961 10.787 34.309 18.475 1.00 33.09 A C ATOM 1197 C ALA A 961 11.568 35.285 16.349 1.00 29.88 A C ATOM 1198 O ALA A 961 10.867 34.457 15.787 1.00 30.47 A O ATOM 1199 N HIS A 962 12.079 36.332 15.709 1.00 27.98 A N ATOM 1200 CA HIS A 962 11.781 36.552 14.293 1.00 26.94 A C ATOM 1201 CB HIS A 962 10.367 37.137 14.150 1.00 26.76 A C ATOM 1202 CG HIS A 962 9.845 37.164 12.746 1.00 29.25 A C ATOM 1203 CD2 HIS A 962 10.482 37.125 11.548 1.00 30.41 A C ATOM 1204 ND1 HIS A 962 8.499 37.259 12.461 1.00 29.15 A N ATOM 1205 CE1 HIS A 962 8.328 37.277 11.149 1.00 29.36 A C ATOM 1206 NE2 HIS A 962 9.515 37.197 10.573 1.00 29.28 A N ATOM 1207 C HIS A 962 12.785 37.483 13.635 1.00 25.52 A C ATOM 1208 O HIS A 962 12.830 38.671 13.934 1.00 24.49 A O ATOM 1209 N VAL A 963 13.583 36.942 12.723 1.00 24.67 A N ATOM 1210 CA VAL A 963 14.579 37.739 12.020 1.00 22.77 A C ATOM 1211 CB VAL A 963 15.997 37.135 12.211 1.00 21.51 A C ATOM 1212 CG1 VAL A 963 16.385 37.214 13.677 1.00 18.57 A C ATOM 1213 CG2 VAL A 963 16.043 35.690 11.716 1.00 15.30 A C ATOM 1214 C VAL A 963 14.253 37.831 10.532 1.00 24.24 A C ATOM 1215 O VAL A 963 13.710 36.888 9.950 1.00 24.35 A O ATOM 1216 N LYS A 964 14.577 38.968 9.920 1.00 24.66 A N ATOM 1217 CA LYS A 964 14.306 39.159 8.493 1.00 26.34 A C ATOM 1218 CB LYS A 964 13.298 40.291 8.284 1.00 29.10 A C ATOM 1219 CG LYS A 964 11.887 40.014 8.784 1.00 27.26 A C ATOM 1220 CD LYS A 964 10.995 41.233 8.537 1.00 26.26 A C ATOM 1221 CE LYS A 964 9.534 40.902 8.778 1.00 26.90 A C ATOM 1222 NZ LYS A 964 8.647 42.060 8.526 1.00 30.62 A N ATOM 1223 C LYS A 964 15.546 39.468 7.665 1.00 25.93 A C ATOM 1224 O LYS A 964 16.495 40.076 8.155 1.00 28.44 A O ATOM 1225 N ILE A 965 15.535 39.040 6.408 1.00 24.00 A N ATOM 1226 CA ILE A 965 16.654 39.305 5.510 1.00 23.02 A C ATOM 1227 CB ILE A 965 16.684 38.296 4.332 1.00 23.20 A C ATOM 1228 CG2 ILE A 965 17.821 38.625 3.385 1.00 21.71 A C ATOM 1229 CG1 ILE A 965 16.894 36.871 4.857 1.00 22.96 A C ATOM 1230 CD1 ILE A 965 16.961 35.812 3.758 1.00 21.77 A C ATOM 1231 C ILE A 965 16.506 40.735 4.972 1.00 23.73 A C ATOM 1232 O ILE A 965 15.398 41.173 4.614 1.00 22.06 A O ATOM 1233 N ALA A 966 17.625 41.460 4.919 1.00 23.15 A N ATOM 1234 CA ALA A 966 17.627 42.852 4.470 1.00 21.44 A C ATOM 1235 CB ALA A 966 17.822 43.780 5.676 1.00 19.27 A C ATOM 1236 C ALA A 966 18.669 43.176 3.410 1.00 21.34 A C ATOM 1237 O ALA A 966 19.700 42.518 3.319 1.00 19.18 A O ATOM 1238 N ASP A 967 18.373 44.197 2.605 1.00 20.95 A N ATOM 1239 CA ASP A 967 19.280 44.669 1.565 1.00 21.84 A C ATOM 1240 CB ASP A 967 20.620 45.061 2.203 1.00 25.14 A C ATOM 1241 CG ASP A 967 20.589 46.450 2.832 1.00 28.31 A C ATOM 1242 OD1 ASP A 967 19.687 46.736 3.661 1.00 33.06 A O ATOM 1243 OD2 ASP A 967 21.474 47.260 2.491 1.00 28.34 A O ATOM 1244 C ASP A 967 19.508 43.681 0.431 1.00 20.89 A C ATOM 1245 O ASP A 967 20.583 43.615 −0.144 1.00 19.01 A O ATOM 1246 N PHE A 968 18.472 42.936 0.087 1.00 23.31 A N ATOM 1247 CA PHE A 968 18.578 41.948 −0.973 1.00 23.74 A C ATOM 1248 CB PHE A 968 17.660 40.776 −0.643 1.00 22.73 A C ATOM 1249 CG PHE A 968 16.220 41.174 −0.452 1.00 21.43 A C ATOM 1250 CD1 PHE A 968 15.337 41.180 −1.518 1.00 21.04 A C ATOM 1251 CD2 PHE A 968 15.752 41.535 0.795 1.00 21.28 A C ATOM 1252 CE1 PHE A 968 14.014 41.535 −1.340 1.00 21.80 A C ATOM 1253 CE2 PHE A 968 14.427 41.893 0.977 1.00 21.96 A C ATOM 1254 CZ PHE A 968 13.558 41.890 −0.094 1.00 21.99 A C ATOM 1255 C PHE A 968 18.246 42.484 −2.364 1.00 25.69 A C ATOM 1256 O PHE A 968 17.488 43.454 −2.513 1.00 24.40 A O ATOM 1257 N GLY A 969 18.841 41.835 −3.368 1.00 27.11 A N ATOM 1258 CA GLY A 969 18.623 42.164 −4.770 1.00 28.84 A C ATOM 1259 C GLY A 969 18.930 43.573 −5.239 1.00 28.12 A C ATOM 1260 O GLY A 969 18.100 44.195 −5.887 1.00 29.45 A O ATOM 1261 N LEU A 970 20.128 44.066 −4.945 1.00 27.97 A N ATOM 1262 CA LEU A 970 20.522 45.415 −5.345 1.00 27.04 A C ATOM 1263 CB LEU A 970 20.882 46.223 −4.098 1.00 27.31 A C ATOM 1264 CG LEU A 970 19.885 47.280 −3.650 1.00 29.99 A C ATOM 1265 CD1 LEU A 970 18.475 46.876 −4.035 1.00 29.45 A C ATOM 1266 CD2 LEU A 970 20.017 47.474 −2.149 1.00 31.52 A C ATOM 1267 C LEU A 970 21.705 45.418 −6.313 1.00 25.60 A C ATOM 1268 O LEU A 970 22.214 46.480 −6.671 1.00 24.22 A O ATOM 1269 N ALA A 971 22.134 44.234 −6.736 1.00 24.75 A N ATOM 1270 CA ALA A 971 23.278 44.103 −7.638 1.00 27.57 A C ATOM 1271 CB ALA A 971 23.325 42.695 −8.231 1.00 26.59 A C ATOM 1272 C ALA A 971 23.271 45.135 −8.753 1.00 29.20 A C ATOM 1273 O ALA A 971 24.162 45.980 −8.820 1.00 31.64 A O ATOM 1274 N LYS A 972 22.259 45.065 −9.615 1.00 29.46 A N ATOM 1275 CA LYS A 972 22.112 45.979 −10.744 1.00 30.77 A C ATOM 1276 CB LYS A 972 20.697 45.850 −11.322 1.00 32.32 A C ATOM 1277 CG LYS A 972 20.347 44.427 −11.749 1.00 34.37 A C ATOM 1278 CD LYS A 972 21.454 43.844 −12.607 1.00 36.13 A C ATOM 1279 CE LYS A 972 21.197 42.389 −12.946 1.00 39.38 A C ATOM 1280 NZ LYS A 972 22.346 41.812 −13.722 1.00 41.41 A N ATOM 1281 C LYS A 972 22.406 47.446 −10.414 1.00 30.81 A C ATOM 1282 O LYS A 972 23.055 48.155 −11.182 1.00 30.44 A O ATOM 1283 N LEU A 973 21.930 47.899 −9.265 1.00 30.52 A N ATOM 1284 CA LEU A 973 22.141 49.276 −8.858 1.00 29.45 A C ATOM 1285 CB LEU A 973 21.110 49.654 −7.792 1.00 27.35 A C ATOM 1286 CG LEU A 973 19.690 50.011 −8.250 1.00 26.99 A C ATOM 1287 CD1 LEU A 973 19.474 49.507 −9.674 1.00 27.84 A C ATOM 1288 CD2 LEU A 973 18.645 49.444 −7.269 1.00 23.63 A C ATOM 1289 C LEU A 973 23.548 49.544 −8.322 1.00 30.66 A C ATOM 1290 O LEU A 973 23.988 50.685 −8.308 1.00 30.62 A O ATOM 1291 N LEU A 974 24.258 48.504 −7.888 1.00 32.78 A N ATOM 1292 CA LEU A 974 25.589 48.690 −7.314 1.00 35.10 A C ATOM 1293 CB LEU A 974 26.035 47.429 −6.560 1.00 34.09 A C ATOM 1294 CG LEU A 974 25.141 47.021 −5.372 1.00 31.33 A C ATOM 1295 CD1 LEU A 974 25.844 46.011 −4.476 1.00 31.22 A C ATOM 1296 CD2 LEU A 974 24.786 48.258 −4.582 1.00 29.58 A C ATOM 1297 C LEU A 974 26.644 49.095 −8.327 1.00 39.13 A C ATOM 1298 O LEU A 974 26.683 48.588 −9.444 1.00 39.72 A O ATOM 1299 N PRO A 975 27.533 50.013 −7.931 1.00 42.43 A N ATOM 1300 CD PRO A 975 27.809 50.379 −6.532 1.00 41.80 A C ATOM 1301 CA PRO A 975 28.594 50.500 −8.811 1.00 43.55 A C ATOM 1302 CB PRO A 975 29.427 51.381 −7.883 1.00 43.38 A C ATOM 1303 CG PRO A 975 29.288 50.685 −6.574 1.00 42.77 A C ATOM 1304 C PRO A 975 29.407 49.380 −9.438 1.00 44.80 A C ATOM 1305 O PRO A 975 29.676 48.370 −8.799 1.00 45.65 A O ATOM 1306 N LEU A 976 29.778 49.563 −10.700 1.00 46.34 A N ATOM 1307 CA LEU A 976 30.580 48.578 −11.403 1.00 47.22 A C ATOM 1308 CB LEU A 976 30.980 49.108 −12.787 1.00 47.95 A C ATOM 1309 CG LEU A 976 29.859 49.044 −13.840 1.00 48.59 A C ATOM 1310 CD1 LEU A 976 29.441 47.571 −14.033 1.00 48.06 A C ATOM 1311 CD2 LEU A 976 28.666 49.890 −13.389 1.00 47.77 A C ATOM 1312 C LEU A 976 31.815 48.314 −10.558 1.00 48.24 A C ATOM 1313 O LEU A 976 31.776 47.482 −9.643 1.00 49.05 A O ATOM 1314 N ASP A 977 32.898 49.039 −10.854 1.00 48.80 A N ATOM 1315 CA ASP A 977 34.163 48.909 −10.119 1.00 48.49 A C ATOM 1316 CB ASP A 977 35.294 49.712 −10.785 1.00 50.18 A C ATOM 1317 CG ASP A 977 36.480 49.982 −9.818 1.00 52.34 A C ATOM 1318 OD1 ASP A 977 37.652 49.670 −10.196 1.00 52.04 A O ATOM 1319 OD2 ASP A 977 36.233 50.509 −8.690 1.00 51.47 A O ATOM 1320 C ASP A 977 34.033 49.427 −8.706 1.00 47.71 A C ATOM 1321 O ASP A 977 33.806 50.620 −8.506 1.00 47.53 A O ATOM 1322 N LYS A 978 34.207 48.547 −7.726 1.00 46.64 A N ATOM 1323 CA LYS A 978 34.139 48.946 −6.315 1.00 46.31 A C ATOM 1324 CB LYS A 978 33.282 47.950 −5.522 1.00 44.80 A C ATOM 1325 CG LYS A 978 33.214 48.272 −4.029 1.00 43.21 A C ATOM 1326 CD LYS A 978 32.755 49.717 −3.804 1.00 41.49 A C ATOM 1327 CE LYS A 978 32.597 50.038 −2.322 1.00 40.48 A C ATOM 1328 NZ LYS A 978 31.726 49.077 −1.599 1.00 37.88 A N ATOM 1329 C LYS A 978 35.552 49.007 −5.714 1.00 46.70 A C ATOM 1330 O LYS A 978 36.359 48.077 −5.894 1.00 46.71 A O ATOM 1331 N ASP A 979 35.861 50.097 −5.016 1.00 47.20 A N ATOM 1332 CA ASP A 979 37.182 50.241 −4.396 1.00 47.47 A C ATOM 1333 CB ASP A 979 37.659 51.698 −4.492 1.00 49.44 A C ATOM 1334 CG ASP A 979 39.165 51.840 −4.312 1.00 49.88 A C ATOM 1335 OD1 ASP A 979 39.708 52.886 −4.737 1.00 50.87 A O ATOM 1336 OD2 ASP A 979 39.798 50.921 −3.742 1.00 49.55 A O ATOM 1337 C ASP A 979 37.052 49.805 −2.942 1.00 45.95 A C ATOM 1338 O ASP A 979 36.785 50.618 −2.052 1.00 44.33 A O ATOM 1339 N TYR A 980 37.233 48.505 −2.727 1.00 45.35 A N ATOM 1340 CA TYR A 980 37.107 47.891 −1.407 1.00 45.75 A C ATOM 1341 CB TYR A 980 37.086 46.367 −1.557 1.00 42.56 A C ATOM 1342 CG TYR A 980 35.856 45.844 −2.267 1.00 40.45 A C ATOM 1343 CD1 TYR A 980 34.639 45.743 −1.613 1.00 37.80 A C ATOM 1344 CE1 TYR A 980 33.512 45.271 −2.267 1.00 36.59 A C ATOM 1345 CD2 TYR A 980 35.912 45.461 −3.597 1.00 39.77 A C ATOM 1346 CE2 TYR A 980 34.793 44.993 −4.256 1.00 37.65 A C ATOM 1347 CZ TYR A 980 33.597 44.898 −3.591 1.00 36.99 A C ATOM 1348 OH TYR A 980 32.489 44.433 −4.267 1.00 36.66 A O ATOM 1349 C TYR A 980 38.153 48.296 −0.367 1.00 47.00 A C ATOM 1350 O TYR A 980 38.011 47.982 0.814 1.00 47.86 A O ATOM 1351 N TYR A 981 39.196 48.994 −0.800 1.00 48.44 A N ATOM 1352 CA TYR A 981 40.239 49.433 0.117 1.00 49.65 A C ATOM 1353 CB TYR A 981 41.552 49.597 −0.641 1.00 51.45 A C ATOM 1354 CG TYR A 981 42.026 48.307 −1.261 1.00 54.63 A C ATOM 1355 CD1 TYR A 981 42.798 48.311 −2.416 1.00 55.85 A C ATOM 1356 CE1 TYR A 981 43.214 47.127 −3.002 1.00 57.90 A C ATOM 1357 CD2 TYR A 981 41.680 47.080 −0.703 1.00 56.41 A C ATOM 1358 CE2 TYR A 981 42.089 45.888 −1.281 1.00 57.59 A C ATOM 1359 CZ TYR A 981 42.854 45.919 −2.431 1.00 58.54 A C ATOM 1360 OH TYR A 981 43.256 44.741 −3.016 1.00 60.20 A O ATOM 1361 C TYR A 981 39.824 50.743 0.781 1.00 48.81 A C ATOM 1362 O TYR A 981 40.504 51.260 1.673 1.00 48.86 A O ATOM 1363 N VAL A 982 38.688 51.266 0.339 1.00 48.42 A N ATOM 1364 CA VAL A 982 38.140 52.501 0.880 1.00 46.99 A C ATOM 1365 CB VAL A 982 37.831 53.528 −0.243 1.00 46.43 A C ATOM 1366 CG1 VAL A 982 37.265 54.802 0.359 1.00 45.87 A C ATOM 1367 CG2 VAL A 982 39.090 53.827 −1.045 1.00 44.80 A C ATOM 1368 C VAL A 982 36.845 52.148 1.605 1.00 46.90 A C ATOM 1369 O VAL A 982 35.773 52.122 1.004 1.00 45.78 A O ATOM 1370 N VAL A 983 36.965 51.866 2.898 1.00 47.59 A N ATOM 1371 CA VAL A 983 35.824 51.510 3.729 1.00 48.25 A C ATOM 1372 CB VAL A 983 35.733 49.970 3.898 1.00 48.58 A C ATOM 1373 CG1 VAL A 983 37.076 49.417 4.360 1.00 49.17 A C ATOM 1374 CG2 VAL A 983 34.631 49.608 4.884 1.00 47.78 A C ATOM 1375 C VAL A 983 35.928 52.175 5.100 1.00 49.02 A C ATOM 1376 O VAL A 983 37.005 52.243 5.691 1.00 49.70 A O ATOM 1377 N ARG A 984 34.803 52.671 5.601 1.00 49.82 A N ATOM 1378 CA ARG A 984 34.778 53.333 6.895 1.00 49.53 A C ATOM 1379 CB ARG A 984 33.426 54.011 7.127 1.00 52.18 A C ATOM 1380 CG ARG A 984 33.463 55.085 8.205 1.00 55.52 A C ATOM 1381 CD ARG A 984 32.063 55.466 8.673 1.00 59.59 A C ATOM 1382 NE ARG A 984 32.062 56.701 9.457 1.00 62.13 A N ATOM 1383 CZ ARG A 984 32.749 56.885 10.581 1.00 63.45 A C ATOM 1384 NH1 ARG A 984 32.678 58.052 11.210 1.00 64.01 A N ATOM 1385 NH2 ARG A 984 33.499 55.908 11.079 1.00 61.84 A N ATOM 1386 C ARG A 984 35.036 52.324 8.001 1.00 48.55 A C ATOM 1387 O ARG A 984 35.748 52.619 8.962 1.00 49.22 A O ATOM 1388 N GLU A 985 34.449 51.137 7.871 1.00 46.54 A N ATOM 1389 CA GLU A 985 34.631 50.081 8.864 1.00 44.17 A C ATOM 1390 CB GLU A 985 33.338 49.854 9.653 1.00 45.48 A C ATOM 1391 CG GLU A 985 33.574 49.373 11.092 1.00 50.99 A C ATOM 1392 CD GLU A 985 33.937 50.504 12.068 1.00 53.46 A C ATOM 1393 OE1 GLU A 985 34.598 50.216 13.094 1.00 54.69 A O ATOM 1394 OE2 GLU A 985 33.549 51.672 11.820 1.00 54.79 A O ATOM 1395 C GLU A 985 35.050 48.793 8.159 1.00 41.59 A C ATOM 1396 O GLU A 985 34.220 47.947 7.842 1.00 41.99 A O ATOM 1397 N PRO A 986 36.363 48.626 7.928 1.00 39.68 A N ATOM 1398 CD PRO A 986 37.384 49.483 8.550 1.00 37.11 A C ATOM 1399 CA PRO A 986 36.988 47.476 7.261 1.00 37.84 A C ATOM 1400 CB PRO A 986 38.479 47.779 7.389 1.00 37.70 A C ATOM 1401 CG PRO A 986 38.550 48.546 8.663 1.00 37.19 A C ATOM 1402 C PRO A 986 36.613 46.090 7.788 1.00 36.77 A C ATOM 1403 O PRO A 986 36.536 45.131 7.026 1.00 37.02 A O ATOM 1404 N GLY A 987 36.380 45.970 9.085 1.00 35.59 A N ATOM 1405 CA GLY A 987 36.010 44.671 9.607 1.00 33.97 A C ATOM 1406 C GLY A 987 34.746 44.114 8.963 1.00 32.82 A C ATOM 1407 O GLY A 987 34.510 42.912 9.012 1.00 32.56 A O ATOM 1408 N GLN A 988 33.927 44.974 8.366 1.00 30.14 A N ATOM 1409 CA GLN A 988 32.700 44.512 7.737 1.00 29.16 A C ATOM 1410 CB GLN A 988 31.493 45.292 8.268 1.00 30.41 A C ATOM 1411 CG GLN A 988 31.206 45.078 9.756 1.00 29.44 A C ATOM 1412 CD GLN A 988 30.776 43.654 10.082 1.00 31.42 A C ATOM 1413 OE1 GLN A 988 29.653 43.244 9.684 1.00 26.26 A O ATOM 1414 NE2 GLN A 988 31.576 42.947 10.735 1.00 32.03 A O ATOM 1415 C GLN A 988 32.765 44.645 6.226 1.00 29.17 A C ATOM 1416 O GLN A 988 31.740 44.806 5.570 1.00 27.90 A O ATOM 1417 N SER A 989 33.978 44.584 5.678 1.00 29.64 A N ATOM 1418 CA SER A 989 34.172 44.687 4.236 1.00 27.96 A C ATOM 1419 CB SER A 989 35.656 44.774 3.888 1.00 29.01 A C ATOM 1420 OG SER A 989 35.843 44.762 2.483 1.00 28.27 A O ATOM 1421 C SER A 989 33.587 43.442 3.604 1.00 28.16 A C ATOM 1422 O SER A 989 33.928 42.327 3.982 1.00 26.58 A O ATOM 1423 N PRO A 990 32.714 43.624 2.608 1.00 28.39 A N ATOM 1424 CD PRO A 990 32.449 44.935 1.982 1.00 29.19 A C ATOM 1425 CA PRO A 990 32.035 42.551 1.879 1.00 28.46 A C ATOM 1426 CB PRO A 990 31.472 43.272 0.653 1.00 29.64 A C ATOM 1427 CG PRO A 990 31.205 44.662 1.169 1.00 28.86 A C ATOM 1428 C PRO A 990 32.893 41.355 1.489 1.00 26.71 A C ATOM 1429 O PRO A 990 32.386 40.242 1.408 1.00 27.68 A O ATOM 1430 N ILE A 991 34.181 41.590 1.247 1.00 25.64 A N ATOM 1431 CA ILE A 991 35.109 40.542 0.829 1.00 23.27 A C ATOM 1432 CB ILE A 991 36.508 41.121 0.543 1.00 22.53 A C ATOM 1433 CG2 ILE A 991 36.390 42.242 −0.472 1.00 21.72 A C ATOM 1434 CG1 ILE A 991 37.162 41.592 1.851 1.00 21.38 A C ATOM 1435 CD1 ILE A 991 38.659 41.885 1.740 1.00 17.35 A C ATOM 1436 C ILE A 991 35.282 39.340 1.759 1.00 22.89 A C ATOM 1437 O ILE A 991 35.628 38.267 1.292 1.00 22.75 A O ATOM 1438 N PHE A 992 35.061 39.504 3.060 1.00 22.83 A N ATOM 1439 CA PHE A 992 35.218 38.367 3.972 1.00 24.27 A C ATOM 1440 CB PHE A 992 35.468 38.832 5.423 1.00 21.98 A C ATOM 1441 CG PHE A 992 36.692 39.675 5.575 1.00 18.63 A C ATOM 1442 CD1 PHE A 992 37.905 39.225 5.092 1.00 19.36 A C ATOM 1443 CD2 PHE A 992 36.621 40.944 6.129 1.00 18.42 A C ATOM 1444 CE1 PHE A 992 39.042 40.021 5.144 1.00 18.38 A C ATOM 1445 CE2 PHE A 992 37.747 41.751 6.188 1.00 20.39 A C ATOM 1446 CZ PHE A 992 38.965 41.286 5.689 1.00 19.03 A C ATOM 1447 C PHE A 992 34.010 37.434 3.945 1.00 24.41 A C ATOM 1448 O PHE A 992 33.986 36.436 4.669 1.00 23.48 A O ATOM 1449 N TRP A 993 33.014 37.767 3.122 1.00 24.17 A N ATOM 1450 CA TRP A 993 31.801 36.952 2.977 1.00 24.08 A C ATOM 1451 CB TRP A 993 30.549 37.762 3.318 1.00 20.25 A C ATOM 1452 CG TRP A 993 30.322 37.968 4.776 1.00 18.22 A C ATOM 1453 CD2 TRP A 993 30.934 38.962 5.609 1.00 17.81 A C ATOM 1454 CE2 TRP A 993 30.465 38.750 6.923 1.00 16.65 A C ATOM 1455 CE3 TRP A 993 31.836 40.012 5.371 1.00 17.27 A C ATOM 1456 CD1 TRP A 993 29.524 37.222 5.593 1.00 18.48 A C ATOM 1457 NE1 TRP A 993 29.608 37.683 6.885 1.00 18.25 A N ATOM 1458 CZ2 TRP A 993 30.867 39.544 7.998 1.00 16.84 A C ATOM 1459 CZ3 TRP A 993 32.235 40.800 6.439 1.00 13.99 A C ATOM 1460 CH2 TRP A 993 31.752 40.562 7.738 1.00 15.16 A C ATOM 1461 C TRP A 993 31.674 36.458 1.547 1.00 25.04 A C ATOM 1462 O TRP A 993 30.772 35.691 1.224 1.00 27.65 A O ATOM 1463 N TYR A 994 32.590 36.891 0.691 1.00 26.08 A N ATOM 1464 CA TYR A 994 32.539 36.516 −0.713 1.00 26.22 A C ATOM 1465 CB TYR A 994 33.385 37.473 −1.556 1.00 26.01 A C ATOM 1466 CG TYR A 994 32.752 38.812 −1.830 1.00 25.79 A C ATOM 1467 CD1 TYR A 994 31.565 39.180 −1.224 1.00 25.47 A C ATOM 1468 CE1 TYR A 994 30.997 40.421 −1.472 1.00 29.26 A C ATOM 1469 CD2 TYR A 994 33.358 39.719 −2.695 1.00 27.78 A C ATOM 1470 CE2 TYR A 994 32.798 40.958 −2.949 1.00 27.26 A C ATOM 1471 CZ TYR A 994 31.620 41.304 −2.337 1.00 28.81 A C ATOM 1472 OH TYR A 994 31.056 42.529 −2.598 1.00 31.86 A O ATOM 1473 C TYR A 994 33.018 35.111 −0.989 1.00 26.70 A C ATOM 1474 O TYR A 994 33.871 34.587 −0.281 1.00 26.37 A O ATOM 1475 N ALA A 995 32.462 34.516 −2.040 1.00 27.56 A N ATOM 1476 CA ALA A 995 32.846 33.180 −2.479 1.00 27.85 A C ATOM 1477 CB ALA A 995 31.653 32.478 −3.148 1.00 26.19 A C ATOM 1478 C ALA A 995 33.980 33.383 −3.488 1.00 28.75 A C ATOM 1479 O ALA A 995 34.156 34.486 −4.027 1.00 29.61 A O ATOM 1480 N PRO A 996 34.762 32.329 −3.760 1.00 27.48 A N ATOM 1481 CD PRO A 996 34.696 30.981 −3.181 1.00 26.63 A C ATOM 1482 CA PRO A 996 35.872 32.429 −4.711 1.00 28.77 A C ATOM 1483 CB PRO A 996 36.309 30.978 −4.880 1.00 26.97 A C ATOM 1484 CG PRO A 996 36.050 30.418 −3.535 1.00 25.72 A C ATOM 1485 C PRO A 996 35.494 33.082 −6.041 1.00 29.95 A C ATOM 1486 O PRO A 996 36.092 34.089 −6.423 1.00 32.04 A O ATOM 1487 N GLU A 997 34.507 32.517 −6.736 1.00 30.01 A N ATOM 1488 CA GLU A 997 34.080 33.050 −8.026 1.00 30.26 A C ATOM 1489 CB GLU A 997 32.822 32.323 −8.549 1.00 30.28 A C ATOM 1490 CG GLU A 997 31.606 32.373 −7.648 1.00 30.56 A C ATOM 1491 CD GLU A 997 31.601 31.268 −6.606 1.00 32.94 A C ATOM 1492 OE1 GLU A 997 32.683 30.961 −6.052 1.00 31.09 A O ATOM 1493 OE2 GLU A 997 30.506 30.717 −6.338 1.00 33.32 A O ATOM 1494 C GLU A 997 33.829 34.550 −7.948 1.00 30.85 A C ATOM 1495 O GLU A 997 34.057 35.281 −8.909 1.00 31.80 A O ATOM 1496 N SER A 998 33.368 35.017 −6.797 1.00 32.03 A N ATOM 1497 CA SER A 998 33.132 36.440 −6.626 1.00 32.09 A C ATOM 1498 CB SER A 998 32.300 36.688 −5.379 1.00 31.27 A C ATOM 1499 OG SER A 998 30.955 36.327 −5.607 1.00 32.96 A O ATOM 1500 C SER A 998 34.442 37.214 −6.522 1.00 32.18 A C ATOM 1501 O SER A 998 34.644 38.198 −7.224 1.00 34.53 A O ATOM 1502 N LEU A 999 35.329 36.770 −5.642 1.00 32.83 A N ATOM 1503 CA LEU A 999 36.606 37.447 −5.448 1.00 33.92 A C ATOM 1504 CB LEU A 999 37.435 36.730 −4.374 1.00 31.31 A C ATOM 1505 CG LEU A 999 37.076 36.949 −2.897 1.00 29.60 A C ATOM 1506 CD1 LEU A 999 37.992 36.101 −2.035 1.00 28.05 A C ATOM 1507 CD2 LEU A 999 37.226 38.417 −2.515 1.00 28.42 A C ATOM 1508 C LEU A 999 37.432 37.568 −6.724 1.00 35.90 A C ATOM 1509 O LEU A 999 38.101 38.574 −6.936 1.00 36.64 A O ATOM 1510 N SER A 1000 37.374 36.556 −7.581 1.00 36.91 A N ATOM 1511 CA SER A 1000 38.152 36.566 −8.808 1.00 37.30 A C ATOM 1512 CB SER A 1000 38.755 35.192 −9.032 1.00 36.47 A C ATOM 1513 OG SER A 1000 37.724 34.247 −9.246 1.00 34.60 A O ATOM 1514 C SER A 1000 37.425 36.977 −10.084 1.00 39.08 A C ATOM 1515 O SER A 1000 38.062 37.421 −11.033 1.00 40.17 A O ATOM 1516 N ASP A 1001 36.109 36.831 −10.132 1.00 40.32 A N ATOM 1517 CA ASP A 1001 35.396 37.191 −11.351 1.00 42.54 A C ATOM 1518 CB ASP A 1001 35.041 35.925 −12.126 1.00 43.98 A C ATOM 1519 CG ASP A 1001 36.266 35.162 −12.574 1.00 45.00 A C ATOM 1520 OD1 ASP A 1001 37.062 35.734 −13.349 1.00 44.52 A O ATOM 1521 OD2 ASP A 1001 36.433 33.998 −12.147 1.00 45.98 A O ATOM 1522 C ASP A 1001 34.142 38.031 −11.171 1.00 42.36 A C ATOM 1523 O ASP A 1001 33.359 38.178 −12.104 1.00 42.53 A O ATOM 1524 N ASN A 1002 33.957 38.589 −9.983 1.00 42.42 A N ATOM 1525 CA ASN A 1002 32.781 39.390 −9.703 1.00 42.92 A C ATOM 1526 CB ASN A 1002 32.703 40.590 −10.641 1.00 44.00 A C ATOM 1527 CG ASN A 1002 33.246 41.847 −10.015 1.00 45.61 A C ATOM 1528 OD1 ASN A 1002 34.455 42.005 −9.846 1.00 49.08 A O ATOM 1529 ND2 ASN A 1002 32.349 42.753 −9.653 1.00 45.40 A N ATOM 1530 C ASN A 1002 31.514 38.570 −9.841 1.00 42.00 A C ATOM 1531 O ASN A 1002 30.421 39.095 −9.676 1.00 43.55 A O ATOM 1532 N ILE A 1003 31.667 37.285 −10.143 1.00 40.07 A N ATOM 1533 CA ILE A 1003 30.535 36.376 −10.303 1.00 37.80 A C ATOM 1534 CB ILE A 1003 30.994 34.944 −10.651 1.00 38.03 A C ATOM 1535 CG2 ILE A 1003 29.822 33.987 −10.536 1.00 35.71 A C ATOM 1536 CG1 ILE A 1003 31.629 34.902 −12.037 1.00 35.29 A C ATOM 1537 CD1 ILE A 1003 31.993 33.514 −12.454 1.00 33.06 A C ATOM 1538 C ILE A 1003 29.704 36.255 −9.037 1.00 37.43 A C ATOM 1539 O ILE A 1003 30.230 35.936 −7.969 1.00 38.59 A O ATOM 1540 N PHE A 1004 28.404 36.488 −9.170 1.00 36.18 A N ATOM 1541 CA PHE A 1004 27.474 36.390 −8.055 1.00 34.51 A C ATOM 1542 CB PHE A 1004 27.055 37.787 −7.598 1.00 32.45 A C ATOM 1543 CG PHE A 1004 28.126 38.525 −6.828 1.00 34.32 A C ATOM 1544 CD1 PHE A 1004 28.492 38.110 −5.549 1.00 32.69 A C ATOM 1545 CD2 PHE A 1004 28.757 39.637 −7.371 1.00 31.98 A C ATOM 1546 CE1 PHE A 1004 29.462 38.789 −4.824 1.00 31.46 A C ATOM 1547 CE2 PHE A 1004 29.730 40.322 −6.651 1.00 33.05 A C ATOM 1548 CZ PHE A 1004 30.081 39.895 −5.373 1.00 32.10 A C ATOM 1549 C PHE A 1004 26.256 35.591 −8.511 1.00 35.47 A C ATOM 1550 O PHE A 1004 25.696 35.854 −9.575 1.00 37.28 A O ATOM 1551 N SER A 1005 25.853 34.610 −7.709 1.00 34.92 A N ATOM 1552 CA SER A 1005 24.713 33.774 −8.045 1.00 32.73 A C ATOM 1553 CB SER A 1005 25.158 32.584 −8.888 1.00 33.36 A C ATOM 1554 OG SER A 1005 25.959 31.704 −8.114 1.00 36.71 A O ATOM 1555 C SER A 1005 24.051 33.245 −6.794 1.00 31.68 A C ATOM 1556 O SER A 1005 24.536 33.449 −5.681 1.00 31.32 A O ATOM 1557 N ARG A 1006 22.937 32.553 −6.996 1.00 29.32 A N ATOM 1558 CA ARG A 1006 22.197 31.961 −5.900 1.00 28.94 A C ATOM 1559 CB ARG A 1006 21.040 31.130 −6.452 1.00 29.85 A C ATOM 1560 CG ARG A 1006 20.005 31.949 −7.202 1.00 35.55 A C ATOM 1561 CD ARG A 1006 18.924 31.062 −7.843 1.00 38.40 A C ATOM 1562 NE ARG A 1006 18.345 30.128 −6.876 1.00 43.57 A N ATOM 1563 CZ ARG A 1006 17.471 29.168 −7.174 1.00 44.56 A C ATOM 1564 NH1 ARG A 1006 17.009 28.367 −6.220 1.00 41.70 A N ATOM 1565 NH2 ARG A 1006 17.053 29.012 −8.420 1.00 44.91 A N ATOM 1566 C ARG A 1006 23.125 31.068 −5.081 1.00 27.76 A C ATOM 1567 O ARG A 1006 22.995 30.967 −3.861 1.00 25.65 A O ATOM 1568 N GLN A 1007 24.077 30.433 −5.755 1.00 27.21 A N ATOM 1569 CA GLN A 1007 24.979 29.524 −5.067 1.00 27.69 A C ATOM 1570 CB GLN A 1007 25.552 28.492 −6.041 1.00 27.27 A C ATOM 1571 CG GLN A 1007 24.566 27.386 −6.456 1.00 30.11 A C ATOM 1572 CD GLN A 1007 24.008 26.541 −5.273 1.00 32.03 A C ATOM 1573 OE1 GLN A 1007 22.897 26.788 −4.771 1.00 28.18 A O ATOM 1574 NE2 GLN A 1007 24.785 25.542 −4.836 1.00 29.04 A N ATOM 1575 C GLN A 1007 26.093 30.236 −4.313 1.00 27.70 A C ATOM 1576 O GLN A 1007 26.567 29.750 −3.276 1.00 26.19 A O ATOM 1577 N SER A 1008 26.506 31.390 −4.822 1.00 26.86 A N ATOM 1578 CA SER A 1008 27.542 32.155 −4.150 1.00 26.66 A C ATOM 1579 CB SER A 1008 27.997 33.331 −5.018 1.00 29.18 A C ATOM 1580 OG SER A 1008 26.903 34.144 −5.400 1.00 31.80 A O ATOM 1581 C SER A 1008 26.950 32.654 −2.830 1.00 26.32 A C ATOM 1582 O SER A 1008 27.659 32.816 −1.828 1.00 26.69 A O ATOM 1583 N ASP A 1009 25.641 32.892 −2.830 1.00 25.13 A N ATOM 1584 CA ASP A 1009 24.974 33.341 −1.620 1.00 24.62 A C ATOM 1585 CB ASP A 1009 23.493 33.663 −1.882 1.00 26.26 A C ATOM 1586 CG ASP A 1009 23.275 35.087 −2.421 1.00 29.77 A C ATOM 1587 OD1 ASP A 1009 22.195 35.364 −2.993 1.00 31.03 A O ATOM 1588 OD2 ASP A 1009 24.175 35.937 −2.268 1.00 30.20 A O ATOM 1589 C ASP A 1009 25.097 32.221 −0.602 1.00 23.09 A C ATOM 1590 O ASP A 1009 25.382 32.469 0.566 1.00 24.34 A O ATOM 1591 N VAL A 1010 24.904 30.987 −1.051 1.00 21.87 A N ATOM 1592 CA VAL A 1010 24.986 29.833 −0.155 1.00 21.43 A C ATOM 1593 CB VAL A 1010 24.906 28.497 −0.933 1.00 18.75 A C ATOM 1594 CG1 VAL A 1010 25.308 27.344 −0.033 1.00 18.01 A C ATOM 1595 CG2 VAL A 1010 23.499 28.277 −1.432 1.00 17.23 A C ATOM 1596 C VAL A 1010 26.279 29.868 0.649 1.00 21.21 A C ATOM 1597 O VAL A 1010 26.285 29.538 1.827 1.00 18.67 A O ATOM 1598 N TRP A 1011 27.355 30.289 −0.012 1.00 22.19 A N ATOM 1599 CA TRP A 1011 28.671 30.408 0.582 1.00 21.30 A C ATOM 1600 CB TRP A 1011 29.676 30.823 −0.494 1.00 21.09 A C ATOM 1601 CG TRP A 1011 31.004 31.272 0.051 1.00 22.20 A C ATOM 1602 CD2 TRP A 1011 32.242 30.555 −0.013 1.00 23.32 A C ATOM 1603 CE2 TRP A 1011 33.216 31.343 0.643 1.00 23.77 A C ATOM 1604 CE3 TRP A 1011 32.622 29.326 −0.558 1.00 23.63 A C ATOM 1605 CD1 TRP A 1011 31.271 32.436 0.726 1.00 22.11 A C ATOM 1606 NE1 TRP A 1011 32.596 32.484 1.084 1.00 22.41 A N ATOM 1607 CZ2 TRP A 1011 34.546 30.940 0.769 1.00 23.00 A C ATOM 1608 CZ3 TRP A 1011 33.949 28.926 −0.433 1.00 25.04 A C ATOM 1609 CH2 TRP A 1011 34.893 29.734 0.226 1.00 24.41 A C ATOM 1610 C TRP A 1011 28.642 31.456 1.690 1.00 21.41 A C ATOM 1611 O TRP A 1011 29.159 31.231 2.780 1.00 20.92 A O ATOM 1612 N SER A 1012 28.035 32.602 1.401 1.00 22.30 A N ATOM 1613 CA SER A 1012 27.940 33.684 2.373 1.00 21.76 A C ATOM 1614 CB SER A 1012 27.286 34.926 1.742 1.00 24.85 A C ATOM 1615 OG SER A 1012 27.933 35.297 0.534 1.00 28.52 A O ATOM 1616 C SER A 1012 27.107 33.232 3.565 1.00 19.93 A C ATOM 1617 O SER A 1012 27.303 33.713 4.677 1.00 20.35 A O ATOM 1618 N PHE A 1013 26.167 32.322 3.332 1.00 18.72 A N ATOM 1619 CA PHE A 1013 25.324 31.823 4.409 1.00 19.74 A C ATOM 1620 CB PHE A 1013 24.197 30.958 3.850 1.00 21.64 A C ATOM 1621 CG PHE A 1013 23.267 30.431 4.902 1.00 21.29 A C ATOM 1622 CD1 PHE A 1013 22.582 31.307 5.738 1.00 21.35 A C ATOM 1623 CD2 PHE A 1013 23.048 29.069 5.033 1.00 20.51 A C ATOM 1624 CE1 PHE A 1013 21.689 30.832 6.684 1.00 20.93 A C ATOM 1625 CE2 PHE A 1013 22.156 28.579 5.973 1.00 21.44 A C ATOM 1626 CZ PHE A 1013 21.470 29.462 6.804 1.00 21.79 A C ATOM 1627 C PHE A 1013 26.191 31.002 5.355 1.00 18.87 A C ATOM 1628 O PHE A 1013 25.924 30.912 6.549 1.00 18.16 A O ATOM 1629 N GLY A 1014 27.236 30.399 4.806 1.00 19.32 A N ATOM 1630 CA GLY A 1014 28.143 29.634 5.639 1.00 23.18 A C ATOM 1631 C GLY A 1014 28.825 30.545 6.654 1.00 24.21 A C ATOM 1632 O GLY A 1014 28.994 30.177 7.815 1.00 23.51 A O ATOM 1633 N VAL A 1015 29.206 31.745 6.216 1.00 25.95 A N ATOM 1634 CA VAL A 1015 29.874 32.705 7.093 1.00 26.43 A C ATOM 1635 CB VAL A 1015 30.547 33.841 6.282 1.00 25.36 A C ATOM 1636 CG1 VAL A 1015 31.399 34.710 7.195 1.00 26.40 A C ATOM 1637 CG2 VAL A 1015 31.404 33.253 5.185 1.00 24.13 A C ATOM 1638 C VAL A 1015 28.873 33.305 8.070 1.00 27.70 A C ATOM 1639 O VAL A 1015 29.229 33.721 9.174 1.00 29.33 A O ATOM 1640 N VAL A 1016 27.610 33.345 7.674 1.00 26.63 A N ATOM 1641 CA VAL A 1016 26.600 33.897 8.559 1.00 26.58 A C ATOM 1642 CB VAL A 1016 25.275 34.134 7.813 1.00 27.70 A C ATOM 1643 CG1 VAL A 1016 24.194 34.545 8.804 1.00 25.02 A C ATOM 1644 CG2 VAL A 1016 25.469 35.196 6.738 1.00 24.95 A C ATOM 1645 C VAL A 1016 26.363 32.924 9.709 1.00 26.56 A C ATOM 1646 O VAL A 1016 26.105 33.334 10.843 1.00 25.68 A O ATOM 1647 N LEU A 1017 26.445 31.630 9.406 1.00 25.79 A N ATOM 1648 CA LEU A 1017 26.259 30.595 10.420 1.00 25.37 A C ATOM 1649 CB LEU A 1017 26.231 29.204 9.768 1.00 24.57 A C ATOM 1650 CG LEU A 1017 24.935 28.765 9.069 1.00 23.17 A C ATOM 1651 CD1 LEU A 1017 25.212 27.540 8.190 1.00 22.94 A C ATOM 1652 CD2 LEU A 1017 23.856 28.468 10.107 1.00 19.40 A C ATOM 1653 C LEU A 1017 27.417 30.702 11.404 1.00 25.14 A C ATOM 1654 O LEU A 1017 27.242 30.556 12.609 1.00 24.28 A O ATOM 1655 N TYR A 1018 28.603 30.964 10.871 1.00 26.09 A N ATOM 1656 CA TYR A 1018 29.788 31.130 11.687 1.00 27.05 A C ATOM 1657 CB TYR A 1018 31.003 31.388 10.801 1.00 28.96 A C ATOM 1658 CG TYR A 1018 32.276 31.654 11.584 1.00 32.69 A C ATOM 1659 CD1 TYR A 1018 32.924 30.627 12.263 1.00 31.98 A C ATOM 1660 CE1 TYR A 1018 34.082 30.865 12.978 1.00 31.92 A C ATOM 1661 CD2 TYR A 1018 32.830 32.936 11.647 1.00 31.48 A C ATOM 1662 CE2 TYR A 1018 33.993 33.180 12.364 1.00 31.23 A C ATOM 1663 CZ TYR A 1018 34.610 32.139 13.023 1.00 32.76 A C ATOM 1664 OH TYR A 1018 35.763 32.357 13.732 1.00 34.73 A O ATOM 1665 C TYR A 1018 29.590 32.316 12.636 1.00 28.41 A C ATOM 1666 O TYR A 1018 29.937 32.228 13.807 1.00 29.27 A O ATOM 1667 N GLU A 1019 29.024 33.416 12.130 1.00 28.77 A N ATOM 1668 CA GLU A 1019 28.786 34.623 12.931 1.00 28.13 A C ATOM 1669 CB GLU A 1019 28.258 35.773 12.046 1.00 29.97 A C ATOM 1670 CG GLU A 1019 29.188 36.251 10.919 1.00 29.60 A C ATOM 1671 CD GLU A 1019 28.738 37.577 10.299 1.00 29.59 A C ATOM 1672 OE1 GLU A 1019 28.910 38.638 10.937 1.00 31.77 A O ATOM 1673 OE2 GLU A 1019 28.208 37.564 9.171 1.00 28.17 A O ATOM 1674 C GLU A 1019 27.796 34.396 14.086 1.00 27.33 A C ATOM 1675 O GLU A 1019 27.988 34.897 15.195 1.00 25.68 A O ATOM 1676 N LEU A 1020 26.730 33.650 13.825 1.00 27.14 A N ATOM 1677 CA LEU A 1020 25.735 33.394 14.855 1.00 26.16 A C ATOM 1678 CB LEU A 1020 24.513 32.683 14.255 1.00 25.72 A C ATOM 1679 CG LEU A 1020 23.673 33.449 13.223 1.00 27.06 A C ATOM 1680 CD1 LEU A 1020 22.199 33.148 13.464 1.00 26.70 A C ATOM 1681 CD2 LEU A 1020 23.917 34.949 13.329 1.00 26.86 A C ATOM 1682 C LEU A 1020 26.318 32.560 15.988 1.00 25.00 A C ATOM 1683 O LEU A 1020 26.214 32.929 17.153 1.00 23.85 A O ATOM 1684 N PHE A 1021 26.935 31.438 15.637 1.00 25.96 A N ATOM 1685 CA PHE A 1021 27.540 30.551 16.622 1.00 28.26 A C ATOM 1686 CB PHE A 1021 27.756 29.173 15.998 1.00 28.65 A C ATOM 1687 CG PHE A 1021 26.514 28.328 15.974 1.00 30.48 A C ATOM 1688 CD1 PHE A 1021 26.105 27.648 17.107 1.00 30.22 A C ATOM 1689 CD2 PHE A 1021 25.721 28.270 14.846 1.00 31.61 A C ATOM 1690 CE1 PHE A 1021 24.932 26.932 17.119 1.00 32.06 A C ATOM 1691 CE2 PHE A 1021 24.537 27.552 14.853 1.00 33.64 A C ATOM 1692 CZ PHE A 1021 24.145 26.882 15.994 1.00 33.78 A C ATOM 1693 C PHE A 1021 28.848 31.115 17.184 1.00 29.12 A C ATOM 1694 O PHE A 1021 29.517 30.477 17.992 1.00 30.42 A O ATOM 1695 N THR A 1022 29.190 32.325 16.751 1.00 29.23 A N ATOM 1696 CA THR A 1022 30.386 33.014 17.201 1.00 28.15 A C ATOM 1697 CB THR A 1022 31.291 33.380 15.994 1.00 28.82 A C ATOM 1698 OG1 THR A 1022 32.643 32.998 16.273 1.00 30.39 A O ATOM 1699 CG2 THR A 1022 31.237 34.859 15.693 1.00 28.63 A C ATOM 1700 C THR A 1022 29.899 34.276 17.905 1.00 28.32 A C ATOM 1701 O THR A 1022 30.692 35.071 18.422 1.00 27.51 A O ATOM 1702 N TYR A 1023 28.573 34.427 17.931 1.00 28.68 A N ATOM 1703 CA TYR A 1023 27.897 35.573 18.545 1.00 27.59 A C ATOM 1704 CB TYR A 1023 28.003 35.531 20.067 1.00 27.08 A C ATOM 1705 CG TYR A 1023 27.151 34.471 20.710 1.00 27.19 A C ATOM 1706 CD1 TYR A 1023 27.691 33.252 21.089 1.00 27.11 A C ATOM 1707 CE1 TYR A 1023 26.900 32.281 21.682 1.00 26.29 A C ATOM 1708 CD2 TYR A 1023 25.799 34.690 20.937 1.00 26.09 A C ATOM 1709 CE2 TYR A 1023 25.006 33.730 21.524 1.00 25.32 A C ATOM 1710 CZ TYR A 1023 25.559 32.528 21.896 1.00 26.71 A C ATOM 1711 OH TYR A 1023 24.766 31.569 22.484 1.00 27.13 A O ATOM 1712 C TYR A 1023 28.471 36.886 18.062 1.00 26.01 A C ATOM 1713 O TYR A 1023 28.307 37.913 18.712 1.00 26.91 A O ATOM 1714 N CYS A 1024 29.150 36.849 16.924 1.00 24.48 A N ATOM 1715 CA CYS A 1024 29.760 38.042 16.359 1.00 27.84 A C ATOM 1716 CB CYS A 1024 28.698 39.077 15.971 1.00 27.22 A C ATOM 1717 SG CYS A 1024 27.882 38.643 14.441 1.00 31.28 A S ATOM 1718 C CYS A 1024 30.787 38.681 17.266 1.00 28.38 A C ATOM 1719 O CYS A 1024 30.903 39.905 17.346 1.00 28.99 A O ATOM 1720 N ASP A 1025 31.543 37.845 17.950 1.00 28.57 A N ATOM 1721 CA ASP A 1025 32.582 38.353 18.807 1.00 30.59 A C ATOM 1722 CB ASP A 1025 33.163 37.211 19.630 1.00 35.06 A C ATOM 1723 CG ASP A 1025 34.099 37.697 20.698 1.00 39.47 A C ATOM 1724 OD1 ASP A 1025 33.658 38.530 21.525 1.00 42.23 A O ATOM 1725 OD2 ASP A 1025 35.269 37.249 20.704 1.00 42.12 A O ATOM 1726 C ASP A 1025 33.647 38.945 17.874 1.00 30.39 A C ATOM 1727 O ASP A 1025 34.007 38.326 16.870 1.00 29.56 A O ATOM 1728 N LYS A 1026 34.139 40.136 18.201 1.00 31.27 A N ATOM 1729 CA LYS A 1026 35.143 40.817 17.381 1.00 33.10 A C ATOM 1730 CB LYS A 1026 35.401 42.228 17.914 1.00 35.51 A C ATOM 1731 CG LYS A 1026 34.153 43.016 18.261 1.00 39.16 A C ATOM 1732 CD LYS A 1026 33.229 43.169 17.082 1.00 42.21 A C ATOM 1733 CE LYS A 1026 33.853 43.995 15.984 1.00 43.30 A C ATOM 1734 NZ LYS A 1026 32.833 44.288 14.939 1.00 46.56 A N ATOM 1735 C LYS A 1026 36.468 40.065 17.327 1.00 33.00 A C ATOM 1736 O LYS A 1026 37.176 40.116 16.323 1.00 32.10 A O ATOM 1737 N SER A 1027 36.797 39.368 18.410 1.00 34.41 A N ATOM 1738 CA SER A 1027 38.042 38.605 18.491 1.00 34.79 A C ATOM 1739 CB SER A 1027 38.153 37.909 19.856 1.00 33.89 A C ATOM 1740 OG SER A 1027 37.889 38.809 20.914 1.00 38.74 A O ATOM 1741 C SER A 1027 38.156 37.545 17.391 1.00 34.36 A C ATOM 1742 O SER A 1027 39.198 37.413 16.750 1.00 33.83 A O ATOM 1743 N CYS A 1028 37.080 36.790 17.178 1.00 33.80 A N ATOM 1744 CA CYS A 1028 37.075 35.716 16.182 1.00 32.68 A C ATOM 1745 CB CYS A 1028 36.650 34.408 16.850 1.00 32.82 A C ATOM 1746 SG CYS A 1028 35.060 34.533 17.704 1.00 33.09 A S ATOM 1747 C CYS A 1028 36.164 35.973 14.982 1.00 30.73 A C ATOM 1748 O CYS A 1028 35.772 35.043 14.282 1.00 30.74 A O ATOM 1749 N SER A 1029 35.827 37.230 14.741 1.00 29.90 A N ATOM 1750 CA SER A 1029 34.959 37.558 13.626 1.00 29.19 A C ATOM 1751 CB SER A 1029 34.726 39.067 13.567 1.00 28.86 A C ATOM 1752 OG SER A 1029 35.884 39.732 13.096 1.00 31.25 A O ATOM 1753 C SER A 1029 35.598 37.086 12.327 1.00 28.26 A C ATOM 1754 O SER A 1029 36.762 36.669 12.303 1.00 30.05 A O ATOM 1755 N PRO A 1030 34.834 37.121 11.229 1.00 25.74 A N ATOM 1756 CD PRO A 1030 33.369 37.260 11.198 1.00 22.85 A C ATOM 1757 CA PRO A 1030 35.350 36.694 9.928 1.00 24.51 A C ATOM 1758 CB PRO A 1030 34.149 36.904 9.017 1.00 23.05 A C ATOM 1759 CG PRO A 1030 33.010 36.539 9.929 1.00 24.45 A C ATOM 1760 C PRO A 1030 36.605 37.469 9.475 1.00 24.86 A C ATOM 1761 O PRO A 1030 37.535 36.898 8.872 1.00 23.18 A O ATOM 1762 N SER A 1031 36.632 38.766 9.768 1.00 24.48 A N ATOM 1763 CA SER A 1031 37.772 39.609 9.406 1.00 24.82 A C ATOM 1764 CB SER A 1031 37.422 41.084 9.609 1.00 21.99 A C ATOM 1765 OG SER A 1031 36.210 41.207 10.327 1.00 27.23 A O ATOM 1766 C SER A 1031 39.013 39.245 10.231 1.00 25.14 A C ATOM 1767 O SER A 1031 40.072 38.938 9.685 1.00 25.36 A O ATOM 1768 N ALA A 1032 38.875 39.279 11.548 1.00 27.52 A N ATOM 1769 CA ALA A 1032 39.979 38.950 12.435 1.00 28.18 A C ATOM 1770 CB ALA A 1032 39.474 38.857 13.876 1.00 27.52 A C ATOM 1771 C ALA A 1032 40.668 37.648 12.031 1.00 29.01 A C ATOM 1772 O ALA A 1032 41.877 37.637 11.783 1.00 30.30 A O ATOM 1773 N GLU A 1033 39.905 36.556 11.966 1.00 29.03 A N ATOM 1774 CA GLU A 1033 40.458 35.247 11.593 1.00 28.45 A C ATOM 1775 CB GLU A 1033 39.354 34.183 11.531 1.00 31.07 A C ATOM 1776 CG GLU A 1033 38.745 33.851 12.870 1.00 33.50 A C ATOM 1777 CD GLU A 1033 39.798 33.685 13.925 1.00 35.91 A C ATOM 1778 OE1 GLU A 1033 40.810 33.015 13.637 1.00 37.80 A O ATOM 1779 OE2 GLU A 1033 39.615 34.220 15.036 1.00 36.97 A O ATOM 1780 C GLU A 1033 41.190 35.262 10.260 1.00 26.35 A C ATOM 1781 O GLU A 1033 42.372 34.948 10.186 1.00 25.54 A O ATOM 1782 N PHE A 1034 40.479 35.610 9.199 1.00 27.44 A N ATOM 1783 CA PHE A 1034 41.083 35.649 7.879 1.00 27.26 A C ATOM 1784 CB PHE A 1034 40.080 36.198 6.872 1.00 26.93 A C ATOM 1785 CG PHE A 1034 39.129 35.165 6.337 1.00 29.70 A C ATOM 1786 CD1 PHE A 1034 37.809 35.493 6.063 1.00 29.12 A C ATOM 1787 CD2 PHE A 1034 39.566 33.882 6.055 1.00 28.02 A C ATOM 1788 CE1 PHE A 1034 36.947 34.559 5.517 1.00 29.46 A C ATOM 1789 CE2 PHE A 1034 38.707 32.950 5.508 1.00 29.09 A C ATOM 1790 CZ PHE A 1034 37.396 33.289 5.238 1.00 29.30 A C ATOM 1791 C PHE A 1034 42.323 36.512 7.899 1.00 27.70 A C ATOM 1792 O PHE A 1034 43.342 36.168 7.298 1.00 28.43 A O ATOM 1793 N LEU A 1035 42.242 37.635 8.600 1.00 28.83 A N ATOM 1794 CA LEU A 1035 43.371 38.550 8.668 1.00 31.32 A C ATOM 1795 CB LEU A 1035 42.936 39.863 9.326 1.00 30.92 A C ATOM 1796 CG LEU A 1035 43.110 41.158 8.527 1.00 29.53 A C ATOM 1797 CD1 LEU A 1035 42.484 41.056 7.144 1.00 27.99 A C ATOM 1798 CD2 LEU A 1035 42.468 42.274 9.318 1.00 29.65 A C ATOM 1799 C LEU A 1035 44.560 37.936 9.408 1.00 33.17 A C ATOM 1800 O LEU A 1035 45.703 38.007 8.938 1.00 31.72 A O ATOM 1801 N ARG A 1036 44.300 37.322 10.560 1.00 31.84 A N ATOM 1802 CA ARG A 1036 45.395 36.717 11.292 1.00 34.63 A C ATOM 1803 CB ARG A 1036 45.012 36.432 12.746 1.00 34.04 A C ATOM 1804 CG ARG A 1036 43.831 35.531 12.933 1.00 36.91 A C ATOM 1805 CD ARG A 1036 43.730 35.091 14.385 1.00 36.17 A C ATOM 1806 NE ARG A 1036 44.811 34.176 14.715 1.00 34.71 A N ATOM 1807 CZ ARG A 1036 44.721 32.855 14.611 1.00 33.73 A C ATOM 1808 NH1 ARG A 1036 43.590 32.298 14.203 1.00 32.21 A N ATOM 1809 NH2 ARG A 1036 45.775 32.093 14.879 1.00 33.32 A N ATOM 1810 C ARG A 1036 45.890 35.441 10.621 1.00 36.65 A C ATOM 1811 O ARG A 1036 47.060 35.084 10.752 1.00 38.90 A O ATOM 1812 N MET A 1037 45.014 34.764 9.886 1.00 38.66 A N ATOM 1813 CA MET A 1037 45.404 33.539 9.207 1.00 40.19 A C ATOM 1814 CB MET A 1037 44.189 32.894 8.525 1.00 41.26 A C ATOM 1815 CG MET A 1037 43.389 31.971 9.443 1.00 41.69 A C ATOM 1816 SD MET A 1037 41.858 31.301 8.730 1.00 42.48 A S ATOM 1817 CE MET A 1037 42.498 30.138 7.523 1.00 42.39 A C ATOM 1818 C MET A 1037 46.516 33.791 8.192 1.00 41.59 A C ATOM 1819 O MET A 1037 47.477 33.023 8.108 1.00 42.63 A O ATOM 1820 N MET A 1038 46.398 34.871 7.428 1.00 43.48 A N ATOM 1821 CA MET A 1038 47.418 35.187 6.433 1.00 43.88 A C ATOM 1822 CB MET A 1038 46.753 35.624 5.120 1.00 44.08 A C ATOM 1823 CG MET A 1038 45.450 36.379 5.283 1.00 44.10 A C ATOM 1824 SD MET A 1038 44.666 36.794 3.686 1.00 42.80 A S ATOM 1825 CE MET A 1038 43.115 37.477 4.272 1.00 43.10 A C ATOM 1826 C MET A 1038 48.457 36.218 6.897 1.00 44.50 A C ATOM 1827 O MET A 1038 49.252 36.722 6.096 1.00 44.74 A O ATOM 1828 N GLY A 1039 48.443 36.508 8.196 1.00 44.49 A N ATOM 1829 CA GLY A 1039 49.394 37.434 8.791 1.00 45.60 A C ATOM 1830 C GLY A 1039 49.386 38.877 8.331 1.00 46.45 A C ATOM 1831 O GLY A 1039 50.383 39.579 8.503 1.00 46.86 A O ATOM 1832 N CYS A 1040 48.265 39.324 7.768 1.00 47.04 A N ATOM 1833 CA CYS A 1040 48.124 40.690 7.270 1.00 45.91 A C ATOM 1834 CB CYS A 1040 46.874 40.805 6.406 1.00 44.80 A C ATOM 1835 SG CYS A 1040 46.619 42.464 5.760 1.00 44.01 A S ATOM 1836 C CYS A 1040 48.033 41.715 8.392 1.00 46.80 A C ATOM 1837 O CYS A 1040 47.246 41.552 9.321 1.00 45.47 A O ATOM 1838 N GLU A 1041 48.834 42.774 8.299 1.00 47.51 A N ATOM 1839 CA GLU A 1041 48.823 43.823 9.314 1.00 49.46 A C ATOM 1840 CB GLU A 1041 50.229 44.395 9.504 1.00 49.04 A C ATOM 1841 CG GLU A 1041 51.136 44.225 8.317 1.00 49.42 A C ATOM 1842 CD GLU A 1041 52.547 44.678 8.612 1.00 50.81 A C ATOM 1843 OE1 GLU A 1041 53.438 44.401 7.784 1.00 50.66 A O ATOM 1844 OE2 GLU A 1041 52.765 45.315 9.670 1.00 50.52 A O ATOM 1845 C GLU A 1041 47.834 44.929 8.957 1.00 50.58 A C ATOM 1846 O GLU A 1041 47.369 45.680 9.822 1.00 50.40 A O ATOM 1847 N ARG A 1042 47.522 45.017 7.668 1.00 50.93 A N ATOM 1848 CA ARG A 1042 46.558 45.985 7.164 1.00 51.11 A C ATOM 1849 CB ARG A 1042 46.623 46.047 5.638 1.00 52.02 A C ATOM 1850 CG ARG A 1042 47.953 46.510 5.094 1.00 54.33 A C ATOM 1851 CD ARG A 1042 47.964 46.457 3.580 1.00 56.72 A C ATOM 1852 NE ARG A 1042 48.896 47.432 3.029 1.00 58.81 A N ATOM 1853 CZ ARG A 1042 48.728 48.746 3.124 1.00 59.85 A C ATOM 1854 NH1 ARG A 1042 47.661 49.232 3.746 1.00 59.79 A N ATOM 1855 NH2 ARG A 1042 49.629 49.572 2.609 1.00 60.58 A N ATOM 1856 C ARG A 1042 45.177 45.499 7.583 1.00 50.01 A C ATOM 1857 O ARG A 1042 44.984 44.308 7.843 1.00 49.66 A O ATOM 1858 N ASP A 1043 44.210 46.406 7.644 1.00 48.38 A N ATOM 1859 CA ASP A 1043 42.866 46.002 8.031 1.00 46.88 A C ATOM 1860 CB ASP A 1043 42.072 47.208 8.536 1.00 48.76 A C ATOM 1861 CG ASP A 1043 42.676 47.815 9.780 1.00 50.44 A C ATOM 1862 OD1 ASP A 1043 43.032 47.040 10.692 1.00 49.73 A O ATOM 1863 OD2 ASP A 1043 42.793 49.061 9.848 1.00 53.87 A O ATOM 1864 C ASP A 1043 42.131 45.344 6.869 1.00 44.75 A C ATOM 1865 O ASP A 1043 41.085 44.720 7.058 1.00 44.07 A O ATOM 1866 N VAL A 1044 42.686 45.487 5.669 1.00 43.28 A N ATOM 1867 CA VAL A 1044 42.088 44.918 4.461 1.00 42.27 A C ATOM 1868 CB VAL A 1044 41.217 45.960 3.700 1.00 39.69 A C ATOM 1869 CG1 VAL A 1044 40.503 45.297 2.552 1.00 38.77 A C ATOM 1870 CG2 VAL A 1044 40.219 46.602 4.631 1.00 39.30 A C ATOM 1871 C VAL A 1044 43.219 44.479 3.543 1.00 41.86 A C ATOM 1872 O VAL A 1044 43.960 45.303 3.018 1.00 42.88 A O ATOM 1873 N PRO A 1045 43.353 43.170 3.328 1.00 41.70 A N ATOM 1874 CD PRO A 1045 42.500 42.111 3.901 1.00 42.62 A C ATOM 1875 CA PRO A 1045 44.394 42.596 2.477 1.00 41.48 A C ATOM 1876 CB PRO A 1045 44.510 41.181 3.013 1.00 42.55 A C ATOM 1877 CG PRO A 1045 43.055 40.839 3.243 1.00 42.55 A C ATOM 1878 C PRO A 1045 44.017 42.597 1.007 1.00 41.10 A C ATOM 1879 O PRO A 1045 42.840 42.654 0.672 1.00 41.90 A O ATOM 1880 N ALA A 1046 45.018 42.532 0.133 1.00 40.68 A N ATOM 1881 CA ALA A 1046 44.763 42.478 −1.300 1.00 40.27 A C ATOM 1882 CB ALA A 1046 46.063 42.224 −2.060 1.00 38.59 A C ATOM 1883 C ALA A 1046 43.797 41.313 −1.500 1.00 40.14 A C ATOM 1884 O ALA A 1046 43.802 40.359 −0.718 1.00 39.01 A O ATOM 1885 N LEU A 1047 42.973 41.387 −2.540 1.00 39.96 A N ATOM 1886 CA LEU A 1047 42.002 40.330 −2.801 1.00 39.57 A C ATOM 1887 CB LEU A 1047 40.917 40.840 −3.754 1.00 40.40 A C ATOM 1888 CG LEU A 1047 39.964 41.889 −3.172 1.00 41.57 A C ATOM 1889 CD1 LEU A 1047 40.729 42.949 −2.374 1.00 41.75 A C ATOM 1890 CD2 LEU A 1047 39.193 42.524 −4.306 1.00 41.77 A C ATOM 1891 C LEU A 1047 42.651 39.070 −3.364 1.00 39.02 A C ATOM 1892 O LEU A 1047 42.210 37.954 −3.084 1.00 37.37 A O ATOM 1893 N CYS A 1048 43.700 39.247 −4.156 1.00 37.99 A N ATOM 1894 CA CYS A 1048 44.390 38.105 −4.735 1.00 39.05 A C ATOM 1895 CB CYS A 1048 45.504 38.576 −5.687 1.00 40.67 A C ATOM 1896 SG CYS A 1048 46.817 39.620 −4.933 1.00 44.56 A S ATOM 1897 C CYS A 1048 44.974 37.254 −3.609 1.00 38.04 A C ATOM 1898 O CYS A 1048 45.072 36.038 −3.726 1.00 37.74 A O ATOM 1899 N ARG A 1049 45.337 37.912 −2.512 1.00 37.48 A N ATOM 1900 CA ARG A 1049 45.903 37.260 −1.334 1.00 38.07 A C ATOM 1901 CB ARG A 1049 46.426 38.334 −0.385 1.00 41.00 A C ATOM 1902 CG ARG A 1049 47.138 37.822 0.848 1.00 44.03 A C ATOM 1903 CD ARG A 1049 47.472 38.995 1.746 1.00 49.13 A C ATOM 1904 NE ARG A 1049 48.367 38.655 2.849 1.00 52.70 A N ATOM 1905 CZ ARG A 1049 48.742 39.529 3.777 1.00 54.00 A C ATOM 1906 NH1 ARG A 1049 49.559 39.168 4.756 1.00 54.29 A N ATOM 1907 NH2 ARG A 1049 48.288 40.775 3.722 1.00 55.55 A N ATOM 1908 C ARG A 1049 44.845 36.408 −0.616 1.00 36.85 A C ATOM 1909 O ARG A 1049 45.070 35.237 −0.297 1.00 35.82 A O ATOM 1910 N LEU A 1050 43.695 37.022 −0.359 1.00 33.99 A N ATOM 1911 CA LEU A 1050 42.583 36.357 0.296 1.00 33.03 A C ATOM 1912 CB LEU A 1050 41.436 37.352 0.511 1.00 31.26 A C ATOM 1913 CG LEU A 1050 40.191 36.791 1.203 1.00 31.23 A C ATOM 1914 CD1 LEU A 1050 40.584 36.118 2.516 1.00 31.70 A C ATOM 1915 CD2 LEU A 1050 39.196 37.891 1.447 1.00 27.72 A C ATOM 1916 C LEU A 1050 42.110 35.184 −0.564 1.00 32.10 A C ATOM 1917 O LEU A 1050 41.851 34.098 −0.050 1.00 29.58 A O ATOM 1918 N LEU A 1051 42.001 35.413 −1.870 1.00 32.63 A N ATOM 1919 CA LEU A 1051 41.587 34.376 −2.813 1.00 34.32 A C ATOM 1920 CB LEU A 1051 41.476 34.957 −4.226 1.00 33.80 A C ATOM 1921 CG LEU A 1051 41.255 33.929 −5.342 1.00 34.32 A C ATOM 1922 CD1 LEU A 1051 39.849 33.357 −5.237 1.00 31.96 A C ATOM 1923 CD2 LEU A 1051 41.469 34.582 −6.716 1.00 33.65 A C ATOM 1924 C LEU A 1051 42.603 33.233 −2.817 1.00 34.75 A C ATOM 1925 O LEU A 1051 42.243 32.065 −2.967 1.00 34.98 A O ATOM 1926 N GLU A 1052 43.875 33.586 −2.663 1.00 35.72 A N ATOM 1927 CA GLU A 1052 44.958 32.609 −2.631 1.00 36.23 A C ATOM 1928 CB GLU A 1052 46.304 33.326 −2.548 1.00 39.64 A C ATOM 1929 CG GLU A 1052 47.475 32.427 −2.167 1.00 43.74 A C ATOM 1930 CD GLU A 1052 48.809 33.137 −2.295 1.00 46.95 A C ATOM 1931 OE1 GLU A 1052 49.015 34.155 −1.591 1.00 48.67 A O ATOM 1932 OE2 GLU A 1052 49.644 32.678 −3.106 1.00 47.66 A O ATOM 1933 C GLU A 1052 44.811 31.692 −1.429 1.00 35.08 A C ATOM 1934 O GLU A 1052 45.019 30.487 −1.522 1.00 33.30 A O ATOM 1935 N LEU A 1053 44.469 32.281 −0.292 1.00 35.01 A N ATOM 1936 CA LEU A 1053 44.285 31.518 0.930 1.00 32.96 A C ATOM 1937 CB LEU A 1053 43.964 32.459 2.096 1.00 30.50 A C ATOM 1938 CG LEU A 1053 43.745 31.774 3.443 1.00 30.65 A C ATOM 1939 CD1 LEU A 1053 45.030 31.079 3.864 1.00 32.92 A C ATOM 1940 CD2 LEU A 1053 43.321 32.784 4.487 1.00 32.45 A C ATOM 1941 C LEU A 1053 43.144 30.521 0.743 1.00 32.04 A C ATOM 1942 O LEU A 1053 43.240 29.378 1.182 1.00 32.79 A O ATOM 1943 N LEU A 1054 42.072 30.958 0.085 1.00 31.62 A N ATOM 1944 CA LEU A 1054 40.907 30.105 −0.145 1.00 31.95 A C ATOM 1945 CB LEU A 1054 39.682 30.957 −0.527 1.00 30.46 A C ATOM 1946 CG LEU A 1054 39.007 31.743 0.619 1.00 28.90 A C ATOM 1947 CD1 LEU A 1054 37.990 32.716 0.083 1.00 27.05 A C ATOM 1948 CD2 LEU A 1054 38.336 30.776 1.571 1.00 28.35 A C ATOM 1949 C LEU A 1054 41.176 29.056 −1.212 1.00 32.04 A C ATOM 1950 O LEU A 1054 40.636 27.951 −1.152 1.00 30.77 A O ATOM 1951 N GLU A 1055 42.022 29.406 −2.178 1.00 34.23 A N ATOM 1952 CA GLU A 1055 42.391 28.499 −3.261 1.00 35.51 A C ATOM 1953 CB GLU A 1055 43.157 29.265 −4.344 1.00 35.87 A C ATOM 1954 CG GLU A 1055 42.246 30.077 −5.257 1.00 39.71 A C ATOM 1955 CD GLU A 1055 42.980 30.842 −6.353 1.00 39.88 A C ATOM 1956 OE1 GLU A 1055 42.318 31.202 −7.349 1.00 39.86 A O ATOM 1957 OE2 GLU A 1055 44.199 31.095 −6.223 1.00 40.73 A O ATOM 1958 C GLU A 1055 43.228 27.321 −2.764 1.00 36.34 A C ATOM 1959 O GLU A 1055 43.353 26.306 −3.445 1.00 35.49 A O ATOM 1960 N GLU A 1056 43.799 27.456 −1.575 1.00 37.58 A N ATOM 1961 CA GLU A 1056 44.615 26.396 −1.014 1.00 38.62 A C ATOM 1962 CB GLU A 1056 45.799 26.980 −0.239 1.00 40.75 A C ATOM 1963 CG GLU A 1056 46.638 27.967 −1.050 1.00 46.03 A C ATOM 1964 CD GLU A 1056 47.817 28.551 −0.266 1.00 49.39 A C ATOM 1965 OE1 GLU A 1056 47.625 29.026 0.879 1.00 50.27 A O ATOM 1966 OE2 GLU A 1056 48.944 28.544 −0.812 1.00 51.90 A O ATOM 1967 C GLU A 1056 43.776 25.541 −0.090 1.00 38.57 A C ATOM 1968 O GLU A 1056 44.303 24.669 0.596 1.00 39.87 A O ATOM 1969 N GLY A 1057 42.473 25.803 −0.061 1.00 37.04 A N ATOM 1970 CA GLY A 1057 41.579 25.030 0.784 1.00 36.00 A C ATOM 1971 C GLY A 1057 41.388 25.534 2.203 1.00 36.34 A C ATOM 1972 O GLY A 1057 40.717 24.884 3.007 1.00 37.96 A O ATOM 1973 N GLN A 1058 41.959 26.691 2.520 1.00 34.56 A N ATOM 1974 CA GLN A 1058 41.837 27.261 3.855 1.00 33.27 A C ATOM 1975 CB GLN A 1058 42.883 28.358 4.032 1.00 34.13 A C ATOM 1976 CG GLN A 1058 44.307 27.852 3.907 1.00 35.03 A C ATOM 1977 CD GLN A 1058 44.927 27.530 5.250 1.00 36.09 A C ATOM 1978 OE1 GLN A 1058 44.310 26.873 6.087 1.00 37.42 A O ATOM 1979 NE2 GLN A 1058 46.159 27.989 5.461 1.00 35.08 A N ATOM 1980 C GLN A 1058 40.435 27.820 4.122 1.00 33.23 A C ATOM 1981 O GLN A 1058 39.807 28.399 3.236 1.00 33.08 A O ATOM 1982 N ARG A 1059 39.951 27.646 5.349 1.00 31.87 A N ATOM 1983 CA ARG A 1059 38.626 28.123 5.724 1.00 31.24 A C ATOM 1984 CB ARG A 1059 37.595 26.995 5.609 1.00 28.73 A C ATOM 1985 CG ARG A 1059 37.471 26.382 4.211 1.00 30.52 A C ATOM 1986 CD ARG A 1059 36.676 27.284 3.264 1.00 31.00 A C ATOM 1987 NE ARG A 1059 36.415 26.677 1.960 1.00 27.97 A N ATOM 1988 CZ ARG A 1059 37.266 26.682 0.936 1.00 27.94 A C ATOM 1989 NH1 ARG A 1059 38.448 27.265 1.046 1.00 24.82 A N ATOM 1990 NH2 ARG A 1059 36.934 26.100 −0.210 1.00 28.85 A N ATOM 1991 C ARG A 1059 38.664 28.618 7.158 1.00 31.11 A C ATOM 1992 O ARG A 1059 39.686 28.523 7.817 1.00 31.41 A O ATOM 1993 N LEU A 1060 37.548 29.162 7.627 1.00 33.19 A N ATOM 1994 CA LEU A 1060 37.441 29.660 8.987 1.00 34.25 A C ATOM 1995 CB LEU A 1060 36.165 30.477 9.142 1.00 32.03 A C ATOM 1996 CG LEU A 1060 36.057 31.822 8.416 1.00 34.02 A C ATOM 1997 CD1 LEU A 1060 34.688 32.454 8.726 1.00 32.53 A C ATOM 1998 CD2 LEU A 1060 37.182 32.749 8.854 1.00 30.27 A C ATOM 1999 C LEU A 1060 37.413 28.517 9.998 1.00 36.03 A C ATOM 2000 O LEU A 1060 36.772 27.495 9.769 1.00 36.83 A O ATOM 2001 N PRO A 1061 38.112 28.678 11.132 1.00 37.96 A N ATOM 2002 CD PRO A 1061 38.966 29.821 11.495 1.00 37.87 A C ATOM 2003 CA PRO A 1061 38.153 27.652 12.180 1.00 39.04 A C ATOM 2004 CB PRO A 1061 39.247 28.154 13.110 1.00 38.27 A C ATOM 2005 CG PRO A 1061 39.108 29.640 12.998 1.00 38.72 A C ATOM 2006 C PRO A 1061 36.821 27.544 12.907 1.00 41.03 A C ATOM 2007 O PRO A 1061 36.318 28.537 13.428 1.00 44.44 A O ATOM 2008 N ALA A 1062 36.264 26.337 12.943 1.00 41.14 A N ATOM 2009 CA ALA A 1062 34.997 26.075 13.615 1.00 41.14 A C ATOM 2010 CB ALA A 1062 34.888 24.596 13.941 1.00 40.50 A C ATOM 2011 C ALA A 1062 34.867 26.890 14.894 1.00 41.04 A C ATOM 2012 O ALA A 1062 35.752 26.870 15.744 1.00 42.44 A O ATOM 2013 N PRO A 1063 33.759 27.627 15.044 1.00 40.13 A N ATOM 2014 CD PRO A 1063 32.615 27.790 14.130 1.00 37.87 A C ATOM 2015 CA PRO A 1063 33.586 28.426 16.257 1.00 41.05 A C ATOM 2016 CB PRO A 1063 32.262 29.153 16.003 1.00 38.84 A C ATOM 2017 CG PRO A 1063 31.540 28.242 15.057 1.00 38.22 A C ATOM 2018 C PRO A 1063 33.584 27.547 17.518 1.00 42.11 A C ATOM 2019 O PRO A 1063 33.066 26.431 17.513 1.00 41.67 A O ATOM 2020 N PRO A 1064 34.190 28.045 18.607 1.00 43.41 A N ATOM 2021 CD PRO A 1064 34.900 29.335 18.645 1.00 42.90 A C ATOM 2022 CA PRO A 1064 34.301 27.363 19.902 1.00 43.90 A C ATOM 2023 CB PRO A 1064 34.942 28.425 20.794 1.00 42.85 A C ATOM 2024 CG PRO A 1064 35.826 29.152 19.838 1.00 42.18 A C ATOM 2025 C PRO A 1064 32.986 26.853 20.475 1.00 44.26 A C ATOM 2026 O PRO A 1064 32.100 27.641 20.809 1.00 45.70 A O ATOM 2027 N ALA A 1065 32.879 25.530 20.589 1.00 43.97 A N ATOM 2028 CA ALA A 1065 31.699 24.866 21.141 1.00 44.07 A C ATOM 2029 CB ALA A 1065 31.305 25.523 22.459 1.00 42.97 A C ATOM 2030 C ALA A 1065 30.508 24.854 20.187 1.00 44.37 A C ATOM 2031 O ALA A 1065 29.356 24.964 20.611 1.00 45.07 A O ATOM 2032 N CYS A 1066 30.784 24.706 18.900 1.00 43.46 A N ATOM 2033 CA CYS A 1066 29.723 24.696 17.909 1.00 43.03 A C ATOM 2034 CB CYS A 1066 30.255 25.251 16.582 1.00 43.32 A C ATOM 2035 SG CYS A 1066 28.994 25.547 15.320 1.00 45.07 A S ATOM 2036 C CYS A 1066 29.188 23.284 17.714 1.00 42.43 A C ATOM 2037 O CYS A 1066 29.952 22.318 17.665 1.00 42.66 A O ATOM 2038 N PRO A 1067 27.860 23.144 17.616 1.00 40.86 A N ATOM 2039 CD PRO A 1067 26.841 24.185 17.802 1.00 40.79 A C ATOM 2040 CA PRO A 1067 27.236 21.834 17.423 1.00 40.84 A C ATOM 2041 CB PRO A 1067 25.766 22.185 17.246 1.00 41.20 A C ATOM 2042 CG PRO A 1067 25.617 23.370 18.152 1.00 40.13 A C ATOM 2043 C PRO A 1067 27.831 21.147 16.200 1.00 40.94 A C ATOM 2044 O PRO A 1067 27.826 21.700 15.096 1.00 42.30 A O ATOM 2045 N ALA A 1068 28.351 19.943 16.409 1.00 39.79 A N ATOM 2046 CA ALA A 1068 28.977 19.168 15.344 1.00 39.39 A C ATOM 2047 CB ALA A 1068 29.105 17.706 15.779 1.00 37.82 A C ATOM 2048 C ALA A 1068 28.261 19.254 13.993 1.00 38.42 A C ATOM 2049 O ALA A 1068 28.881 19.558 12.970 1.00 36.38 A O ATOM 2050 N GLU A 1069 26.959 18.985 13.992 1.00 38.56 A N ATOM 2051 CA GLU A 1069 26.185 19.013 12.761 1.00 40.94 A C ATOM 2052 CB GLU A 1069 24.825 18.344 12.980 1.00 43.16 A C ATOM 2053 CG GLU A 1069 24.115 18.787 14.246 1.00 48.31 A C ATOM 2054 CD GLU A 1069 24.606 18.064 15.490 1.00 48.90 A C ATOM 2055 OE1 GLU A 1069 24.303 16.860 15.636 1.00 48.25 A O ATOM 2056 OE2 GLU A 1069 25.291 18.704 16.318 1.00 50.20 A O ATOM 2057 C GLU A 1069 26.004 20.416 12.170 1.00 40.52 A C ATOM 2058 O GLU A 1069 25.711 20.561 10.984 1.00 40.07 A O ATOM 2059 N VAL A 1070 26.182 21.447 12.990 1.00 39.74 A N ATOM 2060 CA VAL A 1070 26.056 22.822 12.511 1.00 39.24 A C ATOM 2061 CB VAL A 1070 25.897 23.811 13.679 1.00 39.84 A C ATOM 2062 CG1 VAL A 1070 26.045 25.229 13.167 1.00 41.40 A C ATOM 2063 CG2 VAL A 1070 24.542 23.633 14.337 1.00 40.18 A C ATOM 2064 C VAL A 1070 27.307 23.207 11.715 1.00 38.46 A C ATOM 2065 O VAL A 1070 27.232 23.876 10.683 1.00 35.39 A O ATOM 2066 N HIS A 1071 28.461 22.774 12.211 1.00 39.05 A N ATOM 2067 CA HIS A 1071 29.731 23.049 11.561 1.00 38.75 A C ATOM 2068 CB HIS A 1071 30.880 22.686 12.506 1.00 39.65 A C ATOM 2069 CG HIS A 1071 32.235 22.962 11.939 1.00 40.75 A C ATOM 2070 CD2 HIS A 1071 33.282 22.138 11.693 1.00 41.51 A C ATOM 2071 ND1 HIS A 1071 32.618 24.212 11.508 1.00 42.40 A N ATOM 2072 CE1 HIS A 1071 33.843 24.147 11.014 1.00 42.63 A C ATOM 2073 NE2 HIS A 1071 34.267 22.900 11.115 1.00 43.15 A N ATOM 2074 C HIS A 1071 29.847 22.265 10.248 1.00 38.96 A C ATOM 2075 O HIS A 1071 30.521 22.696 9.308 1.00 38.24 A O ATOM 2076 N GLU A 1072 29.176 21.119 10.172 1.00 38.32 A N ATOM 2077 CA GLU A 1072 29.233 20.318 8.955 1.00 39.59 A C ATOM 2078 CB GLU A 1072 28.687 18.914 9.213 1.00 44.08 A C ATOM 2079 CG GLU A 1072 29.130 17.901 8.180 1.00 49.99 A C ATOM 2080 CD GLU A 1072 29.125 16.493 8.735 1.00 55.49 A C ATOM 2081 OE1 GLU A 1072 28.020 15.960 8.998 1.00 57.05 A O ATOM 2082 OE2 GLU A 1072 30.231 15.930 8.919 1.00 57.75 A O ATOM 2083 C GLU A 1072 28.458 20.975 7.814 1.00 37.22 A C ATOM 2084 O GLU A 1072 28.882 20.927 6.657 1.00 36.12 A O ATOM 2085 N LEU A 1073 27.324 21.586 8.146 1.00 34.76 A N ATOM 2086 CA LEU A 1073 26.502 22.270 7.156 1.00 34.30 A C ATOM 2087 CB LEU A 1073 25.197 22.783 7.793 1.00 33.32 A C ATOM 2088 CG LEU A 1073 24.188 21.723 8.263 1.00 32.92 A C ATOM 2089 CD1 LEU A 1073 22.954 22.376 8.870 1.00 32.52 A C ATOM 2090 CD2 LEU A 1073 23.802 20.851 7.070 1.00 32.45 A C ATOM 2091 C LEU A 1073 27.281 23.444 6.567 1.00 34.69 A C ATOM 2092 O LEU A 1073 27.421 23.569 5.347 1.00 34.74 A O ATOM 2093 N MET A 1074 27.806 24.298 7.437 1.00 34.59 A N ATOM 2094 CA MET A 1074 28.549 25.441 6.961 1.00 33.88 A C ATOM 2095 CB MET A 1074 28.911 26.381 8.113 1.00 33.70 A C ATOM 2096 CG MET A 1074 30.006 25.915 9.028 1.00 32.46 A C ATOM 2097 SD MET A 1074 30.443 27.221 10.202 1.00 30.20 A S ATOM 2098 CE MET A 1074 28.953 27.318 11.178 1.00 24.80 A C ATOM 2099 C MET A 1074 29.790 24.960 6.245 1.00 34.28 A C ATOM 2100 O MET A 1074 30.260 25.598 5.309 1.00 36.55 A O ATOM 2101 N LYS A 1075 30.313 23.818 6.672 1.00 33.90 A N ATOM 2102 CA LYS A 1075 31.498 23.258 6.034 1.00 33.51 A C ATOM 2103 CB LYS A 1075 31.914 21.970 6.742 1.00 35.85 A C ATOM 2104 CG LYS A 1075 33.385 21.659 6.671 1.00 35.71 A C ATOM 2105 CD LYS A 1075 34.094 22.141 7.929 1.00 37.92 A C ATOM 2106 CE LYS A 1075 35.611 22.142 7.732 1.00 39.92 A C ATOM 2107 NZ LYS A 1075 36.041 23.064 6.618 1.00 37.97 A N ATOM 2108 C LYS A 1075 31.150 22.954 4.572 1.00 32.67 A C ATOM 2109 O LYS A 1075 31.969 23.147 3.688 1.00 34.17 A O ATOM 2110 N LEU A 1076 29.926 22.476 4.340 1.00 30.61 A N ATOM 2111 CA LEU A 1076 29.419 22.154 3.004 1.00 28.22 A C ATOM 2112 CB LEU A 1076 28.101 21.389 3.127 1.00 27.15 A C ATOM 2113 CG LEU A 1076 28.083 20.006 3.787 1.00 27.60 A C ATOM 2114 CD1 LEU A 1076 26.637 19.545 3.999 1.00 25.25 A C ATOM 2115 CD2 LEU A 1076 28.831 19.031 2.911 1.00 24.89 A C ATOM 2116 C LEU A 1076 29.175 23.409 2.147 1.00 28.61 A C ATOM 2117 O LEU A 1076 29.316 23.383 0.923 1.00 27.41 A O ATOM 2118 N CYS A 1077 28.785 24.502 2.796 1.00 26.68 A N ATOM 2119 CA CYS A 1077 28.529 25.746 2.088 1.00 24.29 A C ATOM 2120 CB CYS A 1077 27.953 26.794 3.032 1.00 21.98 A C ATOM 2121 SG CYS A 1077 26.297 26.455 3.616 1.00 19.81 A S ATOM 2122 C CYS A 1077 29.798 26.301 1.476 1.00 24.04 A C ATOM 2123 O CYS A 1077 29.738 27.048 0.500 1.00 23.84 A O ATOM 2124 N TRP A 1078 30.951 25.940 2.042 1.00 24.55 A N ATOM 2125 CA TRP A 1078 32.224 26.450 1.529 1.00 23.47 A C ATOM 2126 CB TRP A 1078 33.164 26.849 2.670 1.00 24.02 A C ATOM 2127 CG TRP A 1078 32.570 27.812 3.646 1.00 23.46 A C ATOM 2128 CD2 TRP A 1078 32.859 27.895 5.042 1.00 23.76 A C ATOM 2129 CE2 TRP A 1078 32.073 28.943 5.571 1.00 23.34 A C ATOM 2130 CE3 TRP A 1078 33.705 27.183 5.901 1.00 21.71 A C ATOM 2131 CD1 TRP A 1078 31.651 28.789 3.386 1.00 24.07 A C ATOM 2132 NE1 TRP A 1078 31.344 29.472 4.537 1.00 24.54 A N ATOM 2133 CZ2 TRP A 1078 32.107 29.300 6.916 1.00 21.87 A C ATOM 2134 CZ3 TRP A 1078 33.737 27.538 7.235 1.00 22.31 A C ATOM 2135 CH2 TRP A 1078 32.942 28.587 7.730 1.00 22.33 A C ATOM 2136 C TRP A 1078 32.962 25.514 0.594 1.00 23.07 A C ATOM 2137 O TRP A 1078 34.191 25.455 0.609 1.00 21.26 A O ATOM 2138 N ALA A 1079 32.216 24.790 −0.229 1.00 24.72 A N ATOM 2139 CA ALA A 1079 32.837 23.889 −1.190 1.00 26.31 A C ATOM 2140 CB ALA A 1079 31.791 22.931 −1.788 1.00 25.35 A C ATOM 2141 C ALA A 1079 33.421 24.768 −2.281 1.00 26.85 A C ATOM 2142 O ALA A 1079 32.825 25.766 −2.669 1.00 25.36 A O ATOM 2143 N PRO A 1080 34.602 24.410 −2.791 1.00 28.40 A N ATOM 2144 CD PRO A 1080 35.464 23.286 −2.388 1.00 27.17 A C ATOM 2145 CA PRO A 1080 35.228 25.207 −3.848 1.00 29.11 A C ATOM 2146 CB PRO A 1080 36.371 24.318 −4.318 1.00 27.39 A C ATOM 2147 CG PRO A 1080 36.780 23.622 −3.072 1.00 27.10 A C ATOM 2148 C PRO A 1080 34.263 25.547 −4.979 1.00 30.79 A C ATOM 2149 O PRO A 1080 33.973 26.716 −5.219 1.00 32.38 A O ATOM 2150 N SER A 1081 33.767 24.521 −5.667 1.00 31.66 A N ATOM 2151 CA SER A 1081 32.851 24.716 −6.791 1.00 31.24 A C ATOM 2152 CB SER A 1081 32.873 23.504 −7.724 1.00 35.04 A C ATOM 2153 OG SER A 1081 32.003 23.698 −8.829 1.00 39.04 A O ATOM 2154 C SER A 1081 31.427 24.958 −6.345 1.00 28.44 A C ATOM 2155 O SER A 1081 30.903 24.244 −5.494 1.00 28.65 A O ATOM 2156 N PRO A 1082 30.775 25.968 −6.939 1.00 26.44 A N ATOM 2157 CD PRO A 1082 31.403 26.880 −7.908 1.00 25.21 A C ATOM 2158 CA PRO A 1082 29.397 26.383 −6.667 1.00 26.31 A C ATOM 2159 CB PRO A 1082 29.188 27.519 −7.655 1.00 23.89 A C ATOM 2160 CG PRO A 1082 30.552 28.100 −7.783 1.00 24.30 A C ATOM 2161 C PRO A 1082 28.376 25.264 −6.852 1.00 28.12 A C ATOM 2162 O PRO A 1082 27.398 25.178 −6.113 1.00 28.72 A O ATOM 2163 N GLN A 1083 28.604 24.409 −7.839 1.00 28.62 A N ATOM 2164 CA GLN A 1083 27.691 23.315 −8.095 1.00 31.77 A C ATOM 2165 CB GLN A 1083 27.953 22.722 −9.477 1.00 36.51 A C ATOM 2166 CG GLN A 1083 29.425 22.603 −9.827 1.00 43.60 A C ATOM 2167 CD GLN A 1083 29.670 21.625 −10.960 1.00 48.06 A C ATOM 2168 OE1 GLN A 1083 29.004 21.683 −11.997 1.00 50.45 A O ATOM 2169 NE2 GLN A 1083 30.633 20.721 −10.771 1.00 50.35 A N ATOM 2170 C GLN A 1083 27.805 22.227 −7.040 1.00 31.92 A C ATOM 2171 O GLN A 1083 27.016 21.289 −7.031 1.00 30.95 A O ATOM 2172 N ASP A 1084 28.775 22.350 −6.141 1.00 33.65 A N ATOM 2173 CA ASP A 1084 28.944 21.336 −5.101 1.00 35.56 A C ATOM 2174 CB ASP A 1084 30.420 20.927 −4.989 1.00 37.26 A C ATOM 2175 CG ASP A 1084 30.863 19.995 −6.113 1.00 37.96 A C ATOM 2176 OD1 ASP A 1084 32.049 20.052 −6.502 1.00 39.77 A O ATOM 2177 OD2 ASP A 1084 30.037 19.196 −6.598 1.00 38.93 A O ATOM 2178 C ASP A 1084 28.406 21.769 −3.733 1.00 34.87 A C ATOM 2179 O ASP A 1084 28.311 20.954 −2.813 1.00 33.98 A O ATOM 2180 N ARG A 1085 28.057 23.049 −3.600 1.00 32.96 A N ATOM 2181 CA ARG A 1085 27.509 23.557 −2.343 1.00 29.33 A C ATOM 2182 CB ARG A 1085 27.624 25.072 −2.275 1.00 25.99 A C ATOM 2183 CG ARG A 1085 29.028 25.556 −2.474 1.00 25.88 A C ATOM 2184 CD ARG A 1085 29.052 27.026 −2.784 1.00 25.19 A C ATOM 2185 NE ARG A 1085 30.372 27.424 −3.241 1.00 22.90 A N ATOM 2186 CZ ARG A 1085 30.617 28.516 −3.949 1.00 23.32 A C ATOM 2187 NH1 ARG A 1085 29.616 29.330 −4.282 1.00 20.28 A N ATOM 2188 NH2 ARG A 1085 31.862 28.770 −4.341 1.00 22.67 A N ATOM 2189 C ARG A 1085 26.051 23.183 −2.325 1.00 29.39 A C ATOM 2190 O ARG A 1085 25.404 23.136 −3.369 1.00 30.36 A O ATOM 2191 N PRO A 1086 25.508 22.908 −1.139 1.00 29.52 A N ATOM 2192 CD PRO A 1086 26.123 22.945 0.198 1.00 27.74 A C ATOM 2193 CA PRO A 1086 24.097 22.541 −1.064 1.00 29.00 A C ATOM 2194 CB PRO A 1086 23.946 22.070 0.375 1.00 29.16 A C ATOM 2195 CG PRO A 1086 24.918 22.947 1.101 1.00 29.76 A C ATOM 2196 C PRO A 1086 23.218 23.742 −1.373 1.00 29.28 A C ATOM 2197 O PRO A 1086 23.659 24.884 −1.287 1.00 30.82 A O ATOM 2198 N SER A 1087 21.976 23.475 −1.744 1.00 28.64 A N ATOM 2199 CA SER A 1087 21.040 24.538 −2.048 1.00 29.08 A C ATOM 2200 CB SER A 1087 19.990 24.048 −3.055 1.00 26.07 A C ATOM 2201 OG SER A 1087 18.954 23.323 −2.414 1.00 28.14 A O ATOM 2202 C SER A 1087 20.371 24.936 −0.723 1.00 29.13 A C ATOM 2203 O SER A 1087 20.535 24.255 0.292 1.00 30.28 A O ATOM 2204 N PHE A 1088 19.631 26.039 −0.727 1.00 27.78 A N ATOM 2205 CA PHE A 1088 18.958 26.480 0.476 1.00 27.90 A C ATOM 2206 CB PHE A 1088 18.426 27.906 0.289 1.00 27.36 A C ATOM 2207 CG PHE A 1088 19.481 28.974 0.431 1.00 28.07 A C ATOM 2208 CD1 PHE A 1088 19.957 29.337 1.690 1.00 25.93 A C ATOM 2209 CD2 PHE A 1088 20.032 29.586 −0.696 1.00 25.71 A C ATOM 2210 CE1 PHE A 1088 20.960 30.285 1.816 1.00 25.98 A C ATOM 2211 CE2 PHE A 1088 21.035 30.532 −0.580 1.00 24.01 A C ATOM 2212 CZ PHE A 1088 21.504 30.884 0.675 1.00 24.15 A C ATOM 2213 C PHE A 1088 17.813 25.527 0.809 1.00 29.45 A C ATOM 2214 O PHE A 1088 17.482 25.321 1.976 1.00 30.46 A O ATOM 2215 N SER A 1089 17.217 24.930 −0.216 1.00 29.59 A N ATOM 2216 CA SER A 1089 16.099 24.025 0.007 1.00 30.75 A C ATOM 2217 CB SER A 1089 15.436 23.665 −1.315 1.00 30.39 A C ATOM 2218 OG SER A 1089 16.272 22.786 −2.037 1.00 34.77 A O ATOM 2219 C SER A 1089 16.581 22.758 0.698 1.00 31.30 A C ATOM 2220 O SER A 1089 15.834 22.117 1.439 1.00 30.83 A O ATOM 2221 N ALA A 1090 17.837 22.405 0.445 1.00 31.74 A N ATOM 2222 CA ALA A 1090 18.444 21.227 1.056 1.00 33.23 A C ATOM 2223 CB ALA A 1090 19.648 20.771 0.228 1.00 32.69 A C ATOM 2224 C ALA A 1090 18.874 21.507 2.505 1.00 33.07 A C ATOM 2225 O ALA A 1090 18.610 20.710 3.399 1.00 33.17 A O ATOM 2226 N LEU A 1091 19.524 22.644 2.740 1.00 33.22 A N ATOM 2227 CA LEU A 1091 19.979 22.993 4.089 1.00 33.26 A C ATOM 2228 CB LEU A 1091 20.848 24.252 4.044 1.00 31.95 A C ATOM 2229 CG LEU A 1091 22.176 24.091 3.305 1.00 31.49 A C ATOM 2230 CD1 LEU A 1091 22.732 25.436 2.893 1.00 29.88 A C ATOM 2231 CD2 LEU A 1091 23.146 23.352 4.208 1.00 32.95 A C ATOM 2232 C LEU A 1091 18.819 23.219 5.047 1.00 33.65 A C ATOM 2233 O LEU A 1091 18.876 22.810 6.210 1.00 33.75 A O ATOM 2234 N GLY A 1092 17.771 23.869 4.545 1.00 33.60 A N ATOM 2235 CA GLY A 1092 16.597 24.172 5.350 1.00 33.92 A C ATOM 2236 C GLY A 1092 16.140 23.084 6.307 1.00 35.32 A C ATOM 2237 O GLY A 1092 16.383 23.174 7.514 1.00 33.70 A O ATOM 2238 N PRO A 1093 15.463 22.042 5.798 1.00 35.60 A N ATOM 2239 CD PRO A 1093 15.256 21.731 4.376 1.00 36.28 A C ATOM 2240 CA PRO A 1093 14.985 20.949 6.646 1.00 37.04 A C ATOM 2241 CB PRO A 1093 14.523 19.899 5.633 1.00 37.68 A C ATOM 2242 CG PRO A 1093 15.311 20.234 4.383 1.00 37.09 A C ATOM 2243 C PRO A 1093 16.056 20.441 7.610 1.00 38.12 A C ATOM 2244 O PRO A 1093 15.751 20.082 8.750 1.00 38.30 A O ATOM 2245 N GLN A 1094 17.309 20.417 7.155 1.00 38.45 A N ATOM 2246 CA GLN A 1094 18.422 19.992 8.004 1.00 38.71 A C ATOM 2247 CB GLN A 1094 19.751 20.139 7.264 1.00 39.86 A C ATOM 2248 CG GLN A 1094 20.135 18.928 6.425 1.00 43.63 A C ATOM 2249 CD GLN A 1094 20.575 17.740 7.275 1.00 46.77 A C ATOM 2250 OE1 GLN A 1094 19.800 17.213 8.083 1.00 45.34 A O ATOM 2251 NE2 GLN A 1094 21.831 17.317 7.100 1.00 46.94 A N ATOM 2252 C GLN A 1094 18.442 20.850 9.268 1.00 39.49 A C ATOM 2253 O GLN A 1094 18.443 20.331 10.385 1.00 39.14 A O ATOM 2254 N LEU A 1095 18.446 22.168 9.087 1.00 40.38 A N ATOM 2255 CA LEU A 1095 18.448 23.089 10.220 1.00 40.12 A C ATOM 2256 CB LEU A 1095 18.596 24.533 9.727 1.00 37.84 A C ATOM 2257 CG LEU A 1095 19.983 24.906 9.179 1.00 38.91 A C ATOM 2258 CD1 LEU A 1095 19.930 26.219 8.418 1.00 37.27 A C ATOM 2259 CD2 LEU A 1095 20.973 24.992 10.324 1.00 37.75 A C ATOM 2260 C LEU A 1095 17.180 22.946 11.066 1.00 40.39 A C ATOM 2261 O LEU A 1095 17.237 22.991 12.296 1.00 38.60 A O ATOM 2262 N ASP A 1096 16.036 22.773 10.414 1.00 41.84 A N ATOM 2263 CA ASP A 1096 14.789 22.622 11.153 1.00 44.60 A C ATOM 2264 CB ASP A 1096 13.633 22.347 10.200 1.00 46.86 A C ATOM 2265 CG ASP A 1096 12.893 23.603 9.813 1.00 49.73 A C ATOM 2266 OD1 ASP A 1096 12.144 23.554 8.812 1.00 51.70 A O ATOM 2267 OD2 ASP A 1096 13.058 24.635 10.507 1.00 50.84 A O ATOM 2268 C ASP A 1096 14.883 21.496 12.172 1.00 44.97 A C ATOM 2269 O ASP A 1096 14.418 21.637 13.302 1.00 43.90 A O ATOM 2270 N MET A 1097 15.484 20.381 11.761 1.00 46.10 A N ATOM 2271 CA MET A 1097 15.649 19.227 12.636 1.00 46.72 A C ATOM 2272 CB MET A 1097 16.219 18.041 11.863 1.00 49.78 A C ATOM 2273 CG MET A 1097 15.238 17.360 10.932 1.00 51.99 A C ATOM 2274 SD MET A 1097 16.001 15.928 10.169 1.00 55.68 A S ATOM 2275 CE MET A 1097 16.746 16.676 8.742 1.00 54.91 A C ATOM 2276 C MET A 1097 16.580 19.548 13.788 1.00 46.48 A C ATOM 2277 O MET A 1097 16.275 19.246 14.938 1.00 47.57 A O ATOM 2278 N LEU A 1098 17.722 20.149 13.478 1.00 45.27 A N ATOM 2279 CA LEU A 1098 18.686 20.504 14.508 1.00 45.26 A C ATOM 2280 CB LEU A 1098 19.872 21.240 13.890 1.00 44.97 A C ATOM 2281 CG LEU A 1098 20.593 20.490 12.767 1.00 44.21 A C ATOM 2282 CD1 LEU A 1098 21.756 21.322 12.245 1.00 45.02 A C ATOM 2283 CD2 LEU A 1098 21.084 19.150 13.294 1.00 44.66 A C ATOM 2284 C LEU A 1098 18.031 21.383 15.566 1.00 46.70 A C ATOM 2285 O LEU A 1098 18.218 21.170 16.768 1.00 46.72 A O ATOM 2286 N TRP A 1099 17.261 22.367 15.108 1.00 47.34 A N ATOM 2287 CA TRP A 1099 16.568 23.288 16.003 1.00 47.89 A C ATOM 2288 CB TRP A 1099 15.587 24.157 15.210 1.00 46.51 A C ATOM 2289 CG TRP A 1099 14.761 25.053 16.073 1.00 46.41 A C ATOM 2290 CD2 TRP A 1099 13.347 24.974 16.274 1.00 46.89 A C ATOM 2291 CE2 TRP A 1099 12.999 25.985 17.190 1.00 46.27 A C ATOM 2292 CE3 TRP A 1099 12.341 24.144 15.770 1.00 46.19 A C ATOM 2293 CD1 TRP A 1099 15.202 26.085 16.852 1.00 46.39 A C ATOM 2294 NE1 TRP A 1099 14.148 26.649 17.528 1.00 44.71 A N ATOM 2295 CZ2 TRP A 1099 11.691 26.189 17.610 1.00 46.50 A C ATOM 2296 CZ3 TRP A 1099 11.043 24.347 16.189 1.00 45.66 A C ATOM 2297 CH2 TRP A 1099 10.729 25.359 17.100 1.00 46.54 A C ATOM 2298 C TRP A 1099 15.824 22.527 17.098 1.00 48.58 A C ATOM 2299 O TRP A 1099 15.812 22.943 18.258 1.00 48.53 A O ATOM 2300 N SER A 1100 15.210 21.408 16.723 1.00 49.93 A N ATOM 2301 CA SER A 1100 14.475 20.578 17.673 1.00 51.25 A C ATOM 2302 CB SER A 1100 13.238 19.965 16.997 1.00 51.15 A C ATOM 2303 OG SER A 1100 13.586 19.037 15.982 1.00 49.25 A O ATOM 2304 C SER A 1100 15.375 19.471 18.240 1.00 52.03 A C ATOM 2305 O SER A 1100 15.541 19.416 19.478 1.00 53.12 A O ATOM 2306 OXT SER A 1100 15.915 18.674 17.445 1.00 51.89 A O TER 1 SER A 1100 A ATOM 2307 CB ASP B 813 2.825 23.672 6.637 1.00 41.77 B C ATOM 2308 CG ASP B 813 1.930 24.126 7.778 1.00 43.25 B C ATOM 2309 OD1 ASP B 813 1.989 23.509 8.863 1.00 45.61 B O ATOM 2310 OD2 ASP B 813 1.169 25.103 7.587 1.00 43.25 B O ATOM 2311 C ASP B 813 1.324 21.690 6.566 1.00 39.86 B C ATOM 2312 O ASP B 813 0.396 22.265 5.997 1.00 40.64 B O ATOM 2313 N ASP B 813 3.241 21.818 5.032 1.00 40.52 B N ATOM 2314 CA ASP B 813 2.754 22.160 6.398 1.00 40.76 B C ATOM 2315 N PRO B 814 1.133 20.629 7.357 1.00 38.57 B N ATOM 2316 CD PRO B 814 2.240 19.827 7.910 1.00 37.96 B C ATOM 2317 CA PRO B 814 −0.157 20.006 7.657 1.00 36.41 B C ATOM 2318 CB PRO B 814 0.233 18.772 8.474 1.00 37.07 B C ATOM 2319 CG PRO B 814 1.617 18.459 8.004 1.00 36.97 B C ATOM 2320 C PRO B 814 −1.126 20.888 8.433 1.00 35.03 B C ATOM 2321 O PRO B 814 −0.726 21.746 9.224 1.00 34.82 B O ATOM 2322 N THR B 815 −2.408 20.645 8.194 1.00 33.52 B N ATOM 2323 CA THR B 815 −3.495 21.344 8.859 1.00 32.14 B C ATOM 2324 CB THR B 815 −4.327 22.158 7.862 1.00 31.18 B C ATOM 2325 OG1 THR B 815 −3.534 23.238 7.352 1.00 30.84 B O ATOM 2326 CG2 THR B 815 −5.563 22.711 8.533 1.00 28.45 B C ATOM 2327 C THR B 815 −4.364 20.247 9.461 1.00 32.63 B C ATOM 2328 O THR B 815 −5.159 20.484 10.372 1.00 31.96 B O ATOM 2329 N ILE B 816 −4.178 19.040 8.932 1.00 33.41 B N ATOM 2330 CA ILE B 816 −4.896 17.842 9.352 1.00 33.58 B C ATOM 2331 CB ILE B 816 −5.660 17.235 8.164 1.00 35.25 B C ATOM 2332 CG2 ILE B 816 −6.418 15.992 8.595 1.00 37.17 B C ATOM 2333 CG1 ILE B 816 −6.647 18.268 7.622 1.00 37.48 B C ATOM 2334 CD1 ILE B 816 −7.728 18.638 8.595 1.00 34.45 B C ATOM 2335 C ILE B 816 −3.858 16.846 9.850 1.00 32.05 B C ATOM 2336 O ILE B 816 −3.011 16.390 9.087 1.00 34.53 B O ATOM 2337 N PHE B 817 −3.933 16.505 11.128 1.00 29.25 B N ATOM 2338 CA PHE B 817 −2.967 15.600 11.729 1.00 28.03 B C ATOM 2339 CB PHE B 817 −2.381 16.230 13.002 1.00 26.53 B C ATOM 2340 CG PHE B 817 −1.354 17.315 12.743 1.00 22.84 B C ATOM 2341 CD1 PHE B 817 0.001 17.017 12.719 1.00 22.76 B C ATOM 2342 CD2 PHE B 817 −1.744 18.627 12.537 1.00 20.42 B C ATOM 2343 CE1 PHE B 817 0.949 18.013 12.496 1.00 21.47 B C ATOM 2344 CE2 PHE B 817 −0.801 19.628 12.311 1.00 21.52 B C ATOM 2345 CZ PHE B 817 0.546 19.319 12.292 1.00 19.38 B C ATOM 2346 C PHE B 817 −3.543 14.243 12.069 1.00 28.62 B C ATOM 2347 O PHE B 817 −4.620 14.125 12.661 1.00 28.42 B O ATOM 2348 N GLU B 818 −2.801 13.212 11.706 1.00 28.25 B N ATOM 2349 CA GLU B 818 −3.231 11.859 11.976 1.00 30.35 B C ATOM 2350 CB GLU B 818 −2.673 10.932 10.901 1.00 31.20 B C ATOM 2351 CG GLU B 818 −3.408 9.624 10.807 1.00 33.27 B C ATOM 2352 CD GLU B 818 −2.963 8.817 9.632 1.00 34.34 B C ATOM 2353 OE1 GLU B 818 −3.443 7.671 9.498 1.00 35.01 B O ATOM 2354 OE2 GLU B 818 −2.136 9.334 8.849 1.00 33.80 B O ATOM 2355 C GLU B 818 −2.740 11.430 13.358 1.00 30.11 B C ATOM 2356 O GLU B 818 −1.557 11.591 13.670 1.00 29.23 B O ATOM 2357 N GLU B 819 −3.651 10.898 14.178 1.00 28.41 B N ATOM 2358 CA GLU B 819 −3.326 10.444 15.536 1.00 29.21 B C ATOM 2359 CB GLU B 819 −4.560 9.853 16.228 1.00 27.11 B C ATOM 2360 CG GLU B 819 −5.454 10.856 16.963 1.00 26.82 B C ATOM 2361 CD GLU B 819 −4.707 11.618 18.056 1.00 26.05 B C ATOM 2362 OE1 GLU B 819 −3.821 11.016 18.694 1.00 25.30 B O ATOM 2363 OE2 GLU B 819 −5.010 12.809 18.282 1.00 22.67 B O ATOM 2364 C GLU B 819 −2.186 9.428 15.630 1.00 31.75 B C ATOM 2365 O GLU B 819 −1.368 9.499 16.551 1.00 33.63 B O ATOM 2366 N ARG B 820 −2.120 8.485 14.694 1.00 32.89 B N ATOM 2367 CA ARG B 820 −1.057 7.488 14.741 1.00 34.85 B C ATOM 2368 CB ARG B 820 −1.301 6.394 13.685 1.00 37.02 B C ATOM 2369 CG ARG B 820 −0.780 6.690 12.289 1.00 41.86 B C ATOM 2370 CD ARG B 820 0.333 5.717 11.892 1.00 46.24 B C ATOM 2371 NE ARG B 820 1.482 5.810 12.795 1.00 50.85 B N ATOM 2372 CZ ARG B 820 2.666 5.237 12.587 1.00 51.37 B C ATOM 2373 NH1 ARG B 820 2.884 4.516 11.494 1.00 53.33 B N ATOM 2374 NH2 ARG B 820 3.637 5.387 13.478 1.00 51.30 B N ATOM 2375 C ARG B 820 0.349 8.107 14.571 1.00 35.30 B C ATOM 2376 O ARG B 820 1.371 7.455 14.819 1.00 35.40 B O ATOM 2377 N HIS B 821 0.411 9.368 14.165 1.00 32.42 B N ATOM 2378 CA HIS B 821 1.706 9.996 13.997 1.00 31.18 B C ATOM 2379 CB HIS B 821 1.756 10.803 12.695 1.00 32.60 B C ATOM 2380 CG HIS B 821 1.583 9.969 11.460 1.00 35.70 B C ATOM 2381 CD2 HIS B 821 1.094 10.282 10.235 1.00 35.90 B C ATOM 2382 ND1 HIS B 821 1.964 8.645 11.391 1.00 37.49 B N ATOM 2383 CE1 HIS B 821 1.715 8.177 10.180 1.00 36.47 B C ATOM 2384 NE2 HIS B 821 1.187 9.150 9.461 1.00 37.66 B N ATOM 2385 C HIS B 821 2.050 10.887 15.184 1.00 30.63 B C ATOM 2386 O HIS B 821 3.115 11.508 15.215 1.00 30.21 B O ATOM 2387 N LEU B 822 1.157 10.955 16.166 1.00 28.80 B N ATOM 2388 CA LEU B 822 1.428 11.776 17.339 1.00 29.94 B C ATOM 2389 CB LEU B 822 0.172 12.579 17.739 1.00 28.15 B C ATOM 2390 CG LEU B 822 −0.372 13.555 16.676 1.00 28.24 B C ATOM 2391 CD1 LEU B 822 −1.490 14.423 17.249 1.00 27.85 B C ATOM 2392 CD2 LEU B 822 0.753 14.449 16.184 1.00 27.24 B C ATOM 2393 C LEU B 822 1.935 10.911 18.508 1.00 30.54 B C ATOM 2394 O LEU B 822 1.157 10.351 19.269 1.00 29.84 B O ATOM 2395 N LYS B 823 3.252 10.794 18.638 1.00 31.98 B N ATOM 2396 CA LYS B 823 3.811 9.987 19.715 1.00 32.61 B C ATOM 2397 CB LYS B 823 5.234 9.546 19.368 1.00 33.58 B C ATOM 2398 CG LYS B 823 5.295 8.359 18.418 1.00 36.00 B C ATOM 2399 CD LYS B 823 4.736 8.690 17.048 1.00 37.37 B C ATOM 2400 CE LYS B 823 4.240 7.436 16.336 1.00 37.83 B C ATOM 2401 NZ LYS B 823 5.262 6.364 16.216 1.00 40.50 B N ATOM 2402 C LYS B 823 3.809 10.698 21.065 1.00 31.17 B C ATOM 2403 O LYS B 823 4.499 11.696 21.255 1.00 31.27 B O ATOM 2404 N TYR B 824 3.014 10.178 21.992 1.00 30.97 B N ATOM 2405 CA TYR B 824 2.922 10.726 23.335 1.00 33.67 B C ATOM 2406 CB TYR B 824 1.984 9.868 24.184 1.00 34.02 B C ATOM 2407 CG TYR B 824 2.066 10.155 25.670 1.00 34.31 B C ATOM 2408 CD1 TYR B 824 1.183 11.035 26.276 1.00 34.19 B C ATOM 2409 CE1 TYR B 824 1.253 11.302 27.626 1.00 34.94 B C ATOM 2410 CD2 TYR B 824 3.030 9.549 26.463 1.00 36.32 B C ATOM 2411 CE2 TYR B 824 3.110 9.814 27.821 1.00 37.02 B C ATOM 2412 CZ TYR B 824 2.216 10.692 28.394 1.00 37.15 B C ATOM 2413 OH TYR B 824 2.275 10.962 29.746 1.00 39.76 B O ATOM 2414 C TYR B 824 4.299 10.757 24.010 1.00 34.77 B C ATOM 2415 O TYR B 824 5.037 9.769 23.988 1.00 31.82 B O ATOM 2416 N ILE B 825 4.632 11.885 24.626 1.00 35.64 B N ATOM 2417 CA ILE B 825 5.910 12.004 25.305 1.00 36.01 B C ATOM 2418 CB ILE B 825 6.751 13.173 24.749 1.00 34.52 B C ATOM 2419 CG2 ILE B 825 8.031 13.325 25.571 1.00 34.43 B C ATOM 2420 CG1 ILE B 825 7.083 12.926 23.275 1.00 33.06 B C ATOM 2421 CD1 ILE B 825 8.072 13.922 22.688 1.00 31.39 B C ATOM 2422 C ILE B 825 5.711 12.208 26.799 1.00 35.95 B C ATOM 2423 O ILE B 825 6.537 11.783 27.605 1.00 35.84 B O ATOM 2424 N SER B 826 4.610 12.853 27.165 1.00 36.03 B N ATOM 2425 CA SER B 826 4.303 13.115 28.573 1.00 36.98 B C ATOM 2426 CB SER B 826 5.507 13.725 29.300 1.00 36.75 B C ATOM 2427 OG SER B 826 5.831 15.003 28.779 1.00 37.67 B O ATOM 2428 C SER B 826 3.144 14.082 28.668 1.00 35.86 B C ATOM 2429 O SER B 826 2.789 14.734 27.688 1.00 37.04 B O ATOM 2430 N GLN B 827 2.565 14.179 29.857 1.00 36.30 B N ATOM 2431 CA GLN B 827 1.439 15.073 30.087 1.00 36.00 B C ATOM 2432 CB GLN B 827 0.463 14.425 31.073 1.00 37.07 B C ATOM 2433 CG GLN B 827 −0.743 13.784 30.402 1.00 42.24 B C ATOM 2434 CD GLN B 827 −1.219 12.532 31.120 1.00 46.18 B C ATOM 2435 OE1 GLN B 827 −0.546 11.491 31.104 1.00 47.45 B O ATOM 2436 NE2 GLN B 827 −2.382 12.625 31.759 1.00 47.48 B N ATOM 2437 C GLN B 827 1.893 16.433 30.609 1.00 34.37 B C ATOM 2438 O GLN B 827 2.720 16.510 31.521 1.00 33.94 B O ATOM 2439 N LEU B 828 1.350 17.501 30.023 1.00 32.18 B N ATOM 2440 CA LEU B 828 1.694 18.862 30.435 1.00 30.39 B C ATOM 2441 CB LEU B 828 1.616 19.814 29.239 1.00 29.07 B C ATOM 2442 CG LEU B 828 2.633 19.544 28.133 1.00 27.77 B C ATOM 2443 CD1 LEU B 828 2.337 20.429 26.957 1.00 25.72 B C ATOM 2444 CD2 LEU B 828 4.051 19.780 28.654 1.00 25.98 B C ATOM 2445 C LEU B 828 0.829 19.401 31.574 1.00 29.13 B C ATOM 2446 O LEU B 828 1.286 20.229 32.356 1.00 30.42 B O ATOM 2447 N GLY B 829 −0.412 18.930 31.675 1.00 29.64 B N ATOM 2448 CA GLY B 829 −1.303 19.384 32.733 1.00 27.62 B C ATOM 2449 C GLY B 829 −2.758 19.513 32.304 1.00 29.05 B C ATOM 2450 O GLY B 829 −3.083 19.433 31.115 1.00 29.17 B O ATOM 2451 N LYS B 830 −3.642 19.706 33.277 1.00 29.83 B N ATOM 2452 CA LYS B 830 −5.072 19.859 33.018 1.00 29.11 B C ATOM 2453 CB LYS B 830 −5.867 18.796 33.775 1.00 31.52 B C ATOM 2454 CG LYS B 830 −7.294 19.234 34.070 1.00 38.23 B C ATOM 2455 CD LYS B 830 −8.018 18.309 35.034 1.00 41.99 B C ATOM 2456 CE LYS B 830 −9.305 18.962 35.542 1.00 43.97 B C ATOM 2457 NZ LYS B 830 −10.060 18.082 36.480 1.00 45.94 B N ATOM 2458 C LYS B 830 −5.516 21.246 33.489 1.00 27.73 B C ATOM 2459 O LYS B 830 −5.007 21.744 34.487 1.00 26.97 B O ATOM 2460 N GLY B 831 −6.457 21.865 32.774 1.00 25.89 B N ATOM 2461 CA GLY B 831 −6.937 23.182 33.153 1.00 23.83 B C ATOM 2462 C GLY B 831 −8.447 23.217 33.310 1.00 24.22 B C ATOM 2463 O GLY B 831 −9.044 22.225 33.717 1.00 24.73 B O ATOM 2464 N ASN B 832 −9.055 24.353 32.961 1.00 23.96 B N ATOM 2465 CA ASN B 832 −10.502 24.580 33.046 1.00 21.93 B C ATOM 2466 CB ASN B 832 −10.804 26.075 33.033 1.00 21.24 B C ATOM 2467 CG ASN B 832 −10.376 26.770 34.290 1.00 19.88 B C ATOM 2468 OD1 ASN B 832 −10.895 26.475 35.363 1.00 18.71 B O ATOM 2469 ND2 ASN B 832 −9.429 27.710 34.171 1.00 15.25 B N ATOM 2470 C ASN B 832 −11.351 23.970 31.940 1.00 23.37 B C ATOM 2471 O ASN B 832 −12.535 23.717 32.151 1.00 22.56 B O ATOM 2472 N PHE B 833 −10.779 23.772 30.753 1.00 23.17 B N ATOM 2473 CA PHE B 833 −11.567 23.228 29.647 1.00 24.16 B C ATOM 2474 CB PHE B 833 −11.790 24.303 28.573 1.00 23.51 B C ATOM 2475 CG PHE B 833 −12.414 25.567 29.094 1.00 23.24 B C ATOM 2476 CD1 PHE B 833 −11.627 26.641 29.455 1.00 23.38 B C ATOM 2477 CD2 PHE B 833 −13.791 25.675 29.242 1.00 22.46 B C ATOM 2478 CE1 PHE B 833 −12.198 27.808 29.958 1.00 23.81 B C ATOM 2479 CE2 PHE B 833 −14.369 26.842 29.747 1.00 23.47 B C ATOM 2480 CZ PHE B 833 −13.572 27.905 30.104 1.00 23.00 B C ATOM 2481 C PHE B 833 −11.005 21.973 28.974 1.00 25.60 B C ATOM 2482 O PHE B 833 −11.657 21.397 28.106 1.00 25.79 B O ATOM 2483 N GLY B 834 −9.805 21.548 29.360 1.00 24.96 B N ATOM 2484 CA GLY B 834 −9.242 20.369 28.746 1.00 24.52 B C ATOM 2485 C GLY B 834 −7.951 19.924 29.390 1.00 27.71 B C ATOM 2486 O GLY B 834 −7.689 20.223 30.557 1.00 29.31 B O ATOM 2487 N SER B 835 −7.149 19.189 28.626 1.00 27.33 B N ATOM 2488 CA SER B 835 −5.872 18.688 29.096 1.00 28.87 B C ATOM 2489 CB SER B 835 −6.027 17.258 29.604 1.00 28.44 B C ATOM 2490 OG SER B 835 −6.763 16.488 28.673 1.00 32.42 B O ATOM 2491 C SER B 835 −4.888 18.746 27.939 1.00 29.32 B C ATOM 2492 O SER B 835 −5.280 18.656 26.775 1.00 30.81 B O ATOM 2493 N VAL B 836 −3.610 18.892 28.263 1.00 28.87 B N ATOM 2494 CA VAL B 836 −2.573 19.005 27.250 1.00 27.94 B C ATOM 2495 CB VAL B 836 −1.864 20.358 27.379 1.00 27.26 B C ATOM 2496 CG1 VAL B 836 −0.904 20.560 26.221 1.00 27.80 B C ATOM 2497 CG2 VAL B 836 −2.902 21.478 27.442 1.00 28.52 B C ATOM 2498 C VAL B 836 −1.525 17.915 27.352 1.00 29.07 B C ATOM 2499 O VAL B 836 −1.244 17.412 28.437 1.00 30.56 B O ATOM 2500 N GLU B 837 −0.941 17.556 26.213 1.00 30.14 B N ATOM 2501 CA GLU B 837 0.101 16.540 26.172 1.00 29.01 B C ATOM 2502 CB GLU B 837 −0.432 15.215 25.635 1.00 29.10 B C ATOM 2503 CG GLU B 837 −1.601 14.646 26.378 1.00 28.69 B C ATOM 2504 CD GLU B 837 −1.757 13.170 26.110 1.00 26.28 B C ATOM 2505 OE1 GLU B 837 −1.559 12.759 24.949 1.00 26.70 B O ATOM 2506 OE2 GLU B 837 −2.081 12.427 27.054 1.00 25.64 B O ATOM 2507 C GLU B 837 1.213 16.997 25.252 1.00 29.17 B C ATOM 2508 O GLU B 837 0.973 17.733 24.293 1.00 27.85 B O ATOM 2509 N LEU B 838 2.430 16.552 25.564 1.00 30.14 B N ATOM 2510 CA LEU B 838 3.620 16.858 24.769 1.00 30.84 B C ATOM 2511 CB LEU B 838 4.837 17.118 25.671 1.00 30.33 B C ATOM 2512 CG LEU B 838 6.222 17.126 24.999 1.00 31.49 B C ATOM 2513 CD1 LEU B 838 6.315 18.235 23.951 1.00 31.48 B C ATOM 2514 CD2 LEU B 838 7.303 17.315 26.059 1.00 30.64 B C ATOM 2515 C LEU B 838 3.876 15.628 23.917 1.00 30.49 B C ATOM 2516 O LEU B 838 4.277 14.587 24.433 1.00 32.32 B O ATOM 2517 N CYS B 839 3.624 15.742 22.619 1.00 29.82 B N ATOM 2518 CA CYS B 839 3.819 14.627 21.700 1.00 29.62 B C ATOM 2519 CB CYS B 839 2.521 14.304 20.960 1.00 26.21 B C ATOM 2520 SG CYS B 839 1.103 14.029 21.990 1.00 25.86 B S ATOM 2521 C CYS B 839 4.867 14.972 20.655 1.00 30.35 B C ATOM 2522 O CYS B 839 5.418 16.069 20.646 1.00 29.37 B O ATOM 2523 N ARG B 840 5.138 14.023 19.769 1.00 32.26 B N ATOM 2524 CA ARG B 840 6.083 14.272 18.692 1.00 35.32 B C ATOM 2525 CB ARG B 840 7.361 13.442 18.879 1.00 36.76 B C ATOM 2526 CG ARG B 840 8.401 13.640 17.780 1.00 39.60 B C ATOM 2527 CD ARG B 840 9.699 12.899 18.083 1.00 42.80 B C ATOM 2528 NE ARG B 840 10.542 13.641 19.019 1.00 44.90 B N ATOM 2529 CZ ARG B 840 11.121 13.129 20.104 1.00 45.26 B C ATOM 2530 NH1 ARG B 840 10.964 11.845 20.421 1.00 44.02 B N ATOM 2531 NH2 ARG B 840 11.847 13.921 20.883 1.00 44.63 B N ATOM 2532 C ARG B 840 5.393 13.908 17.384 1.00 34.75 B C ATOM 2533 O ARG B 840 4.787 12.841 17.273 1.00 33.34 B O ATOM 2534 N TYR B 841 5.446 14.817 16.413 1.00 36.29 B N ATOM 2535 CA TYR B 841 4.832 14.566 15.116 1.00 39.08 B C ATOM 2536 CB TYR B 841 4.463 15.877 14.407 1.00 38.47 B C ATOM 2537 CG TYR B 841 3.756 15.674 13.079 1.00 39.29 B C ATOM 2538 CD1 TYR B 841 2.737 14.736 12.950 1.00 38.25 B C ATOM 2539 CE1 TYR B 841 2.092 14.538 11.743 1.00 37.76 B C ATOM 2540 CD2 TYR B 841 4.109 16.416 11.956 1.00 39.45 B C ATOM 2541 CE2 TYR B 841 3.467 16.228 10.741 1.00 38.84 B C ATOM 2542 CZ TYR B 841 2.458 15.285 10.642 1.00 39.62 B C ATOM 2543 OH TYR B 841 1.809 15.084 9.441 1.00 40.43 B O ATOM 2544 C TYR B 841 5.890 13.820 14.345 1.00 41.24 B C ATOM 2545 O TYR B 841 6.773 14.420 13.753 1.00 42.10 B O ATOM 2546 N ASP B 842 5.793 12.497 14.362 1.00 44.63 B N ATOM 2547 CA ASP B 842 6.781 11.662 13.711 1.00 46.51 B C ATOM 2548 CB ASP B 842 7.449 10.796 14.779 1.00 45.68 B C ATOM 2549 CG ASP B 842 8.819 10.324 14.369 1.00 45.45 B C ATOM 2550 OD1 ASP B 842 9.593 11.153 13.849 1.00 44.25 B O ATOM 2551 OD2 ASP B 842 9.124 9.130 14.579 1.00 44.55 B O ATOM 2552 C ASP B 842 6.237 10.787 12.586 1.00 48.84 B C ATOM 2553 O ASP B 842 6.237 9.558 12.688 1.00 49.65 B O ATOM 2554 N PRO B 843 5.773 11.412 11.491 1.00 51.03 B N ATOM 2555 CD PRO B 843 5.703 12.871 11.295 1.00 51.92 B C ATOM 2556 CA PRO B 843 5.228 10.700 10.330 1.00 52.68 B C ATOM 2557 CB PRO B 843 5.019 11.814 9.310 1.00 52.46 B C ATOM 2558 CG PRO B 843 4.709 12.999 10.165 1.00 52.25 B C ATOM 2559 C PRO B 843 6.197 9.628 9.819 1.00 54.74 B C ATOM 2560 O PRO B 843 5.793 8.688 9.141 1.00 55.91 B O ATOM 2561 N LEU B 844 7.478 9.780 10.145 1.00 56.20 B N ATOM 2562 CA LEU B 844 8.497 8.820 9.730 1.00 58.07 B C ATOM 2563 CB LEU B 844 9.699 9.555 9.133 1.00 58.51 B C ATOM 2564 CG LEU B 844 9.416 10.518 7.974 1.00 59.43 B C ATOM 2565 CD1 LEU B 844 8.650 9.777 6.893 1.00 58.93 B C ATOM 2566 CD2 LEU B 844 8.610 11.715 8.455 1.00 59.39 B C ATOM 2567 C LEU B 844 8.941 8.003 10.945 1.00 59.20 B C ATOM 2568 O LEU B 844 8.979 8.516 12.060 1.00 60.38 B O ATOM 2569 N GLY B 845 9.274 6.735 10.728 1.00 60.38 B N ATOM 2570 CA GLY B 845 9.694 5.882 11.826 1.00 60.46 B C ATOM 2571 C GLY B 845 10.727 6.510 12.740 1.00 61.81 B C ATOM 2572 O GLY B 845 10.627 6.417 13.966 1.00 62.35 B O ATOM 2573 N ASP B 846 11.725 7.149 12.138 1.00 61.41 B N ATOM 2574 CA ASP B 846 12.796 7.801 12.880 1.00 61.12 B C ATOM 2575 CB ASP B 846 13.815 8.393 11.902 1.00 63.52 B C ATOM 2576 CG ASP B 846 13.163 9.224 10.804 1.00 64.79 B C ATOM 2577 OD1 ASP B 846 13.865 9.584 9.833 1.00 65.93 B O ATOM 2578 OD2 ASP B 846 11.953 9.520 10.910 1.00 66.12 B O ATOM 2579 C ASP B 846 12.252 8.893 13.788 1.00 60.47 B C ATOM 2580 O ASP B 846 11.215 9.476 13.501 1.00 61.57 B O ATOM 2581 N ASN B 847 12.958 9.174 14.877 1.00 59.01 B N ATOM 2582 CA ASN B 847 12.530 10.199 15.827 1.00 56.87 B C ATOM 2583 CB ASN B 847 13.062 9.863 17.214 1.00 58.01 B C ATOM 2584 CG ASN B 847 12.536 8.551 17.722 1.00 58.36 B C ATOM 2585 OD1 ASN B 847 11.474 8.494 18.341 1.00 58.73 B O ATOM 2586 ND2 ASN B 847 13.265 7.475 17.441 1.00 58.76 B N ATOM 2587 C ASN B 847 13.005 11.588 15.442 1.00 54.91 B C ATOM 2588 O ASN B 847 13.483 12.343 16.289 1.00 54.35 B O ATOM 2589 N THR B 848 12.870 11.924 14.167 1.00 52.24 B N ATOM 2590 CA THR B 848 13.299 13.226 13.684 1.00 51.03 B C ATOM 2591 CB THR B 848 13.704 13.157 12.214 1.00 50.95 B C ATOM 2592 OG1 THR B 848 12.547 12.871 11.419 1.00 50.21 B O ATOM 2593 CG2 THR B 848 14.738 12.069 12.004 1.00 50.33 B C ATOM 2594 C THR B 848 12.199 14.272 13.817 1.00 49.92 B C ATOM 2595 O THR B 848 12.481 15.465 13.911 1.00 49.66 B O ATOM 2596 N GLY B 849 10.950 13.817 13.820 1.00 47.29 B N ATOM 2597 CA GLY B 849 9.817 14.722 13.923 1.00 44.59 B C ATOM 2598 C GLY B 849 9.944 15.813 14.969 1.00 41.66 B C ATOM 2599 O GLY B 849 10.759 15.708 15.881 1.00 41.89 B O ATOM 2600 N ALA B 850 9.125 16.855 14.835 1.00 40.04 B N ATOM 2601 CA ALA B 850 9.124 17.993 15.755 1.00 37.64 B C ATOM 2602 CB ALA B 850 8.782 19.269 14.993 1.00 37.63 B C ATOM 2603 C ALA B 850 8.163 17.831 16.931 1.00 36.65 B C ATOM 2604 O ALA B 850 7.197 17.067 16.869 1.00 35.41 B O ATOM 2605 N LEU B 851 8.432 18.566 18.005 1.00 35.80 B N ATOM 2606 CA LEU B 851 7.581 18.515 19.189 1.00 35.03 B C ATOM 2607 CB LEU B 851 8.384 18.865 20.440 1.00 36.07 B C ATOM 2608 CG LEU B 851 9.620 18.013 20.740 1.00 38.49 B C ATOM 2609 CD1 LEU B 851 10.456 18.721 21.792 1.00 38.97 B C ATOM 2610 CD2 LEU B 851 9.214 16.630 21.219 1.00 38.23 B C ATOM 2611 C LEU B 851 6.429 19.501 19.045 1.00 32.82 B C ATOM 2612 O LEU B 851 6.566 20.529 18.386 1.00 32.71 B O ATOM 2613 N VAL B 852 5.293 19.179 19.658 1.00 30.52 B N ATOM 2614 CA VAL B 852 4.124 20.054 19.619 1.00 28.26 B C ATOM 2615 CB VAL B 852 3.228 19.804 18.360 1.00 28.68 B C ATOM 2616 CG1 VAL B 852 3.906 20.344 17.105 1.00 28.83 B C ATOM 2617 CG2 VAL B 852 2.923 18.315 18.212 1.00 26.07 B C ATOM 2618 C VAL B 852 3.251 19.850 20.852 1.00 27.93 B C ATOM 2619 O VAL B 852 3.344 18.832 21.537 1.00 27.53 B O ATOM 2620 N ALA B 853 2.407 20.826 21.147 1.00 26.02 B N ATOM 2621 CA ALA B 853 1.504 20.680 22.269 1.00 25.71 B C ATOM 2622 CB ALA B 853 1.305 21.998 22.946 1.00 25.74 B C ATOM 2623 C ALA B 853 0.178 20.181 21.694 1.00 27.28 B C ATOM 2624 O ALA B 853 −0.270 20.650 20.642 1.00 26.81 B O ATOM 2625 N VAL B 854 −0.446 19.223 22.371 1.00 26.44 B N ATOM 2626 CA VAL B 854 −1.719 18.704 21.897 1.00 26.10 B C ATOM 2627 CB VAL B 854 −1.603 17.240 21.464 1.00 24.99 B C ATOM 2628 CG1 VAL B 854 −2.890 16.797 20.801 1.00 26.57 B C ATOM 2629 CG2 VAL B 854 −0.433 17.074 20.509 1.00 25.76 B C ATOM 2630 C VAL B 854 −2.793 18.817 22.971 1.00 26.92 B C ATOM 2631 O VAL B 854 −2.791 18.068 23.945 1.00 27.18 B O ATOM 2632 N LYS B 855 −3.709 19.766 22.798 1.00 26.33 B N ATOM 2633 CA LYS B 855 −4.775 19.934 23.768 1.00 25.94 B C ATOM 2634 CB LYS B 855 −5.015 21.409 24.084 1.00 22.34 B C ATOM 2635 CG LYS B 855 −6.335 21.613 24.811 1.00 23.65 B C ATOM 2636 CD LYS B 855 −6.706 23.063 25.021 1.00 19.73 B C ATOM 2637 CE LYS B 855 −5.997 23.682 26.197 1.00 17.77 B C ATOM 2638 NZ LYS B 855 −6.896 24.693 26.805 1.00 15.49 B N ATOM 2639 C LYS B 855 −6.089 19.321 23.300 1.00 26.94 B C ATOM 2640 O LYS B 855 −6.501 19.506 22.159 1.00 26.18 B O ATOM 2641 N GLN B 856 −6.732 18.577 24.196 1.00 29.24 B N ATOM 2642 CA GLN B 856 −8.021 17.964 23.919 1.00 29.00 B C ATOM 2643 CB GLN B 856 −7.965 16.456 24.152 1.00 29.02 B C ATOM 2644 CG GLN B 856 −9.299 15.739 23.913 1.00 31.97 B C ATOM 2645 CD GLN B 856 −9.154 14.220 23.867 1.00 33.49 B C ATOM 2646 OE1 GLN B 856 −8.570 13.613 24.764 1.00 37.69 B O ATOM 2647 NE2 GLN B 856 −9.682 13.603 22.818 1.00 31.47 B N ATOM 2648 C GLN B 856 −9.026 18.598 24.875 1.00 30.25 B C ATOM 2649 O GLN B 856 −8.826 18.596 26.089 1.00 30.29 B O ATOM 2650 N LEU B 857 −10.096 19.152 24.320 1.00 32.05 B N ATOM 2651 CA LEU B 857 −11.135 19.793 25.116 1.00 34.93 B C ATOM 2652 CB LEU B 857 −11.879 20.828 24.259 1.00 32.54 B C ATOM 2653 CG LEU B 857 −11.173 22.161 23.971 1.00 32.83 B C ATOM 2654 CD1 LEU B 857 −9.699 21.937 23.781 1.00 34.65 B C ATOM 2655 CD2 LEU B 857 −11.765 22.817 22.733 1.00 32.44 B C ATOM 2656 C LEU B 857 −12.133 18.779 25.670 1.00 37.68 B C ATOM 2657 O LEU B 857 −12.298 17.689 25.125 1.00 35.98 B O ATOM 2658 N GLN B 858 −12.771 19.135 26.778 1.00 41.97 B N ATOM 2659 CA GLN B 858 −13.785 18.285 27.377 1.00 48.02 B C ATOM 2660 CB GLN B 858 −14.058 18.705 28.820 1.00 49.27 B C ATOM 2661 CG GLN B 858 −15.107 17.856 29.506 1.00 53.78 B C ATOM 2662 CD GLN B 858 −15.374 18.277 30.942 1.00 56.64 B C ATOM 2663 OE1 GLN B 858 −14.453 18.366 31.764 1.00 57.31 B O ATOM 2664 NE2 GLN B 858 −16.643 18.533 31.254 1.00 56.69 B N ATOM 2665 C GLN B 858 −15.009 18.565 26.518 1.00 51.34 B C ATOM 2666 O GLN B 858 −15.540 19.678 26.516 1.00 51.97 B O ATOM 2667 N HIS B 859 −15.451 17.564 25.774 1.00 55.49 B N ATOM 2668 CA HIS B 859 −16.585 17.750 24.888 1.00 59.37 B C ATOM 2669 CB HIS B 859 −16.117 17.622 23.434 1.00 60.01 B C ATOM 2670 CG HIS B 859 −17.057 18.227 22.438 1.00 61.60 B C ATOM 2671 CD2 HIS B 859 −16.825 19.001 21.352 1.00 61.93 B C ATOM 2672 ND1 HIS B 859 −18.419 18.026 22.482 1.00 62.55 B N ATOM 2673 CE1 HIS B 859 −18.987 18.650 21.465 1.00 62.95 B C ATOM 2674 NE2 HIS B 859 −18.042 19.248 20.764 1.00 63.01 B N ATOM 2675 C HIS B 859 −17.670 16.728 25.172 1.00 61.41 B C ATOM 2676 O HIS B 859 −17.551 15.563 24.791 1.00 62.79 B O ATOM 2677 N SER B 860 −18.725 17.160 25.850 1.00 63.19 B N ATOM 2678 CA SER B 860 −19.830 16.262 26.158 1.00 64.59 B C ATOM 2679 CB SER B 860 −20.137 16.266 27.658 1.00 65.49 B C ATOM 2680 OG SER B 860 −19.100 15.632 28.388 1.00 65.65 B O ATOM 2681 C SER B 860 −21.061 16.671 25.369 1.00 65.19 B C ATOM 2682 O SER B 860 −21.907 17.428 25.847 1.00 65.42 B O ATOM 2683 N GLY B 861 −21.133 16.161 24.145 1.00 65.17 B N ATOM 2684 CA GLY B 861 −22.241 16.438 23.252 1.00 64.91 B C ATOM 2685 C GLY B 861 −21.825 15.917 21.892 1.00 64.88 B C ATOM 2686 O GLY B 861 −20.727 15.374 21.771 1.00 65.32 B O ATOM 2687 N PRO B 862 −22.664 16.039 20.854 1.00 64.29 B N ATOM 2688 CD PRO B 862 −23.978 16.696 20.759 1.00 64.63 B C ATOM 2689 CA PRO B 862 −22.231 15.533 19.547 1.00 63.09 B C ATOM 2690 CB PRO B 862 −23.435 15.824 18.649 1.00 63.47 B C ATOM 2691 CG PRO B 862 −24.050 17.029 19.291 1.00 63.98 B C ATOM 2692 C PRO B 862 −20.954 16.244 19.082 1.00 61.34 B C ATOM 2693 O PRO B 862 −20.909 17.471 18.994 1.00 60.26 B O ATOM 2694 N ASP B 863 −19.913 15.464 18.815 1.00 59.65 B N ATOM 2695 CA ASP B 863 −18.641 16.013 18.361 1.00 57.84 B C ATOM 2696 CB ASP B 863 −17.621 14.898 18.145 1.00 59.72 B C ATOM 2697 CG ASP B 863 −17.906 14.092 16.885 1.00 59.59 B C ATOM 2698 OD1 ASP B 863 −19.027 13.543 16.778 1.00 60.44 B O ATOM 2699 OD2 ASP B 863 −17.017 14.015 16.007 1.00 58.51 B O ATOM 2700 C ASP B 863 −18.911 16.660 17.023 1.00 55.52 B C ATOM 2701 O ASP B 863 −19.630 16.097 16.202 1.00 56.67 B O ATOM 2702 N GLN B 864 −18.340 17.833 16.790 1.00 50.93 B N ATOM 2703 CA GLN B 864 −18.553 18.496 15.518 1.00 45.49 B C ATOM 2704 CB GLN B 864 −19.307 19.798 15.720 1.00 48.68 B C ATOM 2705 CG GLN B 864 −20.798 19.572 15.845 1.00 51.79 B C ATOM 2706 CD GLN B 864 −21.292 18.598 14.792 1.00 53.83 B C ATOM 2707 OE1 GLN B 864 −21.023 18.775 13.597 1.00 55.56 B O ATOM 2708 NE2 GLN B 864 −22.013 17.561 15.224 1.00 52.86 B N ATOM 2709 C GLN B 864 −17.254 18.738 14.782 1.00 40.84 B C ATOM 2710 O GLN B 864 −16.640 19.798 14.890 1.00 40.71 B O ATOM 2711 N GLN B 865 −16.852 17.725 14.029 1.00 34.97 B N ATOM 2712 CA GLN B 865 −15.629 17.754 13.266 1.00 31.61 B C ATOM 2713 CB GLN B 865 −15.589 16.516 12.378 1.00 28.65 B C ATOM 2714 CG GLN B 865 −14.437 16.458 11.410 1.00 27.56 B C ATOM 2715 CD GLN B 865 −14.698 17.265 10.155 1.00 26.59 B C ATOM 2716 OE1 GLN B 865 −15.741 17.111 9.508 1.00 24.08 B O ATOM 2717 NE2 GLN B 865 −13.747 18.126 9.797 1.00 25.55 B N ATOM 2718 C GLN B 865 −15.479 19.035 12.445 1.00 30.61 B C ATOM 2719 O GLN B 865 −14.467 19.735 12.552 1.00 28.62 B O ATOM 2720 N ARG B 866 −16.490 19.339 11.638 1.00 29.87 B N ATOM 2721 CA ARG B 866 −16.476 20.532 10.800 1.00 28.92 B C ATOM 2722 CB ARG B 866 −17.797 20.668 10.040 1.00 29.98 B C ATOM 2723 CG ARG B 866 −17.936 19.702 8.876 1.00 32.46 B C ATOM 2724 CD ARG B 866 −19.170 20.020 8.056 1.00 31.87 B C ATOM 2725 NE ARG B 866 −20.035 18.859 7.879 1.00 34.46 B N ATOM 2726 CZ ARG B 866 −19.936 17.987 6.881 1.00 33.51 B C ATOM 2727 NH1 ARG B 866 −19.005 18.129 5.948 1.00 33.94 B N ATOM 2728 NH2 ARG B 866 −20.783 16.974 6.806 1.00 30.60 B N ATOM 2729 C ARG B 866 −16.196 21.805 11.596 1.00 27.94 B C ATOM 2730 O ARG B 866 −15.380 22.623 11.182 1.00 25.73 B O ATOM 2731 N ASP B 867 −16.869 21.978 12.730 1.00 29.03 B N ATOM 2732 CA ASP B 867 −16.635 23.151 13.566 1.00 30.85 B C ATOM 2733 CB ASP B 867 −17.448 23.070 14.859 1.00 32.87 B C ATOM 2734 CG ASP B 867 −18.942 23.283 14.630 1.00 36.23 B C ATOM 2735 OD1 ASP B 867 −19.339 24.352 14.103 1.00 36.54 B O ATOM 2736 OD2 ASP B 867 −19.726 22.376 14.985 1.00 38.32 B O ATOM 2737 C ASP B 867 −15.157 23.296 13.904 1.00 30.96 B C ATOM 2738 O ASP B 867 −14.558 24.329 13.599 1.00 31.28 B O ATOM 2739 N PHE B 868 −14.571 22.267 14.526 1.00 32.13 B N ATOM 2740 CA PHE B 868 −13.148 22.297 14.894 1.00 31.94 B C ATOM 2741 CB PHE B 868 −12.675 20.940 15.446 1.00 29.88 B C ATOM 2742 CG PHE B 868 −13.005 20.707 16.896 1.00 27.56 B C ATOM 2743 CD1 PHE B 868 −14.312 20.517 17.306 1.00 26.67 B C ATOM 2744 CD2 PHE B 868 −11.999 20.675 17.852 1.00 28.33 B C ATOM 2745 CE1 PHE B 868 −14.612 20.301 18.648 1.00 27.39 B C ATOM 2746 CE2 PHE B 868 −12.289 20.461 19.196 1.00 27.40 B C ATOM 2747 CZ PHE B 868 −13.596 20.275 19.595 1.00 25.66 B C ATOM 2748 C PHE B 868 −12.312 22.627 13.662 1.00 32.28 B C ATOM 2749 O PHE B 868 −11.351 23.389 13.722 1.00 33.97 B O ATOM 2750 N GLN B 869 −12.688 22.038 12.540 1.00 32.23 B N ATOM 2751 CA GLN B 869 −11.974 22.249 11.291 1.00 32.63 B C ATOM 2752 CB GLN B 869 −12.571 21.327 10.223 1.00 33.42 B C ATOM 2753 CG GLN B 869 −11.852 21.318 8.896 1.00 38.59 B C ATOM 2754 CD GLN B 869 −10.454 20.729 8.970 1.00 42.27 B C ATOM 2755 OE1 GLN B 869 −9.720 20.742 7.982 1.00 45.09 B O ATOM 2756 NE2 GLN B 869 −10.078 20.209 10.135 1.00 42.53 B N ATOM 2757 C GLN B 869 −12.056 23.713 10.850 1.00 31.04 B C ATOM 2758 O GLN B 869 −11.073 24.300 10.398 1.00 31.14 B O ATOM 2759 N ARG B 870 −13.232 24.303 11.002 1.00 29.80 B N ATOM 2760 CA ARG B 870 −13.453 25.684 10.600 1.00 28.79 B C ATOM 2761 CB ARG B 870 −14.947 26.016 10.751 1.00 28.73 B C ATOM 2762 CG ARG B 870 −15.346 27.449 10.417 1.00 29.41 B C ATOM 2763 CD ARG B 870 −16.761 27.746 10.889 1.00 26.01 B C ATOM 2764 NE ARG B 870 −16.875 27.628 12.338 1.00 24.89 B N ATOM 2765 CZ ARG B 870 −17.761 26.859 12.960 1.00 26.54 B C ATOM 2766 NH1 ARG B 870 −18.624 26.129 12.258 1.00 23.91 B N ATOM 2767 NH2 ARG B 870 −17.780 26.815 14.288 1.00 23.42 B N ATOM 2768 C ARG B 870 −12.602 26.657 11.415 1.00 28.20 B C ATOM 2769 O ARG B 870 −11.893 27.492 10.857 1.00 27.89 B O ATOM 2770 N GLU B 871 −12.670 26.535 12.735 1.00 28.44 B N ATOM 2771 CA GLU B 871 −11.932 27.416 13.629 1.00 29.10 B C ATOM 2772 CB GLU B 871 −12.327 27.110 15.073 1.00 28.98 B C ATOM 2773 CG GLU B 871 −13.821 27.293 15.330 1.00 27.67 B C ATOM 2774 CD GLU B 871 −14.295 28.709 15.029 1.00 30.59 B C ATOM 2775 OE1 GLU B 871 −15.422 28.862 14.501 1.00 28.93 B O ATOM 2776 OE2 GLU B 871 −13.542 29.668 15.326 1.00 29.15 B O ATOM 2777 C GLU B 871 −10.414 27.353 13.454 1.00 30.42 B C ATOM 2778 O GLU B 871 −9.746 28.386 13.315 1.00 29.98 B O ATOM 2779 N ILE B 872 −9.864 26.147 13.448 1.00 30.79 B N ATOM 2780 CA ILE B 872 −8.426 26.001 13.283 1.00 32.19 B C ATOM 2781 CB ILE B 872 −8.012 24.524 13.279 1.00 33.29 B C ATOM 2782 CG2 ILE B 872 −6.888 24.301 12.305 1.00 34.00 B C ATOM 2783 CG1 ILE B 872 −7.572 24.114 14.678 1.00 33.72 B C ATOM 2784 CD1 ILE B 872 −6.373 24.849 15.148 1.00 29.33 B C ATOM 2785 C ILE B 872 −7.916 26.662 12.012 1.00 32.54 B C ATOM 2786 O ILE B 872 −6.819 27.215 11.997 1.00 34.61 B O ATOM 2787 N GLN B 873 −8.696 26.609 10.936 1.00 32.00 B N ATOM 2788 CA GLN B 873 −8.253 27.234 9.697 1.00 29.37 B C ATOM 2789 CB GLN B 873 −9.112 26.785 8.516 1.00 30.42 B C ATOM 2790 CG GLN B 873 −9.011 25.305 8.255 1.00 33.60 B C ATOM 2791 CD GLN B 873 −9.613 24.874 6.935 1.00 36.54 B C ATOM 2792 OE1 GLN B 873 −9.545 23.695 6.584 1.00 40.58 B O ATOM 2793 NE2 GLN B 873 −10.202 25.820 6.193 1.00 36.08 B N ATOM 2794 C GLN B 873 −8.316 28.741 9.845 1.00 28.83 B C ATOM 2795 O GLN B 873 −7.571 29.471 9.189 1.00 27.50 B O ATOM 2796 N ILE B 874 −9.213 29.201 10.714 1.00 26.87 B N ATOM 2797 CA ILE B 874 −9.365 30.627 10.971 1.00 26.03 B C ATOM 2798 CB ILE B 874 −10.718 30.939 11.681 1.00 25.77 B C ATOM 2799 CG2 ILE B 874 −10.687 32.326 12.277 1.00 25.42 B C ATOM 2800 CG1 ILE B 874 −11.874 30.854 10.690 1.00 24.44 B C ATOM 2801 CD1 ILE B 874 −13.199 31.183 11.296 1.00 25.79 B C ATOM 2802 C ILE B 874 −8.216 31.066 11.875 1.00 27.22 B C ATOM 2803 O ILE B 874 −7.586 32.106 11.648 1.00 26.87 B O ATOM 2804 N LEU B 875 −7.947 30.251 12.898 1.00 27.62 B N ATOM 2805 CA LEU B 875 −6.886 30.535 13.859 1.00 25.96 B C ATOM 2806 CB LEU B 875 −7.024 29.638 15.099 1.00 24.59 B C ATOM 2807 CG LEU B 875 −8.270 29.838 15.983 1.00 24.64 B C ATOM 2808 CD1 LEU B 875 −8.328 28.786 17.075 1.00 22.44 B C ATOM 2809 CD2 LEU B 875 −8.248 31.208 16.601 1.00 24.13 B C ATOM 2810 C LEU B 875 −5.510 30.377 13.228 1.00 26.34 B C ATOM 2811 O LEU B 875 −4.621 31.206 13.439 1.00 27.82 B O ATOM 2812 N LYS B 876 −5.328 29.335 12.430 1.00 25.15 B N ATOM 2813 CA LYS B 876 −4.034 29.145 11.796 1.00 25.86 B C ATOM 2814 CB LYS B 876 −4.012 27.832 11.022 1.00 24.63 B C ATOM 2815 CG LYS B 876 −2.646 27.477 10.473 1.00 24.05 B C ATOM 2816 CD LYS B 876 −2.659 26.077 9.898 1.00 23.72 B C ATOM 2817 CE LYS B 876 −1.280 25.687 9.445 1.00 23.59 B C ATOM 2818 NZ LYS B 876 −1.240 24.405 8.706 1.00 24.88 B N ATOM 2819 C LYS B 876 −3.648 30.307 10.866 1.00 26.99 B C ATOM 2820 O LYS B 876 −2.461 30.594 10.689 1.00 29.84 B O ATOM 2821 N ALA B 877 −4.634 30.973 10.269 1.00 26.24 B N ATOM 2822 CA ALA B 877 −4.350 32.100 9.377 1.00 27.52 B C ATOM 2823 CB ALA B 877 −5.592 32.435 8.548 1.00 26.74 B C ATOM 2824 C ALA B 877 −3.858 33.352 10.144 1.00 28.24 B C ATOM 2825 O ALA B 877 −3.229 34.229 9.569 1.00 27.71 B O ATOM 2826 N LEU B 878 −4.140 33.428 11.442 1.00 30.40 B N ATOM 2827 CA LEU B 878 −3.702 34.561 12.266 1.00 29.17 B C ATOM 2828 CB LEU B 878 −4.304 34.452 13.656 1.00 27.14 B C ATOM 2829 CG LEU B 878 −5.822 34.321 13.719 1.00 27.92 B C ATOM 2830 CD1 LEU B 878 −6.218 33.768 15.073 1.00 27.76 B C ATOM 2831 CD2 LEU B 878 −6.465 35.663 13.458 1.00 26.98 B C ATOM 2832 C LEU B 878 −2.186 34.521 12.383 1.00 29.28 B C ATOM 2833 O LEU B 878 −1.619 33.457 12.610 1.00 28.90 B O ATOM 2834 N HIS B 879 −1.536 35.672 12.237 1.00 30.42 B N ATOM 2835 CA HIS B 879 −0.081 35.741 12.321 1.00 31.74 B C ATOM 2836 CB HIS B 879 0.514 35.780 10.925 1.00 32.65 B C ATOM 2837 CG HIS B 879 0.386 34.489 10.186 1.00 37.56 B C ATOM 2838 CD2 HIS B 879 0.520 33.208 10.602 1.00 39.16 B C ATOM 2839 ND1 HIS B 879 0.112 34.426 8.837 1.00 39.12 B N ATOM 2840 CE1 HIS B 879 0.083 33.163 8.453 1.00 39.56 B C ATOM 2841 NE2 HIS B 879 0.328 32.405 9.506 1.00 41.59 B N ATOM 2842 C HIS B 879 0.459 36.918 13.125 1.00 32.27 B C ATOM 2843 O HIS B 879 0.257 38.076 12.762 1.00 32.06 B O ATOM 2844 N SER B 880 1.165 36.597 14.207 1.00 30.30 B N ATOM 2845 CA SER B 880 1.767 37.590 15.091 1.00 30.83 B C ATOM 2846 CB SER B 880 0.720 38.147 16.062 1.00 29.12 B C ATOM 2847 OG SER B 880 1.336 38.938 17.063 1.00 25.06 B O ATOM 2848 C SER B 880 2.923 36.964 15.882 1.00 31.96 B C ATOM 2849 O SER B 880 2.840 35.818 16.334 1.00 32.79 B O ATOM 2850 N ASP B 881 4.003 37.711 16.053 1.00 31.67 B N ATOM 2851 CA ASP B 881 5.131 37.172 16.786 1.00 31.34 B C ATOM 2852 CB ASP B 881 6.346 38.069 16.642 1.00 34.15 B C ATOM 2853 CG ASP B 881 6.976 37.961 15.283 1.00 38.28 B C ATOM 2854 OD1 ASP B 881 8.035 38.584 15.081 1.00 41.45 B O ATOM 2855 OD2 ASP B 881 6.414 37.258 14.416 1.00 40.35 B O ATOM 2856 C ASP B 881 4.806 37.010 18.249 1.00 28.71 B C ATOM 2857 O ASP B 881 5.532 36.346 18.977 1.00 26.63 B O ATOM 2858 N PHE B 882 3.709 37.618 18.681 1.00 26.82 B N ATOM 2859 CA PHE B 882 3.319 37.526 20.081 1.00 25.00 B C ATOM 2860 CB PHE B 882 3.045 38.923 20.628 1.00 25.06 B C ATOM 2861 CG PHE B 882 4.170 39.886 20.397 1.00 25.00 B C ATOM 2862 CD1 PHE B 882 5.431 39.631 20.899 1.00 26.44 B C ATOM 2863 CD2 PHE B 882 3.979 41.021 19.631 1.00 27.51 B C ATOM 2864 CE1 PHE B 882 6.491 40.492 20.636 1.00 27.79 B C ATOM 2865 CE2 PHE B 882 5.030 41.884 19.365 1.00 27.41 B C ATOM 2866 CZ PHE B 882 6.287 41.620 19.866 1.00 25.41 B C ATOM 2867 C PHE B 882 2.093 36.630 20.254 1.00 23.95 B C ATOM 2868 O PHE B 882 1.238 36.892 21.092 1.00 24.37 B O ATOM 2869 N ILE B 883 2.033 35.561 19.463 1.00 23.06 B N ATOM 2870 CA ILE B 883 0.921 34.616 19.492 1.00 23.35 B C ATOM 2871 CB ILE B 883 −0.083 34.904 18.339 1.00 25.35 B C ATOM 2872 CG2 ILE B 883 −0.362 33.652 17.546 1.00 25.61 B C ATOM 2873 CG1 ILE B 883 −1.378 35.470 18.907 1.00 24.93 B C ATOM 2874 CD1 ILE B 883 −1.239 36.865 19.365 1.00 23.61 B C ATOM 2875 C ILE B 883 1.430 33.190 19.351 1.00 22.62 B C ATOM 2876 O ILE B 883 2.351 32.917 18.587 1.00 19.13 B O ATOM 2877 N VAL B 884 0.842 32.276 20.105 1.00 24.11 B N ATOM 2878 CA VAL B 884 1.257 30.881 20.025 1.00 24.99 B C ATOM 2879 CB VAL B 884 0.836 30.129 21.289 1.00 25.13 B C ATOM 2880 CG1 VAL B 884 1.339 28.699 21.232 1.00 24.82 B C ATOM 2881 CG2 VAL B 884 1.361 30.859 22.520 1.00 27.61 B C ATOM 2882 C VAL B 884 0.595 30.252 18.792 1.00 24.61 B C ATOM 2883 O VAL B 884 −0.627 30.199 18.698 1.00 23.23 B O ATOM 2884 N LYS B 885 1.415 29.783 17.857 1.00 25.26 B N ATOM 2885 CA LYS B 885 0.929 29.198 16.612 1.00 25.39 B C ATOM 2886 CB LYS B 885 2.100 28.837 15.702 1.00 25.63 B C ATOM 2887 CG LYS B 885 3.023 29.989 15.351 1.00 28.38 B C ATOM 2888 CD LYS B 885 4.276 29.480 14.643 1.00 30.17 B C ATOM 2889 CE LYS B 885 5.217 30.615 14.293 1.00 32.49 B C ATOM 2890 NZ LYS B 885 4.547 31.591 13.381 1.00 35.37 B N ATOM 2891 C LYS B 885 0.058 27.968 16.751 1.00 25.44 B C ATOM 2892 O LYS B 885 0.393 27.036 17.469 1.00 26.56 B O ATOM 2893 N TYR B 886 −1.073 27.982 16.063 1.00 25.34 B N ATOM 2894 CA TYR B 886 −1.954 26.833 16.045 1.00 25.02 B C ATOM 2895 CB TYR B 886 −3.417 27.277 15.944 1.00 25.04 B C ATOM 2896 CG TYR B 886 −4.100 27.564 17.274 1.00 21.78 B C ATOM 2897 CD1 TYR B 886 −4.291 26.560 18.220 1.00 20.76 B C ATOM 2898 CE1 TYR B 886 −4.962 26.809 19.403 1.00 18.65 B C ATOM 2899 CD2 TYR B 886 −4.597 28.820 17.556 1.00 20.53 B C ATOM 2900 CE2 TYR B 886 −5.266 29.075 18.728 1.00 20.17 B C ATOM 2901 CZ TYR B 886 −5.447 28.074 19.648 1.00 19.43 B C ATOM 2902 OH TYR B 886 −6.118 28.366 20.815 1.00 17.53 B O ATOM 2903 C TYR B 886 −1.508 26.123 14.768 1.00 24.51 B C ATOM 2904 O TYR B 886 −1.266 26.772 13.743 1.00 22.88 B O ATOM 2905 N ARG B 887 −1.378 24.803 14.818 1.00 24.90 B N ATOM 2906 CA ARG B 887 −0.916 24.070 13.645 1.00 24.72 B C ATOM 2907 CB ARG B 887 0.283 23.199 14.016 1.00 25.16 B C ATOM 2908 CG ARG B 887 1.551 23.983 14.248 1.00 27.60 B C ATOM 2909 CD ARG B 887 2.733 23.042 14.379 1.00 30.25 B C ATOM 2910 NE ARG B 887 2.962 22.287 13.154 1.00 31.62 B N ATOM 2911 CZ ARG B 887 3.892 21.349 13.023 1.00 32.40 B C ATOM 2912 NH1 ARG B 887 4.674 21.054 14.046 1.00 34.33 B N ATOM 2913 NH2 ARG B 887 4.049 20.710 11.869 1.00 33.94 B N ATOM 2914 C ARG B 887 −1.946 23.220 12.919 1.00 23.82 B C ATOM 2915 O ARG B 887 −1.855 23.047 11.706 1.00 24.22 B O ATOM 2916 N GLY B 888 −2.916 22.681 13.649 1.00 23.86 B N ATOM 2917 CA GLY B 888 −3.923 21.852 13.011 1.00 22.84 B C ATOM 2918 C GLY B 888 −4.841 21.140 13.984 1.00 23.38 B C ATOM 2919 O GLY B 888 −4.868 21.450 15.182 1.00 23.89 B O ATOM 2920 N VAL B 889 −5.594 20.181 13.448 1.00 21.47 B N ATOM 2921 CA VAL B 889 −6.543 19.373 14.210 1.00 21.70 B C ATOM 2922 CB VAL B 889 −7.998 19.607 13.725 1.00 20.93 B C ATOM 2923 CG1 VAL B 889 −8.921 18.534 14.281 1.00 19.14 B C ATOM 2924 CG2 VAL B 889 −8.471 20.966 14.169 1.00 23.06 B C ATOM 2925 C VAL B 889 −6.221 17.898 14.012 1.00 21.52 B C ATOM 2926 O VAL B 889 −5.950 17.462 12.900 1.00 22.29 B O ATOM 2927 N SER B 890 −6.276 17.117 15.080 1.00 22.47 B N ATOM 2928 CA SER B 890 −5.966 15.705 14.945 1.00 24.44 B C ATOM 2929 CB SER B 890 −5.233 15.195 16.183 1.00 21.47 B C ATOM 2930 OG SER B 890 −6.168 14.893 17.203 1.00 23.05 B O ATOM 2931 C SER B 890 −7.228 14.875 14.745 1.00 26.17 B C ATOM 2932 O SER B 890 −8.289 15.185 15.291 1.00 27.00 B O ATOM 2933 N TYR B 891 −7.105 13.820 13.948 1.00 27.10 B N ATOM 2934 CA TYR B 891 −8.223 12.926 13.708 1.00 27.93 B C ATOM 2935 CB TYR B 891 −8.644 12.987 12.243 1.00 27.86 B C ATOM 2936 CG TYR B 891 −9.260 14.312 11.916 1.00 30.15 B C ATOM 2937 CD1 TYR B 891 −10.480 14.672 12.447 1.00 31.47 B C ATOM 2938 CE1 TYR B 891 −11.015 15.912 12.216 1.00 30.53 B C ATOM 2939 CD2 TYR B 891 −8.594 15.231 11.140 1.00 27.69 B C ATOM 2940 CE2 TYR B 891 −9.118 16.468 10.905 1.00 28.64 B C ATOM 2941 CZ TYR B 891 −10.329 16.809 11.447 1.00 29.64 B C ATOM 2942 OH TYR B 891 −10.851 18.069 11.246 1.00 30.89 B O ATOM 2943 C TYR B 891 −7.863 11.506 14.116 1.00 28.23 B C ATOM 2944 O TYR B 891 −6.875 10.943 13.648 1.00 25.30 B O ATOM 2945 N GLY B 892 −8.698 10.956 14.992 1.00 30.66 B N ATOM 2946 CA GLY B 892 −8.548 9.619 15.539 1.00 35.15 B C ATOM 2947 C GLY B 892 −8.159 8.464 14.652 1.00 36.94 B C ATOM 2948 O GLY B 892 −7.194 8.567 13.900 1.00 40.72 B O ATOM 2949 N PRO B 893 −8.865 7.326 14.752 1.00 37.28 B N ATOM 2950 CD PRO B 893 −8.482 6.075 14.068 1.00 37.20 B C ATOM 2951 CA PRO B 893 −9.997 7.096 15.655 1.00 37.62 B C ATOM 2952 CB PRO B 893 −10.583 5.791 15.135 1.00 37.35 B C ATOM 2953 CG PRO B 893 −9.338 5.035 14.768 1.00 38.08 B C ATOM 2954 C PRO B 893 −9.597 6.973 17.124 1.00 37.60 B C ATOM 2955 O PRO B 893 −8.594 7.546 17.585 1.00 37.03 B O ATOM 2956 N GLY B 894 −10.392 6.201 17.851 1.00 35.38 B N ATOM 2957 CA GLY B 894 −10.121 6.004 19.262 1.00 33.52 B C ATOM 2958 C GLY B 894 −10.552 7.189 20.100 1.00 31.99 B C ATOM 2959 O GLY B 894 −11.030 8.188 19.565 1.00 29.77 B O ATOM 2960 N ARG B 895 −10.383 7.070 21.417 1.00 32.32 B N ATOM 2961 CA ARG B 895 −10.753 8.122 22.365 1.00 30.91 B C ATOM 2962 CB ARG B 895 −10.360 7.722 23.797 1.00 32.42 B C ATOM 2963 CG ARG B 895 −11.237 6.645 24.398 1.00 35.42 B C ATOM 2964 CD ARG B 895 −10.720 6.093 25.744 1.00 37.59 B C ATOM 2965 NE ARG B 895 −10.850 7.020 26.866 1.00 38.06 B N ATOM 2966 CZ ARG B 895 −9.883 7.830 27.285 1.00 41.12 B C ATOM 2967 NH1 ARG B 895 −8.699 7.829 26.676 1.00 40.31 B N ATOM 2968 NH2 ARG B 895 −10.105 8.641 28.313 1.00 40.07 B N ATOM 2969 C ARG B 895 −10.109 9.460 22.032 1.00 28.48 B C ATOM 2970 O ARG B 895 −10.770 10.496 22.077 1.00 27.31 B O ATOM 2971 N GLN B 896 −8.826 9.452 21.695 1.00 26.23 B N ATOM 2972 CA GLN B 896 −8.167 10.711 21.397 1.00 27.50 B C ATOM 2973 CB GLN B 896 −6.704 10.671 21.852 1.00 26.61 B C ATOM 2974 CG GLN B 896 −6.539 10.509 23.361 1.00 21.98 B C ATOM 2975 CD GLN B 896 −5.128 10.816 23.834 1.00 23.58 B C ATOM 2976 OE1 GLN B 896 −4.150 10.290 23.298 1.00 26.22 B O ATOM 2977 NE2 GLN B 896 −5.015 11.667 24.845 1.00 21.74 B N ATOM 2978 C GLN B 896 −8.248 11.133 19.941 1.00 28.56 B C ATOM 2979 O GLN B 896 −7.594 10.558 19.074 1.00 31.99 B O ATOM 2980 N SER B 897 −9.051 12.158 19.679 1.00 28.29 B N ATOM 2981 CA SER B 897 −9.218 12.678 18.327 1.00 26.97 B C ATOM 2982 CB SER B 897 −10.161 11.770 17.532 1.00 26.11 B C ATOM 2983 OG SER B 897 −10.161 12.129 16.162 1.00 24.03 B O ATOM 2984 C SER B 897 −9.767 14.113 18.357 1.00 26.27 B C ATOM 2985 O SER B 897 −10.235 14.587 19.392 1.00 24.86 B O ATOM 2986 N LEU B 898 −9.722 14.798 17.219 1.00 25.36 B N ATOM 2987 CA LEU B 898 −10.204 16.170 17.160 1.00 26.00 B C ATOM 2988 CB LEU B 898 −11.723 16.216 17.341 1.00 26.02 B C ATOM 2989 CG LEU B 898 −12.565 15.882 16.108 1.00 24.07 B C ATOM 2990 CD1 LEU B 898 −14.011 15.662 16.510 1.00 23.90 B C ATOM 2991 CD2 LEU B 898 −12.459 17.016 15.113 1.00 24.33 B C ATOM 2992 C LEU B 898 −9.530 17.007 18.242 1.00 26.30 B C ATOM 2993 O LEU B 898 −10.170 17.830 18.888 1.00 28.60 B O ATOM 2994 N ARG B 899 −8.234 16.779 18.437 1.00 25.95 B N ATOM 2995 CA ARG B 899 −7.457 17.516 19.425 1.00 24.40 B C ATOM 2996 CB ARG B 899 −6.443 16.595 20.114 1.00 22.59 B C ATOM 2997 CG ARG B 899 −7.058 15.350 20.727 1.00 22.64 B C ATOM 2998 CD ARG B 899 −6.076 14.637 21.641 1.00 23.58 B C ATOM 2999 NE ARG B 899 −4.855 14.240 20.951 1.00 23.78 B N ATOM 3000 CZ ARG B 899 −3.763 13.805 21.570 1.00 24.40 B C ATOM 3001 NH1 ARG B 899 −2.696 13.461 20.868 1.00 26.08 B N ATOM 3002 NH2 ARG B 899 −3.727 13.730 22.890 1.00 23.65 B N ATOM 3003 C ARG B 899 −6.731 18.659 18.711 1.00 24.37 B C ATOM 3004 O ARG B 899 −6.476 18.601 17.509 1.00 25.32 B O ATOM 3005 N LEU B 900 −6.394 19.693 19.461 1.00 22.83 B N ATOM 3006 CA LEU B 900 −5.736 20.848 18.901 1.00 22.29 B C ATOM 3007 CB LEU B 900 −6.203 22.095 19.673 1.00 23.06 B C ATOM 3008 CG LEU B 900 −7.727 22.284 19.877 1.00 18.99 B C ATOM 3009 CD1 LEU B 900 −8.021 23.367 20.901 1.00 20.49 B C ATOM 3010 CD2 LEU B 900 −8.369 22.632 18.564 1.00 20.01 B C ATOM 3011 C LEU B 900 −4.218 20.681 18.980 1.00 23.70 B C ATOM 3012 O LEU B 900 −3.663 20.403 20.047 1.00 24.33 B O ATOM 3013 N VAL B 901 −3.552 20.839 17.841 1.00 24.29 B N ATOM 3014 CA VAL B 901 −2.102 20.713 17.765 1.00 23.11 B C ATOM 3015 CB VAL B 901 −1.679 19.896 16.508 1.00 23.04 B C ATOM 3016 CG1 VAL B 901 −0.170 19.702 16.485 1.00 16.20 B C ATOM 3017 CG2 VAL B 901 −2.396 18.538 16.500 1.00 21.11 B C ATOM 3018 C VAL B 901 −1.499 22.113 17.677 1.00 24.80 B C ATOM 3019 O VAL B 901 −1.844 22.890 16.790 1.00 25.60 B O ATOM 3020 N MET B 902 −0.587 22.433 18.587 1.00 26.09 B N ATOM 3021 CA MET B 902 0.026 23.752 18.591 1.00 25.58 B C ATOM 3022 CB MET B 902 −0.412 24.530 19.822 1.00 26.88 B C ATOM 3023 CG MET B 902 −1.878 24.456 20.127 1.00 27.85 B C ATOM 3024 SD MET B 902 −2.092 24.944 21.814 1.00 28.15 B S ATOM 3025 CE MET B 902 −2.056 23.354 22.644 1.00 23.45 B C ATOM 3026 C MET B 902 1.533 23.636 18.650 1.00 25.59 B C ATOM 3027 O MET B 902 2.072 22.556 18.912 1.00 24.38 B O ATOM 3028 N GLU B 903 2.205 24.762 18.420 1.00 24.65 B N ATOM 3029 CA GLU B 903 3.650 24.798 18.509 1.00 26.30 B C ATOM 3030 CB GLU B 903 4.199 26.136 17.987 1.00 25.66 B C ATOM 3031 CG GLU B 903 3.970 27.328 18.910 1.00 27.57 B C ATOM 3032 CD GLU B 903 4.572 28.629 18.381 1.00 26.55 B C ATOM 3033 OE1 GLU B 903 5.638 28.581 17.728 1.00 25.12 B O ATOM 3034 OE2 GLU B 903 3.980 29.699 18.638 1.00 25.41 B O ATOM 3035 C GLU B 903 3.910 24.651 20.010 1.00 26.13 B C ATOM 3036 O GLU B 903 3.087 25.068 20.830 1.00 28.56 B O ATOM 3037 N TYR B 904 5.039 24.058 20.369 1.00 24.40 B N ATOM 3038 CA TYR B 904 5.384 23.840 21.769 1.00 24.74 B C ATOM 3039 CB TYR B 904 5.891 22.409 21.921 1.00 23.92 B C ATOM 3040 CG TYR B 904 6.433 22.085 23.289 1.00 24.77 B C ATOM 3041 CD1 TYR B 904 5.590 21.959 24.379 1.00 24.64 B C ATOM 3042 CE1 TYR B 904 6.084 21.600 25.613 1.00 24.42 B C ATOM 3043 CD2 TYR B 904 7.791 21.852 23.480 1.00 24.71 B C ATOM 3044 CE2 TYR B 904 8.291 21.492 24.706 1.00 22.58 B C ATOM 3045 CZ TYR B 904 7.435 21.363 25.766 1.00 23.33 B C ATOM 3046 OH TYR B 904 7.932 20.953 26.978 1.00 25.34 B O ATOM 3047 C TYR B 904 6.433 24.809 22.340 1.00 24.37 B C ATOM 3048 O TYR B 904 7.525 24.950 21.780 1.00 23.11 B O ATOM 3049 N LEU B 905 6.097 25.470 23.448 1.00 23.71 B N ATOM 3050 CA LEU B 905 7.025 26.394 24.113 1.00 23.78 B C ATOM 3051 CB LEU B 905 6.398 27.770 24.306 1.00 23.71 B C ATOM 3052 CG LEU B 905 6.535 28.734 23.124 1.00 24.68 B C ATOM 3053 CD1 LEU B 905 5.750 28.211 21.936 1.00 22.49 B C ATOM 3054 CD2 LEU B 905 6.026 30.119 23.541 1.00 23.69 B C ATOM 3055 C LEU B 905 7.372 25.823 25.470 1.00 23.58 B C ATOM 3056 O LEU B 905 6.633 26.026 26.429 1.00 24.54 B O ATOM 3057 N PRO B 906 8.513 25.114 25.568 1.00 24.82 B N ATOM 3058 CD PRO B 906 9.481 25.084 24.457 1.00 26.24 B C ATOM 3059 CA PRO B 906 9.080 24.443 26.743 1.00 26.73 B C ATOM 3060 CB PRO B 906 10.366 23.822 26.191 1.00 26.64 B C ATOM 3061 CG PRO B 906 10.787 24.789 25.168 1.00 25.89 B C ATOM 3062 C PRO B 906 9.316 25.248 28.024 1.00 28.44 B C ATOM 3063 O PRO B 906 9.476 24.663 29.098 1.00 31.05 B O ATOM 3064 N SER B 907 9.338 26.571 27.938 1.00 27.81 B N ATOM 3065 CA SER B 907 9.552 27.360 29.143 1.00 25.91 B C ATOM 3066 CB SER B 907 10.091 28.739 28.793 1.00 25.32 B C ATOM 3067 OG SER B 907 11.451 28.635 28.422 1.00 25.14 B O ATOM 3068 C SER B 907 8.319 27.486 30.024 1.00 24.89 B C ATOM 3069 O SER B 907 8.420 27.921 31.164 1.00 25.08 B O ATOM 3070 N GLY B 908 7.153 27.115 29.504 1.00 24.02 B N ATOM 3071 CA GLY B 908 5.949 27.173 30.318 1.00 23.21 B C ATOM 3072 C GLY B 908 5.254 28.513 30.404 1.00 23.91 B C ATOM 3073 O GLY B 908 5.668 29.485 29.762 1.00 23.15 B O ATOM 3074 N CYS B 909 4.199 28.565 31.220 1.00 23.69 B N ATOM 3075 CA CYS B 909 3.405 29.783 31.391 1.00 24.23 B C ATOM 3076 CB CYS B 909 2.080 29.468 32.097 1.00 23.91 B C ATOM 3077 SG CYS B 909 2.192 28.992 33.844 1.00 26.62 B S ATOM 3078 C CYS B 909 4.116 30.922 32.116 1.00 25.56 B C ATOM 3079 O CYS B 909 5.124 30.722 32.781 1.00 28.14 B O ATOM 3080 N LEU B 910 3.575 32.126 31.994 1.00 25.80 B N ATOM 3081 CA LEU B 910 4.187 33.280 32.612 1.00 25.97 B C ATOM 3082 CB LEU B 910 3.703 34.555 31.928 1.00 25.51 B C ATOM 3083 CG LEU B 910 4.255 35.889 32.424 1.00 21.94 B C ATOM 3084 CD1 LEU B 910 5.764 35.900 32.325 1.00 19.02 B C ATOM 3085 CD2 LEU B 910 3.651 37.004 31.588 1.00 21.42 B C ATOM 3086 C LEU B 910 3.841 33.319 34.075 1.00 27.73 B C ATOM 3087 O LEU B 910 4.581 33.882 34.872 1.00 29.03 B O ATOM 3088 N ARG B 911 2.710 32.718 34.423 1.00 29.17 B N ATOM 3089 CA ARG B 911 2.261 32.677 35.804 1.00 30.07 B C ATOM 3090 CB ARG B 911 0.955 31.886 35.907 1.00 30.79 B C ATOM 3091 CG ARG B 911 0.360 31.832 37.299 1.00 31.95 B C ATOM 3092 CD ARG B 911 0.525 30.472 37.965 1.00 35.46 B C ATOM 3093 NE ARG B 911 −0.638 29.607 37.749 1.00 37.85 B N ATOM 3094 CZ ARG B 911 −0.706 28.645 36.831 1.00 37.82 B C ATOM 3095 NH1 ARG B 911 0.336 28.414 36.039 1.00 37.46 B N ATOM 3096 NH2 ARG B 911 −1.819 27.924 36.696 1.00 34.64 B N ATOM 3097 C ARG B 911 3.329 32.051 36.692 1.00 31.19 B C ATOM 3098 O ARG B 911 3.693 32.627 37.711 1.00 31.62 B O ATOM 3099 N ASP B 912 3.842 30.886 36.298 1.00 31.73 B N ATOM 3100 CA ASP B 912 4.870 30.195 37.081 1.00 32.01 B C ATOM 3101 CB ASP B 912 4.969 28.732 36.654 1.00 31.15 B C ATOM 3102 CG ASP B 912 3.686 27.962 36.903 1.00 33.95 B C ATOM 3103 OD1 ASP B 912 3.597 26.796 36.461 1.00 37.34 B O ATOM 3104 OD2 ASP B 912 2.768 28.515 37.542 1.00 35.80 B O ATOM 3105 C ASP B 912 6.244 30.846 36.946 1.00 32.72 B C ATOM 3106 O ASP B 912 7.044 30.842 37.886 1.00 35.14 B O ATOM 3107 N PHE B 913 6.512 31.396 35.768 1.00 30.42 B N ATOM 3108 CA PHE B 913 7.781 32.047 35.493 1.00 27.92 B C ATOM 3109 CB PHE B 913 7.789 32.552 34.057 1.00 27.63 B C ATOM 3110 CG PHE B 913 9.131 32.976 33.575 1.00 24.31 B C ATOM 3111 CD1 PHE B 913 10.023 32.041 33.077 1.00 25.48 B C ATOM 3112 CD2 PHE B 913 9.498 34.313 33.601 1.00 25.91 B C ATOM 3113 CE1 PHE B 913 11.270 32.427 32.604 1.00 25.71 B C ATOM 3114 CE2 PHE B 913 10.741 34.717 33.133 1.00 26.67 B C ATOM 3115 CZ PHE B 913 11.632 33.769 32.630 1.00 26.64 B C ATOM 3116 C PHE B 913 7.969 33.228 36.439 1.00 28.84 B C ATOM 3117 O PHE B 913 9.021 33.396 37.061 1.00 28.01 B O ATOM 3118 N LEU B 914 6.941 34.059 36.525 1.00 28.32 B N ATOM 3119 CA LEU B 914 6.989 35.217 37.389 1.00 28.91 B C ATOM 3120 CB LEU B 914 5.641 35.944 37.369 1.00 26.17 B C ATOM 3121 CG LEU B 914 5.350 36.893 36.203 1.00 25.31 B C ATOM 3122 CD1 LEU B 914 3.852 37.120 36.120 1.00 23.40 B C ATOM 3123 CD2 LEU B 914 6.086 38.217 36.391 1.00 21.60 B C ATOM 3124 C LEU B 914 7.351 34.839 38.823 1.00 30.29 B C ATOM 3125 O LEU B 914 8.151 35.518 39.461 1.00 31.24 B O ATOM 3126 N GLN B 915 6.778 33.750 39.322 1.00 30.78 B N ATOM 3127 CA GLN B 915 7.036 33.326 40.695 1.00 31.85 B C ATOM 3128 CB GLN B 915 6.017 32.263 41.107 1.00 28.47 B C ATOM 3129 CG GLN B 915 4.599 32.792 41.121 1.00 26.27 B C ATOM 3130 CD GLN B 915 3.551 31.705 41.216 1.00 27.48 B C ATOM 3131 OE1 GLN B 915 2.756 31.690 42.143 1.00 28.95 B O ATOM 3132 NE2 GLN B 915 3.545 30.791 40.253 1.00 29.42 B N ATOM 3133 C GLN B 915 8.453 32.817 40.943 1.00 32.63 B C ATOM 3134 O GLN B 915 9.059 33.123 41.962 1.00 31.97 B O ATOM 3135 N ARG B 916 8.980 32.049 40.008 1.00 35.56 B N ATOM 3136 CA ARG B 916 10.318 31.510 40.144 1.00 39.61 B C ATOM 3137 CB ARG B 916 10.593 30.538 39.001 1.00 41.84 B C ATOM 3138 CG ARG B 916 12.058 30.148 38.868 1.00 46.16 B C ATOM 3139 CD ARG B 916 12.473 29.106 39.908 1.00 51.32 B C ATOM 3140 NE ARG B 916 12.152 27.738 39.487 1.00 55.40 B N ATOM 3141 CZ ARG B 916 12.816 27.058 38.554 1.00 55.68 B C ATOM 3142 NH1 ARG B 916 13.853 27.607 37.931 1.00 55.82 B N ATOM 3143 NH2 ARG B 916 12.441 25.824 38.243 1.00 56.52 B N ATOM 3144 C ARG B 916 11.420 32.568 40.162 1.00 41.25 B C ATOM 3145 O ARG B 916 12.159 32.697 41.136 1.00 43.76 B O ATOM 3146 N HIS B 917 11.532 33.323 39.076 1.00 41.99 B N ATOM 3147 CA HIS B 917 12.578 34.324 38.954 1.00 41.77 B C ATOM 3148 CB HIS B 917 13.046 34.404 37.504 1.00 42.37 B C ATOM 3149 CG HIS B 917 13.113 33.077 36.817 1.00 43.07 B C ATOM 3150 CD2 HIS B 917 14.170 32.340 36.402 1.00 43.65 B C ATOM 3151 ND1 HIS B 917 11.987 32.376 36.443 1.00 44.34 B N ATOM 3152 CE1 HIS B 917 12.347 31.267 35.822 1.00 44.79 B C ATOM 3153 NE2 HIS B 917 13.666 31.222 35.783 1.00 44.29 B N ATOM 3154 C HIS B 917 12.179 35.707 39.419 1.00 41.88 B C ATOM 3155 O HIS B 917 12.767 36.696 38.989 1.00 41.51 B O ATOM 3156 N ARG B 918 11.184 35.778 40.294 1.00 42.86 B N ATOM 3157 CA ARG B 918 10.718 37.060 40.813 1.00 44.49 B C ATOM 3158 CB ARG B 918 9.802 36.849 42.017 1.00 45.42 B C ATOM 3159 CG ARG B 918 9.269 38.145 42.613 1.00 47.61 B C ATOM 3160 CD ARG B 918 8.412 37.874 43.839 1.00 49.68 B C ATOM 3161 NE ARG B 918 7.700 39.061 44.301 1.00 52.10 B N ATOM 3162 CZ ARG B 918 8.266 40.249 44.470 1.00 55.07 B C ATOM 3163 NH1 ARG B 918 9.557 40.410 44.208 1.00 56.53 B N ATOM 3164 NH2 ARG B 918 7.547 41.274 44.919 1.00 55.39 B N ATOM 3165 C ARG B 918 11.901 37.900 41.254 1.00 45.45 B C ATOM 3166 O ARG B 918 11.879 39.126 41.168 1.00 45.70 B O ATOM 3167 N ALA B 919 12.934 37.217 41.730 1.00 46.64 B N ATOM 3168 CA ALA B 919 14.135 37.868 42.219 1.00 46.70 B C ATOM 3169 CB ALA B 919 15.139 36.816 42.670 1.00 46.55 B C ATOM 3170 C ALA B 919 14.789 38.813 41.222 1.00 46.47 B C ATOM 3171 O ALA B 919 15.070 39.959 41.555 1.00 46.26 B O ATOM 3172 N ARG B 920 15.020 38.345 40.000 1.00 45.92 B N ATOM 3173 CA ARG B 920 15.680 39.180 39.011 1.00 46.71 B C ATOM 3174 CB ARG B 920 16.943 38.464 38.500 1.00 48.83 B C ATOM 3175 CG ARG B 920 16.764 36.992 38.107 1.00 50.57 B C ATOM 3176 CD ARG B 920 16.469 36.813 36.607 1.00 53.25 B C ATOM 3177 NE ARG B 920 16.442 35.401 36.206 1.00 54.08 B N ATOM 3178 CZ ARG B 920 16.323 34.966 34.952 1.00 52.53 B C ATOM 3179 NH1 ARG B 920 16.216 35.828 33.945 1.00 51.03 B N ATOM 3180 NH2 ARG B 920 16.317 33.664 34.707 1.00 50.11 B N ATOM 3181 C ARG B 920 14.833 39.657 37.839 1.00 45.45 B C ATOM 3182 O ARG B 920 15.245 39.558 36.688 1.00 44.69 B O ATOM 3183 N LEU B 921 13.659 40.204 38.138 1.00 45.01 B N ATOM 3184 CA LEU B 921 12.759 40.714 37.102 1.00 44.34 B C ATOM 3185 CB LEU B 921 11.623 39.720 36.840 1.00 44.36 B C ATOM 3186 CG LEU B 921 11.900 38.396 36.128 1.00 44.22 B C ATOM 3187 CD1 LEU B 921 10.599 37.620 35.958 1.00 44.74 B C ATOM 3188 CD2 LEU B 921 12.511 38.669 34.775 1.00 45.69 B C ATOM 3189 C LEU B 921 12.167 42.055 37.539 1.00 43.53 B C ATOM 3190 O LEU B 921 11.150 42.097 38.237 1.00 44.06 B O ATOM 3191 N ASP B 922 12.799 43.147 37.120 1.00 42.34 B N ATOM 3192 CA ASP B 922 12.335 44.477 37.499 1.00 41.85 B C ATOM 3193 CB ASP B 922 13.462 45.511 37.339 1.00 41.06 B C ATOM 3194 CG ASP B 922 13.976 45.614 35.909 1.00 42.29 B C ATOM 3195 OD1 ASP B 922 13.142 45.659 34.975 1.00 39.58 B O ATOM 3196 OD2 ASP B 922 15.219 45.666 35.730 1.00 43.31 B O ATOM 3197 C ASP B 922 11.106 44.943 36.731 1.00 39.87 B C ATOM 3198 O ASP B 922 10.672 44.306 35.781 1.00 41.23 B O ATOM 3199 N ALA B 923 10.552 46.068 37.158 1.00 37.59 B N ATOM 3200 CA ALA B 923 9.376 46.629 36.523 1.00 36.35 B C ATOM 3201 CB ALA B 923 9.017 47.950 37.187 1.00 35.54 B C ATOM 3202 C ALA B 923 9.553 46.824 35.017 1.00 35.68 B C ATOM 3203 O ALA B 923 8.588 46.730 34.260 1.00 35.30 B O ATOM 3204 N SER B 924 10.775 47.097 34.574 1.00 33.91 B N ATOM 3205 CA SER B 924 10.991 47.290 33.151 1.00 33.74 B C ATOM 3206 CB SER B 924 12.465 47.551 32.859 1.00 34.61 B C ATOM 3207 OG SER B 924 12.840 48.836 33.318 1.00 40.21 B O ATOM 3208 C SER B 924 10.523 46.061 32.390 1.00 33.14 B C ATOM 3209 O SER B 924 9.803 46.163 31.395 1.00 32.57 B O ATOM 3210 N ARG B 925 10.931 44.899 32.876 1.00 30.83 B N ATOM 3211 CA ARG B 925 10.552 43.653 32.259 1.00 31.63 B C ATOM 3212 CB ARG B 925 11.199 42.489 33.003 1.00 33.57 B C ATOM 3213 CG ARG B 925 10.900 41.147 32.394 1.00 35.20 B C ATOM 3214 CD ARG B 925 12.156 40.548 31.836 1.00 39.12 B C ATOM 3215 NE ARG B 925 12.823 41.461 30.920 1.00 41.44 B N ATOM 3216 CZ ARG B 925 14.029 41.240 30.416 1.00 42.69 B C ATOM 3217 NH1 ARG B 925 14.576 42.117 29.585 1.00 43.07 B N ATOM 3218 NH2 ARG B 925 14.685 40.138 30.753 1.00 41.67 B N ATOM 3219 C ARG B 925 9.035 43.493 32.286 1.00 31.85 B C ATOM 3220 O ARG B 925 8.415 43.165 31.270 1.00 30.05 B O ATOM 3221 N LEU B 926 8.442 43.723 33.457 1.00 30.42 B N ATOM 3222 CA LEU B 926 6.998 43.589 33.614 1.00 28.04 B C ATOM 3223 CB LEU B 926 6.570 44.056 35.002 1.00 27.26 B C ATOM 3224 CG LEU B 926 7.230 43.348 36.185 1.00 28.68 B C ATOM 3225 CD1 LEU B 926 6.539 43.811 37.487 1.00 26.24 B C ATOM 3226 CD2 LEU B 926 7.119 41.819 36.004 1.00 24.28 B C ATOM 3227 C LEU B 926 6.285 44.412 32.551 1.00 27.32 B C ATOM 3228 O LEU B 926 5.294 43.971 31.969 1.00 27.38 B O ATOM 3229 N LEU B 927 6.806 45.610 32.302 1.00 25.79 B N ATOM 3230 CA LEU B 927 6.239 46.509 31.305 1.00 25.06 B C ATOM 3231 CB LEU B 927 6.829 47.921 31.474 1.00 22.03 B C ATOM 3232 CG LEU B 927 6.221 48.706 32.650 1.00 20.16 B C ATOM 3233 CD1 LEU B 927 6.929 50.021 32.861 1.00 19.40 B C ATOM 3234 CD2 LEU B 927 4.742 48.949 32.363 1.00 21.09 B C ATOM 3235 C LEU B 927 6.488 45.959 29.897 1.00 25.65 B C ATOM 3236 O LEU B 927 5.660 46.115 28.996 1.00 25.31 B O ATOM 3237 N LEU B 928 7.622 45.298 29.714 1.00 26.41 B N ATOM 3238 CA LEU B 928 7.922 44.693 28.429 1.00 27.69 B C ATOM 3239 CB LEU B 928 9.310 44.038 28.452 1.00 27.36 B C ATOM 3240 CG LEU B 928 9.829 43.541 27.093 1.00 29.18 B C ATOM 3241 CD1 LEU B 928 9.870 44.697 26.100 1.00 26.86 B C ATOM 3242 CD2 LEU B 928 11.220 42.930 27.259 1.00 28.41 B C ATOM 3243 C LEU B 928 6.840 43.635 28.141 1.00 27.69 B C ATOM 3244 O LEU B 928 6.178 43.695 27.109 1.00 29.81 B O ATOM 3245 N TYR B 929 6.649 42.685 29.059 1.00 26.62 B N ATOM 3246 CA TYR B 929 5.646 41.634 28.873 1.00 25.73 B C ATOM 3247 CB TYR B 929 5.570 40.676 30.078 1.00 24.73 B C ATOM 3248 CG TYR B 929 6.863 39.964 30.423 1.00 25.65 B C ATOM 3249 CD1 TYR B 929 7.710 39.488 29.428 1.00 26.25 B C ATOM 3250 CE1 TYR B 929 8.900 38.847 29.749 1.00 26.35 B C ATOM 3251 CD2 TYR B 929 7.241 39.771 31.750 1.00 25.40 B C ATOM 3252 CE2 TYR B 929 8.421 39.131 32.077 1.00 23.77 B C ATOM 3253 CZ TYR B 929 9.245 38.675 31.077 1.00 26.10 B C ATOM 3254 OH TYR B 929 10.427 38.057 31.394 1.00 26.76 B O ATOM 3255 C TYR B 929 4.270 42.236 28.676 1.00 24.74 B C ATOM 3256 O TYR B 929 3.439 41.656 27.995 1.00 23.60 B O ATOM 3257 N SER B 930 4.029 43.391 29.289 1.00 25.64 B N ATOM 3258 CA SER B 930 2.730 44.052 29.183 1.00 26.06 B C ATOM 3259 CB SER B 930 2.622 45.176 30.213 1.00 26.82 B C ATOM 3260 OG SER B 930 2.832 44.674 31.525 1.00 28.96 B O ATOM 3261 C SER B 930 2.512 44.600 27.782 1.00 25.97 B C ATOM 3262 O SER B 930 1.434 44.454 27.210 1.00 26.37 B O ATOM 3263 N SER B 931 3.550 45.208 27.221 1.00 26.24 B N ATOM 3264 CA SER B 931 3.472 45.768 25.877 1.00 24.72 B C ATOM 3265 CB SER B 931 4.746 46.562 25.559 1.00 25.41 B C ATOM 3266 OG SER B 931 4.663 47.190 24.288 1.00 25.63 B O ATOM 3267 C SER B 931 3.272 44.671 24.829 1.00 22.71 B C ATOM 3268 O SER B 931 2.440 44.804 23.937 1.00 22.21 B O ATOM 3269 N GLN B 932 4.043 43.594 24.926 1.00 21.13 B N ATOM 3270 CA GLN B 932 3.922 42.501 23.967 1.00 20.19 B C ATOM 3271 CB GLN B 932 5.018 41.469 24.195 1.00 18.59 B C ATOM 3272 CG GLN B 932 6.417 42.034 24.201 1.00 16.41 B C ATOM 3273 CD GLN B 932 7.450 40.960 24.447 1.00 18.92 B C ATOM 3274 OE1 GLN B 932 7.173 39.963 25.111 1.00 19.34 B O ATOM 3275 NE2 GLN B 932 8.659 41.161 23.928 1.00 20.97 B N ATOM 3276 C GLN B 932 2.552 41.830 24.062 1.00 20.13 B C ATOM 3277 O GLN B 932 1.987 41.438 23.052 1.00 20.51 B O ATOM 3278 N ILE B 933 2.014 41.708 25.272 1.00 19.68 B N ATOM 3279 CA ILE B 933 0.714 41.087 25.452 1.00 20.83 B C ATOM 3280 CB ILE B 933 0.396 40.865 26.957 1.00 20.65 B C ATOM 3281 CG2 ILE B 933 −1.099 40.537 27.156 1.00 18.30 B C ATOM 3282 CG1 ILE B 933 1.274 39.731 27.506 1.00 17.48 B C ATOM 3283 CD1 ILE B 933 1.297 39.640 29.005 1.00 14.75 B C ATOM 3284 C ILE B 933 −0.330 41.997 24.825 1.00 23.98 B C ATOM 3285 O ILE B 933 −1.262 41.530 24.165 1.00 27.92 B O ATOM 3286 N CYS B 934 −0.162 43.302 25.009 1.00 24.95 B N ATOM 3287 CA CYS B 934 −1.096 44.271 24.450 1.00 23.96 B C ATOM 3288 CB CYS B 934 −0.771 45.675 24.962 1.00 22.48 B C ATOM 3289 SG CYS B 934 −2.047 46.909 24.612 1.00 26.90 B S ATOM 3290 C CYS B 934 −1.027 44.258 22.927 1.00 23.61 B C ATOM 3291 O CYS B 934 −2.050 44.291 22.236 1.00 21.24 B O ATOM 3292 N LYS B 935 0.189 44.212 22.401 1.00 25.11 B N ATOM 3293 CA LYS B 935 0.378 44.212 20.957 1.00 25.85 B C ATOM 3294 CB LYS B 935 1.878 44.169 20.629 1.00 28.60 B C ATOM 3295 CG LYS B 935 2.217 44.378 19.162 1.00 31.12 B C ATOM 3296 CD LYS B 935 1.628 45.673 18.661 1.00 36.08 B C ATOM 3297 CE LYS B 935 1.778 45.817 17.159 1.00 37.38 B C ATOM 3298 NZ LYS B 935 0.958 46.965 16.669 1.00 39.57 B N ATOM 3299 C LYS B 935 −0.356 43.008 20.370 1.00 25.95 B C ATOM 3300 O LYS B 935 −1.099 43.147 19.403 1.00 26.64 B O ATOM 3301 N GLY B 936 −0.176 41.840 20.981 1.00 24.87 B N ATOM 3302 CA GLY B 936 −0.846 40.645 20.503 1.00 25.53 B C ATOM 3303 C GLY B 936 −2.367 40.737 20.520 1.00 25.87 B C ATOM 3304 O GLY B 936 −3.046 40.382 19.541 1.00 22.39 B O ATOM 3305 N MET B 937 −2.903 41.218 21.637 1.00 24.22 B N ATOM 3306 CA MET B 937 −4.344 41.354 21.784 1.00 25.26 B C ATOM 3307 CB MET B 937 −4.680 41.810 23.208 1.00 22.36 B C ATOM 3308 CG MET B 937 −4.476 40.693 24.213 1.00 23.06 B C ATOM 3309 SD MET B 937 −5.425 39.200 23.698 1.00 20.48 B S ATOM 3310 CE MET B 937 −7.049 39.901 23.661 1.00 15.72 B C ATOM 3311 C MET B 937 −4.908 42.319 20.746 1.00 25.24 B C ATOM 3312 O MET B 937 −6.030 42.155 20.276 1.00 25.83 B O ATOM 3313 N GLU B 938 −4.115 43.314 20.372 1.00 27.10 B N ATOM 3314 CA GLU B 938 −4.553 44.279 19.373 1.00 29.62 B C ATOM 3315 CB GLU B 938 −3.575 45.458 19.307 1.00 30.48 B C ATOM 3316 CG GLU B 938 −3.911 46.454 18.221 1.00 35.52 B C ATOM 3317 CD GLU B 938 −2.834 47.506 18.000 1.00 38.79 B C ATOM 3318 OE1 GLU B 938 −1.636 47.140 17.896 1.00 40.52 B O ATOM 3319 OE2 GLU B 938 −3.198 48.698 17.915 1.00 38.59 B O ATOM 3320 C GLU B 938 −4.675 43.609 17.993 1.00 28.94 B C ATOM 3321 O GLU B 938 −5.659 43.803 17.282 1.00 27.75 B O ATOM 3322 N TYR B 939 −3.677 42.819 17.623 1.00 27.57 B N ATOM 3323 CA TYR B 939 −3.720 42.139 16.345 1.00 27.18 B C ATOM 3324 CB TYR B 939 −2.428 41.354 16.133 1.00 26.82 B C ATOM 3325 CG TYR B 939 −2.512 40.410 14.969 1.00 28.23 B C ATOM 3326 CD1 TYR B 939 −2.672 40.879 13.676 1.00 27.67 B C ATOM 3327 CE1 TYR B 939 −2.818 39.995 12.613 1.00 27.50 B C ATOM 3328 CD2 TYR B 939 −2.495 39.034 15.170 1.00 30.11 B C ATOM 3329 CE2 TYR B 939 −2.641 38.143 14.113 1.00 27.69 B C ATOM 3330 CZ TYR B 939 −2.803 38.630 12.844 1.00 25.76 B C ATOM 3331 OH TYR B 939 −2.969 37.746 11.809 1.00 28.05 B O ATOM 3332 C TYR B 939 −4.936 41.196 16.283 1.00 27.22 B C ATOM 3333 O TYR B 939 −5.730 41.229 15.333 1.00 25.58 B O ATOM 3334 N LEU B 940 −5.084 40.365 17.312 1.00 27.83 B N ATOM 3335 CA LEU B 940 −6.194 39.422 17.370 1.00 27.45 B C ATOM 3336 CB LEU B 940 −6.159 38.621 18.678 1.00 25.08 B C ATOM 3337 CG LEU B 940 −4.922 37.722 18.864 1.00 27.64 B C ATOM 3338 CD1 LEU B 940 −5.154 36.762 20.017 1.00 24.40 B C ATOM 3339 CD2 LEU B 940 −4.625 36.931 17.591 1.00 27.99 B C ATOM 3340 C LEU B 940 −7.533 40.138 17.216 1.00 26.86 B C ATOM 3341 O LEU B 940 −8.439 39.627 16.562 1.00 28.15 B O ATOM 3342 N GLY B 941 −7.643 41.329 17.796 1.00 26.05 B N ATOM 3343 CA GLY B 941 −8.879 42.092 17.707 1.00 23.74 B C ATOM 3344 C GLY B 941 −9.205 42.585 16.312 1.00 21.83 B C ATOM 3345 O GLY B 941 −10.338 42.461 15.841 1.00 19.35 B O ATOM 3346 N SER B 942 −8.206 43.153 15.651 1.00 21.40 B N ATOM 3347 CA SER B 942 −8.384 43.660 14.307 1.00 23.07 B C ATOM 3348 CB SER B 942 −7.086 44.309 13.815 1.00 20.62 B C ATOM 3349 OG SER B 942 −6.006 43.388 13.817 1.00 16.12 B O ATOM 3350 C SER B 942 −8.801 42.536 13.359 1.00 26.33 B C ATOM 3351 O SER B 942 −9.307 42.793 12.260 1.00 29.50 B O ATOM 3352 N ARG B 943 −8.593 41.293 13.782 1.00 24.35 B N ATOM 3353 CA ARG B 943 −8.954 40.161 12.963 1.00 23.61 B C ATOM 3354 CB ARG B 943 −7.827 39.141 12.956 1.00 26.33 B C ATOM 3355 CG ARG B 943 −6.624 39.601 12.198 1.00 29.12 B C ATOM 3356 CD ARG B 943 −6.909 39.625 10.718 1.00 34.41 B C ATOM 3357 NE ARG B 943 −5.854 40.306 9.975 1.00 37.63 B N ATOM 3358 CZ ARG B 943 −5.479 41.557 10.216 1.00 38.64 B C ATOM 3359 NH1 ARG B 943 −4.512 42.127 9.502 1.00 38.73 B N ATOM 3360 NH2 ARG B 943 −6.075 42.233 11.188 1.00 40.59 B N ATOM 3361 C ARG B 943 −10.221 39.535 13.494 1.00 24.10 B C ATOM 3362 O ARG B 943 −10.549 38.392 13.171 1.00 23.79 B O ATOM 3363 N ARG B 944 −10.929 40.288 14.327 1.00 25.80 B N ATOM 3364 CA ARG B 944 −12.190 39.832 14.902 1.00 27.06 B C ATOM 3365 CB ARG B 944 −13.222 39.690 13.786 1.00 29.29 B C ATOM 3366 CG ARG B 944 −13.328 40.944 12.931 1.00 33.03 B C ATOM 3367 CD ARG B 944 −14.432 40.833 11.901 1.00 37.88 B C ATOM 3368 NE ARG B 944 −14.475 42.000 11.018 1.00 41.34 B N ATOM 3369 CZ ARG B 944 −14.967 43.192 11.345 1.00 42.38 B C ATOM 3370 NH1 ARG B 944 −15.482 43.410 12.550 1.00 43.09 B N ATOM 3371 NH2 ARG B 944 −14.928 44.179 10.460 1.00 43.07 B N ATOM 3372 C ARG B 944 −12.137 38.538 15.722 1.00 27.11 B C ATOM 3373 O ARG B 944 −13.102 37.777 15.739 1.00 27.61 B O ATOM 3374 N CYS B 945 −11.020 38.298 16.404 1.00 24.94 B N ATOM 3375 CA CYS B 945 −10.863 37.112 17.239 1.00 24.53 B C ATOM 3376 CB CYS B 945 −9.489 36.485 17.004 1.00 25.33 B C ATOM 3377 SG CYS B 945 −9.124 35.025 18.022 1.00 30.16 B S ATOM 3378 C CYS B 945 −11.014 37.466 18.728 1.00 23.62 B C ATOM 3379 O CYS B 945 −10.477 38.472 19.188 1.00 23.54 B O ATOM 3380 N VAL B 946 −11.745 36.635 19.468 1.00 22.35 B N ATOM 3381 CA VAL B 946 −11.959 36.844 20.900 1.00 21.99 B C ATOM 3382 CB VAL B 946 −13.468 36.922 21.219 1.00 19.57 B C ATOM 3383 CG1 VAL B 946 −13.699 37.058 22.729 1.00 17.37 B C ATOM 3384 CG2 VAL B 946 −14.064 38.114 20.500 1.00 17.89 B C ATOM 3385 C VAL B 946 −11.300 35.725 21.728 1.00 23.03 B C ATOM 3386 O VAL B 946 −11.554 34.537 21.510 1.00 26.36 B O ATOM 3387 N HIS B 947 −10.454 36.120 22.671 1.00 20.78 B N ATOM 3388 CA HIS B 947 −9.731 35.172 23.510 1.00 22.55 B C ATOM 3389 CB HIS B 947 −8.707 35.896 24.395 1.00 20.18 B C ATOM 3390 CG HIS B 947 −7.680 34.980 24.980 1.00 17.97 B C ATOM 3391 CD2 HIS B 947 −7.802 33.946 25.842 1.00 16.23 B C ATOM 3392 ND1 HIS B 947 −6.363 34.987 24.573 1.00 16.76 B N ATOM 3393 CE1 HIS B 947 −5.719 33.990 25.152 1.00 14.12 B C ATOM 3394 NE2 HIS B 947 −6.569 33.341 25.925 1.00 16.69 B N ATOM 3395 C HIS B 947 −10.636 34.354 24.404 1.00 22.03 B C ATOM 3396 O HIS B 947 −10.644 33.138 24.324 1.00 24.74 B O ATOM 3397 N ARG B 948 −11.378 35.030 25.268 1.00 24.81 B N ATOM 3398 CA ARG B 948 −12.302 34.386 26.204 1.00 29.26 B C ATOM 3399 CB ARG B 948 −13.059 33.233 25.530 1.00 32.27 B C ATOM 3400 CG ARG B 948 −14.516 33.556 25.207 1.00 37.63 B C ATOM 3401 CD ARG B 948 −15.406 32.314 25.302 1.00 43.26 B C ATOM 3402 NE ARG B 948 −15.330 31.674 26.617 1.00 46.10 B N ATOM 3403 CZ ARG B 948 −16.182 30.753 27.057 1.00 48.54 B C ATOM 3404 NH1 ARG B 948 −16.021 30.238 28.268 1.00 49.33 B N ATOM 3405 NH2 ARG B 948 −17.195 30.352 26.294 1.00 49.77 B N ATOM 3406 C ARG B 948 −11.697 33.889 27.522 1.00 28.75 B C ATOM 3407 O ARG B 948 −12.397 33.831 28.532 1.00 30.89 B O ATOM 3408 N ASP B 949 −10.415 33.542 27.536 1.00 28.05 B N ATOM 3409 CA ASP B 949 −9.801 33.070 28.773 1.00 26.91 B C ATOM 3410 CB ASP B 949 −9.766 31.535 28.779 1.00 28.13 B C ATOM 3411 CG ASP B 949 −9.324 30.955 30.116 1.00 30.51 B C ATOM 3412 OD1 ASP B 949 −9.744 31.469 31.166 1.00 32.59 B O ATOM 3413 OD2 ASP B 949 −8.565 29.969 30.124 1.00 31.18 B O ATOM 3414 C ASP B 949 −8.393 33.653 28.937 1.00 25.45 B C ATOM 3415 O ASP B 949 −7.426 32.927 29.151 1.00 25.26 B O ATOM 3416 N LEU B 950 −8.279 34.971 28.829 1.00 23.58 B N ATOM 3417 CA LEU B 950 −6.976 35.608 28.958 1.00 22.80 B C ATOM 3418 CB LEU B 950 −7.000 37.024 28.392 1.00 20.62 B C ATOM 3419 CG LEU B 950 −5.676 37.798 28.285 1.00 18.98 B C ATOM 3420 CD1 LEU B 950 −4.751 37.141 27.253 1.00 13.37 B C ATOM 3421 CD2 LEU B 950 −5.970 39.246 27.867 1.00 12.59 B C ATOM 3422 C LEU B 950 −6.618 35.644 30.425 1.00 22.41 B C ATOM 3423 O LEU B 950 −7.473 35.910 31.264 1.00 20.85 B O ATOM 3424 N ALA B 951 −5.352 35.362 30.717 1.00 20.76 B N ATOM 3425 CA ALA B 951 −4.852 35.331 32.078 1.00 17.81 B C ATOM 3426 CB ALA B 951 −5.594 34.306 32.859 1.00 12.31 B C ATOM 3427 C ALA B 951 −3.368 34.997 32.041 1.00 19.23 B C ATOM 3428 O ALA B 951 −2.879 34.395 31.084 1.00 22.05 B O ATOM 3429 N ALA B 952 −2.647 35.393 33.083 1.00 19.76 B N ATOM 3430 CA ALA B 952 −1.209 35.154 33.157 1.00 18.16 B C ATOM 3431 CB ALA B 952 −0.671 35.622 34.518 1.00 18.36 B C ATOM 3432 C ALA B 952 −0.831 33.696 32.911 1.00 17.28 B C ATOM 3433 O ALA B 952 0.298 33.403 32.503 1.00 18.38 B O ATOM 3434 N ARG B 953 −1.761 32.783 33.174 1.00 17.20 B N ATOM 3435 CA ARG B 953 −1.501 31.359 32.958 1.00 19.59 B C ATOM 3436 CB ARG B 953 −2.502 30.490 33.734 1.00 18.77 B C ATOM 3437 CG ARG B 953 −3.902 30.571 33.184 1.00 18.10 B C ATOM 3438 CD ARG B 953 −4.843 29.692 33.962 1.00 19.26 B C ATOM 3439 NE ARG B 953 −6.241 30.056 33.733 1.00 19.94 B N ATOM 3440 CZ ARG B 953 −6.897 30.984 34.421 1.00 20.48 B C ATOM 3441 NH1 ARG B 953 −6.292 31.652 35.395 1.00 22.23 B N ATOM 3442 NH2 ARG B 953 −8.161 31.246 34.137 1.00 19.77 B N ATOM 3443 C ARG B 953 −1.606 31.044 31.462 1.00 21.37 B C ATOM 3444 O ARG B 953 −0.991 30.090 30.967 1.00 20.33 B O ATOM 3445 N ASN B 954 −2.389 31.837 30.734 1.00 21.32 B N ATOM 3446 CA ASN B 954 −2.507 31.594 29.301 1.00 22.57 B C ATOM 3447 CB ASN B 954 −3.966 31.740 28.836 1.00 19.78 B C ATOM 3448 CG ASN B 954 −4.824 30.542 29.243 1.00 18.80 B C ATOM 3449 OD1 ASN B 954 −4.347 29.404 29.258 1.00 16.51 B O ATOM 3450 ND2 ASN B 954 −6.088 30.791 29.568 1.00 18.61 B N ATOM 3451 C ASN B 954 −1.563 32.460 28.467 1.00 23.15 B C ATOM 3452 O ASN B 954 −1.837 32.764 27.305 1.00 24.11 B O ATOM 3453 N ILE B 955 −0.447 32.840 29.085 1.00 22.78 B N ATOM 3454 CA ILE B 955 0.600 33.636 28.446 1.00 23.25 B C ATOM 3455 CB ILE B 955 0.911 34.930 29.252 1.00 22.42 B C ATOM 3456 CG2 ILE B 955 2.137 35.627 28.660 1.00 21.63 B C ATOM 3457 CG1 ILE B 955 −0.317 35.851 29.285 1.00 20.99 B C ATOM 3458 CD1 ILE B 955 −0.663 36.492 27.966 1.00 19.44 B C ATOM 3459 C ILE B 955 1.846 32.761 28.489 1.00 24.65 B C ATOM 3460 O ILE B 955 2.390 32.527 29.570 1.00 27.02 B O ATOM 3461 N LEU B 956 2.302 32.274 27.339 1.00 24.24 B N ATOM 3462 CA LEU B 956 3.480 31.405 27.315 1.00 24.52 B C ATOM 3463 CB LEU B 956 3.298 30.311 26.244 1.00 23.14 B C ATOM 3464 CG LEU B 956 2.291 29.206 26.637 1.00 21.34 B C ATOM 3465 CD1 LEU B 956 1.936 28.336 25.446 1.00 20.11 B C ATOM 3466 CD2 LEU B 956 2.875 28.338 27.737 1.00 19.45 B C ATOM 3467 C LEU B 956 4.793 32.169 27.113 1.00 26.13 B C ATOM 3468 O LEU B 956 4.827 33.196 26.437 1.00 27.09 B O ATOM 3469 N VAL B 957 5.869 31.664 27.716 1.00 26.24 B N ATOM 3470 CA VAL B 957 7.187 32.296 27.631 1.00 25.04 B C ATOM 3471 CB VAL B 957 8.000 32.098 28.950 1.00 25.69 B C ATOM 3472 CG1 VAL B 957 9.431 32.628 28.780 1.00 21.14 B C ATOM 3473 CG2 VAL B 957 7.297 32.805 30.113 1.00 24.99 B C ATOM 3474 C VAL B 957 8.045 31.787 26.477 1.00 25.81 B C ATOM 3475 O VAL B 957 8.475 30.630 26.469 1.00 27.02 B O ATOM 3476 N GLU B 958 8.288 32.649 25.498 1.00 26.44 B N ATOM 3477 CA GLU B 958 9.126 32.274 24.368 1.00 28.76 B C ATOM 3478 CB GLU B 958 8.912 33.237 23.196 1.00 28.56 B C ATOM 3479 CG GLU B 958 9.876 33.025 22.035 1.00 30.73 B C ATOM 3480 CD GLU B 958 9.599 31.765 21.224 1.00 32.95 B C ATOM 3481 OE1 GLU B 958 10.401 31.465 20.315 1.00 35.94 B O ATOM 3482 OE2 GLU B 958 8.592 31.075 21.474 1.00 33.94 B O ATOM 3483 C GLU B 958 10.567 32.364 24.868 1.00 29.72 B C ATOM 3484 O GLU B 958 11.401 31.514 24.571 1.00 30.94 B O ATOM 3485 N SER B 959 10.842 33.404 25.645 1.00 31.11 B N ATOM 3486 CA SER B 959 12.164 33.609 26.210 1.00 32.58 B C ATOM 3487 CB SER B 959 13.152 34.054 25.137 1.00 30.97 B C ATOM 3488 OG SER B 959 13.235 35.465 25.113 1.00 33.82 B O ATOM 3489 C SER B 959 12.039 34.688 27.286 1.00 34.54 B C ATOM 3490 O SER B 959 10.961 35.246 27.482 1.00 33.70 B O ATOM 3491 N GLU B 960 13.147 34.978 27.962 1.00 35.55 B N ATOM 3492 CA GLU B 960 13.189 35.961 29.038 1.00 36.85 B C ATOM 3493 CB GLU B 960 14.615 36.058 29.594 1.00 39.46 B C ATOM 3494 CG GLU B 960 15.207 34.704 29.961 1.00 46.26 B C ATOM 3495 CD GLU B 960 15.453 33.813 28.738 1.00 50.12 B C ATOM 3496 OE1 GLU B 960 15.423 32.565 28.888 1.00 51.89 B O ATOM 3497 OE2 GLU B 960 15.684 34.358 27.629 1.00 51.11 B O ATOM 3498 C GLU B 960 12.703 37.344 28.622 1.00 35.60 B C ATOM 3499 O GLU B 960 12.252 38.134 29.455 1.00 35.96 B O ATOM 3500 N ALA B 961 12.788 37.644 27.336 1.00 32.86 B N ATOM 3501 CA ALA B 961 12.347 38.945 26.869 1.00 31.54 B C ATOM 3502 CB ALA B 961 13.542 39.737 26.370 1.00 32.46 B C ATOM 3503 C ALA B 961 11.282 38.857 25.776 1.00 30.73 B C ATOM 3504 O ALA B 961 11.186 39.740 24.928 1.00 30.46 B O ATOM 3505 N HIS B 962 10.474 37.801 25.802 1.00 29.79 B N ATOM 3506 CA HIS B 962 9.433 37.627 24.791 1.00 28.25 B C ATOM 3507 CB HIS B 962 10.070 37.195 23.468 1.00 27.95 B C ATOM 3508 CG HIS B 962 9.109 37.137 22.322 1.00 28.31 B C ATOM 3509 CD2 HIS B 962 7.810 36.764 22.263 1.00 28.79 B C ATOM 3510 ND1 HIS B 962 9.461 37.504 21.041 1.00 31.00 B N ATOM 3511 CE1 HIS B 962 8.418 37.365 20.243 1.00 29.74 B C ATOM 3512 NE2 HIS B 962 7.404 36.918 20.959 1.00 30.22 B N ATOM 3513 C HIS B 962 8.354 36.623 25.191 1.00 28.20 B C ATOM 3514 O HIS B 962 8.611 35.419 25.293 1.00 28.83 B O ATOM 3515 N VAL B 963 7.139 37.123 25.393 1.00 25.95 B N ATOM 3516 CA VAL B 963 6.013 36.279 25.768 1.00 24.74 B C ATOM 3517 CB VAL B 963 5.334 36.815 27.055 1.00 23.78 B C ATOM 3518 CG1 VAL B 963 6.308 36.684 28.219 1.00 21.06 B C ATOM 3519 CG2 VAL B 963 4.897 38.280 26.876 1.00 17.99 B C ATOM 3520 C VAL B 963 4.980 36.159 24.644 1.00 25.21 B C ATOM 3521 O VAL B 963 4.918 37.004 23.754 1.00 26.73 B O ATOM 3522 N LYS B 964 4.176 35.102 24.683 1.00 24.96 B N ATOM 3523 CA LYS B 964 3.155 34.877 23.655 1.00 25.16 B C ATOM 3524 CB LYS B 964 3.553 33.727 22.729 1.00 25.01 B C ATOM 3525 CG LYS B 964 4.701 34.011 21.783 1.00 24.77 B C ATOM 3526 CD LYS B 964 5.061 32.737 21.023 1.00 26.76 B C ATOM 3527 CE LYS B 964 6.084 32.982 19.931 1.00 28.31 B C ATOM 3528 NZ LYS B 964 6.299 31.771 19.085 1.00 28.80 B N ATOM 3529 C LYS B 964 1.794 34.547 24.243 1.00 25.01 B C ATOM 3530 O LYS B 964 1.702 33.913 25.296 1.00 25.35 B O ATOM 3531 N ILE B 965 0.743 34.982 23.549 1.00 24.07 B N ATOM 3532 CA ILE B 965 −0.629 34.721 23.971 1.00 23.22 B C ATOM 3533 CB ILE B 965 −1.615 35.726 23.326 1.00 24.06 B C ATOM 3534 CG2 ILE B 965 −3.035 35.382 23.708 1.00 22.79 B C ATOM 3535 CG1 ILE B 965 −1.303 37.145 23.800 1.00 24.57 B C ATOM 3536 CD1 ILE B 965 −2.055 38.217 23.050 1.00 24.62 B C ATOM 3537 C ILE B 965 −1.010 33.305 23.539 1.00 23.90 B C ATOM 3538 O ILE B 965 −0.729 32.883 22.406 1.00 23.98 B O ATOM 3539 N ALA B 966 −1.653 32.577 24.445 1.00 23.77 B N ATOM 3540 CA ALA B 966 −2.062 31.199 24.181 1.00 22.79 B C ATOM 3541 CB ALA B 966 −1.185 30.222 24.992 1.00 20.10 B C ATOM 3542 C ALA B 966 −3.529 30.935 24.494 1.00 21.11 B C ATOM 3543 O ALA B 966 −4.151 31.653 25.272 1.00 19.04 B O ATOM 3544 N ASP B 967 −4.065 29.887 23.875 1.00 20.78 B N ATOM 3545 CA ASP B 967 −5.440 29.482 24.089 1.00 22.00 B C ATOM 3546 CB ASP B 967 −5.625 29.127 25.555 1.00 24.96 B C ATOM 3547 CG ASP B 967 −5.199 27.729 25.851 1.00 28.88 B C ATOM 3548 OD1 ASP B 967 −4.008 27.409 25.637 1.00 35.17 B O ATOM 3549 OD2 ASP B 967 −6.058 26.943 26.279 1.00 30.71 B O ATOM 3550 C ASP B 967 −6.489 30.498 23.677 1.00 21.34 B C ATOM 3551 O ASP B 967 −7.487 30.687 24.374 1.00 19.28 B O ATOM 3552 N PHE B 968 −6.256 31.147 22.546 1.00 21.34 B N ATOM 3553 CA PHE B 968 −7.172 32.154 22.042 1.00 23.12 B C ATOM 3554 CB PHE B 968 −6.373 33.312 21.440 1.00 19.95 B C ATOM 3555 CG PHE B 968 −5.428 32.897 20.346 1.00 20.95 B C ATOM 3556 CD1 PHE B 968 −5.844 32.850 19.021 1.00 19.89 B C ATOM 3557 CD2 PHE B 968 −4.107 32.586 20.637 1.00 20.34 B C ATOM 3558 CE1 PHE B 968 −4.955 32.507 18.000 1.00 19.70 B C ATOM 3559 CE2 PHE B 968 −3.210 32.240 19.623 1.00 20.58 B C ATOM 3560 CZ PHE B 968 −3.633 32.202 18.304 1.00 20.85 B C ATOM 3561 C PHE B 968 −8.156 31.609 21.005 1.00 24.50 B C ATOM 3562 O PHE B 968 −7.913 30.571 20.384 1.00 24.19 B O ATOM 3563 N GLY B 969 −9.273 32.316 20.855 1.00 25.76 B N ATOM 3564 CA GLY B 969 −10.296 31.964 19.888 1.00 28.10 B C ATOM 3565 C GLY B 969 −10.837 30.551 19.900 1.00 28.39 B C ATOM 3566 O GLY B 969 −10.864 29.902 18.863 1.00 29.91 B O ATOM 3567 N LEU B 970 −11.287 30.083 21.060 1.00 29.33 B N ATOM 3568 CA LEU B 970 −11.832 28.733 21.198 1.00 27.90 B C ATOM 3569 CB LEU B 970 −11.023 27.938 22.221 1.00 25.43 B C ATOM 3570 CG LEU B 970 −10.135 26.800 21.722 1.00 27.12 B C ATOM 3571 CD1 LEU B 970 −9.196 27.267 20.639 1.00 25.92 B C ATOM 3572 CD2 LEU B 970 −9.351 26.256 22.897 1.00 30.60 B C ATOM 3573 C LEU B 970 −13.285 28.765 21.631 1.00 27.45 B C ATOM 3574 O LEU B 970 −13.894 27.714 21.823 1.00 28.00 B O ATOM 3575 N ALA B 971 −13.830 29.974 21.774 1.00 27.93 B N ATOM 3576 CA ALA B 971 −15.222 30.189 22.193 1.00 29.28 B C ATOM 3577 CB ALA B 971 −15.618 31.631 21.926 1.00 28.90 B C ATOM 3578 C ALA B 971 −16.220 29.252 21.519 1.00 30.92 B C ATOM 3579 O ALA B 971 −17.003 28.584 22.193 1.00 33.05 B O ATOM 3580 N LYS B 972 −16.189 29.209 20.188 1.00 30.45 B N ATOM 3581 CA LYS B 972 −17.083 28.348 19.419 1.00 30.30 B C ATOM 3582 CB LYS B 972 −16.811 28.512 17.915 1.00 32.31 B C ATOM 3583 CG LYS B 972 −17.115 29.900 17.374 1.00 33.11 B C ATOM 3584 CD LYS B 972 −18.541 30.263 17.675 1.00 35.45 B C ATOM 3585 CE LYS B 972 −18.803 31.733 17.461 1.00 38.07 B C ATOM 3586 NZ LYS B 972 −20.202 32.046 17.893 1.00 40.65 B N ATOM 3587 C LYS B 972 −16.968 26.868 19.795 1.00 29.76 B C ATOM 3588 O LYS B 972 −17.890 26.094 19.553 1.00 29.15 B O ATOM 3589 N LEU B 973 −15.837 26.473 20.375 1.00 29.72 B N ATOM 3590 CA LEU B 973 −15.630 25.078 20.766 1.00 29.44 B C ATOM 3591 CB LEU B 973 −14.195 24.643 20.436 1.00 28.00 B C ATOM 3592 CG LEU B 973 −13.825 24.196 19.010 1.00 28.81 B C ATOM 3593 CD1 LEU B 973 −14.845 24.746 18.014 1.00 30.28 B C ATOM 3594 CD2 LEU B 973 −12.403 24.649 18.659 1.00 24.48 B C ATOM 3595 C LEU B 973 −15.900 24.803 22.246 1.00 31.37 B C ATOM 3596 O LEU B 973 −15.989 23.647 22.649 1.00 30.12 B O ATOM 3597 N LEU B 974 −16.027 25.854 23.057 1.00 32.64 B N ATOM 3598 CA LEU B 974 −16.243 25.666 24.487 1.00 34.63 B C ATOM 3599 CB LEU B 974 −15.721 26.865 25.283 1.00 33.19 B C ATOM 3600 CG LEU B 974 −14.238 27.196 25.105 1.00 30.52 B C ATOM 3601 CD1 LEU B 974 −13.887 28.402 25.940 1.00 30.49 B C ATOM 3602 CD2 LEU B 974 −13.392 25.993 25.471 1.00 28.88 B C ATOM 3603 C LEU B 974 −17.681 25.399 24.870 1.00 38.43 B C ATOM 3604 O LEU B 974 −18.615 26.000 24.340 1.00 38.84 B O ATOM 3605 N PRO B 975 −17.873 24.500 25.836 1.00 42.06 B N ATOM 3606 CD PRO B 975 −16.847 23.998 26.771 1.00 40.92 B C ATOM 3607 CA PRO B 975 −19.211 24.148 26.295 1.00 42.75 B C ATOM 3608 CB PRO B 975 −18.925 23.212 27.466 1.00 43.15 B C ATOM 3609 CG PRO B 975 −17.649 23.768 28.024 1.00 41.14 B C ATOM 3610 C PRO B 975 −20.055 25.354 26.694 1.00 44.41 B C ATOM 3611 O PRO B 975 −19.644 26.179 27.501 1.00 45.61 B O ATOM 3612 N LEU B 976 −21.238 25.453 26.103 1.00 46.22 B N ATOM 3613 CA LEU B 976 −22.163 26.529 26.412 1.00 47.83 B C ATOM 3614 CB LEU B 976 −23.509 26.249 25.723 1.00 48.67 B C ATOM 3615 CG LEU B 976 −23.555 26.755 24.275 1.00 49.00 B C ATOM 3616 CD1 LEU B 976 −23.755 28.270 24.297 1.00 48.21 B C ATOM 3617 CD2 LEU B 976 −22.231 26.379 23.542 1.00 48.02 B C ATOM 3618 C LEU B 976 −22.340 26.661 27.929 1.00 48.28 B C ATOM 3619 O LEU B 976 −21.939 27.668 28.520 1.00 48.72 B O ATOM 3620 N ASP B 977 −22.925 25.646 28.560 1.00 48.12 B N ATOM 3621 CA ASP B 977 −23.113 25.678 30.007 1.00 48.62 B C ATOM 3622 CB ASP B 977 −24.536 25.268 30.380 1.00 50.40 B C ATOM 3623 CG ASP B 977 −24.668 24.898 31.863 1.00 53.25 B C ATOM 3624 OD1 ASP B 977 −25.490 25.542 32.578 1.00 53.02 B O ATOM 3625 OD2 ASP B 977 −23.943 23.959 32.302 1.00 53.55 B O ATOM 3626 C ASP B 977 −22.145 24.730 30.704 1.00 48.29 B C ATOM 3627 O ASP B 977 −22.227 23.513 30.525 1.00 48.69 B O ATOM 3628 N LYS B 978 −21.232 25.273 31.502 1.00 47.40 B N ATOM 3629 CA LYS B 978 −20.272 24.430 32.223 1.00 47.27 B C ATOM 3630 CB LYS B 978 −18.848 24.663 31.710 1.00 46.05 B C ATOM 3631 CG LYS B 978 −18.223 25.970 32.220 1.00 44.25 B C ATOM 3632 CD LYS B 978 −16.986 25.663 33.059 1.00 42.04 B C ATOM 3633 CE LYS B 978 −15.979 24.889 32.225 1.00 40.46 B C ATOM 3634 NZ LYS B 978 −14.751 24.538 32.986 1.00 39.42 B N ATOM 3635 C LYS B 978 −20.297 24.745 33.717 1.00 46.58 B C ATOM 3636 O LYS B 978 −20.163 25.903 34.116 1.00 46.31 B O ATOM 3637 N ASP B 979 −20.458 23.716 34.539 1.00 47.40 B N ATOM 3638 CA ASP B 979 −20.485 23.904 35.984 1.00 47.45 B C ATOM 3639 CB ASP B 979 −20.788 22.577 36.677 1.00 49.65 B C ATOM 3640 CG ASP B 979 −21.116 22.747 38.138 1.00 50.70 B C ATOM 3641 OD1 ASP B 979 −21.512 21.737 38.765 1.00 51.90 B O ATOM 3642 OD2 ASP B 979 −20.977 23.883 38.651 1.00 50.64 B O ATOM 3643 C ASP B 979 −19.140 24.437 36.453 1.00 46.35 B C ATOM 3644 O ASP B 979 −18.150 23.702 36.515 1.00 44.91 B O ATOM 3645 N TYR B 980 −19.115 25.724 36.781 1.00 45.52 B N ATOM 3646 CA TYR B 980 −17.897 26.383 37.230 1.00 45.44 B C ATOM 3647 CB TYR B 980 −18.069 27.899 37.131 1.00 43.35 B C ATOM 3648 CG TYR B 980 −17.833 28.436 35.739 1.00 41.95 B C ATOM 3649 CD1 TYR B 980 −16.548 28.502 35.207 1.00 39.92 B C ATOM 3650 CE1 TYR B 980 −16.326 28.968 33.918 1.00 37.64 B C ATOM 3651 CD2 TYR B 980 −18.893 28.851 34.944 1.00 39.33 B C ATOM 3652 CE2 TYR B 980 −18.683 29.317 33.654 1.00 37.16 B C ATOM 3653 CZ TYR B 980 −17.401 29.374 33.144 1.00 36.17 B C ATOM 3654 OH TYR B 980 −17.205 29.827 31.859 1.00 32.46 B O ATOM 3655 C TYR B 980 −17.431 26.006 38.635 1.00 46.34 B C ATOM 3656 O TYR B 980 −16.342 26.403 39.061 1.00 47.06 B O ATOM 3657 N TYR B 981 −18.235 25.229 39.351 1.00 46.87 B N ATOM 3658 CA TYR B 981 −17.856 24.830 40.696 1.00 48.41 B C ATOM 3659 CB TYR B 981 −19.096 24.676 41.570 1.00 50.55 B C ATOM 3660 CG TYR B 981 −19.918 25.940 41.626 1.00 54.49 B C ATOM 3661 CD1 TYR B 981 −20.882 26.207 40.655 1.00 56.05 B C ATOM 3662 CE1 TYR B 981 −21.594 27.398 40.656 1.00 57.69 B C ATOM 3663 CD2 TYR B 981 −19.689 26.902 42.610 1.00 55.62 B C ATOM 3664 CE2 TYR B 981 −20.397 28.101 42.620 1.00 57.77 B C ATOM 3665 CZ TYR B 981 −21.347 28.340 41.638 1.00 58.18 B C ATOM 3666 OH TYR B 981 −22.043 29.525 41.629 1.00 59.14 B O ATOM 3667 C TYR B 981 −17.037 23.551 40.688 1.00 47.81 B C ATOM 3668 O TYR B 981 −16.376 23.211 41.674 1.00 47.25 B O ATOM 3669 N VAL B 982 −17.076 22.850 39.563 1.00 47.13 B N ATOM 3670 CA VAL B 982 −16.317 21.621 39.411 1.00 46.15 B C ATOM 3671 CB VAL B 982 −17.082 20.599 38.547 1.00 45.79 B C ATOM 3672 CG1 VAL B 982 −16.290 19.319 38.426 1.00 44.97 B C ATOM 3673 CG2 VAL B 982 −18.435 20.316 39.161 1.00 45.38 B C ATOM 3674 C VAL B 982 −14.993 21.971 38.735 1.00 46.37 B C ATOM 3675 O VAL B 982 −14.864 21.867 37.515 1.00 46.84 B O ATOM 3676 N VAL B 983 −14.021 22.401 39.537 1.00 46.67 B N ATOM 3677 CA VAL B 983 −12.703 22.774 39.031 1.00 47.04 B C ATOM 3678 CB VAL B 983 −12.512 24.313 39.075 1.00 47.43 B C ATOM 3679 CG1 VAL B 983 −12.785 24.836 40.482 1.00 45.36 B C ATOM 3680 CG2 VAL B 983 −11.109 24.681 38.614 1.00 44.47 B C ATOM 3681 C VAL B 983 −11.594 22.095 39.837 1.00 47.73 B C ATOM 3682 O VAL B 983 −11.692 21.968 41.054 1.00 48.13 B O ATOM 3683 N ARG B 984 −10.545 21.652 39.148 1.00 48.65 B N ATOM 3684 CA ARG B 984 −9.426 20.974 39.795 1.00 49.00 B C ATOM 3685 CB ARG B 984 −8.537 20.288 38.746 1.00 51.15 B C ATOM 3686 CG ARG B 984 −8.174 18.838 39.065 1.00 54.57 B C ATOM 3687 CD ARG B 984 −7.740 18.701 40.513 1.00 59.55 B C ATOM 3688 NE ARG B 984 −7.279 17.355 40.849 1.00 62.55 B N ATOM 3689 CZ ARG B 984 −6.104 16.851 40.487 1.00 64.30 B C ATOM 3690 NH1 ARG B 984 −5.780 15.614 40.843 1.00 65.05 B N ATOM 3691 NH2 ARG B 984 −5.252 17.582 39.776 1.00 63.24 B N ATOM 3692 C ARG B 984 −8.594 21.966 40.598 1.00 48.48 B C ATOM 3693 O ARG B 984 −7.965 21.602 41.593 1.00 49.43 B O ATOM 3694 N GLU B 985 −8.581 23.219 40.161 1.00 46.65 B N ATOM 3695 CA GLU B 985 −7.828 24.248 40.861 1.00 43.97 B C ATOM 3696 CB GLU B 985 −6.458 24.443 40.208 1.00 45.70 B C ATOM 3697 CG GLU B 985 −5.408 25.041 41.147 1.00 51.85 B C ATOM 3698 CD GLU B 985 −4.850 24.038 42.161 1.00 53.27 B C ATOM 3699 OE1 GLU B 985 −4.300 24.479 43.195 1.00 54.45 B O ATOM 3700 OE2 GLU B 985 −4.944 22.814 41.921 1.00 55.23 B O ATOM 3701 C GLU B 985 −8.625 25.542 40.811 1.00 41.24 B C ATOM 3702 O GLU B 985 −8.401 26.387 39.947 1.00 40.60 B O ATOM 3703 N PRO B 986 −9.564 25.712 41.756 1.00 38.73 B N ATOM 3704 CD PRO B 986 −9.658 24.841 42.939 1.00 37.63 B C ATOM 3705 CA PRO B 986 −10.456 26.869 41.903 1.00 37.13 B C ATOM 3706 CB PRO B 986 −11.165 26.589 43.231 1.00 35.86 B C ATOM 3707 CG PRO B 986 −10.161 25.801 43.991 1.00 36.53 B C ATOM 3708 C PRO B 986 −9.799 28.258 41.853 1.00 36.29 B C ATOM 3709 O PRO B 986 −10.418 29.220 41.405 1.00 36.29 B O ATOM 3710 N GLY B 987 −8.557 28.372 42.310 1.00 34.80 B N ATOM 3711 CA GLY B 987 −7.900 29.665 42.266 1.00 32.48 B C ATOM 3712 C GLY B 987 −7.729 30.195 40.848 1.00 30.71 B C ATOM 3713 O GLY B 987 −7.573 31.397 40.654 1.00 28.46 B O ATOM 3714 N GLN B 988 −7.750 29.298 39.862 1.00 28.88 B N ATOM 3715 CA GLN B 988 −7.593 29.674 38.461 1.00 27.63 B C ATOM 3716 CB GLN B 988 −6.546 28.788 37.791 1.00 28.47 B C ATOM 3717 CG GLN B 988 −5.165 28.913 38.413 1.00 29.70 B C ATOM 3718 CD GLN B 988 −4.569 30.293 38.220 1.00 29.60 B C ATOM 3719 OE1 GLN B 988 −4.197 30.621 37.078 1.00 25.73 B O ATOM 3720 NE2 GLN B 988 −4.484 31.049 39.212 1.00 31.49 B O ATOM 3721 C GLN B 988 −8.904 29.588 37.688 1.00 28.49 B C ATOM 3722 O GLN B 988 −8.904 29.479 36.460 1.00 26.59 B O ATOM 3723 N SER B 989 −10.017 29.625 38.421 1.00 29.21 B N ATOM 3724 CA SER B 989 −11.344 29.581 37.824 1.00 29.21 B C ATOM 3725 CB SER B 989 −12.427 29.566 38.896 1.00 28.70 B C ATOM 3726 OG SER B 989 −13.694 29.771 38.300 1.00 29.29 B O ATOM 3727 C SER B 989 −11.505 30.833 36.982 1.00 29.58 B C ATOM 3728 O SER B 989 −11.334 31.945 37.474 1.00 30.64 B O ATOM 3729 N PRO B 990 −11.860 30.666 35.703 1.00 29.48 B N ATOM 3730 CD PRO B 990 −12.224 29.381 35.078 1.00 29.21 B C ATOM 3731 CA PRO B 990 −12.044 31.775 34.762 1.00 29.66 B C ATOM 3732 CB PRO B 990 −12.692 31.095 33.555 1.00 30.57 B C ATOM 3733 CG PRO B 990 −12.097 29.698 33.609 1.00 30.85 B C ATOM 3734 C PRO B 990 −12.865 32.951 35.278 1.00 27.44 B C ATOM 3735 O PRO B 990 −12.640 34.081 34.856 1.00 28.69 B O ATOM 3736 N ILE B 991 −13.807 32.689 36.180 1.00 25.37 B N ATOM 3737 CA ILE B 991 −14.656 33.751 36.717 1.00 24.21 B C ATOM 3738 CB ILE B 991 −15.636 33.216 37.789 1.00 22.18 B C ATOM 3739 CG2 ILE B 991 −16.408 32.041 37.252 1.00 21.00 B C ATOM 3740 CG1 ILE B 991 −14.872 32.797 39.037 1.00 22.49 B C ATOM 3741 CD1 ILE B 991 −15.770 32.280 40.129 1.00 20.47 B C ATOM 3742 C ILE B 991 −13.915 34.956 37.318 1.00 22.89 B C ATOM 3743 O ILE B 991 −14.380 36.084 37.184 1.00 22.11 B O ATOM 3744 N PHE B 992 −12.771 34.738 37.961 1.00 20.98 B N ATOM 3745 CA PHE B 992 −12.052 35.867 38.555 1.00 21.73 B C ATOM 3746 CB PHE B 992 −10.972 35.365 39.528 1.00 19.62 B C ATOM 3747 CG PHE B 992 −11.520 34.512 40.634 1.00 18.15 B C ATOM 3748 CD1 PHE B 992 −12.614 34.947 41.378 1.00 17.59 B C ATOM 3749 CD2 PHE B 992 −10.968 33.272 40.912 1.00 16.48 B C ATOM 3750 CE1 PHE B 992 −13.154 34.162 42.379 1.00 17.22 B C ATOM 3751 CE2 PHE B 992 −11.495 32.476 41.909 1.00 18.83 B C ATOM 3752 CZ PHE B 992 −12.596 32.921 42.650 1.00 18.84 B C ATOM 3753 C PHE B 992 −11.439 36.841 37.544 1.00 21.99 B C ATOM 3754 O PHE B 992 −10.912 37.884 37.933 1.00 21.24 B O ATOM 3755 N TRP B 993 −11.520 36.494 36.257 1.00 21.93 B N ATOM 3756 CA TRP B 993 −11.004 37.325 35.159 1.00 23.05 B C ATOM 3757 CB TRP B 993 −10.049 36.515 34.275 1.00 19.09 B C ATOM 3758 CG TRP B 993 −8.689 36.325 34.848 1.00 20.94 B C ATOM 3759 CD2 TRP B 993 −8.296 35.374 35.852 1.00 20.70 B C ATOM 3760 CE2 TRP B 993 −6.932 35.608 36.129 1.00 20.32 B C ATOM 3761 CE3 TRP B 993 −8.965 34.348 36.541 1.00 20.74 B C ATOM 3762 CD1 TRP B 993 −7.579 37.065 34.568 1.00 21.22 B C ATOM 3763 NE1 TRP B 993 −6.523 36.644 35.336 1.00 22.28 B N ATOM 3764 CZ2 TRP B 993 −6.222 34.857 37.073 1.00 18.70 B C ATOM 3765 CZ3 TRP B 993 −8.257 33.602 37.479 1.00 16.48 B C ATOM 3766 CH2 TRP B 993 −6.897 33.864 37.734 1.00 17.27 B C ATOM 3767 C TRP B 993 −12.153 37.841 34.288 1.00 24.85 B C ATOM 3768 O TRP B 993 −11.966 38.714 33.436 1.00 26.79 B O ATOM 3769 N TYR B 994 −13.347 37.307 34.506 1.00 25.07 B N ATOM 3770 CA TYR B 994 −14.492 37.685 33.689 1.00 25.56 B C ATOM 3771 CB TYR B 994 −15.661 36.721 33.929 1.00 26.05 B C ATOM 3772 CG TYR B 994 −15.487 35.343 33.314 1.00 26.17 B C ATOM 3773 CD1 TYR B 994 −14.323 35.005 32.624 1.00 25.80 B C ATOM 3774 CE1 TYR B 994 −14.189 33.761 32.008 1.00 26.46 B C ATOM 3775 CD2 TYR B 994 −16.510 34.397 33.376 1.00 26.01 B C ATOM 3776 CE2 TYR B 994 −16.384 33.153 32.763 1.00 25.93 B C ATOM 3777 CZ TYR B 994 −15.223 32.840 32.079 1.00 26.41 B C ATOM 3778 OH TYR B 994 −15.090 31.616 31.458 1.00 27.87 B O ATOM 3779 C TYR B 994 −14.981 39.095 33.902 1.00 25.85 B C ATOM 3780 O TYR B 994 −15.005 39.587 35.020 1.00 27.26 B O ATOM 3781 N ALA B 995 −15.369 39.752 32.816 1.00 26.65 B N ATOM 3782 CA ALA B 995 −15.911 41.094 32.925 1.00 25.40 B C ATOM 3783 CB ALA B 995 −15.883 41.789 31.578 1.00 23.16 B C ATOM 3784 C ALA B 995 −17.352 40.907 33.389 1.00 25.46 B C ATOM 3785 O ALA B 995 −17.916 39.813 33.284 1.00 23.51 B O ATOM 3786 N PRO B 996 −17.963 41.970 33.917 1.00 25.58 B N ATOM 3787 CD PRO B 996 −17.400 43.304 34.173 1.00 25.53 B C ATOM 3788 CA PRO B 996 −19.344 41.893 34.389 1.00 27.00 B C ATOM 3789 CB PRO B 996 −19.683 43.349 34.682 1.00 24.54 B C ATOM 3790 CG PRO B 996 −18.395 43.888 35.131 1.00 24.67 B C ATOM 3791 C PRO B 996 −20.303 41.263 33.374 1.00 28.59 B C ATOM 3792 O PRO B 996 −20.943 40.252 33.674 1.00 28.72 B O ATOM 3793 N GLU B 997 −20.391 41.850 32.179 1.00 29.28 B N ATOM 3794 CA GLU B 997 −21.301 41.342 31.153 1.00 30.88 B C ATOM 3795 CB GLU B 997 −21.101 42.057 29.798 1.00 31.68 B C ATOM 3796 CG GLU B 997 −19.734 41.900 29.169 1.00 30.63 B C ATOM 3797 CD GLU B 997 −18.779 42.982 29.608 1.00 32.64 B C ATOM 3798 OE1 GLU B 997 −18.945 43.483 30.745 1.00 31.73 B O ATOM 3799 OE2 GLU B 997 −17.864 43.322 28.822 1.00 31.67 B O ATOM 3800 C GLU B 997 −21.134 39.847 30.963 1.00 31.40 B C ATOM 3801 O GLU B 997 −22.082 39.151 30.611 1.00 31.19 B O ATOM 3802 N SER B 998 −19.926 39.348 31.202 1.00 31.66 B N ATOM 3803 CA SER B 998 −19.676 37.923 31.053 1.00 30.81 B C ATOM 3804 CB SER B 998 −18.178 37.633 31.053 1.00 29.42 B C ATOM 3805 OG SER B 998 −17.611 37.933 29.793 1.00 30.14 B O ATOM 3806 C SER B 998 −20.343 37.131 32.159 1.00 30.19 B C ATOM 3807 O SER B 998 −20.926 36.081 31.911 1.00 32.24 B O ATOM 3808 N LEU B 999 −20.261 37.631 33.381 1.00 31.65 B N ATOM 3809 CA LEU B 999 −20.854 36.931 34.508 1.00 33.55 B C ATOM 3810 CB LEU B 999 −20.399 37.560 35.828 1.00 30.58 B C ATOM 3811 CG LEU B 999 −18.949 37.373 36.287 1.00 30.41 B C ATOM 3812 CD1 LEU B 999 −18.792 37.992 37.667 1.00 29.34 B C ATOM 3813 CD2 LEU B 999 −18.595 35.904 36.351 1.00 28.97 B C ATOM 3814 C LEU B 999 −22.378 36.909 34.458 1.00 35.12 B C ATOM 3815 O LEU B 999 −22.999 35.902 34.788 1.00 35.62 B O ATOM 3816 N SER B 1000 −22.982 38.014 34.039 1.00 36.04 B N ATOM 3817 CA SER B 1000 −24.433 38.094 33.986 1.00 37.54 B C ATOM 3818 CB SER B 1000 −24.889 39.515 34.319 1.00 38.20 B C ATOM 3819 OG SER B 1000 −24.368 40.453 33.391 1.00 39.11 B O ATOM 3820 C SER B 1000 −25.076 37.677 32.671 1.00 38.49 B C ATOM 3821 O SER B 1000 −26.296 37.563 32.603 1.00 38.27 B O ATOM 3822 N ASP B 1001 −24.279 37.445 31.633 1.00 38.91 B N ATOM 3823 CA ASP B 1001 −24.847 37.075 30.339 1.00 41.24 B C ATOM 3824 CB ASP B 1001 −25.201 38.350 29.573 1.00 42.19 B C ATOM 3825 CG ASP B 1001 −26.330 39.118 30.220 1.00 44.29 B C ATOM 3826 OD1 ASP B 1001 −27.446 38.561 30.286 1.00 43.63 B O ATOM 3827 OD2 ASP B 1001 −26.103 40.271 30.660 1.00 45.40 B O ATOM 3828 C ASP B 1001 −24.001 36.167 29.434 1.00 41.18 B C ATOM 3829 O ASP B 1001 −24.409 35.859 28.313 1.00 39.87 B O ATOM 3830 N ASN B 1002 −22.839 35.735 29.914 1.00 40.49 B N ATOM 3831 CA ASN B 1002 −21.952 34.892 29.118 1.00 41.92 B C ATOM 3832 CB ASN B 1002 −22.680 33.636 28.625 1.00 43.88 B C ATOM 3833 CG ASN B 1002 −23.039 32.696 29.748 1.00 47.49 B C ATOM 3834 OD1 ASN B 1002 −22.165 32.216 30.465 1.00 50.58 B O ATOM 3835 ND2 ASN B 1002 −24.331 32.425 29.911 1.00 48.38 B N ATOM 3836 C ASN B 1002 −21.415 35.668 27.916 1.00 42.17 B C ATOM 3837 O ASN B 1002 −20.720 35.109 27.072 1.00 42.74 B O ATOM 3838 N ILE B 1003 −21.737 36.958 27.850 1.00 40.60 B N ATOM 3839 CA ILE B 1003 −21.293 37.822 26.760 1.00 37.90 B C ATOM 3840 CB ILE B 1003 −21.949 39.218 26.855 1.00 38.42 B C ATOM 3841 CG2 ILE B 1003 −21.375 40.150 25.821 1.00 35.41 B C ATOM 3842 CG1 ILE B 1003 −23.456 39.099 26.667 1.00 38.11 B C ATOM 3843 CD1 ILE B 1003 −24.163 40.422 26.794 1.00 36.73 B C ATOM 3844 C ILE B 1003 −19.781 38.007 26.777 1.00 37.25 B C ATOM 3845 O ILE B 1003 −19.209 38.409 27.791 1.00 38.16 B O ATOM 3846 N PHE B 1004 −19.143 37.710 25.649 1.00 34.80 B N ATOM 3847 CA PHE B 1004 −17.701 37.846 25.505 1.00 33.02 B C ATOM 3848 CB PHE B 1004 −17.053 36.468 25.379 1.00 31.30 B C ATOM 3849 CG PHE B 1004 −17.010 35.695 26.672 1.00 33.33 B C ATOM 3850 CD1 PHE B 1004 −16.122 36.053 27.681 1.00 31.07 B C ATOM 3851 CD2 PHE B 1004 −17.871 34.619 26.889 1.00 33.88 B C ATOM 3852 CE1 PHE B 1004 −16.088 35.360 28.882 1.00 31.19 B C ATOM 3853 CE2 PHE B 1004 −17.848 33.913 28.094 1.00 33.73 B C ATOM 3854 CZ PHE B 1004 −16.953 34.284 29.094 1.00 31.84 B C ATOM 3855 C PHE B 1004 −17.416 38.672 24.261 1.00 33.61 B C ATOM 3856 O PHE B 1004 −18.005 38.426 23.214 1.00 36.40 B O ATOM 3857 N SER B 1005 −16.521 39.651 24.373 1.00 32.85 B N ATOM 3858 CA SER B 1005 −16.181 40.507 23.243 1.00 31.81 B C ATOM 3859 CB SER B 1005 −17.128 41.697 23.178 1.00 32.82 B C ATOM 3860 OG SER B 1005 −16.862 42.582 24.254 1.00 35.29 B O ATOM 3861 C SER B 1005 −14.764 41.038 23.368 1.00 31.55 B C ATOM 3862 O SER B 1005 −14.071 40.758 24.346 1.00 30.74 B O ATOM 3863 N ARG B 1006 −14.342 41.811 22.371 1.00 30.35 B N ATOM 3864 CA ARG B 1006 −13.010 42.399 22.375 1.00 31.73 B C ATOM 3865 CB ARG B 1006 −12.791 43.233 21.103 1.00 32.08 B C ATOM 3866 CG ARG B 1006 −12.340 42.401 19.909 1.00 35.73 B C ATOM 3867 CD ARG B 1006 −12.529 43.117 18.571 1.00 38.23 B C ATOM 3868 NE ARG B 1006 −11.797 44.376 18.500 1.00 42.85 B N ATOM 3869 CZ ARG B 1006 −11.646 45.100 17.393 1.00 43.99 B C ATOM 3870 NH1 ARG B 1006 −10.968 46.238 17.433 1.00 42.77 B N ATOM 3871 NH2 ARG B 1006 −12.159 44.681 16.244 1.00 45.31 B N ATOM 3872 C ARG B 1006 −12.836 43.273 23.612 1.00 31.29 B C ATOM 3873 O ARG B 1006 −11.750 43.352 24.191 1.00 30.22 B O ATOM 3874 N GLN B 1007 −13.924 43.910 24.029 1.00 30.47 B N ATOM 3875 CA GLN B 1007 −13.881 44.788 25.184 1.00 28.48 B C ATOM 3876 CB GLN B 1007 −15.064 45.757 25.139 1.00 29.31 B C ATOM 3877 CG GLN B 1007 −14.935 46.827 24.039 1.00 30.12 B C ATOM 3878 CD GLN B 1007 −13.647 47.677 24.155 1.00 31.23 B C ATOM 3879 OE1 GLN B 1007 −12.602 47.362 23.559 1.00 24.82 B O ATOM 3880 NE2 GLN B 1007 −13.729 48.756 24.936 1.00 29.95 B N ATOM 3881 C GLN B 1007 −13.838 44.033 26.509 1.00 26.99 B C ATOM 3882 O GLN B 1007 −13.243 44.505 27.478 1.00 25.04 B O ATOM 3883 N SER B 1008 −14.468 42.865 26.559 1.00 25.68 B N ATOM 3884 CA SER B 1008 −14.434 42.057 27.772 1.00 26.10 B C ATOM 3885 CB SER B 1008 −15.421 40.891 27.665 1.00 27.87 B C ATOM 3886 OG SER B 1008 −15.080 40.026 26.598 1.00 31.41 B O ATOM 3887 C SER B 1008 −12.995 41.538 27.944 1.00 26.67 B C ATOM 3888 O SER B 1008 −12.501 41.384 29.065 1.00 26.79 B O ATOM 3889 N ASP B 1009 −12.324 41.265 26.825 1.00 25.33 B N ATOM 3890 CA ASP B 1009 −10.943 40.806 26.872 1.00 25.36 B C ATOM 3891 CB ASP B 1009 −10.409 40.469 25.468 1.00 26.35 B C ATOM 3892 CG ASP B 1009 −10.917 39.121 24.942 1.00 29.84 B C ATOM 3893 OD1 ASP B 1009 −10.675 38.823 23.742 1.00 30.40 B O ATOM 3894 OD2 ASP B 1009 −11.543 38.365 25.723 1.00 28.13 B O ATOM 3895 C ASP B 1009 −10.105 41.926 27.472 1.00 24.93 B C ATOM 3896 O ASP B 1009 −9.102 41.680 28.143 1.00 24.99 B O ATOM 3897 N VAL B 1010 −10.524 43.162 27.228 1.00 22.69 B N ATOM 3898 CA VAL B 1010 −9.797 44.307 27.751 1.00 23.10 B C ATOM 3899 CB VAL B 1010 −10.400 45.641 27.246 1.00 21.13 B C ATOM 3900 CG1 VAL B 1010 −9.916 46.783 28.110 1.00 21.03 B C ATOM 3901 CG2 VAL B 1010 −9.992 45.886 25.803 1.00 18.23 B C ATOM 3902 C VAL B 1010 −9.823 44.278 29.277 1.00 23.05 B C ATOM 3903 O VAL B 1010 −8.823 44.568 29.927 1.00 22.50 B O ATOM 3904 N TRP B 1011 −10.977 43.924 29.833 1.00 23.37 B N ATOM 3905 CA TRP B 1011 −11.156 43.834 31.274 1.00 22.16 B C ATOM 3906 CB TRP B 1011 −12.605 43.436 31.582 1.00 21.39 B C ATOM 3907 CG TRP B 1011 −12.856 43.017 33.021 1.00 22.17 B C ATOM 3908 CD2 TRP B 1011 −13.633 43.722 33.994 1.00 21.79 B C ATOM 3909 CE2 TRP B 1011 −13.611 42.956 35.187 1.00 22.59 B C ATOM 3910 CE3 TRP B 1011 −14.346 44.924 33.977 1.00 20.63 B C ATOM 3911 CD1 TRP B 1011 −12.400 41.885 33.647 1.00 21.99 B C ATOM 3912 NE1 TRP B 1011 −12.851 41.840 34.946 1.00 20.90 B N ATOM 3913 CZ2 TRP B 1011 −14.276 43.353 36.350 1.00 22.92 B C ATOM 3914 CZ3 TRP B 1011 −15.006 45.318 35.130 1.00 22.87 B C ATOM 3915 CH2 TRP B 1011 −14.966 44.532 36.302 1.00 24.34 B C ATOM 3916 C TRP B 1011 −10.199 42.783 31.832 1.00 22.62 B C ATOM 3917 O TRP B 1011 −9.496 43.006 32.818 1.00 22.51 B O ATOM 3918 N SER B 1012 −10.184 41.628 31.185 1.00 23.22 B N ATOM 3919 CA SER B 1012 −9.329 40.540 31.614 1.00 21.86 B C ATOM 3920 CB SER B 1012 −9.583 39.315 30.745 1.00 23.31 B C ATOM 3921 OG SER B 1012 −10.969 39.024 30.712 1.00 26.28 B O ATOM 3922 C SER B 1012 −7.869 40.952 31.547 1.00 20.42 B C ATOM 3923 O SER B 1012 −7.054 40.446 32.312 1.00 19.32 B O ATOM 3924 N PHE B 1013 −7.544 41.864 30.630 1.00 19.51 B N ATOM 3925 CA PHE B 1013 −6.178 42.369 30.480 1.00 20.32 B C ATOM 3926 CB PHE B 1013 −6.060 43.253 29.241 1.00 22.41 B C ATOM 3927 CG PHE B 1013 −4.738 43.954 29.127 1.00 24.71 B C ATOM 3928 CD1 PHE B 1013 −3.566 43.233 28.933 1.00 25.77 B C ATOM 3929 CD2 PHE B 1013 −4.660 45.335 29.215 1.00 24.66 B C ATOM 3930 CE1 PHE B 1013 −2.340 43.881 28.825 1.00 25.47 B C ATOM 3931 CE2 PHE B 1013 −3.441 45.992 29.109 1.00 24.49 B C ATOM 3932 CZ PHE B 1013 −2.278 45.263 28.912 1.00 24.92 B C ATOM 3933 C PHE B 1013 −5.823 43.189 31.722 1.00 20.57 B C ATOM 3934 O PHE B 1013 −4.671 43.203 32.178 1.00 18.68 B O ATOM 3935 N GLY B 1014 −6.829 43.868 32.261 1.00 18.88 B N ATOM 3936 CA GLY B 1014 −6.621 44.653 33.460 1.00 23.16 B C ATOM 3937 C GLY B 1014 −6.124 43.788 34.616 1.00 25.05 B C ATOM 3938 O GLY B 1014 −5.211 44.166 35.357 1.00 24.37 B O ATOM 3939 N VAL B 1015 −6.729 42.614 34.762 1.00 26.14 B N ATOM 3940 CA VAL B 1015 −6.365 41.681 35.819 1.00 25.90 B C ATOM 3941 CB VAL B 1015 −7.414 40.524 35.941 1.00 25.19 B C ATOM 3942 CG1 VAL B 1015 −7.097 39.649 37.130 1.00 26.98 B C ATOM 3943 CG2 VAL B 1015 −8.811 41.089 36.094 1.00 24.45 B C ATOM 3944 C VAL B 1015 −4.990 41.096 35.514 1.00 26.88 B C ATOM 3945 O VAL B 1015 −4.188 40.881 36.419 1.00 29.42 B O ATOM 3946 N VAL B 1016 −4.707 40.835 34.242 1.00 26.06 B N ATOM 3947 CA VAL B 1016 −3.401 40.296 33.874 1.00 25.47 B C ATOM 3948 CB VAL B 1016 −3.295 40.064 32.363 1.00 26.29 B C ATOM 3949 CG1 VAL B 1016 −1.829 40.017 31.953 1.00 24.37 B C ATOM 3950 CG2 VAL B 1016 −4.007 38.774 31.988 1.00 25.27 B C ATOM 3951 C VAL B 1016 −2.301 41.270 34.290 1.00 24.52 B C ATOM 3952 O VAL B 1016 −1.230 40.859 34.711 1.00 24.76 B O ATOM 3953 N LEU B 1017 −2.565 42.565 34.148 1.00 24.65 B N ATOM 3954 CA LEU B 1017 −1.594 43.582 34.543 1.00 24.58 B C ATOM 3955 CB LEU B 1017 −2.113 44.983 34.216 1.00 23.12 B C ATOM 3956 CG LEU B 1017 −2.027 45.460 32.761 1.00 24.37 B C ATOM 3957 CD1 LEU B 1017 −2.982 46.629 32.545 1.00 23.70 B C ATOM 3958 CD2 LEU B 1017 −0.601 45.846 32.420 1.00 21.72 B C ATOM 3959 C LEU B 1017 −1.373 43.457 36.042 1.00 25.27 B C ATOM 3960 O LEU B 1017 −0.257 43.645 36.540 1.00 24.20 B O ATOM 3961 N TYR B 1018 −2.452 43.132 36.752 1.00 25.30 B N ATOM 3962 CA TYR B 1018 −2.402 42.960 38.195 1.00 26.88 B C ATOM 3963 CB TYR B 1018 −3.794 42.657 38.729 1.00 26.68 B C ATOM 3964 CG TYR B 1018 −3.862 42.524 40.231 1.00 30.83 B C ATOM 3965 CD1 TYR B 1018 −3.656 43.624 41.057 1.00 32.09 B C ATOM 3966 CE1 TYR B 1018 −3.736 43.509 42.430 1.00 30.76 B C ATOM 3967 CD2 TYR B 1018 −4.147 41.301 40.826 1.00 31.00 B C ATOM 3968 CE2 TYR B 1018 −4.228 41.178 42.198 1.00 31.86 B C ATOM 3969 CZ TYR B 1018 −4.022 42.284 42.990 1.00 31.82 B C ATOM 3970 OH TYR B 1018 −4.101 42.159 44.350 1.00 33.07 B O ATOM 3971 C TYR B 1018 −1.449 41.816 38.549 1.00 28.71 B C ATOM 3972 O TYR B 1018 −0.540 41.979 39.372 1.00 29.73 B O ATOM 3973 N GLU B 1019 −1.652 40.669 37.902 1.00 29.08 B N ATOM 3974 CA GLU B 1019 −0.838 39.475 38.138 1.00 28.73 B C ATOM 3975 CB GLU B 1019 −1.273 38.322 37.212 1.00 28.24 B C ATOM 3976 CG GLU B 1019 −2.737 37.877 37.359 1.00 28.46 B C ATOM 3977 CD GLU B 1019 −3.029 36.554 36.653 1.00 29.77 B C ATOM 3978 OE1 GLU B 1019 −2.463 35.518 37.057 1.00 33.63 B O ATOM 3979 OE2 GLU B 1019 −3.824 36.538 35.691 1.00 30.03 B O ATOM 3980 C GLU B 1019 0.654 39.737 37.950 1.00 28.13 B C ATOM 3981 O GLU B 1019 1.475 39.295 38.759 1.00 27.79 B O ATOM 3982 N LEU B 1020 1.002 40.452 36.885 1.00 27.07 B N ATOM 3983 CA LEU B 1020 2.400 40.762 36.598 1.00 28.46 B C ATOM 3984 CB LEU B 1020 2.518 41.508 35.256 1.00 28.04 B C ATOM 3985 CG LEU B 1020 2.371 40.718 33.948 1.00 31.18 B C ATOM 3986 CD1 LEU B 1020 3.729 40.598 33.271 1.00 30.88 B C ATOM 3987 CD2 LEU B 1020 1.763 39.333 34.221 1.00 30.43 B C ATOM 3988 C LEU B 1020 3.054 41.592 37.709 1.00 27.19 B C ATOM 3989 O LEU B 1020 4.108 41.229 38.225 1.00 27.55 B O ATOM 3990 N PHE B 1021 2.428 42.704 38.070 1.00 27.54 B N ATOM 3991 CA PHE B 1021 2.962 43.573 39.108 1.00 30.47 B C ATOM 3992 CB PHE B 1021 2.370 44.977 38.954 1.00 29.66 B C ATOM 3993 CG PHE B 1021 2.887 45.705 37.750 1.00 32.67 B C ATOM 3994 CD1 PHE B 1021 4.129 46.331 37.781 1.00 32.20 B C ATOM 3995 CD2 PHE B 1021 2.190 45.673 36.556 1.00 32.11 B C ATOM 3996 CE1 PHE B 1021 4.667 46.902 36.648 1.00 32.96 B C ATOM 3997 CE2 PHE B 1021 2.726 46.243 35.416 1.00 34.86 B C ATOM 3998 CZ PHE B 1021 3.970 46.858 35.464 1.00 34.05 B C ATOM 3999 C PHE B 1021 2.687 43.005 40.498 1.00 31.35 B C ATOM 4000 O PHE B 1021 2.954 43.640 41.513 1.00 33.73 B O ATOM 4001 N THR B 1022 2.157 41.793 40.531 1.00 29.56 B N ATOM 4002 CA THR B 1022 1.855 41.122 41.782 1.00 27.88 B C ATOM 4003 CB THR B 1022 0.337 40.771 41.815 1.00 27.78 B C ATOM 4004 OG1 THR B 1022 −0.276 41.380 42.959 1.00 29.16 B O ATOM 4005 CG2 THR B 1022 0.105 39.265 41.830 1.00 27.02 B C ATOM 4006 C THR B 1022 2.725 39.857 41.774 1.00 27.55 B C ATOM 4007 O THR B 1022 2.716 39.060 42.711 1.00 25.85 B O ATOM 4008 N TYR B 1023 3.482 39.708 40.686 1.00 28.38 B N ATOM 4009 CA TYR B 1023 4.349 38.554 40.446 1.00 27.73 B C ATOM 4010 CB TYR B 1023 5.563 38.595 41.375 1.00 28.82 B C ATOM 4011 CG TYR B 1023 6.554 39.677 41.004 1.00 29.97 B C ATOM 4012 CD1 TYR B 1023 6.475 40.948 41.562 1.00 30.60 B C ATOM 4013 CE1 TYR B 1023 7.373 41.941 41.213 1.00 28.91 B C ATOM 4014 CD2 TYR B 1023 7.558 39.432 40.083 1.00 29.49 B C ATOM 4015 CE2 TYR B 1023 8.455 40.419 39.732 1.00 29.77 B C ATOM 4016 CZ TYR B 1023 8.356 41.667 40.301 1.00 29.39 B C ATOM 4017 OH TYR B 1023 9.258 42.637 39.961 1.00 29.99 B O ATOM 4018 C TYR B 1023 3.600 37.222 40.610 1.00 26.68 B C ATOM 4019 O TYR B 1023 4.210 36.154 40.690 1.00 23.68 B O ATOM 4020 N CYS B 1024 2.275 37.305 40.633 1.00 25.16 B N ATOM 4021 CA CYS B 1024 1.411 36.141 40.801 1.00 30.36 B C ATOM 4022 CB CYS B 1024 1.695 35.062 39.745 1.00 29.66 B C ATOM 4023 SG CYS B 1024 0.991 35.464 38.132 1.00 31.45 B S ATOM 4024 C CYS B 1024 1.539 35.542 42.180 1.00 31.11 B C ATOM 4025 O CYS B 1024 1.458 34.326 42.353 1.00 33.32 B O ATOM 4026 N ASP B 1025 1.736 36.394 43.172 1.00 30.88 B N ATOM 4027 CA ASP B 1025 1.843 35.888 44.523 1.00 32.73 B C ATOM 4028 CB ASP B 1025 2.062 37.031 45.501 1.00 35.93 B C ATOM 4029 CG ASP B 1025 2.440 36.541 46.869 1.00 39.06 B C ATOM 4030 OD1 ASP B 1025 3.542 35.963 46.993 1.00 41.51 B O ATOM 4031 OD2 ASP B 1025 1.637 36.723 47.809 1.00 41.43 B O ATOM 4032 C ASP B 1025 0.539 35.165 44.859 1.00 31.75 B C ATOM 4033 O ASP B 1025 −0.536 35.619 44.482 1.00 28.94 B O ATOM 4034 N LYS B 1026 0.637 34.046 45.567 1.00 33.64 B N ATOM 4035 CA LYS B 1026 −0.545 33.267 45.934 1.00 34.91 B C ATOM 4036 CB LYS B 1026 −0.140 31.856 46.378 1.00 37.07 B C ATOM 4037 CG LYS B 1026 0.308 30.944 45.244 1.00 39.64 B C ATOM 4038 CD LYS B 1026 −0.822 30.721 44.235 1.00 43.37 B C ATOM 4039 CE LYS B 1026 −0.378 29.791 43.097 1.00 45.58 B C ATOM 4040 NZ LYS B 1026 −1.366 29.696 41.972 1.00 46.97 B N ATOM 4041 C LYS B 1026 −1.358 33.928 47.035 1.00 34.73 B C ATOM 4042 O LYS B 1026 −2.544 33.653 47.184 1.00 34.89 B O ATOM 4043 N SER B 1027 −0.712 34.803 47.798 1.00 35.10 B N ATOM 4044 CA SER B 1027 −1.366 35.507 48.891 1.00 34.69 B C ATOM 4045 CB SER B 1027 −0.314 36.141 49.788 1.00 35.42 B C ATOM 4046 OG SER B 1027 0.677 35.191 50.131 1.00 39.15 B O ATOM 4047 C SER B 1027 −2.329 36.586 48.410 1.00 34.71 B C ATOM 4048 O SER B 1027 −3.418 36.741 48.960 1.00 35.34 B O ATOM 4049 N CYS B 1028 −1.935 37.335 47.386 1.00 34.72 B N ATOM 4050 CA CYS B 1028 −2.795 38.405 46.879 1.00 34.48 B C ATOM 4051 CB CYS B 1028 −2.073 39.741 47.008 1.00 34.38 B C ATOM 4052 SG CYS B 1028 −0.504 39.739 46.191 1.00 37.79 B S ATOM 4053 C CYS B 1028 −3.262 38.220 45.434 1.00 31.11 B C ATOM 4054 O CYS B 1028 −3.480 39.187 44.713 1.00 31.03 B O ATOM 4055 N SER B 1029 −3.417 36.974 45.020 1.00 30.32 B N ATOM 4056 CA SER B 1029 −3.867 36.665 43.670 1.00 29.14 B C ATOM 4057 CB SER B 1029 −3.800 35.163 43.449 1.00 29.51 B C ATOM 4058 OG SER B 1029 −4.812 34.543 44.225 1.00 32.23 B O ATOM 4059 C SER B 1029 −5.317 37.115 43.517 1.00 26.52 B C ATOM 4060 O SER B 1029 −5.968 37.498 44.489 1.00 27.24 B O ATOM 4061 N PRO B 1030 −5.839 37.062 42.287 1.00 24.08 B N ATOM 4062 CD PRO B 1030 −5.086 36.857 41.039 1.00 22.45 B C ATOM 4063 CA PRO B 1030 −7.210 37.457 41.987 1.00 23.13 B C ATOM 4064 CB PRO B 1030 −7.299 37.196 40.496 1.00 22.81 B C ATOM 4065 CG PRO B 1030 −5.934 37.581 40.043 1.00 20.71 B C ATOM 4066 C PRO B 1030 −8.262 36.702 42.796 1.00 24.05 B C ATOM 4067 O PRO B 1030 −9.180 37.309 43.374 1.00 23.62 B O ATOM 4068 N SER B 1031 −8.136 35.380 42.834 1.00 24.60 B N ATOM 4069 CA SER B 1031 −9.066 34.567 43.600 1.00 25.29 B C ATOM 4070 CB SER B 1031 −8.741 33.081 43.411 1.00 24.41 B C ATOM 4071 OG SER B 1031 −7.367 32.829 43.619 1.00 29.84 B O ATOM 4072 C SER B 1031 −9.035 34.936 45.098 1.00 26.53 B C ATOM 4073 O SER B 1031 −10.082 35.168 45.707 1.00 26.40 B O ATOM 4074 N ALA B 1032 −7.836 35.000 45.680 1.00 27.33 B N ATOM 4075 CA ALA B 1032 −7.675 35.332 47.094 1.00 27.47 B C ATOM 4076 CB ALA B 1032 −6.189 35.394 47.447 1.00 28.40 B C ATOM 4077 C ALA B 1032 −8.364 36.646 47.479 1.00 28.39 B C ATOM 4078 O ALA B 1032 −9.314 36.645 48.266 1.00 27.17 B O ATOM 4079 N GLU B 1033 −7.887 37.760 46.925 1.00 28.39 B N ATOM 4080 CA GLU B 1033 −8.474 39.073 47.208 1.00 28.46 B C ATOM 4081 CB GLU B 1033 −7.907 40.142 46.270 1.00 30.40 B C ATOM 4082 CG GLU B 1033 −6.432 40.445 46.464 1.00 34.55 B C ATOM 4083 CD GLU B 1033 −6.063 40.634 47.920 1.00 36.21 B C ATOM 4084 OE1 GLU B 1033 −6.955 40.978 48.723 1.00 35.21 B O ATOM 4085 OE2 GLU B 1033 −4.874 40.448 48.257 1.00 37.70 B O ATOM 4086 C GLU B 1033 −9.984 39.074 47.068 1.00 27.91 B C ATOM 4087 O GLU B 1033 −10.691 39.580 47.931 1.00 28.02 B O ATOM 4088 N PHE B 1034 −10.480 38.523 45.965 1.00 28.93 B N ATOM 4089 CA PHE B 1034 −11.917 38.466 45.728 1.00 27.01 B C ATOM 4090 CB PHE B 1034 −12.195 37.895 44.335 1.00 25.79 B C ATOM 4091 CG PHE B 1034 −12.171 38.935 43.234 1.00 28.49 B C ATOM 4092 CD1 PHE B 1034 −11.569 38.664 42.009 1.00 25.37 B C ATOM 4093 CD2 PHE B 1034 −12.770 40.178 43.423 1.00 26.16 B C ATOM 4094 CE1 PHE B 1034 −11.564 39.612 40.996 1.00 25.58 B C ATOM 4095 CE2 PHE B 1034 −12.764 41.129 42.407 1.00 26.17 B C ATOM 4096 CZ PHE B 1034 −12.160 40.842 41.194 1.00 25.18 B C ATOM 4097 C PHE B 1034 −12.594 37.620 46.785 1.00 26.89 B C ATOM 4098 O PHE B 1034 −13.633 37.991 47.324 1.00 26.48 B O ATOM 4099 N LEU B 1035 −11.986 36.483 47.091 1.00 29.42 B N ATOM 4100 CA LEU B 1035 −12.533 35.568 48.080 1.00 30.90 B C ATOM 4101 CB LEU B 1035 −11.767 34.243 48.025 1.00 30.10 B C ATOM 4102 CG LEU B 1035 −12.523 33.012 47.518 1.00 28.66 B C ATOM 4103 CD1 LEU B 1035 −13.344 33.332 46.304 1.00 27.57 B C ATOM 4104 CD2 LEU B 1035 −11.527 31.926 47.229 1.00 29.37 B C ATOM 4105 C LEU B 1035 −12.517 36.148 49.494 1.00 32.42 B C ATOM 4106 O LEU B 1035 −13.470 35.959 50.251 1.00 33.93 B O ATOM 4107 N ARG B 1036 −11.446 36.852 49.857 1.00 32.89 B N ATOM 4108 CA ARG B 1036 −11.380 37.443 51.189 1.00 34.45 B C ATOM 4109 CB ARG B 1036 −9.941 37.700 51.627 1.00 33.31 B C ATOM 4110 CG ARG B 1036 −9.195 38.666 50.758 1.00 35.78 B C ATOM 4111 CD ARG B 1036 −7.951 39.174 51.461 1.00 36.21 B C ATOM 4112 NE ARG B 1036 −8.294 40.190 52.447 1.00 34.88 B N ATOM 4113 CZ ARG B 1036 −8.240 41.498 52.220 1.00 33.46 B C ATOM 4114 NH1 ARG B 1036 −7.850 41.955 51.040 1.00 33.99 B N ATOM 4115 NH2 ARG B 1036 −8.589 42.352 53.169 1.00 34.43 B N ATOM 4116 C ARG B 1036 −12.163 38.743 51.250 1.00 35.70 B C ATOM 4117 O ARG B 1036 −12.517 39.196 52.333 1.00 37.83 B O ATOM 4118 N MET B 1037 −12.441 39.342 50.094 1.00 37.15 B N ATOM 4119 CA MET B 1037 −13.209 40.583 50.055 1.00 38.00 B C ATOM 4120 CB MET B 1037 −13.090 41.258 48.678 1.00 37.73 B C ATOM 4121 CG MET B 1037 −11.842 42.134 48.519 1.00 40.65 B C ATOM 4122 SD MET B 1037 −11.573 42.840 46.867 1.00 38.90 B S ATOM 4123 CE MET B 1037 −12.983 43.932 46.734 1.00 40.28 B C ATOM 4124 C MET B 1037 −14.680 40.331 50.389 1.00 39.11 B C ATOM 4125 O MET B 1037 −15.257 41.003 51.245 1.00 39.07 B O ATOM 4126 N MET B 1038 −15.292 39.357 49.728 1.00 41.37 B N ATOM 4127 CA MET B 1038 −16.697 39.072 49.991 1.00 43.13 B C ATOM 4128 CB MET B 1038 −17.395 38.660 48.692 1.00 43.22 B C ATOM 4129 CG MET B 1038 −16.556 37.788 47.794 1.00 43.58 B C ATOM 4130 SD MET B 1038 −17.231 37.655 46.142 1.00 41.45 B S ATOM 4131 CE MET B 1038 −18.295 36.342 46.357 1.00 41.55 B C ATOM 4132 C MET B 1038 −16.910 38.037 51.097 1.00 44.01 B C ATOM 4133 O MET B 1038 −18.017 37.543 51.301 1.00 44.45 B O ATOM 4134 N GLY B 1039 −15.834 37.739 51.820 1.00 46.15 B N ATOM 4135 CA GLY B 1039 −15.889 36.795 52.923 1.00 47.55 B C ATOM 4136 C GLY B 1039 −16.353 35.393 52.593 1.00 49.20 B C ATOM 4137 O GLY B 1039 −17.181 34.831 53.309 1.00 50.66 B O ATOM 4138 N CYS B 1040 −15.810 34.814 51.526 1.00 48.90 B N ATOM 4139 CA CYS B 1040 −16.198 33.471 51.119 1.00 47.27 B C ATOM 4140 CB CYS B 1040 −16.251 33.391 49.597 1.00 46.11 B C ATOM 4141 SG CYS B 1040 −16.885 31.828 48.977 1.00 45.49 B S ATOM 4142 C CYS B 1040 −15.242 32.411 51.655 1.00 47.59 B C ATOM 4143 O CYS B 1040 −14.040 32.468 51.405 1.00 46.95 B O ATOM 4144 N GLU B 1041 −15.780 31.445 52.395 1.00 48.51 B N ATOM 4145 CA GLU B 1041 −14.968 30.369 52.951 1.00 49.20 B C ATOM 4146 CB GLU B 1041 −15.517 29.926 54.317 1.00 48.69 B C ATOM 4147 CG GLU B 1041 −17.032 29.972 54.468 1.00 48.21 B C ATOM 4148 CD GLU B 1041 −17.513 29.317 55.764 1.00 48.81 B C ATOM 4149 OE1 GLU B 1041 −18.715 29.444 56.080 1.00 47.24 B O ATOM 4150 OE2 GLU B 1041 −16.691 28.670 56.461 1.00 48.13 B O ATOM 4151 C GLU B 1041 −14.894 29.186 51.986 1.00 49.69 B C ATOM 4152 O GLU B 1041 −14.219 28.186 52.243 1.00 49.89 B O ATOM 4153 N ARG B 1042 −15.598 29.315 50.868 1.00 50.29 B N ATOM 4154 CA ARG B 1042 −15.597 28.293 49.830 1.00 50.96 B C ATOM 4155 CB ARG B 1042 −16.953 28.251 49.123 1.00 52.40 B C ATOM 4156 CG ARG B 1042 −18.076 27.691 49.965 1.00 54.46 B C ATOM 4157 CD ARG B 1042 −19.371 27.654 49.179 1.00 56.84 B C ATOM 4158 NE ARG B 1042 −20.129 26.438 49.455 1.00 59.33 B N ATOM 4159 CZ ARG B 1042 −19.777 25.222 49.041 1.00 60.78 B C ATOM 4160 NH1 ARG B 1042 −18.675 25.047 48.321 1.00 60.88 B N ATOM 4161 NH2 ARG B 1042 −20.529 24.177 49.355 1.00 61.43 B N ATOM 4162 C ARG B 1042 −14.506 28.647 48.818 1.00 50.04 B C ATOM 4163 O ARG B 1042 −14.296 29.822 48.511 1.00 49.09 B O ATOM 4164 N ASP B 1043 −13.808 27.633 48.313 1.00 49.24 B N ATOM 4165 CA ASP B 1043 −12.747 27.846 47.336 1.00 46.56 B C ATOM 4166 CB ASP B 1043 −12.223 26.510 46.820 1.00 49.16 B C ATOM 4167 CG ASP B 1043 −11.444 25.747 47.864 1.00 52.26 B C ATOM 4168 OD1 ASP B 1043 −10.478 26.327 48.401 1.00 52.24 B O ATOM 4169 OD2 ASP B 1043 −11.793 24.571 48.135 1.00 53.66 B O ATOM 4170 C ASP B 1043 −13.247 28.673 46.160 1.00 43.96 B C ATOM 4171 O ASP B 1043 −12.509 29.483 45.609 1.00 43.39 B O ATOM 4172 N VAL B 1044 −14.496 28.448 45.768 1.00 42.85 B N ATOM 4173 CA VAL B 1044 −15.104 29.173 44.653 1.00 41.15 B C ATOM 4174 CB VAL B 1044 −15.403 28.255 43.436 1.00 38.53 B C ATOM 4175 CG1 VAL B 1044 −16.208 29.008 42.390 1.00 37.89 B C ATOM 4176 CG2 VAL B 1044 −14.120 27.781 42.821 1.00 38.24 B C ATOM 4177 C VAL B 1044 −16.416 29.743 45.143 1.00 40.47 B C ATOM 4178 O VAL B 1044 −17.240 29.034 45.701 1.00 40.60 B O ATOM 4179 N PRO B 1045 −16.621 31.042 44.938 1.00 40.56 B N ATOM 4180 CD PRO B 1045 −15.641 32.000 44.385 1.00 40.52 B C ATOM 4181 CA PRO B 1045 −17.843 31.719 45.362 1.00 40.24 B C ATOM 4182 CB PRO B 1045 −17.381 33.160 45.519 1.00 41.27 B C ATOM 4183 CG PRO B 1045 −16.426 33.307 44.352 1.00 40.98 B C ATOM 4184 C PRO B 1045 −18.935 31.597 44.318 1.00 39.56 B C ATOM 4185 O PRO B 1045 −18.665 31.260 43.173 1.00 39.45 B O ATOM 4186 N ALA B 1046 −20.170 31.868 44.725 1.00 40.46 B N ATOM 4187 CA ALA B 1046 −21.300 31.839 43.809 1.00 40.51 B C ATOM 4188 CB ALA B 1046 −22.600 32.073 44.568 1.00 40.27 B C ATOM 4189 C ALA B 1046 −21.038 32.989 42.838 1.00 40.45 B C ATOM 4190 O ALA B 1046 −20.504 34.029 43.235 1.00 39.83 B O ATOM 4191 N LEU B 1047 −21.403 32.807 41.574 1.00 39.65 B N ATOM 4192 CA LEU B 1047 −21.169 33.846 40.583 1.00 40.13 B C ATOM 4193 CB LEU B 1047 −21.357 33.289 39.162 1.00 40.46 B C ATOM 4194 CG LEU B 1047 −20.193 32.428 38.639 1.00 41.20 B C ATOM 4195 CD1 LEU B 1047 −20.117 31.114 39.423 1.00 41.20 B C ATOM 4196 CD2 LEU B 1047 −20.380 32.145 37.162 1.00 40.74 B C ATOM 4197 C LEU B 1047 −22.024 35.095 40.781 1.00 39.34 B C ATOM 4198 O LEU B 1047 −21.537 36.212 40.610 1.00 38.91 B O ATOM 4199 N CYS B 1048 −23.287 34.920 41.151 1.00 39.20 B N ATOM 4200 CA CYS B 1048 −24.162 36.068 41.363 1.00 39.30 B C ATOM 4201 CB CYS B 1048 −25.573 35.603 41.723 1.00 39.50 B C ATOM 4202 SG CYS B 1048 −25.664 34.837 43.349 1.00 42.73 B S ATOM 4203 C CYS B 1048 −23.600 36.928 42.495 1.00 39.35 B C ATOM 4204 O CYS B 1048 −23.779 38.145 42.519 1.00 39.73 B O ATOM 4205 N ARG B 1049 −22.916 36.282 43.432 1.00 38.09 B N ATOM 4206 CA ARG B 1049 −22.316 36.974 44.568 1.00 38.17 B C ATOM 4207 CB ARG B 1049 −21.897 35.931 45.600 1.00 40.51 B C ATOM 4208 CG ARG B 1049 −21.512 36.458 46.959 1.00 44.21 B C ATOM 4209 CD ARG B 1049 −21.091 35.286 47.845 1.00 48.40 B C ATOM 4210 NE ARG B 1049 −20.499 35.709 49.111 1.00 51.54 B N ATOM 4211 CZ ARG B 1049 −19.797 34.906 49.903 1.00 52.10 B C ATOM 4212 NH1 ARG B 1049 −19.293 35.360 51.039 1.00 52.46 B N ATOM 4213 NH2 ARG B 1049 −19.592 33.644 49.551 1.00 53.64 B N ATOM 4214 C ARG B 1049 −21.098 37.790 44.092 1.00 36.74 B C ATOM 4215 O ARG B 1049 −20.865 38.922 44.526 1.00 34.35 B O ATOM 4216 N LEU B 1050 −20.335 37.198 43.183 1.00 34.32 B N ATOM 4217 CA LEU B 1050 −19.152 37.840 42.630 1.00 33.57 B C ATOM 4218 CB LEU B 1050 −18.341 36.816 41.815 1.00 30.44 B C ATOM 4219 CG LEU B 1050 −17.161 37.394 41.031 1.00 29.65 B C ATOM 4220 CD1 LEU B 1050 −16.365 38.366 41.921 1.00 26.93 B C ATOM 4221 CD2 LEU B 1050 −16.306 36.283 40.494 1.00 22.80 B C ATOM 4222 C LEU B 1050 −19.563 39.028 41.753 1.00 33.51 B C ATOM 4223 O LEU B 1050 −18.971 40.105 41.835 1.00 32.04 B O ATOM 4224 N LEU B 1051 −20.581 38.817 40.920 1.00 34.24 B N ATOM 4225 CA LEU B 1051 −21.113 39.857 40.041 1.00 34.48 B C ATOM 4226 CB LEU B 1051 −22.277 39.287 39.216 1.00 34.57 B C ATOM 4227 CG LEU B 1051 −23.108 40.276 38.394 1.00 33.44 B C ATOM 4228 CD1 LEU B 1051 −22.273 40.836 37.250 1.00 31.21 B C ATOM 4229 CD2 LEU B 1051 −24.341 39.583 37.871 1.00 30.70 B C ATOM 4230 C LEU B 1051 −21.604 41.043 40.887 1.00 35.06 B C ATOM 4231 O LEU B 1051 −21.340 42.199 40.571 1.00 35.49 B O ATOM 4232 N GLU B 1052 −22.329 40.746 41.957 1.00 35.65 B N ATOM 4233 CA GLU B 1052 −22.837 41.781 42.848 1.00 37.17 B C ATOM 4234 CB GLU B 1052 −23.554 41.124 44.025 1.00 39.94 B C ATOM 4235 CG GLU B 1052 −24.094 42.072 45.076 1.00 42.75 B C ATOM 4236 CD GLU B 1052 −24.868 41.331 46.152 1.00 46.05 B C ATOM 4237 OE1 GLU B 1052 −24.237 40.571 46.921 1.00 49.05 B O ATOM 4238 OE2 GLU B 1052 −26.106 41.495 46.225 1.00 46.95 B O ATOM 4239 C GLU B 1052 −21.701 42.667 43.369 1.00 37.09 B C ATOM 4240 O GLU B 1052 −21.793 43.892 43.353 1.00 35.90 B O ATOM 4241 N LEU B 1053 −20.633 42.028 43.839 1.00 37.03 B N ATOM 4242 CA LEU B 1053 −19.476 42.735 44.371 1.00 34.66 B C ATOM 4243 CB LEU B 1053 −18.366 41.736 44.720 1.00 33.52 B C ATOM 4244 CG LEU B 1053 −17.020 42.336 45.133 1.00 33.63 B C ATOM 4245 CD1 LEU B 1053 −17.136 42.940 46.515 1.00 32.45 B C ATOM 4246 CD2 LEU B 1053 −15.945 41.268 45.100 1.00 34.11 B C ATOM 4247 C LEU B 1053 −18.970 43.734 43.340 1.00 34.06 B C ATOM 4248 O LEU B 1053 −18.637 44.868 43.678 1.00 33.84 B O ATOM 4249 N LEU B 1054 −18.913 43.303 42.083 1.00 33.58 B N ATOM 4250 CA LEU B 1054 −18.460 44.166 40.988 1.00 34.37 B C ATOM 4251 CB LEU B 1054 −18.126 43.323 39.747 1.00 33.25 B C ATOM 4252 CG LEU B 1054 −16.869 42.443 39.809 1.00 32.78 B C ATOM 4253 CD1 LEU B 1054 −16.779 41.554 38.584 1.00 32.14 B C ATOM 4254 CD2 LEU B 1054 −15.649 43.321 39.897 1.00 31.57 B C ATOM 4255 C LEU B 1054 −19.522 45.217 40.635 1.00 34.18 B C ATOM 4256 O LEU B 1054 −19.198 46.362 40.311 1.00 32.80 B O ATOM 4257 N GLU B 1055 −20.790 44.826 40.704 1.00 36.25 B N ATOM 4258 CA GLU B 1055 −21.877 45.748 40.396 1.00 38.15 B C ATOM 4259 CB GLU B 1055 −23.212 44.996 40.321 1.00 37.35 B C ATOM 4260 CG GLU B 1055 −23.379 44.222 39.022 1.00 40.80 B C ATOM 4261 CD GLU B 1055 −24.735 43.542 38.884 1.00 41.88 B C ATOM 4262 OE1 GLU B 1055 −25.159 43.295 37.735 1.00 41.74 B O ATOM 4263 OE2 GLU B 1055 −25.372 43.240 39.914 1.00 44.00 B O ATOM 4264 C GLU B 1055 −21.957 46.873 41.421 1.00 38.20 B C ATOM 4265 O GLU B 1055 −22.727 47.816 41.261 1.00 38.44 B O ATOM 4266 N GLU B 1056 −21.155 46.777 42.473 1.00 38.46 B N ATOM 4267 CA GLU B 1056 −21.156 47.811 43.490 1.00 39.89 B C ATOM 4268 CB GLU B 1056 −21.195 47.207 44.890 1.00 42.00 B C ATOM 4269 CG GLU B 1056 −22.401 46.326 45.151 1.00 47.57 B C ATOM 4270 CD GLU B 1056 −22.500 45.872 46.602 1.00 49.21 B C ATOM 4271 OE1 GLU B 1056 −21.445 45.560 47.205 1.00 48.52 B O ATOM 4272 OE2 GLU B 1056 −23.639 45.820 47.127 1.00 50.36 B O ATOM 4273 C GLU B 1056 −19.935 48.701 43.368 1.00 40.12 B C ATOM 4274 O GLU B 1056 −19.733 49.575 44.203 1.00 42.38 B O ATOM 4275 N GLY B 1057 −19.114 48.474 42.347 1.00 38.76 B N ATOM 4276 CA GLY B 1057 −17.934 49.302 42.155 1.00 36.47 B C ATOM 4277 C GLY B 1057 −16.638 48.773 42.739 1.00 36.71 B C ATOM 4278 O GLY B 1057 −15.565 49.343 42.521 1.00 37.03 B O ATOM 4279 N GLN B 1058 −16.728 47.677 43.481 1.00 35.24 B N ATOM 4280 CA GLN B 1058 −15.560 47.069 44.099 1.00 32.79 B C ATOM 4281 CB GLN B 1058 −16.011 45.969 45.057 1.00 32.99 B C ATOM 4282 CG GLN B 1058 −16.917 46.467 46.169 1.00 34.23 B C ATOM 4283 CD GLN B 1058 −16.242 46.452 47.527 1.00 34.06 B C ATOM 4284 OE1 GLN B 1058 −15.024 46.622 47.630 1.00 34.44 B O ATOM 4285 NE2 GLN B 1058 −17.035 46.262 48.581 1.00 31.51 B N ATOM 4286 C GLN B 1058 −14.588 46.487 43.072 1.00 33.29 B C ATOM 4287 O GLN B 1058 −14.984 45.704 42.209 1.00 34.91 B O ATOM 4288 N ARG B 1059 −13.317 46.872 43.174 1.00 32.14 B N ATOM 4289 CA ARG B 1059 −12.267 46.385 42.283 1.00 31.05 B C ATOM 4290 CB ARG B 1059 −11.729 47.519 41.417 1.00 31.00 B C ATOM 4291 CG ARG B 1059 −12.191 47.492 39.963 1.00 33.01 B C ATOM 4292 CD ARG B 1059 −13.652 47.142 39.862 1.00 32.34 B C ATOM 4293 NE ARG B 1059 −14.329 47.791 38.746 1.00 30.92 B N ATOM 4294 CZ ARG B 1059 −15.643 47.738 38.558 1.00 32.32 B C ATOM 4295 NH1 ARG B 1059 −16.399 47.054 39.409 1.00 29.29 B N ATOM 4296 NH2 ARG B 1059 −16.203 48.402 37.554 1.00 32.00 B N ATOM 4297 C ARG B 1059 −11.122 45.814 43.112 1.00 30.78 B C ATOM 4298 O ARG B 1059 −11.116 45.937 44.328 1.00 31.26 B O ATOM 4299 N LEU B 1060 −10.155 45.188 42.449 1.00 31.98 B N ATOM 4300 CA LEU B 1060 −8.999 44.620 43.131 1.00 32.82 B C ATOM 4301 CB LEU B 1060 −8.147 43.810 42.156 1.00 30.99 B C ATOM 4302 CG LEU B 1060 −8.791 42.576 41.510 1.00 33.63 B C ATOM 4303 CD1 LEU B 1060 −7.897 42.047 40.385 1.00 32.89 B C ATOM 4304 CD2 LEU B 1060 −9.035 41.513 42.570 1.00 30.44 B C ATOM 4305 C LEU B 1060 −8.137 45.719 43.731 1.00 35.16 B C ATOM 4306 O LEU B 1060 −8.011 46.808 43.165 1.00 35.31 B O ATOM 4307 N PRO B 1061 −7.526 45.448 44.891 1.00 37.66 B N ATOM 4308 CD PRO B 1061 −7.628 44.209 45.686 1.00 38.68 B C ATOM 4309 CA PRO B 1061 −6.666 46.429 45.557 1.00 38.74 B C ATOM 4310 CB PRO B 1061 −6.472 45.829 46.945 1.00 37.50 B C ATOM 4311 CG PRO B 1061 −6.461 44.351 46.661 1.00 39.71 B C ATOM 4312 C PRO B 1061 −5.355 46.560 44.798 1.00 40.11 B C ATOM 4313 O PRO B 1061 −4.671 45.566 44.570 1.00 42.72 B O ATOM 4314 N ALA B 1062 −5.023 47.787 44.406 1.00 40.89 B N ATOM 4315 CA ALA B 1062 −3.795 48.078 43.669 1.00 41.43 B C ATOM 4316 CB ALA B 1062 −3.455 49.565 43.791 1.00 42.02 B C ATOM 4317 C ALA B 1062 −2.620 47.242 44.162 1.00 40.81 B C ATOM 4318 O ALA B 1062 −2.380 47.136 45.365 1.00 40.36 B O ATOM 4319 N PRO B 1063 −1.874 46.629 43.230 1.00 40.11 B N ATOM 4320 CD PRO B 1063 −2.038 46.655 41.768 1.00 38.16 B C ATOM 4321 CA PRO B 1063 −0.727 45.810 43.619 1.00 40.35 B C ATOM 4322 CB PRO B 1063 −0.190 45.305 42.279 1.00 38.03 B C ATOM 4323 CG PRO B 1063 −0.667 46.318 41.298 1.00 36.80 B C ATOM 4324 C PRO B 1063 0.292 46.630 44.415 1.00 41.69 B C ATOM 4325 O PRO B 1063 0.612 47.763 44.052 1.00 40.07 B O ATOM 4326 N PRO B 1064 0.787 46.064 45.532 1.00 42.80 B N ATOM 4327 CD PRO B 1064 0.311 44.773 46.054 1.00 42.45 B C ATOM 4328 CA PRO B 1064 1.766 46.652 46.455 1.00 43.51 B C ATOM 4329 CB PRO B 1064 2.019 45.522 47.442 1.00 43.04 B C ATOM 4330 CG PRO B 1064 0.685 44.873 47.521 1.00 43.10 B C ATOM 4331 C PRO B 1064 3.051 47.123 45.798 1.00 43.88 B C ATOM 4332 O PRO B 1064 3.897 46.309 45.439 1.00 44.89 B O ATOM 4333 N ALA B 1065 3.182 48.437 45.639 1.00 43.57 B N ATOM 4334 CA ALA B 1065 4.363 49.047 45.033 1.00 44.73 B C ATOM 4335 CB ALA B 1065 5.617 48.244 45.384 1.00 44.54 B C ATOM 4336 C ALA B 1065 4.254 49.204 43.518 1.00 44.87 B C ATOM 4337 O ALA B 1065 5.240 49.491 42.840 1.00 45.51 B O ATOM 4338 N CYS B 1066 3.051 49.017 42.991 1.00 44.57 B N ATOM 4339 CA CYS B 1066 2.813 49.148 41.560 1.00 42.80 B C ATOM 4340 CB CYS B 1066 1.385 48.702 41.220 1.00 41.77 B C ATOM 4341 SG CYS B 1066 0.764 49.168 39.564 1.00 42.74 B S ATOM 4342 C CYS B 1066 2.999 50.582 41.111 1.00 41.34 B C ATOM 4343 O CYS B 1066 2.634 51.516 41.809 1.00 41.68 B O ATOM 4344 N PRO B 1067 3.599 50.774 39.941 1.00 40.50 B N ATOM 4345 CD PRO B 1067 4.318 49.776 39.135 1.00 40.21 B C ATOM 4346 CA PRO B 1067 3.803 52.123 39.423 1.00 40.36 B C ATOM 4347 CB PRO B 1067 4.405 51.863 38.054 1.00 39.69 B C ATOM 4348 CG PRO B 1067 5.223 50.636 38.290 1.00 38.76 B C ATOM 4349 C PRO B 1067 2.434 52.803 39.326 1.00 41.40 B C ATOM 4350 O PRO B 1067 1.429 52.153 39.022 1.00 42.80 B O ATOM 4351 N ALA B 1068 2.402 54.105 39.576 1.00 41.17 B N ATOM 4352 CA ALA B 1068 1.163 54.887 39.535 1.00 41.52 B C ATOM 4353 CB ALA B 1068 1.473 56.353 39.907 1.00 41.43 B C ATOM 4354 C ALA B 1068 0.383 54.829 38.203 1.00 40.64 B C ATOM 4355 O ALA B 1068 −0.825 54.584 38.192 1.00 39.24 B O ATOM 4356 N GLU B 1069 1.065 55.072 37.089 1.00 40.27 B N ATOM 4357 CA GLU B 1069 0.414 55.043 35.784 1.00 41.72 B C ATOM 4358 CB GLU B 1069 1.305 55.718 34.738 1.00 44.54 B C ATOM 4359 CG GLU B 1069 2.792 55.431 34.901 1.00 47.65 B C ATOM 4360 CD GLU B 1069 3.412 56.113 36.114 1.00 47.70 B C ATOM 4361 OE1 GLU B 1069 3.262 57.343 36.252 1.00 47.97 B O ATOM 4362 OE2 GLU B 1069 4.060 55.419 36.925 1.00 48.18 B O ATOM 4363 C GLU B 1069 0.040 53.627 35.332 1.00 41.70 B C ATOM 4364 O GLU B 1069 −0.907 53.441 34.562 1.00 41.28 B O ATOM 4365 N VAL B 1070 0.780 52.631 35.810 1.00 40.03 B N ATOM 4366 CA VAL B 1070 0.485 51.249 35.462 1.00 39.46 B C ATOM 4367 CB VAL B 1070 1.559 50.276 36.014 1.00 41.14 B C ATOM 4368 CG1 VAL B 1070 0.924 48.927 36.330 1.00 41.59 B C ATOM 4369 CG2 VAL B 1070 2.681 50.091 34.987 1.00 40.03 B C ATOM 4370 C VAL B 1070 −0.872 50.875 36.053 1.00 39.70 B C ATOM 4371 O VAL B 1070 −1.700 50.261 35.381 1.00 39.20 B O ATOM 4372 N HIS B 1071 −1.088 51.264 37.312 1.00 40.03 B N ATOM 4373 CA HIS B 1071 −2.331 50.994 38.041 1.00 40.05 B C ATOM 4374 CB HIS B 1071 −2.165 51.344 39.528 1.00 40.50 B C ATOM 4375 CG HIS B 1071 −3.399 51.124 40.349 1.00 41.67 B C ATOM 4376 CD2 HIS B 1071 −4.059 51.943 41.203 1.00 40.99 B C ATOM 4377 ND1 HIS B 1071 −4.090 49.932 40.358 1.00 42.50 B N ATOM 4378 CE1 HIS B 1071 −5.123 50.025 41.177 1.00 38.81 B C ATOM 4379 NE2 HIS B 1071 −5.125 51.235 41.701 1.00 39.78 B N ATOM 4380 C HIS B 1071 −3.488 51.794 37.462 1.00 40.65 B C ATOM 4381 O HIS B 1071 −4.645 51.403 37.587 1.00 40.56 B O ATOM 4382 N GLU B 1072 −3.178 52.919 36.829 1.00 40.18 B N ATOM 4383 CA GLU B 1072 −4.221 53.743 36.240 1.00 40.50 B C ATOM 4384 CB GLU B 1072 −3.693 55.157 35.975 1.00 44.39 B C ATOM 4385 CG GLU B 1072 −4.766 56.138 35.550 1.00 50.86 B C ATOM 4386 CD GLU B 1072 −4.385 57.579 35.834 1.00 55.90 B C ATOM 4387 OE1 GLU B 1072 −3.348 58.034 35.303 1.00 57.49 B O ATOM 4388 OE2 GLU B 1072 −5.122 58.253 36.593 1.00 58.81 B O ATOM 4389 C GLU B 1072 −4.735 53.102 34.947 1.00 38.98 B C ATOM 4390 O GLU B 1072 −5.900 53.263 34.588 1.00 37.76 B O ATOM 4391 N LEU B 1073 −3.870 52.367 34.249 1.00 37.52 B N ATOM 4392 CA LEU B 1073 −4.287 51.697 33.023 1.00 35.30 B C ATOM 4393 CB LEU B 1073 −3.090 51.114 32.267 1.00 34.93 B C ATOM 4394 CG LEU B 1073 −2.101 52.111 31.674 1.00 34.74 B C ATOM 4395 CD1 LEU B 1073 −1.079 51.384 30.837 1.00 33.55 B C ATOM 4396 CD2 LEU B 1073 −2.857 53.111 30.823 1.00 36.36 B C ATOM 4397 C LEU B 1073 −5.252 50.568 33.359 1.00 34.77 B C ATOM 4398 O LEU B 1073 −6.318 50.467 32.765 1.00 34.13 B O ATOM 4399 N MET B 1074 −4.878 49.719 34.313 1.00 35.06 B N ATOM 4400 CA MET B 1074 −5.742 48.608 34.690 1.00 33.81 B C ATOM 4401 CB MET B 1074 −5.022 47.632 35.632 1.00 32.66 B C ATOM 4402 CG MET B 1074 −4.646 48.183 36.999 1.00 30.09 B C ATOM 4403 SD MET B 1074 −3.884 46.950 38.130 1.00 23.51 B S ATOM 4404 CE MET B 1074 −2.271 46.878 37.495 1.00 21.36 B C ATOM 4405 C MET B 1074 −6.983 49.137 35.361 1.00 33.43 B C ATOM 4406 O MET B 1074 −7.960 48.422 35.516 1.00 35.76 B O ATOM 4407 N LYS B 1075 −6.956 50.401 35.748 1.00 32.86 B N ATOM 4408 CA LYS B 1075 −8.105 50.984 36.412 1.00 34.05 B C ATOM 4409 CB LYS B 1075 −7.717 52.305 37.081 1.00 36.76 B C ATOM 4410 CG LYS B 1075 −8.596 52.684 38.266 1.00 36.63 B C ATOM 4411 CD LYS B 1075 −8.189 51.893 39.498 1.00 36.73 B C ATOM 4412 CE LYS B 1075 −9.300 51.859 40.545 1.00 38.31 B C ATOM 4413 NZ LYS B 1075 −10.509 51.089 40.106 1.00 33.91 B N ATOM 4414 C LYS B 1075 −9.193 51.241 35.380 1.00 32.72 B C ATOM 4415 O LYS B 1075 −10.364 50.956 35.614 1.00 33.59 B O ATOM 4416 N LEU B 1076 −8.784 51.790 34.240 1.00 30.33 B N ATOM 4417 CA LEU B 1076 −9.687 52.113 33.143 1.00 27.87 B C ATOM 4418 CB LEU B 1076 −8.935 52.919 32.080 1.00 27.60 B C ATOM 4419 CG LEU B 1076 −8.395 54.307 32.467 1.00 25.81 B C ATOM 4420 CD1 LEU B 1076 −7.729 54.956 31.266 1.00 23.58 B C ATOM 4421 CD2 LEU B 1076 −9.539 55.179 32.947 1.00 23.87 B C ATOM 4422 C LEU B 1076 −10.263 50.853 32.511 1.00 27.92 B C ATOM 4423 O LEU B 1076 −11.416 50.818 32.067 1.00 27.92 B O ATOM 4424 N CYS B 1077 −9.437 49.818 32.466 1.00 25.91 B N ATOM 4425 CA CYS B 1077 −9.838 48.550 31.899 1.00 23.62 B C ATOM 4426 CB CYS B 1077 −8.695 47.538 32.002 1.00 21.19 B C ATOM 4427 SG CYS B 1077 −7.269 47.783 30.894 1.00 21.49 B S ATOM 4428 C CYS B 1077 −11.065 47.986 32.610 1.00 22.56 B C ATOM 4429 O CYS B 1077 −11.830 47.257 31.997 1.00 23.55 B O ATOM 4430 N TRP B 1078 −11.251 48.323 33.892 1.00 23.18 B N ATOM 4431 CA TRP B 1078 −12.374 47.797 34.684 1.00 21.44 B C ATOM 4432 CB TRP B 1078 −11.905 47.359 36.077 1.00 21.43 B C ATOM 4433 CG TRP B 1078 −10.755 46.398 36.077 1.00 23.00 B C ATOM 4434 CD2 TRP B 1078 −9.714 46.318 37.054 1.00 23.77 B C ATOM 4435 CE2 TRP B 1078 −8.834 45.293 36.647 1.00 24.28 B C ATOM 4436 CE3 TRP B 1078 −9.438 47.017 38.233 1.00 22.51 B C ATOM 4437 CD1 TRP B 1078 −10.478 45.437 35.145 1.00 26.11 B C ATOM 4438 NE1 TRP B 1078 −9.322 44.772 35.478 1.00 25.75 B N ATOM 4439 CZ2 TRP B 1078 −7.697 44.954 37.376 1.00 23.37 B C ATOM 4440 CZ3 TRP B 1078 −8.314 46.679 38.950 1.00 22.43 B C ATOM 4441 CH2 TRP B 1078 −7.455 45.656 38.520 1.00 22.90 B C ATOM 4442 C TRP B 1078 −13.592 48.712 34.831 1.00 20.28 B C ATOM 4443 O TRP B 1078 −14.348 48.621 35.798 1.00 15.97 B O ATOM 4444 N ALA B 1079 −13.772 49.593 33.860 1.00 21.94 B N ATOM 4445 CA ALA B 1079 −14.918 50.480 33.844 1.00 23.82 B C ATOM 4446 CB ALA B 1079 −14.838 51.408 32.645 1.00 21.74 B C ATOM 4447 C ALA B 1079 −16.138 49.569 33.726 1.00 26.53 B C ATOM 4448 O ALA B 1079 −16.111 48.555 33.027 1.00 26.44 B O ATOM 4449 N PRO B 1080 −17.221 49.918 34.417 1.00 28.40 B N ATOM 4450 CD PRO B 1080 −17.374 51.083 35.305 1.00 28.57 B C ATOM 4451 CA PRO B 1080 −18.441 49.113 34.374 1.00 29.60 B C ATOM 4452 CB PRO B 1080 −19.463 49.997 35.088 1.00 27.68 B C ATOM 4453 CG PRO B 1080 −18.624 50.737 36.086 1.00 27.42 B C ATOM 4454 C PRO B 1080 −18.876 48.741 32.954 1.00 30.91 B C ATOM 4455 O PRO B 1080 −18.977 47.556 32.625 1.00 33.35 B O ATOM 4456 N SER B 1081 −19.119 49.745 32.116 1.00 30.36 B N ATOM 4457 CA SER B 1081 −19.568 49.498 30.749 1.00 30.13 B C ATOM 4458 CB SER B 1081 −20.373 50.684 30.214 1.00 32.93 B C ATOM 4459 OG SER B 1081 −19.514 51.762 29.886 1.00 37.08 B O ATOM 4460 C SER B 1081 −18.422 49.223 29.799 1.00 28.16 B C ATOM 4461 O SER B 1081 −17.355 49.822 29.894 1.00 28.59 B O ATOM 4462 N PRO B 1082 −18.643 48.313 28.849 1.00 26.55 B N ATOM 4463 CD PRO B 1082 −19.807 47.418 28.779 1.00 23.40 B C ATOM 4464 CA PRO B 1082 −17.633 47.938 27.861 1.00 26.35 B C ATOM 4465 CB PRO B 1082 −18.315 46.807 27.103 1.00 23.94 B C ATOM 4466 CG PRO B 1082 −19.214 46.207 28.152 1.00 22.82 B C ATOM 4467 C PRO B 1082 −17.209 49.097 26.954 1.00 28.24 B C ATOM 4468 O PRO B 1082 −16.021 49.294 26.681 1.00 27.35 B O ATOM 4469 N GLN B 1083 −18.184 49.866 26.493 1.00 28.90 B N ATOM 4470 CA GLN B 1083 −17.897 50.992 25.629 1.00 32.63 B C ATOM 4471 CB GLN B 1083 −19.208 51.615 25.163 1.00 36.33 B C ATOM 4472 CG GLN B 1083 −20.063 52.140 26.290 1.00 44.10 B C ATOM 4473 CD GLN B 1083 −21.349 52.781 25.796 1.00 47.98 B C ATOM 4474 OE1 GLN B 1083 −22.121 52.160 25.059 1.00 50.30 B O ATOM 4475 NE2 GLN B 1083 −21.592 54.029 26.208 1.00 50.00 B N ATOM 4476 C GLN B 1083 −17.012 52.050 26.318 1.00 33.60 B C ATOM 4477 O GLN B 1083 −16.493 52.961 25.669 1.00 33.23 B O ATOM 4478 N ASP B 1084 −16.821 51.926 27.626 1.00 34.03 B N ATOM 4479 CA ASP B 1084 −15.999 52.895 28.341 1.00 35.82 B C ATOM 4480 CB ASP B 1084 −16.627 53.227 29.704 1.00 38.13 B C ATOM 4481 CG ASP B 1084 −17.865 54.113 29.579 1.00 38.77 B C ATOM 4482 OD1 ASP B 1084 −18.596 54.275 30.580 1.00 40.28 B O ATOM 4483 OD2 ASP B 1084 −18.102 54.655 28.479 1.00 40.01 B O ATOM 4484 C ASP B 1084 −14.549 52.438 28.521 1.00 35.43 B C ATOM 4485 O ASP B 1084 −13.646 53.262 28.708 1.00 34.85 B O ATOM 4486 N ARG B 1085 −14.325 51.129 28.460 1.00 33.57 B N ATOM 4487 CA ARG B 1085 −12.980 50.589 28.603 1.00 31.02 B C ATOM 4488 CB ARG B 1085 −13.025 49.064 28.690 1.00 27.37 B C ATOM 4489 CG ARG B 1085 −13.849 48.558 29.856 1.00 25.02 B C ATOM 4490 CD ARG B 1085 −14.021 47.069 29.809 1.00 22.29 B C ATOM 4491 NE ARG B 1085 −15.125 46.671 30.665 1.00 21.69 B N ATOM 4492 CZ ARG B 1085 −15.985 45.702 30.374 1.00 20.52 B C ATOM 4493 NH1 ARG B 1085 −15.873 45.015 29.246 1.00 17.94 B N ATOM 4494 NH2 ARG B 1085 −16.975 45.438 31.210 1.00 20.52 B N ATOM 4495 C ARG B 1085 −12.194 51.012 27.375 1.00 30.75 B C ATOM 4496 O ARG B 1085 −12.742 51.116 26.289 1.00 32.84 B O ATOM 4497 N PRO B 1086 −10.897 51.280 27.532 1.00 30.76 B N ATOM 4498 CD PRO B 1086 −10.048 51.250 28.734 1.00 29.24 B C ATOM 4499 CA PRO B 1086 −10.132 51.688 26.355 1.00 30.29 B C ATOM 4500 CB PRO B 1086 −8.802 52.147 26.950 1.00 29.66 B C ATOM 4501 CG PRO B 1086 −8.654 51.273 28.137 1.00 29.74 B C ATOM 4502 C PRO B 1086 −9.971 50.509 25.421 1.00 29.51 B C ATOM 4503 O PRO B 1086 −10.398 49.407 25.732 1.00 32.54 B O ATOM 4504 N SER B 1087 −9.364 50.742 24.270 1.00 29.78 B N ATOM 4505 CA SER B 1087 −9.141 49.668 23.325 1.00 29.49 B C ATOM 4506 CB SER B 1087 −9.447 50.139 21.906 1.00 26.96 B C ATOM 4507 OG SER B 1087 −8.416 50.983 21.422 1.00 30.79 B O ATOM 4508 C SER B 1087 −7.664 49.300 23.439 1.00 29.09 B C ATOM 4509 O SER B 1087 −6.864 50.087 23.936 1.00 30.95 B O ATOM 4510 N PHE B 1088 −7.303 48.108 22.987 1.00 28.19 B N ATOM 4511 CA PHE B 1088 −5.919 47.679 23.038 1.00 27.93 B C ATOM 4512 CB PHE B 1088 −5.809 46.252 22.509 1.00 26.98 B C ATOM 4513 CG PHE B 1088 −6.217 45.204 23.510 1.00 26.32 B C ATOM 4514 CD1 PHE B 1088 −5.428 44.957 24.627 1.00 23.88 B C ATOM 4515 CD2 PHE B 1088 −7.384 44.466 23.336 1.00 23.74 B C ATOM 4516 CE1 PHE B 1088 −5.793 43.997 25.545 1.00 23.97 B C ATOM 4517 CE2 PHE B 1088 −7.757 43.500 24.257 1.00 23.15 B C ATOM 4518 CZ PHE B 1088 −6.961 43.264 25.362 1.00 24.05 B C ATOM 4519 C PHE B 1088 −5.037 48.622 22.226 1.00 29.08 B C ATOM 4520 O PHE B 1088 −3.855 48.786 22.517 1.00 30.69 B O ATOM 4521 N SER B 1089 −5.619 49.253 21.213 1.00 29.50 B N ATOM 4522 CA SER B 1089 −4.867 50.177 20.381 1.00 31.30 B C ATOM 4523 CB SER B 1089 −5.679 50.555 19.143 1.00 31.23 B C ATOM 4524 OG SER B 1089 −6.889 51.188 19.509 1.00 34.90 B O ATOM 4525 C SER B 1089 −4.530 51.427 21.190 1.00 32.13 B C ATOM 4526 O SER B 1089 −3.568 52.140 20.880 1.00 30.23 B O ATOM 4527 N ALA B 1090 −5.337 51.678 22.221 1.00 31.60 B N ATOM 4528 CA ALA B 1090 −5.138 52.816 23.107 1.00 33.02 B C ATOM 4529 CB ALA B 1090 −6.446 53.174 23.792 1.00 32.78 B C ATOM 4530 C ALA B 1090 −4.064 52.521 24.157 1.00 33.92 B C ATOM 4531 O ALA B 1090 −3.083 53.262 24.286 1.00 34.82 B O ATOM 4532 N LEU B 1091 −4.241 51.430 24.895 1.00 33.05 B N ATOM 4533 CA LEU B 1091 −3.284 51.053 25.929 1.00 32.35 B C ATOM 4534 CB LEU B 1091 −3.745 49.772 26.618 1.00 30.82 B C ATOM 4535 CG LEU B 1091 −5.128 49.884 27.254 1.00 29.77 B C ATOM 4536 CD1 LEU B 1091 −5.770 48.510 27.366 1.00 27.39 B C ATOM 4537 CD2 LEU B 1091 −4.999 50.558 28.605 1.00 31.11 B C ATOM 4538 C LEU B 1091 −1.879 50.858 25.366 1.00 32.88 B C ATOM 4539 O LEU B 1091 −0.893 51.290 25.974 1.00 32.53 B O ATOM 4540 N GLY B 1092 −1.807 50.208 24.204 1.00 32.64 B N ATOM 4541 CA GLY B 1092 −0.540 49.928 23.538 1.00 32.84 B C ATOM 4542 C GLY B 1092 0.515 51.017 23.583 1.00 32.38 B C ATOM 4543 O GLY B 1092 1.548 50.839 24.215 1.00 30.96 B O ATOM 4544 N PRO B 1093 0.293 52.152 22.904 1.00 34.39 B N ATOM 4545 CD PRO B 1093 −0.890 52.468 22.089 1.00 35.39 B C ATOM 4546 CA PRO B 1093 1.239 53.269 22.881 1.00 36.18 B C ATOM 4547 CB PRO B 1093 0.530 54.305 22.000 1.00 36.68 B C ATOM 4548 CG PRO B 1093 −0.915 53.969 22.159 1.00 35.69 B C ATOM 4549 C PRO B 1093 1.557 53.779 24.284 1.00 35.73 B C ATOM 4550 O PRO B 1093 2.705 54.093 24.583 1.00 34.76 B O ATOM 4551 N GLN B 1094 0.547 53.852 25.146 1.00 37.32 B N ATOM 4552 CA GLN B 1094 0.783 54.301 26.516 1.00 39.11 B C ATOM 4553 CB GLN B 1094 −0.526 54.389 27.309 1.00 39.49 B C ATOM 4554 CG GLN B 1094 −1.545 55.394 26.781 1.00 43.75 B C ATOM 4555 CD GLN B 1094 −2.660 55.693 27.789 1.00 47.08 B C ATOM 4556 OE1 GLN B 1094 −2.397 56.218 28.874 1.00 49.17 B O ATOM 4557 NE2 GLN B 1094 −3.903 55.362 27.434 1.00 46.08 B N ATOM 4558 C GLN B 1094 1.740 53.335 27.222 1.00 39.18 B C ATOM 4559 O GLN B 1094 2.728 53.758 27.817 1.00 40.18 B O ATOM 4560 N LEU B 1095 1.452 52.038 27.154 1.00 39.55 B N ATOM 4561 CA LEU B 1095 2.312 51.045 27.793 1.00 40.38 B C ATOM 4562 CB LEU B 1095 1.740 49.637 27.607 1.00 38.68 B C ATOM 4563 CG LEU B 1095 0.575 49.259 28.533 1.00 39.13 B C ATOM 4564 CD1 LEU B 1095 −0.133 48.024 28.010 1.00 37.02 B C ATOM 4565 CD2 LEU B 1095 1.104 49.031 29.943 1.00 37.97 B C ATOM 4566 C LEU B 1095 3.741 51.087 27.257 1.00 41.75 B C ATOM 4567 O LEU B 1095 4.704 51.027 28.023 1.00 40.09 B O ATOM 4568 N ASP B 1096 3.879 51.192 25.941 1.00 43.20 B N ATOM 4569 CA ASP B 1096 5.199 51.229 25.336 1.00 45.21 B C ATOM 4570 CB ASP B 1096 5.086 51.289 23.814 1.00 47.28 B C ATOM 4571 CG ASP B 1096 6.277 50.658 23.127 1.00 50.41 B C ATOM 4572 OD1 ASP B 1096 7.018 51.376 22.411 1.00 51.05 B O ATOM 4573 OD2 ASP B 1096 6.471 49.434 23.317 1.00 51.68 B O ATOM 4574 C ASP B 1096 5.969 52.432 25.857 1.00 44.84 B C ATOM 4575 O ASP B 1096 7.188 52.389 26.014 1.00 43.07 B O ATOM 4576 N MET B 1097 5.240 53.506 26.132 1.00 46.20 B N ATOM 4577 CA MET B 1097 5.839 54.722 26.655 1.00 47.53 B C ATOM 4578 CB MET B 1097 4.805 55.845 26.679 1.00 50.08 B C ATOM 4579 CG MET B 1097 5.362 57.174 27.161 1.00 53.76 B C ATOM 4580 SD MET B 1097 4.083 58.421 27.455 1.00 59.09 B S ATOM 4581 CE MET B 1097 3.697 58.094 29.210 1.00 56.01 B C ATOM 4582 C MET B 1097 6.378 54.482 28.069 1.00 47.41 B C ATOM 4583 O MET B 1097 7.551 54.746 28.346 1.00 47.55 B O ATOM 4584 N LEU B 1098 5.524 53.979 28.960 1.00 45.95 B N ATOM 4585 CA LEU B 1098 5.934 53.703 30.340 1.00 46.87 B C ATOM 4586 CB LEU B 1098 4.808 53.000 31.109 1.00 45.75 B C ATOM 4587 CG LEU B 1098 3.507 53.792 31.244 1.00 45.44 B C ATOM 4588 CD1 LEU B 1098 2.490 53.006 32.075 1.00 45.54 B C ATOM 4589 CD2 LEU B 1098 3.809 55.143 31.891 1.00 45.95 B C ATOM 4590 C LEU B 1098 7.195 52.841 30.395 1.00 47.11 B C ATOM 4591 O LEU B 1098 8.103 53.096 31.188 1.00 48.02 B O ATOM 4592 N TRP B 1099 7.240 51.821 29.547 1.00 47.69 B N ATOM 4593 CA TRP B 1099 8.380 50.920 29.480 1.00 48.25 B C ATOM 4594 CB TRP B 1099 8.231 49.990 28.279 1.00 47.18 B C ATOM 4595 CG TRP B 1099 9.403 49.114 28.085 1.00 45.90 B C ATOM 4596 CD2 TRP B 1099 10.442 49.287 27.124 1.00 46.24 B C ATOM 4597 CE2 TRP B 1099 11.365 48.244 27.319 1.00 46.53 B C ATOM 4598 CE3 TRP B 1099 10.689 50.229 26.126 1.00 46.72 B C ATOM 4599 CD1 TRP B 1099 9.720 48.004 28.800 1.00 46.60 B C ATOM 4600 NE1 TRP B 1099 10.899 47.469 28.346 1.00 45.86 B N ATOM 4601 CZ2 TRP B 1099 12.508 48.110 26.541 1.00 47.39 B C ATOM 4602 CZ3 TRP B 1099 11.825 50.095 25.356 1.00 46.84 B C ATOM 4603 CH2 TRP B 1099 12.723 49.047 25.570 1.00 47.41 B C ATOM 4604 C TRP B 1099 9.682 51.707 29.361 1.00 49.00 B C ATOM 4605 O TRP B 1099 10.600 51.531 30.160 1.00 48.96 B O ATOM 4606 N SER B 1100 9.757 52.575 28.358 1.00 49.38 B N ATOM 4607 CA SER B 1100 10.943 53.395 28.149 1.00 50.99 B C ATOM 4608 CB SER B 1100 10.966 53.916 26.714 1.00 50.66 B C ATOM 4609 OG SER B 1100 9.892 54.814 26.492 1.00 50.60 B O ATOM 4610 C SER B 1100 10.975 54.579 29.128 1.00 51.72 B C ATOM 4611 O SER B 1100 11.903 54.640 29.961 1.00 52.69 B O ATOM 4612 OXT SER B 1100 10.071 55.437 29.060 1.00 52.10 B O TER 1 SER B 1100 B HETATM 4625 P1 AMP Y 1 26.248 46.926 4.305 1.00 28.91 Y P HETATM 4626 O1 AMP Y 1 24.959 46.349 4.017 1.00 29.03 Y O HETATM 4627 O2 AMP Y 1 26.471 48.087 3.460 1.00 23.13 Y O HETATM 4628 O3 AMP Y 1 27.346 45.981 4.135 1.00 27.39 Y O HETATM 4629 P2 AMP Y 1 25.260 48.053 6.796 1.00 28.00 Y P HETATM 4630 O4 AMP Y 1 24.100 47.197 6.818 1.00 27.56 Y O HETATM 4631 O5 AMP Y 1 25.860 48.106 8.087 1.00 27.82 Y O HETATM 4632 N2 AMP Y 1 26.211 47.226 5.864 1.00 28.12 Y N HETATM 4633 P3 AMP Y 1 23.678 50.169 5.602 1.00 24.33 Y P HETATM 4634 O6 AMP Y 1 24.107 51.460 4.951 1.00 28.59 Y O HETATM 4635 O7 AMP Y 1 23.048 49.307 4.652 1.00 25.29 Y O HETATM 4636 O8 AMP Y 1 25.027 49.513 6.240 1.00 26.20 Y O HETATM 4637 O9 AMP Y 1 22.642 50.469 6.693 1.00 23.79 Y O HETATM 4638 C1 AMP Y 1 22.965 51.477 7.584 1.00 22.50 Y C HETATM 4639 C3 AMP Y 1 22.381 51.189 8.968 1.00 23.70 Y C HETATM 4640 O10 AMP Y 1 20.972 51.326 8.978 1.00 22.51 Y O HETATM 4641 C7 AMP Y 1 22.646 49.806 9.574 1.00 23.88 Y C HETATM 4642 O11 AMP Y 1 22.712 49.938 10.970 1.00 27.97 Y O HETATM 4643 C9 AMP Y 1 21.390 49.035 9.243 1.00 23.07 Y C HETATM 4644 O12 AMP Y 1 21.146 48.025 10.175 1.00 20.17 Y O HETATM 4645 C10 AMP Y 1 20.313 50.104 9.309 1.00 22.71 Y C HETATM 4646 N4 AMP Y 1 19.162 49.846 8.397 1.00 23.97 Y N HETATM 4647 C8 AMP Y 1 19.211 49.660 7.018 1.00 23.33 Y C HETATM 4648 N5 AMP Y 1 17.986 49.386 6.524 1.00 23.11 Y N HETATM 4649 C5 AMP Y 1 17.127 49.389 7.573 1.00 23.16 Y C HETATM 4650 C6 AMP Y 1 15.741 49.186 7.842 1.00 23.60 Y C HETATM 4651 N6 AMP Y 1 14.807 48.895 6.873 1.00 22.95 Y N HETATM 4652 N1 AMP Y 1 15.244 49.269 9.124 1.00 26.75 Y N HETATM 4653 C2 AMP Y 1 15.984 49.546 10.260 1.00 22.61 Y C HETATM 4654 N3 AMP Y 1 17.313 49.758 10.097 1.00 23.12 Y N HETATM 4655 C4 AMP Y 1 17.889 49.687 8.808 1.00 23.32 Y C HETATM 4656 MG MG Y 2 22.965 47.144 4.708 1.00 27.65 Y MG HETATM 4657 P1 AMP Z 1 −6.811 27.348 31.249 1.00 29.75 Z P HETATM 4658 O1 AMP Z 1 −6.300 27.933 30.032 1.00 25.93 Z O HETATM 4659 O2 AMP Z 1 −7.551 26.124 30.969 1.00 24.41 Z O HETATM 4660 O3 AMP Z 1 −7.613 28.224 32.090 1.00 26.59 Z O HETATM 4661 P2 AMP Z 1 −4.222 26.039 31.829 1.00 26.40 Z P HETATM 4662 O4 AMP Z 1 −3.371 26.742 30.880 1.00 26.33 Z O HETATM 4663 O5 AMP Z 1 −3.594 25.914 33.084 1.00 27.90 Z O HETATM 4664 N2 AMP Z 1 −5.480 27.010 32.143 1.00 28.13 Z N HETATM 4665 P3 AMP Z 1 −4.457 23.966 29.840 1.00 26.27 Z P HETATM 4666 O6 AMP Z 1 −5.338 22.775 29.725 1.00 28.28 Z O HETATM 4667 O7 AMP Z 1 −4.637 24.880 28.724 1.00 27.16 Z O HETATM 4668 O8 AMP Z 1 −4.755 24.626 31.283 1.00 25.90 Z O HETATM 4669 O9 AMP Z 1 −2.951 23.529 29.790 1.00 25.56 Z O HETATM 4670 C1 AMP Z 1 −2.309 22.819 30.848 1.00 22.33 Z C HETATM 4671 C3 AMP Z 1 −0.795 23.071 30.857 1.00 23.34 Z C HETATM 4672 O10 AMP Z 1 −0.234 22.965 29.547 1.00 22.37 Z O HETATM 4673 C7 AMP Z 1 −0.408 24.496 31.335 1.00 23.19 Z C HETATM 4674 O11 AMP Z 1 0.745 24.342 32.105 1.00 25.77 Z O HETATM 4675 C9 AMP Z 1 −0.090 25.231 30.042 1.00 22.68 Z C HETATM 4676 O12 AMP Z 1 0.844 26.255 30.179 1.00 22.55 Z O HETATM 4677 C10 AMP Z 1 0.452 24.151 29.138 1.00 22.80 Z C HETATM 4678 N4 AMP Z 1 0.396 24.436 27.666 1.00 24.01 Z N HETATM 4679 C8 AMP Z 1 −0.742 24.730 26.933 1.00 24.62 Z C HETATM 4680 N5 AMP Z 1 −0.447 24.966 25.604 1.00 25.25 Z N HETATM 4681 C5 AMP Z 1 0.891 24.823 25.461 1.00 24.14 Z C HETATM 4682 C6 AMP Z 1 1.915 24.885 24.448 1.00 24.17 Z C HETATM 4683 N6 AMP Z 1 1.681 25.214 23.143 1.00 20.34 Z N HETATM 4684 N1 AMP Z 1 3.266 24.622 24.771 1.00 25.74 Z N HETATM 4685 C2 AMP Z 1 3.694 24.311 26.030 1.00 22.91 Z C HETATM 4686 N3 AMP Z 1 2.771 24.244 27.043 1.00 21.55 Z N HETATM 4687 C4 AMP Z 1 1.437 24.478 26.810 1.00 22.73 Z C HETATM 4688 MG MG Z 2 −4.549 27.191 28.573 1.00 31.30 Z MG HETATM 4689 O HOH W 1 −2.475 30.329 15.504 1.00 11.40 W O HETATM 4690 O HOH W 2 12.414 45.490 15.244 1.00 13.21 W O HETATM 4691 O HOH W 3 29.299 47.960 7.015 1.00 20.72 W O HETATM 4692 O HOH W 4 −8.081 23.906 29.636 1.00 24.82 W O HETATM 4693 O HOH W 5 19.546 44.643 17.339 1.00 5.81 W O HETATM 4694 O HOH W 6 −5.932 29.329 7.200 1.00 26.30 W O HETATM 4695 O HOH W 7 13.335 45.024 29.684 1.00 26.89 W O HETATM 4696 O HOH W 8 −2.722 34.331 39.767 1.00 28.35 W O HETATM 4697 O HOH W 9 35.150 40.728 −7.044 1.00 32.32 W O HETATM 4698 O HOH W 10 −21.199 33.084 32.518 1.00 29.13 W O HETATM 4699 O HOH W 11 1.946 41.700 15.699 1.00 17.00 W O HETATM 4700 O HOH W 12 −4.135 15.706 24.394 1.00 26.37 W O HETATM 4701 O HOH W 13 18.978 58.280 2.913 1.00 29.75 W O HETATM 4702 O HOH W 14 24.050 58.118 8.115 1.00 33.81 W O HETATM 4703 O HOH W 15 8.875 64.811 12.194 1.00 32.66 W O HETATM 4704 O HOH W 16 48.673 31.147 15.865 1.00 19.28 W O HETATM 4705 O HOH W 17 51.031 42.556 6.078 1.00 39.02 W O HETATM 4706 O HOH W 18 25.398 50.597 2.357 1.00 20.20 W O HETATM 4707 O HOH W 19 40.324 26.361 16.008 1.00 27.85 W O HETATM 4708 O HOH W 20 33.653 51.255 1.318 1.00 24.99 W O HETATM 4709 O HOH W 21 28.596 48.674 9.568 1.00 27.69 W O HETATM 4710 O HOH W 22 3.864 6.537 26.814 1.00 30.27 W O HETATM 4711 O HOH W 23 34.593 52.731 −2.102 1.00 21.01 W O HETATM 4712 O HOH W 24 3.459 12.452 32.479 1.00 16.68 W O HETATM 4713 O HOH W 25 21.173 61.854 13.602 1.00 18.35 W O HETATM 4714 O HOH W 26 −9.899 40.661 21.126 1.00 14.79 W O HETATM 4715 O HOH W 27 −6.606 26.300 34.986 1.00 26.71 W O HETATM 4716 O HOH W 28 31.882 37.812 13.934 1.00 24.97 W O HETATM 4717 O HOH W 29 5.767 35.379 −5.080 1.00 26.68 W O HETATM 4718 O HOH W 30 −0.387 12.747 10.060 1.00 30.83 W O HETATM 4719 O HOH W 31 −2.871 16.142 31.823 1.00 27.26 W O HETATM 4720 O HOH W 32 −11.338 17.892 21.567 1.00 24.99 W O HETATM 4721 O HOH W 33 27.741 41.030 9.385 1.00 35.57 W O HETATM 4722 O HOH W 34 4.219 40.947 15.023 1.00 26.11 W O HETATM 4723 O HOH W 35 13.358 40.025 45.175 1.00 33.41 W O HETATM 4724 O HOH W 36 10.178 43.642 −0.473 1.00 21.44 W O HETATM 4725 O HOH W 37 −5.670 25.835 23.800 1.00 26.16 W O HETATM 4726 O HOH W 38 22.553 65.325 10.636 1.00 35.15 W O HETATM 4727 O HOH W 39 −19.914 17.680 11.168 1.00 22.16 W O HETATM 4728 O HOH W 40 14.142 46.495 2.450 1.00 24.14 W O HETATM 4729 O HOH W 41 30.519 39.861 12.539 1.00 36.50 W O HETATM 4730 O HOH W 42 19.597 33.906 −3.688 1.00 17.47 W O HETATM 4731 O HOH W 43 16.289 45.356 3.477 1.00 17.51 W O HETATM 4732 O HOH W 44 21.782 43.355 −2.963 1.00 20.88 W O HETATM 4733 O HOH W 45 −8.473 49.357 41.780 1.00 25.18 W O HETATM 4734 O HOH W 46 −14.467 25.593 49.502 1.00 36.38 W O HETATM 4735 O HOH W 47 2.639 57.400 5.791 1.00 28.77 W O HETATM 4736 O HOH W 48 9.875 15.041 10.250 1.00 39.43 W O HETATM 4737 O HOH W 49 12.865 4.298 11.454 1.00 42.78 W O HETATM 4738 O HOH W 50 −18.417 36.077 56.375 1.00 34.15 W O HETATM 4739 O HOH W 51 −1.916 27.652 19.935 1.00 22.92 W O HETATM 4740 O HOH W 52 7.220 17.804 12.275 1.00 44.35 W O HETATM 4741 O HOH W 53 48.699 45.704 12.632 1.00 30.47 W O HETATM 4742 O HOH W 54 −2.981 8.858 20.070 1.00 23.68 W O HETATM 4743 O HOH W 55 −4.013 26.398 36.017 1.00 22.25 W O HETATM 4744 O HOH W 56 40.677 24.839 −3.765 1.00 25.15 W O HETATM 4745 O HOH W 57 −20.509 33.232 20.262 1.00 42.21 W O HETATM 4746 O HOH W 58 18.916 63.958 14.464 1.00 33.09 W O HETATM 4747 O HOH W 59 6.936 41.796 15.875 1.00 31.02 W O HETATM 4748 O HOH W 60 12.623 66.714 5.890 1.00 23.87 W O HETATM 4749 O HOH W 61 11.893 47.134 39.605 1.00 23.05 W O HETATM 4750 O HOH W 62 7.474 40.610 3.914 1.00 31.03 W O HETATM 4751 O HOH W 63 22.606 52.920 −12.732 1.00 42.64 W O HETATM 4752 O HOH W 64 2.426 54.692 4.984 1.00 26.28 W O HETATM 4753 O HOH W 65 48.775 30.973 5.752 1.00 25.77 W O HETATM 4754 O HOH W 66 −11.173 53.513 23.526 1.00 41.70 W O HETATM 4755 O HOH W 67 23.529 26.529 24.314 1.00 38.02 W O HETATM 4756 O HOH W 68 9.992 28.475 25.594 1.00 34.12 W O HETATM 4757 O HOH W 69 3.366 44.401 −5.013 1.00 50.58 W O HETATM 4758 O HOH W 70 34.274 34.206 2.671 1.00 24.77 W O HETATM 4759 O HOH W 71 20.152 56.215 −4.144 1.00 22.22 W O HETATM 4760 O HOH W 72 −8.710 24.835 37.208 1.00 27.50 W O HETATM 4761 O HOH W 73 32.146 41.427 14.964 1.00 28.71 W O HETATM 4762 O HOH W 74 −19.018 31.978 53.014 1.00 38.25 W O HETATM 4763 O HOH W 75 0.080 8.693 33.017 1.00 42.67 W O HETATM 4764 O HOH W 76 −7.947 47.660 19.560 1.00 23.76 W O HETATM 4765 O HOH W 77 36.529 54.767 10.120 1.00 28.79 W O HETATM 4766 O HOH W 78 −12.852 35.028 17.783 1.00 25.41 W O HETATM 4767 O HOH W 79 −0.559 47.749 21.052 1.00 24.10 W O HETATM 4768 O HOH W 80 −17.156 21.792 34.959 1.00 42.68 W O HETATM 4769 O HOH W 81 −13.699 23.195 35.641 1.00 33.42 W O HETATM 4770 O HOH W 82 −9.587 42.543 56.480 1.00 34.56 W O HETATM 4771 O HOH W 83 43.873 33.067 −8.277 1.00 39.60 W O HETATM 4772 O HOH W 84 5.761 57.407 37.269 1.00 45.64 W O HETATM 4773 O HOH W 85 16.884 21.454 20.877 1.00 52.96 W O HETATM 4774 O HOH W 86 47.763 34.049 1.316 1.00 36.54 W O HETATM 4775 O HOH W 87 −6.209 31.119 46.066 1.00 44.92 W O HETATM 4776 O HOH W 88 40.750 51.712 5.730 1.00 33.72 W O HETATM 4777 O HOH W 89 −21.569 39.844 47.646 1.00 29.53 W O HETATM 4778 O HOH W 90 26.302 31.299 25.877 1.00 24.97 W O HETATM 4779 O HOH W 91 −7.619 56.473 35.928 1.00 33.44 W O HETATM 4780 O HOH W 92 19.370 29.016 −3.829 1.00 36.95 W O HETATM 4781 O HOH W 93 22.912 21.947 20.348 1.00 34.74 W O HETATM 4782 O HOH W 94 6.640 33.210 4.482 1.00 25.32 W O HETATM 4783 O HOH W 95 19.761 65.159 5.818 1.00 28.63 W O HETATM 4784 O HOH W 96 −2.429 28.740 22.618 1.00 17.06 W O HETATM 4785 O HOH W 97 −3.064 31.778 42.427 1.00 42.96 W O HETATM 4786 O HOH W 98 −5.388 7.268 11.141 1.00 30.44 W O HETATM 4787 O HOH W 99 −22.456 19.371 11.638 1.00 31.53 W O HETATM 4788 O HOH W 100 4.576 39.683 11.824 1.00 34.42 W O HETATM 4789 O HOH W 101 −11.699 42.668 37.871 1.00 20.12 W O HETATM 4790 O HOH W 102 −20.248 30.467 21.517 1.00 43.20 W O HETATM 4791 O HOH W 103 −2.130 27.300 28.199 1.00 34.69 W O HETATM 4792 O HOH W 104 −28.854 35.295 32.405 1.00 26.50 W O HETATM 4793 O HOH W 105 47.956 33.744 15.640 1.00 34.20 W O HETATM 4794 O HOH W 106 9.854 66.277 −3.306 1.00 36.84 W O HETATM 4795 O HOH W 107 24.030 38.651 −11.161 1.00 50.50 W O HETATM 4796 O HOH W 108 48.420 31.498 3.256 1.00 39.12 W O HETATM 4797 O HOH W 109 −1.253 45.553 15.262 1.00 38.50 W O HETATM 4798 O HOH W 110 33.843 42.792 13.225 1.00 30.63 W O HETATM 4799 O HOH W 111 28.703 42.535 −2.829 1.00 30.19 W O HETATM 4800 O HOH W 112 8.622 12.687 11.102 1.00 29.60 W O HETATM 4801 O HOH W 113 20.128 67.529 1.352 1.00 33.55 W O HETATM 4802 O HOH W 114 −0.770 14.323 8.166 1.00 52.45 W O HETATM 4803 O HOH W 115 −3.656 9.896 7.101 1.00 32.62 W O HETATM 4804 O HOH W 116 −13.602 22.480 44.154 1.00 35.16 W O HETATM 4805 O HOH W 117 22.128 20.904 −3.627 1.00 30.87 W O HETATM 4806 O HOH W 118 −5.070 15.045 27.353 1.00 23.93 W O HETATM 4807 O HOH W 119 36.061 37.125 23.788 1.00 24.47 W O HETATM 4808 O HOH W 120 −25.322 30.252 30.726 1.00 41.44 W O HETATM 4809 O HOH W 121 35.690 29.845 5.576 1.00 16.76 W O HETATM 4810 O HOH W 122 −24.680 19.112 17.711 1.00 37.84 W O HETATM 4811 O HOH W 123 13.080 52.502 31.871 1.00 41.89 W O HETATM 4812 O HOH W 124 2.957 25.901 31.930 1.00 19.65 W O HETATM 4813 O HOH W 125 39.312 38.534 −13.393 1.00 31.38 W O HETATM 4814 O HOH W 126 38.067 33.591 −15.755 1.00 35.74 W O HETATM 4815 O HOH W 127 29.602 55.694 2.224 1.00 36.44 W O HETATM 4816 O HOH W 128 34.510 31.619 3.906 1.00 29.94 W O HETATM 4817 O HOH W 129 9.989 23.860 20.084 1.00 32.28 W O HETATM 4818 O HOH W 130 −17.671 35.139 20.740 1.00 51.29 W O HETATM 4819 O HOH W 131 36.267 31.168 −11.638 1.00 51.65 W O HETATM 4820 O HOH W 132 −14.553 50.627 22.253 1.00 36.45 W O HETATM 4821 O HOH W 133 −16.661 11.632 17.334 1.00 19.62 W O HETATM 4822 O HOH W 134 23.273 35.371 −10.468 1.00 27.93 W O HETATM 4823 O HOH W 135 −23.607 44.003 35.480 1.00 29.99 W O HETATM 4824 O HOH W 136 −11.964 57.410 34.233 1.00 59.88 W O HETATM 4825 O HOH W 137 −19.087 51.552 39.458 1.00 34.48 W O HETATM 4826 O HOH W 138 6.012 22.773 15.789 1.00 32.08 W O HETATM 4827 O HOH W 139 19.642 44.693 −8.548 1.00 30.54 W O HETATM 4828 O HOH W 140 3.705 36.386 50.313 1.00 38.47 W O HETATM 4829 O HOH W 141 1.298 37.283 7.120 1.00 51.13 W O HETATM 4830 O HOH W 142 −23.191 29.343 32.125 1.00 50.13 W O HETATM 4831 O HOH W 143 46.067 49.093 7.670 1.00 42.60 W O HETATM 4832 O HOH W 144 31.146 48.281 12.422 1.00 40.48 W O HETATM 4833 O HOH W 145 31.480 33.377 27.417 1.00 40.50 W O HETATM 4834 O HOH W 146 −0.521 7.311 18.965 1.00 40.93 W O HETATM 4835 O HOH W 147 4.938 47.003 20.293 1.00 35.68 W O HETATM 4836 O HOH W 148 2.572 56.018 12.990 1.00 38.20 W O HETATM 4837 O HOH W 149 4.166 41.330 46.439 1.00 51.22 W O HETATM 4838 O HOH W 150 −27.096 42.038 36.548 1.00 54.71 W O HETATM 4839 O HOH W 151 −9.606 44.717 20.161 1.00 26.34 W O HETATM 4840 O HOH W 152 −12.543 24.530 50.664 1.00 31.97 W O HETATM 4841 O HOH W 153 23.986 57.755 13.449 1.00 41.58 W O HETATM 4842 O HOH W 154 4.142 48.610 −7.954 1.00 41.73 W O HETATM 4843 O HOH W 155 −8.571 34.493 10.496 1.00 35.68 W O HETATM 4844 O HOH W 156 6.535 43.683 −0.301 1.00 28.35 W O HETATM 4845 O HOH W 157 5.098 9.837 31.389 1.00 32.69 W O HETATM 4846 O HOH W 158 4.605 38.451 46.567 1.00 44.80 W O HETATM 4847 O HOH W 159 −12.373 9.262 29.626 1.00 43.00 W O HETATM 4848 O HOH W 160 21.944 64.392 14.788 1.00 43.27 W O HETATM 4849 O HOH W 161 8.410 42.221 0.553 1.00 38.42 W O HETATM 4850 O HOH W 162 −15.092 24.451 51.951 1.00 33.87 W O HETATM 4851 O HOH W 163 −28.497 40.660 38.549 1.00 42.45 W O HETATM 4852 O HOH W 164 4.677 56.197 15.176 1.00 39.88 W O HETATM 4853 O HOH W 165 9.008 31.037 17.696 1.00 37.12 W O HETATM 4854 O HOH W 166 −13.943 48.188 19.442 1.00 51.59 W O HETATM 4855 O HOH W 167 −16.372 52.024 18.619 1.00 30.94 W O HETATM 4856 O HOH W 168 36.587 31.130 −14.714 1.00 37.59 W O HETATM 4857 O HOH W 169 40.198 33.790 −13.561 1.00 51.85 W O HETATM 4858 O HOH W 170 11.326 50.791 32.880 1.00 41.20 W O HETATM 4859 O HOH W 171 24.824 41.289 −12.891 1.00 48.97 W O HETATM 4860 O HOH W 172 −19.243 31.094 23.985 1.00 65.07 W O HETATM 4861 O HOH W 173 22.235 20.511 18.399 1.00 35.72 W O HETATM 4862 O HOH W 174 25.487 19.422 20.119 1.00 42.44 W O HETATM 4863 O HOH W 175 −0.531 31.883 14.385 1.00 36.04 W O HETATM 4864 O HOH W 176 21.134 46.888 6.137 1.00 20.06 W O END 

We claim:
 1. A method for identifying a candidate inhibitor using three-dimensional structure coordinates generated from a human Janus Kinase 3 crystal comprising a human Janus Kinase 3 protein, wherein said human Janus Kinase 3 protein consists of amino acid residues 810-1115 of SEQ ID NO: 1, wherein said human Janus Kinase 3 protein comprises a kinase domain, wherein said human Janus Kinase 3 kinase domain is in complex with a chemical entity selected from the group consisting of adenosine, ATP, an ATP analogue, AMP-PNP, a nucleotide triphosphate, a nucleotide diphosphate, and phosphate, and wherein said method comprises: (a) generating a three-dimensional structure on a computer of a molecular complex comprising a binding site of amino acid residues Gln827, Leu828, Gly829, Lys830, Gly831, Asn832, Phe833, Gly834, Ser835, Val836 Glu837, Leu838, Val852, Ala853, Val854, Lys855, Gln856, Leu857, Val884, Lys885, Tyr886, Leu900, Val901, Met902, Glu903, Tyr904, Leu905, Pro906, Ser907 Gly908, Cys909, Leu910, Arg911, Asp912, His947, Asp949, Leu950, Ala951, Ala952, Arg953, Asn954, Ile955, Leu956, Val957, Ala966, Asp967, Leu970, Glu985, Gln988, Ser989, Pro990 and Trp993 according to Table 2, wherein the root mean square deviation of the backbone atoms is not greater than about 2.5 Å; (b) employing said three-dimensional structure to design or select said candidate inhibitor; and (c) contacting said candidate inhibitor with human Janus Kinase 3 to determine the ability of said candidate inhibitor to bind to human Janus Kinase
 3. 2. The method according to claim 1, wherein said chemical entity is AMP-PNP.
 3. A method for identifying a candidate inhibitor using a human Janus Kinase 3 crystal comprising a human Janus Kinase 3 protein, wherein said human Janus Kinase 3 protein consists of amino acid residues 810-1115 of SEQ ID NO: 1, wherein said human Janus Kinase 3 protein comprises a kinase domain, wherein said human Janus Kinase 3 kinase domain is in complex with a chemical entity selected from the group consisting of adenosine, ATP, an ATP analogue, AMP-PNP, a nucleotide triphosphate, a nucleotide diphosphate, and phosphate, and wherein said crystal is characterized by either: (i) space group P2₁ and has unit cell parameters of a=59.98±4 Å, b=90.19±4 Å, c=69.00±4 Å, α=90°, β=111.5°, γ=90°, or (ii) space group P2₁2₁2₁ and has unit cell parameters of a=72.36±4 Å, b=90.04±4 Å, c=105.60±4 Å, α=β=γ=90°, wherein said method comprises: (a) soaking said human Janus Kinase 3 crystal in the presence of said candidate inhibitor thereby displacing said chemical entity and generating a human Janus Kinase 3 crystal comprising a human Janus Kinase 3 kinase domain in complex with said candidate inhibitor; (b) determining the three-dimensional structure coordinates of human Janus Kinase 3 using the crystal in step (a); (c) using the structure coordinates from step (b) to generate a three-dimensional structure of a molecular complex comprising a binding site of amino acid residues Gln827, Leu828, Gly829, Lys830, Gly831, Asn832, Phe833, Gly834, Ser835, Val836, Glu837, Leu838, Val852, Ala853, Val854, Lys855, Gln856, Leu857, Val884, Lys885, Tyr886, Leu900, Val901, Met902, Glu903, Tyr904, Leu905, Pro906, Ser907, Gly908, Cys909, Leu910, Arg911, Asp912, His947, Asp949, Leu950, Ala951, Ala952, Arg953, Asn954, Ile955, Leu956, Val957, Ala966, Asp967, Leu970, Glu985, Gln988, Ser989, Pro990 and Trp993 according to Table 2, wherein the root mean square deviation of the backbone atoms is not greater than about 2.5 Å; and (d) contacting said candidate inhibitor with human Janus Kinase 3 to determine the ability of said candidate inhibitor to bind to human Janus Kinase
 3. 4. The method according to claim 3, wherein said chemical entity is AMP-PNP. 